data_1t23_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1t23 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.59 ' HG3' ' O ' ' A' ' 21' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.505 2.301 0 CA-C-O 121.259 0.552 . . . . 0.0 111.379 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.61 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 19.4 t-20 -84.99 148.03 26.4 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.593 -0.692 . . . . 0.0 110.284 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -144.03 156.25 44.31 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 17' ' ' GLY . 32.9 m -129.62 132.21 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 120.867 -1.146 . . . . 0.0 111.9 -178.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.605 HD11 ' HB3' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -162.7 164.91 26.22 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.602 -0.686 . . . . 0.0 110.86 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.532 ' O ' ' N ' ' A' ' 14' ' ' ASN . 15.0 mtt85 -130.96 114.51 15.32 Favored 'General case' 0 N--CA 1.514 2.728 0 O-C-N 121.041 -1.037 . . . . 0.0 113.27 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.753 ' HB2' ' CB ' ' A' ' 16' ' ' HIS . 0.8 OUTLIER -75.07 -155.14 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 124.581 1.153 . . . . 0.0 111.216 179.471 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.648 ' HA ' ' HB3' ' A' ' 41' ' ' ASN . 3.4 mp0 69.03 52.3 0.51 Allowed 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 -177.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.635 ' HA ' ' O ' ' A' ' 42' ' ' PRO . 33.5 m-20 58.07 8.8 0.82 Allowed 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 112.101 -2.318 . . . . 0.0 113.286 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.18 -75.65 1.3 Allowed Glycine 0 N--CA 1.487 2.092 0 C-N-CA 118.034 -2.032 . . . . 0.0 109.279 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.596 ' O ' ' HB3' ' A' ' 43' ' ' ASP . 1.0 OUTLIER -118.4 -78.06 0.58 Allowed 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.876 1.322 . . . . 0.0 108.991 178.853 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.605 ' HB3' HD11 ' A' ' 8' ' ' LEU . 2.2 mt-10 -179.23 133.82 0.12 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.753 ' CB ' ' HB2' ' A' ' 10' ' ' ASP . 0.2 OUTLIER -79.72 123.58 27.8 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 115.712 -2.395 . . . . 0.0 111.376 -178.532 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.682 ' HA2' ' CZ ' ' A' ' 19' ' ' PHE . . . -168.89 109.2 0.32 Allowed Glycine 0 C--N 1.285 -2.287 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.872 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.31 81.32 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 176.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.682 ' CZ ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -176.24 -173.32 0.54 Allowed 'General case' 0 N--CA 1.507 2.396 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.032 -178.487 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.61 ' HA ' ' HA ' ' A' ' 5' ' ' ASN . 37.5 p -106.97 137.0 45.87 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.508 -0.745 . . . . 0.0 111.967 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.59 ' O ' ' HG3' ' A' ' 4' ' ' ARG . . . -115.58 128.3 7.98 Favored Glycine 0 N--CA 1.499 2.854 0 N-CA-C 108.172 -1.971 . . . . 0.0 108.172 178.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.7 pttp -57.29 -40.0 76.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.936 -1.332 . . . . 0.0 110.266 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.56 ' HG2' ' HB3' ' A' ' 26' ' ' GLN . 2.4 tp-100 -121.49 136.36 25.86 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 120.975 -1.078 . . . . 0.0 109.311 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.512 ' HB3' ' HD3' ' A' ' 4' ' ' ARG . 38.5 Cg_endo -67.29 -52.84 0.55 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.365 1.192 . . . . 0.0 111.422 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.606 ' HB3' ' HA ' ' A' ' 70' ' ' ASN . 26.8 mtt180 -82.28 -57.55 3.33 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.498 -0.751 . . . . 0.0 111.036 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.56 ' HB3' ' HG2' ' A' ' 23' ' ' GLN . 9.0 tt0 -52.87 -43.21 65.95 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.209 -0.932 . . . . 0.0 111.393 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.455 ' CB ' ' O ' ' A' ' 23' ' ' GLN . . . -77.74 -13.59 59.85 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 120.908 -1.12 . . . . 0.0 109.719 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 24' ' ' PRO . . . -62.1 -51.51 67.63 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.189 -0.944 . . . . 0.0 109.866 178.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.714 ' HB2' ' HG2' ' A' ' 77' ' ' GLU . 3.0 pp -69.2 -42.9 75.16 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.317 -0.953 . . . . 0.0 109.657 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.433 ' H ' ' HG ' ' A' ' 29' ' ' LEU . 11.4 mmtt -61.78 -42.97 99.68 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.43 -0.794 . . . . 0.0 111.305 178.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.413 ' C ' ' HB2' ' A' ' 36' ' ' SER . . . -59.81 -48.43 81.73 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -177.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.642 ' HA ' ' CB ' ' A' ' 36' ' ' SER . . . -62.5 -33.24 74.49 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 118.707 -1.197 . . . . 0.0 109.958 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -44.96 -45.3 10.43 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.7 -70.84 0.72 Allowed 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.346 -0.942 . . . . 0.0 112.441 178.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.546 ' O ' ' CD2' ' A' ' 16' ' ' HIS . . . -114.67 2.07 23.25 Favored Glycine 0 N--CA 1.502 3.079 0 N-CA-C 117.529 1.771 . . . . 0.0 117.529 -175.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.642 ' CB ' ' HA ' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -88.3 -2.51 58.64 Favored 'General case' 0 N--CA 1.511 2.62 0 CA-C-N 123.401 3.6 . . . . 0.0 111.081 -177.238 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 60' ' ' ALA . . . -164.34 117.11 0.74 Allowed Glycine 0 N--CA 1.482 1.759 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -178.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.521 ' O ' ' HB3' ' A' ' 39' ' ' LYS . 50.9 m -76.74 -20.22 56.77 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 119.898 1.849 . . . . 0.0 110.234 -178.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.807 ' CA ' ' HG3' ' A' ' 42' ' ' PRO . 0.3 OUTLIER 76.59 -56.6 0.56 Allowed 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -178.514 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.89 -19.36 65.01 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 175.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.648 ' HB3' ' HA ' ' A' ' 11' ' ' GLU 0.282 0.3 OUTLIER -158.43 68.49 3.61 Favored Pre-proline 0 C--O 1.202 -1.412 0 O-C-N 121.738 -0.602 . . . . 0.0 110.408 179.144 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.807 ' HG3' ' CA ' ' A' ' 39' ' ' LYS 0.251 81.6 Cg_endo -119.1 -173.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.301 -1.955 0 C-N-CA 122.084 1.856 . . . . 0.0 110.442 178.866 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.596 ' HB3' ' O ' ' A' ' 14' ' ' ASN . 4.6 t70 -162.51 -173.44 3.56 Favored 'General case' 0 N--CA 1.507 2.388 0 O-C-N 120.367 -1.458 . . . . 0.0 111.817 176.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.703 ' CD1' ' HG2' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -127.65 123.8 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.546 HG23 HD12 ' A' ' 47' ' ' LEU . 7.7 tt -166.23 170.68 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 119.267 -0.973 . . . . 0.0 110.221 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.531 ' HG3' HG12 ' A' ' 57' ' ' VAL . 2.3 mtp180 -78.21 98.7 5.95 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.554 ' HB2' ' CD2' ' A' ' 56' ' ' HIS . 10.8 mp -70.14 97.04 1.14 Allowed 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.407 ' O ' HG23 ' A' ' 7' ' ' VAL . 6.7 ptt180 . . . . . 0 N--CA 1.489 1.525 0 O-C-N 121.125 -0.984 . . . . 0.0 111.87 -178.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.4 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 120.995 0.426 . . . . 0.0 110.048 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.44 ' O ' HG21 ' A' ' 89' ' ' ILE . 42.8 t -150.59 118.73 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.7 -0.625 . . . . 0.0 110.078 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.637 ' NE2' ' HB2' ' A' ' 58' ' ' PHE . 0.3 OUTLIER -131.04 117.58 19.35 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 178.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.665 ' CG1' ' HB3' ' A' ' 87' ' ' GLU . 7.9 t -105.99 115.86 48.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 C-N-CA 117.571 -1.652 . . . . 0.0 108.377 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.637 ' HB2' ' NE2' ' A' ' 56' ' ' HIS . 0.2 OUTLIER -162.22 -177.19 5.56 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 -178.876 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.703 ' HG2' ' CD1' ' A' ' 44' ' ' ILE . 30.0 mttt -129.98 132.75 46.4 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 177.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.497 ' O ' ' CD1' ' A' ' 61' ' ' TRP . . . -121.62 109.55 14.9 Favored 'General case' 0 N--CA 1.504 2.242 0 CA-C-N 120.429 1.468 . . . . 0.0 112.575 -177.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.773 ' HB2' ' HB2' ' A' ' 83' ' ' PHE . 10.6 m0 -131.24 -173.85 3.22 Favored 'General case' 0 N--CA 1.512 2.638 0 O-C-N 121.673 -0.642 . . . . 0.0 111.1 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.666 ' HB3' ' HG3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -114.52 91.85 3.76 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.157 -0.964 . . . . 0.0 109.876 178.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.893 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 3.4 tp10 -171.04 163.91 7.42 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.561 0.696 . . . . 0.0 110.373 178.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.689 ' HB ' ' HA ' ' A' ' 80' ' ' SER . 6.0 tt -70.2 93.94 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.52 3.038 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 -175.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.611 ' HB ' ' HD1' ' A' ' 83' ' ' PHE . 1.4 p -97.86 -161.08 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 O-C-N 120.096 -1.627 . . . . 0.0 109.067 176.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.672 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 1.0 OUTLIER -115.95 140.4 49.28 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.296 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.797 ' HA ' ' CB ' ' A' ' 77' ' ' GLU 0.254 . . -58.39 100.41 0.22 Allowed Pre-proline 0 N--CA 1.502 2.171 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.297 -178.111 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.641 ' HD3' ' O ' ' A' ' 66' ' ' ASP . 54.5 Cg_endo -76.38 83.82 1.96 Allowed 'Trans proline' 0 N--CA 1.492 1.391 0 O-C-N 124.166 1.614 . . . . 0.0 112.366 -177.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.6 mttt 41.3 38.94 0.87 Allowed 'General case' 0 N--CA 1.507 2.413 0 CA-C-O 121.3 0.571 . . . . 0.0 111.476 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.643 ' ND2' ' HB3' ' A' ' 29' ' ' LEU . 20.0 m-20 -77.81 -19.18 55.42 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.476 -0.765 . . . . 0.0 111.406 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.702 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER 41.77 50.77 5.05 Favored Pre-proline 0 N--CA 1.507 2.412 0 CA-C-O 121.028 0.442 . . . . 0.0 112.02 -178.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.736 ' HG2' ' HA ' ' A' ' 76' ' ' PRO . 55.5 Cg_endo -99.22 99.68 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.591 1.528 . . . . 0.0 108.76 179.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.89 -19.17 16.21 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.191 -0.943 . . . . 0.0 111.829 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.446 ' CD1' ' N ' ' A' ' 74' ' ' TRP . 41.0 m95 -79.41 -42.59 25.15 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 121.443 -0.786 . . . . 0.0 109.808 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 6.6 ttm -176.21 123.55 0.31 Allowed Pre-proline 0 N--CA 1.503 2.177 0 O-C-N 121.581 -0.699 . . . . 0.0 110.487 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.746 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 51.8 Cg_endo -83.18 176.84 7.06 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 O-C-N 124.091 1.574 . . . . 0.0 111.101 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.797 ' CB ' ' HA ' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -87.87 12.67 12.5 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 117.697 -1.601 . . . . 0.0 110.726 -179.645 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.672 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 4.6 tttm -82.63 79.88 8.91 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.597 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 0.3 OUTLIER 177.87 170.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 C-N-CA 118.388 -1.325 . . . . 0.0 111.903 -177.643 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.689 ' HA ' ' HB ' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -69.08 106.29 2.74 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 104.207 -2.516 . . . . 0.0 104.207 175.243 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.825 ' HB3' ' HD2' ' A' ' 82' ' ' PRO 0.26 0.7 OUTLIER -165.02 -155.54 0.01 OUTLIER Pre-proline 0 C--O 1.194 -1.867 0 C-N-CA 119.143 -1.023 . . . . 0.0 108.847 -173.402 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.825 ' HD2' ' HB3' ' A' ' 81' ' ' LYS . 51.2 Cg_endo -78.15 125.01 6.9 Favored 'Trans proline' 0 C--N 1.302 -1.876 0 N-CA-C 108.792 -1.272 . . . . 0.0 108.792 178.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.893 ' CZ ' ' HB3' ' A' ' 63' ' ' GLU . 2.0 m-30 -61.38 145.81 50.35 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.288 -1.508 . . . . 0.0 108.158 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.696 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 2.1 t -143.21 94.84 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.466 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.635 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 2.7 mmtm -88.18 117.08 26.83 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.622 ' HB3' ' CZ ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -72.97 162.36 29.58 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 124.344 2.021 . . . . 0.0 114.091 -175.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.665 ' HB3' ' CG1' ' A' ' 57' ' ' VAL . 5.0 mt-10 -165.53 155.66 13.05 Favored 'General case' 0 C--N 1.271 -2.846 0 CA-C-N 110.544 -3.025 . . . . 0.0 107.857 177.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.45 ' O ' HG21 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -47.01 132.45 11.88 Favored 'General case' 0 N--CA 1.507 2.423 0 CA-C-O 122.194 0.997 . . . . 0.0 113.031 -175.666 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.521 HG21 ' HA ' ' A' ' 56' ' ' HIS . 5.2 mt . . . . . 0 N--CA 1.492 1.665 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.335 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.475 ' HD3' ' N ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.893 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.512 ' HA ' ' CG2' ' A' ' 20' ' ' THR . 0.1 OUTLIER -78.17 121.53 24.46 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.695 -0.628 . . . . 0.0 110.849 -179.3 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.486 ' HB3' ' CD2' ' A' ' 47' ' ' LEU . 39.5 m-85 -109.6 167.45 10.13 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.426 -0.796 . . . . 0.0 110.549 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.478 HG21 ' HG2' ' A' ' 48' ' ' ARG . 29.8 m -139.72 129.83 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 O-C-N 121.527 -0.733 . . . . 0.0 111.695 -178.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.646 ' HB3' ' HG ' ' A' ' 47' ' ' LEU . 0.3 OUTLIER -164.98 159.49 18.08 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.118 -0.989 . . . . 0.0 111.746 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.512 ' O ' ' N ' ' A' ' 14' ' ' ASN . 2.5 ttm-85 -140.12 114.91 9.52 Favored 'General case' 0 N--CA 1.511 2.577 0 O-C-N 121.083 -1.011 . . . . 0.0 112.755 178.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.779 ' HB2' ' CB ' ' A' ' 16' ' ' HIS . 0.7 OUTLIER -73.49 -153.19 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 125.154 1.381 . . . . 0.0 111.444 179.647 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.587 ' HA ' ' HB3' ' A' ' 41' ' ' ASN . 0.6 OUTLIER 71.9 50.95 0.23 Allowed 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 -177.594 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.595 ' HA ' ' O ' ' A' ' 42' ' ' PRO . 86.5 m-20 59.14 6.6 0.72 Allowed 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 112.539 -2.118 . . . . 0.0 112.591 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.04 -77.33 1.34 Allowed Glycine 0 N--CA 1.485 1.903 0 C-N-CA 117.937 -2.078 . . . . 0.0 109.77 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.692 ' CA ' HG12 ' A' ' 45' ' ' ILE . 6.1 m-20 -117.49 -81.67 0.62 Allowed 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 122.183 0.992 . . . . 0.0 111.566 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.556 ' HB3' HD11 ' A' ' 8' ' ' LEU . 7.8 mt-10 -170.12 129.84 0.93 Allowed 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.779 ' CB ' ' HB2' ' A' ' 10' ' ' ASP . 0.2 OUTLIER -81.25 121.51 26.25 Favored 'General case' 0 N--CA 1.505 2.281 0 C-N-CA 115.273 -2.571 . . . . 0.0 112.17 -178.086 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.67 ' HA2' ' CZ ' ' A' ' 19' ' ' PHE . . . -176.89 122.84 0.86 Allowed Glycine 0 C--N 1.284 -2.322 0 CA-C-N 114.149 -1.387 . . . . 0.0 111.977 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.27 86.46 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 176.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.67 ' CZ ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -175.42 -172.11 0.54 Allowed 'General case' 0 N--CA 1.504 2.228 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.022 -178.08 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.512 ' CG2' ' HA ' ' A' ' 5' ' ' ASN . 42.8 p -108.56 153.74 22.94 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.121 -0.987 . . . . 0.0 111.885 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -135.89 131.55 5.78 Favored Glycine 0 N--CA 1.507 3.367 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.14 -50.88 69.89 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.149 -1.206 . . . . 0.0 109.225 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.487 ' HB2' ' HG2' ' A' ' 26' ' ' GLN . 37.2 mm-40 -126.71 124.71 24.22 Favored Pre-proline 0 N--CA 1.492 1.641 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.417 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 42.5 Cg_endo -67.9 -19.67 46.11 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 123.614 1.323 . . . . 0.0 112.085 -178.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.485 ' HD2' ' HA ' ' A' ' 70' ' ' ASN . 8.5 mtt180 -82.84 -68.03 0.74 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.298 -0.877 . . . . 0.0 110.739 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.614 ' HB2' ' HA ' ' A' ' 72' ' ' PRO . 13.6 pt20 -58.93 -37.57 77.01 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.982 -1.073 . . . . 0.0 112.148 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.0 -22.85 63.09 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 120.765 -1.21 . . . . 0.0 109.661 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 24' ' ' PRO . . . -58.77 -58.17 9.8 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.112 -0.992 . . . . 0.0 111.688 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.519 ' HB2' ' NZ ' ' A' ' 81' ' ' LYS . 2.6 pp -56.26 -50.27 71.81 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 119.041 -1.064 . . . . 0.0 110.709 -178.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.426 ' HD3' ' CD1' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -69.79 -37.68 76.42 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 120.582 -1.324 . . . . 0.0 112.892 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.01 -45.09 95.12 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.723 -1.235 . . . . 0.0 112.306 -177.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.622 ' HA ' ' CB ' ' A' ' 36' ' ' SER . . . -62.42 -34.52 76.93 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 118.694 -1.202 . . . . 0.0 109.535 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.606 ' CA ' ' HG3' ' A' ' 82' ' ' PRO . 0.2 OUTLIER -40.88 -48.1 3.06 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.185 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 -97.04 -72.31 0.65 Allowed 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.212 -0.995 . . . . 0.0 112.086 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.532 ' O ' ' CD2' ' A' ' 16' ' ' HIS . . . -114.52 -1.23 23.22 Favored Glycine 0 N--CA 1.501 2.991 0 N-CA-C 117.401 1.72 . . . . 0.0 117.401 -175.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.622 ' CB ' ' HA ' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -86.04 -1.71 57.62 Favored 'General case' 0 N--CA 1.514 2.75 0 CA-C-N 123.255 3.527 . . . . 0.0 110.941 -177.017 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -162.4 119.56 0.89 Allowed Glycine 0 C--N 1.299 -1.521 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.483 ' O ' ' HB3' ' A' ' 39' ' ' LYS . 12.9 m -81.08 -15.2 56.67 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 120.417 -1.637 . . . . 0.0 109.665 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.806 ' CA ' ' HG3' ' A' ' 42' ' ' PRO . 7.6 tttp 72.84 -59.16 0.58 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.45 -18.02 65.12 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.121 -1.436 . . . . 0.0 107.121 175.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.587 ' HB3' ' HA ' ' A' ' 11' ' ' GLU 0.285 0.3 OUTLIER -159.05 67.77 3.2 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.678 -0.639 . . . . 0.0 110.87 179.233 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.806 ' HG3' ' CA ' ' A' ' 39' ' ' LYS . 78.2 Cg_endo -119.13 -174.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.472 2.115 . . . . 0.0 110.927 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -166.47 -172.83 2.3 Favored 'General case' 0 N--CA 1.513 2.716 0 O-C-N 120.156 -1.59 . . . . 0.0 113.029 176.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.642 ' HB ' ' CG ' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -126.02 124.34 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.692 HG12 ' CA ' ' A' ' 14' ' ' ASN . 1.6 pp -157.32 -176.43 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.435 -0.791 . . . . 0.0 110.336 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.552 ' HB3' HG11 ' A' ' 55' ' ' VAL . 16.7 mtt85 -85.56 94.56 9.07 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.646 ' HG ' ' HB3' ' A' ' 8' ' ' LEU . 5.3 tt -73.55 94.41 2.14 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.478 ' HG2' HG21 ' A' ' 7' ' ' VAL . 4.2 ptp180 . . . . . 0 N--CA 1.496 1.839 0 C-N-CA 119.478 -0.889 . . . . 0.0 112.282 -177.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 48' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 121.647 0.737 . . . . 0.0 110.382 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.552 HG11 ' HB3' ' A' ' 46' ' ' ARG . 35.2 t -149.26 94.25 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.637 ' NE2' ' HB2' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -79.92 124.92 29.11 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 179.189 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.618 ' CB ' ' HB2' ' A' ' 87' ' ' GLU . 2.9 t -109.37 106.46 20.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 C-N-CA 117.362 -1.735 . . . . 0.0 107.152 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.745 ' HA ' ' O ' ' A' ' 85' ' ' LYS . 0.3 OUTLIER -150.03 167.74 25.87 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.699 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 8.3 mttm -121.17 118.96 31.0 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.458 ' O ' ' CD1' ' A' ' 61' ' ' TRP . . . -106.69 107.33 18.29 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 118.609 -1.236 . . . . 0.0 112.484 -176.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.763 ' HB2' ' HB2' ' A' ' 83' ' ' PHE . 18.5 m0 -128.49 -166.13 1.59 Allowed 'General case' 0 N--CA 1.512 2.635 0 O-C-N 121.842 -0.536 . . . . 0.0 111.021 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.728 ' HB2' ' HB2' ' A' ' 39' ' ' LYS . 0.3 OUTLIER -123.2 86.53 2.59 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 120.967 -1.083 . . . . 0.0 110.966 179.747 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.757 ' CB ' ' CZ ' ' A' ' 83' ' ' PHE . 19.7 mp0 -161.19 171.14 18.98 Favored 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.639 ' HB ' ' HA ' ' A' ' 80' ' ' SER . 2.8 tt -78.48 98.04 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.136 0 O-C-N 119.301 -2.124 . . . . 0.0 115.49 -177.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.635 HG23 ' HA ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -89.85 -168.41 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.309 -1.495 . . . . 0.0 110.342 177.739 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.632 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 10.9 t70 -119.66 133.85 55.47 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.779 ' HA ' ' CB ' ' A' ' 77' ' ' GLU . . . -66.01 101.33 0.27 Allowed Pre-proline 0 N--CA 1.504 2.273 0 CA-C-O 117.93 -1.033 . . . . 0.0 111.902 -178.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.656 ' CB ' ' HD2' ' A' ' 86' ' ' LYS . 52.5 Cg_endo -86.93 -166.66 0.31 Allowed 'Trans proline' 0 C--N 1.315 -1.221 0 O-C-N 123.875 1.461 . . . . 0.0 111.467 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.0 mmmt -69.44 62.02 0.15 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.447 -0.783 . . . . 0.0 110.295 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.497 ' O ' ' CG ' ' A' ' 71' ' ' ARG . 1.0 OUTLIER -101.65 -9.35 20.99 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.653 -0.654 . . . . 0.0 111.213 -179.842 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.74 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER 56.52 44.06 1.33 Allowed Pre-proline 0 N--CA 1.508 2.441 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -179.244 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.744 ' HG2' ' HA ' ' A' ' 76' ' ' PRO . 49.0 Cg_endo -94.06 98.99 0.13 Allowed 'Trans proline' 0 C--N 1.316 -1.183 0 C-N-CA 120.84 1.026 . . . . 0.0 110.015 178.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.9 -18.33 50.86 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.15 -0.968 . . . . 0.0 111.444 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.519 ' CD1' ' N ' ' A' ' 74' ' ' TRP . 6.9 m0 -80.29 -37.82 32.01 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.154 -0.966 . . . . 0.0 109.579 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.439 ' O ' ' HB2' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -167.64 122.57 0.82 Allowed Pre-proline 0 N--CA 1.496 1.83 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.612 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.744 ' HA ' ' HG2' ' A' ' 72' ' ' PRO . 49.5 Cg_endo -81.92 -179.8 5.06 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.589 1.31 . . . . 0.0 112.62 -178.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.779 ' CB ' ' HA ' ' A' ' 67' ' ' ALA . 1.3 mt-10 -92.2 11.0 27.12 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 118.315 -1.354 . . . . 0.0 110.684 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.61 ' HB2' ' HB1' ' A' ' 67' ' ' ALA . 0.6 OUTLIER -92.46 82.83 4.89 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.94 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.608 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -176.87 161.55 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 C-N-CA 118.146 -1.422 . . . . 0.0 112.392 -177.837 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.639 ' HA ' ' HB ' ' A' ' 64' ' ' ILE . 0.3 OUTLIER -75.07 104.94 5.85 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 175.501 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.727 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 11.5 pttp -169.81 -152.58 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.784 0 C-N-CA 118.843 -1.143 . . . . 0.0 108.393 -174.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.727 ' HD2' ' HB2' ' A' ' 81' ' ' LYS . 51.0 Cg_endo -74.83 127.33 10.72 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 N-CA-C 109.547 -0.982 . . . . 0.0 109.547 178.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.763 ' HB2' ' HB2' ' A' ' 61' ' ' TRP . 0.8 OUTLIER -65.16 160.19 21.84 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.987 -1.071 . . . . 0.0 109.737 179.502 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.699 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -154.64 92.7 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 177.25 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.745 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -77.51 122.35 25.11 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 178.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.656 ' HD2' ' CB ' ' A' ' 68' ' ' PRO . 0.0 OUTLIER -85.24 92.2 8.36 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 122.864 1.316 . . . . 0.0 113.29 -175.783 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.637 ' HG3' HD12 ' A' ' 44' ' ' ILE . 3.2 mm-40 -88.5 153.94 20.75 Favored 'General case' 0 C--N 1.28 -2.448 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.459 176.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -53.38 111.11 0.64 Allowed 'General case' 0 N--CA 1.51 2.557 0 CA-C-O 122.092 0.949 . . . . 0.0 113.087 -176.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.537 ' CG2' ' HA ' ' A' ' 56' ' ' HIS . 10.4 mt . . . . . 0 N--CA 1.5 2.029 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.085 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.477 ' O ' ' HA ' ' A' ' 20' ' ' THR . 3.0 mpt_? . . . . . 0 N--CA 1.5 2.057 0 CA-C-O 120.834 0.349 . . . . 0.0 110.068 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 6.7 t-20 -77.43 143.55 38.5 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.65 -0.657 . . . . 0.0 110.417 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -142.65 137.56 30.05 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.576 -0.702 . . . . 0.0 110.264 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.463 HG22 ' O ' ' A' ' 7' ' ' VAL . 17.0 m -119.39 132.78 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.516 -0.74 . . . . 0.0 111.599 -178.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.572 ' CD2' ' HG ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -163.39 161.45 24.42 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.107 -0.995 . . . . 0.0 111.291 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.472 ' O ' ' N ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -131.99 110.58 10.85 Favored 'General case' 0 N--CA 1.513 2.718 0 O-C-N 121.13 -0.981 . . . . 0.0 113.154 -179.375 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.798 ' HB2' ' CB ' ' A' ' 16' ' ' HIS . 0.9 OUTLIER -73.48 -156.16 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 C-N-CA 124.274 1.03 . . . . 0.0 111.101 179.337 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.695 ' HA ' ' HB3' ' A' ' 41' ' ' ASN . 3.0 mp0 70.92 51.66 0.3 Allowed 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 -177.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.607 ' HA ' ' O ' ' A' ' 42' ' ' PRO . 86.4 m-20 59.45 7.95 1.09 Allowed 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 112.306 -2.224 . . . . 0.0 113.027 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.28 -77.69 1.33 Allowed Glycine 0 N--CA 1.486 1.992 0 C-N-CA 117.954 -2.07 . . . . 0.0 109.061 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.626 ' O ' ' HB3' ' A' ' 43' ' ' ASP . 8.0 m-20 -117.11 -77.24 0.57 Allowed 'General case' 0 C--N 1.296 -1.753 0 CA-C-O 122.606 1.193 . . . . 0.0 109.909 178.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.54 ' HA ' ' OD1' ' A' ' 10' ' ' ASP . 1.3 mt-10 -178.05 138.08 0.19 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 178.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.798 ' CB ' ' HB2' ' A' ' 10' ' ' ASP . 0.2 OUTLIER -87.37 122.45 31.14 Favored 'General case' 0 N--CA 1.501 2.119 0 C-N-CA 115.672 -2.411 . . . . 0.0 112.22 -178.623 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.649 ' HA2' ' CE1' ' A' ' 19' ' ' PHE . . . -174.43 110.16 0.32 Allowed Glycine 0 C--N 1.283 -2.375 0 CA-C-N 113.804 -1.543 . . . . 0.0 110.834 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.449 ' C ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -130.96 81.87 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.2 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.649 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -175.17 -173.49 0.67 Allowed 'General case' 0 N--CA 1.502 2.161 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.077 -179.682 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 4' ' ' ARG . 57.3 p -103.23 144.8 30.86 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.418 -0.801 . . . . 0.0 111.809 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -124.29 133.58 8.76 Favored Glycine 0 N--CA 1.503 3.111 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.4 mttt -66.46 -58.64 4.83 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.241 -1.153 . . . . 0.0 108.752 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.497 ' HB3' ' HB3' ' A' ' 26' ' ' GLN . 0.9 OUTLIER -109.45 106.05 58.02 Favored Pre-proline 0 C--N 1.303 -1.424 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 177.9 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.557 ' HB2' HD13 ' A' ' 89' ' ' ILE . 36.9 Cg_endo -60.04 -26.46 82.49 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.945 1.498 . . . . 0.0 111.309 -178.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.586 ' HD3' ' HA ' ' A' ' 70' ' ' ASN . 3.6 mtt-85 -85.23 -58.39 2.7 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.268 -0.895 . . . . 0.0 109.239 178.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.76 ' HG3' ' HA ' ' A' ' 72' ' ' PRO . 1.0 OUTLIER -59.01 -43.53 91.54 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.921 -1.112 . . . . 0.0 110.807 179.552 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.41 -18.15 63.73 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 118.993 -1.083 . . . . 0.0 109.78 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.474 ' HB2' ' O ' ' A' ' 24' ' ' PRO . . . -59.76 -60.11 4.36 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.436 -0.79 . . . . 0.0 111.703 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.552 ' HB3' ' HG3' ' A' ' 77' ' ' GLU . 1.8 pp -63.89 -44.13 93.93 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 118.933 -1.107 . . . . 0.0 110.524 -179.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.6 mtmt -66.48 -43.7 84.67 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 120.781 -1.199 . . . . 0.0 112.476 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.23 -45.46 88.07 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.929 -1.107 . . . . 0.0 112.864 -177.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.663 ' HA ' ' CB ' ' A' ' 36' ' ' SER . . . -56.64 -37.52 70.87 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 118.781 -1.167 . . . . 0.0 109.493 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.488 ' CB ' ' HG3' ' A' ' 82' ' ' PRO . 4.4 t-20 -42.39 -47.05 4.87 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.98 -73.44 0.58 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 119.035 -1.066 . . . . 0.0 112.545 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.512 ' O ' ' CD2' ' A' ' 16' ' ' HIS . . . -116.76 1.63 19.92 Favored Glycine 0 N--CA 1.502 3.092 0 N-CA-C 117.213 1.645 . . . . 0.0 117.213 -175.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.663 ' CB ' ' HA ' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -85.17 -4.85 59.3 Favored 'General case' 0 N--CA 1.51 2.545 0 CA-C-N 122.929 3.364 . . . . 0.0 110.99 -176.917 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -165.37 120.89 0.96 Allowed Glycine 0 N--CA 1.478 1.494 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.56 ' O ' ' HB3' ' A' ' 39' ' ' LYS . 32.4 m -77.66 -14.81 59.52 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 120.359 -1.671 . . . . 0.0 110.195 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.803 ' CA ' ' HG3' ' A' ' 42' ' ' PRO . 1.2 tmtt? 72.01 -56.57 0.64 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -178.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.97 -18.73 63.36 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 176.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.695 ' HB3' ' HA ' ' A' ' 11' ' ' GLU 0.278 0.4 OUTLIER -156.75 67.73 4.34 Favored Pre-proline 0 C--O 1.199 -1.581 0 O-C-N 121.819 -0.55 . . . . 0.0 109.98 179.083 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.803 ' HG3' ' CA ' ' A' ' 39' ' ' LYS . 80.0 Cg_endo -119.61 -174.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 122.382 2.054 . . . . 0.0 111.075 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.626 ' HB3' ' O ' ' A' ' 14' ' ' ASN . 3.2 t70 -165.11 -168.71 1.47 Allowed 'General case' 0 N--CA 1.51 2.565 0 O-C-N 120.357 -1.464 . . . . 0.0 111.963 176.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.689 ' CD1' ' HG2' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -129.93 120.76 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.715 -0.616 . . . . 0.0 109.778 -179.043 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.529 ' CG2' ' HA ' ' A' ' 14' ' ' ASN . 1.3 pp -157.98 -177.96 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-O 121.829 0.823 . . . . 0.0 109.876 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.505 ' HG2' ' HB ' ' A' ' 57' ' ' VAL . 0.5 OUTLIER -91.19 100.26 13.12 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.102 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.572 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 9.4 mp -69.71 93.32 0.72 Allowed 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.555 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 8.2 ptp85 . . . . . 0 N--CA 1.49 1.547 0 C-N-CA 119.722 -0.791 . . . . 0.0 113.059 -175.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 48' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.404 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.538 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . 3.9 t -138.78 107.58 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 CA-C-O 121.245 0.545 . . . . 0.0 110.547 -178.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.593 ' NE2' ' HB2' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -101.04 127.4 47.58 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 178.54 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.729 ' CG1' ' HB3' ' A' ' 87' ' ' GLU . 2.2 p -117.6 123.84 72.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 C-N-CA 116.611 -2.036 . . . . 0.0 108.852 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.632 ' HA ' ' O ' ' A' ' 85' ' ' LYS . 0.3 OUTLIER -162.75 -176.35 4.92 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 -178.681 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.724 ' CG ' ' HB2' ' A' ' 85' ' ' LYS . 38.2 mttt -133.42 124.48 27.18 Favored 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.522 ' O ' ' CD1' ' A' ' 61' ' ' TRP . . . -110.75 109.29 19.46 Favored 'General case' 0 N--CA 1.505 2.287 0 C-N-CA 118.595 -1.242 . . . . 0.0 113.424 -176.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.796 ' HB2' ' HB2' ' A' ' 83' ' ' PHE . 11.2 m0 -132.38 -163.46 1.34 Allowed 'General case' 0 N--CA 1.515 2.822 0 O-C-N 121.86 -0.525 . . . . 0.0 110.589 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.691 ' CB ' ' HG3' ' A' ' 39' ' ' LYS . 0.5 OUTLIER -125.26 89.04 2.98 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 120.423 -1.423 . . . . 0.0 112.217 179.93 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.85 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 4.3 mt-10 -167.17 -179.44 4.57 Favored 'General case' 0 N--CA 1.514 2.752 0 CA-C-O 121.514 0.674 . . . . 0.0 111.064 177.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.574 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 2.1 mt -78.26 99.88 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.086 0 O-C-N 119.429 -2.045 . . . . 0.0 115.012 -176.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.679 ' CG2' ' HA ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -90.92 -168.91 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 120.586 -1.321 . . . . 0.0 110.317 177.51 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.632 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 12.1 t70 -124.72 129.86 51.3 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.798 ' HA ' ' CB ' ' A' ' 77' ' ' GLU 0.253 . . -66.18 98.6 0.16 Allowed Pre-proline 0 N--CA 1.511 2.623 0 CA-C-O 117.51 -1.233 . . . . 0.0 111.862 -177.542 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.632 ' HD3' ' O ' ' A' ' 66' ' ' ASP . 48.9 Cg_endo -92.95 85.68 0.19 Allowed 'Trans proline' 0 N--CA 1.483 0.893 0 O-C-N 123.818 1.43 . . . . 0.0 112.994 -178.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.5 mttm 38.99 54.03 2.07 Favored 'General case' 0 N--CA 1.511 2.597 0 CA-C-O 121.71 0.767 . . . . 0.0 111.538 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.586 ' HA ' ' HD3' ' A' ' 25' ' ' ARG . 0.9 OUTLIER -91.8 -9.7 42.56 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.289 -0.882 . . . . 0.0 112.216 -179.083 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.742 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER 62.67 35.46 0.21 Allowed Pre-proline 0 N--CA 1.508 2.432 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -179.649 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.794 ' HG2' ' HA ' ' A' ' 76' ' ' PRO . 56.8 Cg_endo -93.41 115.13 0.27 Allowed 'Trans proline' 0 C--N 1.315 -1.193 0 N-CA-C 109.822 -0.876 . . . . 0.0 109.822 178.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.0 -19.75 39.85 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.951 -1.093 . . . . 0.0 111.715 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.457 ' CD1' ' N ' ' A' ' 74' ' ' TRP . 37.8 m95 -82.28 -39.21 23.27 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.398 -0.814 . . . . 0.0 110.137 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.539 ' SD ' ' HE3' ' A' ' 81' ' ' LYS . 2.1 mtm -170.42 132.2 0.96 Allowed Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.708 -0.62 . . . . 0.0 109.556 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.794 ' HA ' ' HG2' ' A' ' 72' ' ' PRO . 46.4 Cg_endo -87.33 -178.16 2.34 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.682 1.359 . . . . 0.0 112.129 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.798 ' CB ' ' HA ' ' A' ' 67' ' ' ALA . 0.3 OUTLIER -88.94 11.39 18.27 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 118.092 -1.443 . . . . 0.0 110.321 -179.328 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.604 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -94.18 81.6 4.08 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.229 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.587 HG12 ' HE2' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -177.97 164.44 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 118.145 -1.422 . . . . 0.0 112.57 -177.462 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.567 ' HA ' ' HA ' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -73.84 104.32 4.68 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 104.556 -2.387 . . . . 0.0 104.556 175.218 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.776 ' HB3' ' HD2' ' A' ' 82' ' ' PRO 0.262 2.8 mttm -164.16 -162.41 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.682 0 C-N-CA 118.857 -1.137 . . . . 0.0 110.112 -174.267 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.776 ' HD2' ' HB3' ' A' ' 81' ' ' LYS . 43.4 Cg_endo -69.87 121.65 8.31 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 N-CA-C 107.529 -1.758 . . . . 0.0 107.529 176.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.85 ' CZ ' ' HB3' ' A' ' 63' ' ' GLU . 0.4 OUTLIER -57.37 151.51 16.12 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.878 -1.139 . . . . 0.0 109.892 -178.734 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.669 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -148.04 88.8 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.51 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.388 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.724 ' HB2' ' CG ' ' A' ' 59' ' ' LYS . 14.6 mmtp -79.93 118.16 21.43 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.557 ' HA ' ' CE1' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -72.67 156.55 38.84 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 124.256 1.979 . . . . 0.0 114.3 -175.419 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.729 ' HB3' ' CG1' ' A' ' 57' ' ' VAL . 0.5 OUTLIER -163.34 143.7 8.98 Favored 'General case' 0 C--N 1.271 -2.817 0 CA-C-N 111.096 -2.774 . . . . 0.0 108.828 177.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.528 ' O ' HG12 ' A' ' 57' ' ' VAL . 1.0 OUTLIER -55.0 117.49 3.49 Favored 'General case' 0 N--CA 1.506 2.351 0 CA-C-O 122.13 0.967 . . . . 0.0 113.38 -176.487 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.557 HD13 ' HB2' ' A' ' 24' ' ' PRO . 42.8 mt . . . . . 0 N--CA 1.494 1.747 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.34 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.494 ' O ' ' HA ' ' A' ' 20' ' ' THR . 22.3 mmt180 . . . . . 0 N--CA 1.499 2.001 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.465 ' HA ' ' CG2' ' A' ' 20' ' ' THR . 6.1 t-20 -72.55 135.86 45.7 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.512 -0.742 . . . . 0.0 109.582 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.688 ' CD1' HD23 ' A' ' 47' ' ' LEU . 4.3 m-85 -142.22 166.81 23.67 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.603 -0.839 . . . . 0.0 111.355 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.45 ' O ' HD22 ' A' ' 47' ' ' LEU . 10.8 m -136.62 131.77 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.808 -0.557 . . . . 0.0 111.143 -178.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.599 ' HB3' ' HG ' ' A' ' 47' ' ' LEU . 0.4 OUTLIER -159.07 161.97 36.53 Favored 'General case' 0 N--CA 1.512 2.641 0 O-C-N 120.922 -1.111 . . . . 0.0 111.877 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.475 ' O ' ' N ' ' A' ' 14' ' ' ASN . 10.7 tpt180 -148.81 112.51 5.08 Favored 'General case' 0 N--CA 1.512 2.647 0 O-C-N 121.012 -1.055 . . . . 0.0 112.832 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.869 ' HB3' ' CD2' ' A' ' 16' ' ' HIS . 5.8 t0 -98.61 -144.09 0.32 Allowed 'General case' 0 N--CA 1.508 2.428 0 O-C-N 121.273 -0.892 . . . . 0.0 109.405 177.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.75 ' HA ' ' HB3' ' A' ' 41' ' ' ASN . 2.4 mt-10 72.63 57.54 0.13 Allowed 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 102.576 -3.12 . . . . 0.0 102.576 -174.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.661 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 69.8 m-20 74.14 -5.15 2.12 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 112.272 -2.24 . . . . 0.0 111.844 -177.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.07 -83.53 1.42 Allowed Glycine 0 N--CA 1.482 1.764 0 C-N-CA 118.25 -1.928 . . . . 0.0 109.729 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.708 ' HB3' ' CD1' ' A' ' 45' ' ' ILE . 0.7 OUTLIER -129.19 -74.49 0.56 Allowed 'General case' 0 N--CA 1.51 2.529 0 O-C-N 121.634 -0.921 . . . . 0.0 112.744 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.747 ' CA ' ' HB2' ' A' ' 10' ' ' ASP . 35.2 tt0 -164.89 127.89 2.3 Favored 'General case' 0 N--CA 1.522 3.136 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.869 ' CD2' ' HB3' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -99.37 124.4 44.45 Favored 'General case' 0 N--CA 1.512 2.671 0 C-N-CA 116.208 -2.197 . . . . 0.0 115.415 -176.377 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.484 ' CA ' ' CE1' ' A' ' 19' ' ' PHE . . . -178.09 134.62 2.45 Favored Glycine 0 N--CA 1.48 1.586 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.212 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.423 ' C ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -132.88 91.07 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 120.87 -1.37 . . . . 0.0 108.112 177.254 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.671 ' N ' ' CD1' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -174.81 -170.65 0.49 Allowed 'General case' 0 N--CA 1.504 2.251 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.727 -178.667 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 4' ' ' ARG . 18.1 p -106.09 151.46 24.66 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.033 -1.042 . . . . 0.0 111.24 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -129.62 142.07 13.25 Favored Glycine 0 N--CA 1.504 3.195 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -71.49 -61.8 1.64 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.158 -1.201 . . . . 0.0 108.564 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.463 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -99.96 115.37 65.6 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.102 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.487 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 36.9 Cg_endo -61.65 -32.63 87.14 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.318 1.167 . . . . 0.0 111.1 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 43.1 mtt180 -83.25 -64.7 1.12 Allowed 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.384 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.654 ' HG3' ' HA ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -57.43 -39.49 76.35 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.967 -1.083 . . . . 0.0 111.528 -179.661 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 23' ' ' GLN . . . -74.57 -16.38 60.81 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 120.396 -1.44 . . . . 0.0 109.669 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 24' ' ' PRO . . . -57.21 -60.05 4.19 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.442 -0.786 . . . . 0.0 110.301 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.608 ' HG ' ' N ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -62.04 -46.08 90.75 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 118.512 -1.275 . . . . 0.0 108.145 179.199 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.608 ' N ' ' HG ' ' A' ' 29' ' ' LEU . 2.8 mmpt? -49.51 -48.07 48.34 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.224 -0.922 . . . . 0.0 110.741 179.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.505 ' C ' ' HB2' ' A' ' 36' ' ' SER . . . -62.13 -49.58 75.31 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.308 -0.87 . . . . 0.0 110.856 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.646 ' HA ' ' CB ' ' A' ' 36' ' ' SER . . . -59.17 -35.32 73.34 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.306 -0.871 . . . . 0.0 109.807 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.439 ' CA ' ' HG3' ' A' ' 82' ' ' PRO . 1.1 t-20 -38.89 -48.43 1.56 Allowed 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.6 mmt180 -92.47 -75.16 0.49 Allowed 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 118.593 -1.243 . . . . 0.0 112.235 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.582 ' O ' ' CG ' ' A' ' 16' ' ' HIS . . . -117.11 -3.03 18.01 Favored Glycine 0 N--CA 1.5 2.946 0 CA-C-O 118.078 -1.401 . . . . 0.0 116.527 -176.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.646 ' CB ' ' HA ' ' A' ' 32' ' ' ALA . 0.4 OUTLIER -82.32 -4.14 56.67 Favored 'General case' 0 N--CA 1.508 2.428 0 CA-C-N 122.358 3.079 . . . . 0.0 111.154 -176.684 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.486 ' CA ' ' O ' ' A' ' 60' ' ' ALA . . . -145.99 109.53 0.5 Allowed Glycine 0 C--N 1.287 -2.145 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.42 ' O ' ' N ' ' A' ' 40' ' ' ALA . 0.3 OUTLIER -76.56 -23.17 53.55 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 117.965 -1.494 . . . . 0.0 109.828 -179.745 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.678 ' HG3' ' HB2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER 67.67 -55.87 0.47 Allowed 'General case' 0 N--CA 1.51 2.564 0 CA-C-O 121.53 0.681 . . . . 0.0 109.188 -179.566 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 38' ' ' THR . . . -65.65 -29.09 69.61 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 104.49 -2.411 . . . . 0.0 104.49 174.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.75 ' HB3' ' HA ' ' A' ' 11' ' ' GLU 0.282 0.7 OUTLIER -140.59 71.94 30.75 Favored Pre-proline 0 N--CA 1.485 1.288 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 176.986 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.944 ' HB2' ' CD1' ' A' ' 61' ' ' TRP . 93.8 Cg_endo -110.71 167.5 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 121.166 1.244 . . . . 0.0 111.779 -177.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -164.96 -170.63 2.0 Favored 'General case' 0 N--CA 1.511 2.59 0 C-N-CA 118.021 -1.472 . . . . 0.0 112.707 177.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.573 ' CG2' ' HD3' ' A' ' 59' ' ' LYS . 0.2 OUTLIER -93.99 134.42 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.708 ' CD1' ' HB3' ' A' ' 14' ' ' ASN . 2.2 tp -120.06 129.96 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.673 -1.267 . . . . 0.0 113.749 -177.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.1 mtm180 -92.3 84.27 5.16 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 104.023 -2.584 . . . . 0.0 104.023 173.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.688 HD23 ' CD1' ' A' ' 6' ' ' PHE . 0.1 OUTLIER -76.03 94.38 3.42 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -177.871 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.433 ' HB2' HG21 ' A' ' 55' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 C-N-CA 119.178 -1.009 . . . . 0.0 111.929 -178.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 121.146 0.498 . . . . 0.0 109.702 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.433 HG21 ' HB2' ' A' ' 48' ' ' ARG . 52.8 t -151.07 129.04 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-O 121.832 0.825 . . . . 0.0 110.797 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.559 ' NE2' ' HB2' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -146.24 110.64 5.09 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 179.334 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.631 ' CG1' ' HB3' ' A' ' 87' ' ' GLU . 21.9 t -105.82 99.95 9.59 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.305 0 C-N-CA 117.497 -1.681 . . . . 0.0 107.735 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.697 ' HA ' ' O ' ' A' ' 85' ' ' LYS . 0.2 OUTLIER -135.03 179.54 6.26 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 179.563 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.774 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 39.7 mttt -133.06 135.07 45.13 Favored 'General case' 0 C--N 1.275 -2.658 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 177.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.681 ' HB3' ' HG3' ' A' ' 15' ' ' GLU . . . -122.85 111.29 16.48 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-N 120.8 1.636 . . . . 0.0 112.911 -175.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.944 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 2.7 m0 -128.11 -165.07 1.44 Allowed 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.708 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 7.3 mmtp -122.25 92.2 3.67 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 120.669 -1.27 . . . . 0.0 111.083 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.922 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 4.5 tp10 -173.51 169.74 4.28 Favored 'General case' 0 N--CA 1.502 2.175 0 CA-C-O 121.469 0.652 . . . . 0.0 110.955 178.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.669 ' CG1' ' HA ' ' A' ' 80' ' ' SER . 2.1 mt -71.71 102.14 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.533 3.679 0 O-C-N 119.421 -2.049 . . . . 0.0 116.305 -175.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.617 ' CG2' ' HA ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -102.0 -167.94 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 120.449 -1.407 . . . . 0.0 110.858 177.09 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.684 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 11.6 t70 -116.1 134.58 54.79 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.509 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.757 ' HA ' ' HB2' ' A' ' 77' ' ' GLU 0.28 . . -72.46 97.57 0.15 Allowed Pre-proline 0 N--CA 1.511 2.595 0 CA-C-O 117.466 -1.254 . . . . 0.0 112.761 -178.242 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.684 ' HD3' ' O ' ' A' ' 66' ' ' ASP . 53.6 Cg_endo -73.35 123.81 8.98 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 O-C-N 123.273 1.144 . . . . 0.0 111.315 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER 53.25 37.9 26.34 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.313 -0.867 . . . . 0.0 109.044 -179.307 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.588 ' HB3' ' HD3' ' A' ' 72' ' ' PRO . 6.6 m-80 2.07 -75.57 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.756 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 11.8 ptm180 34.63 44.22 0.29 Allowed Pre-proline 0 N--CA 1.513 2.707 0 CA-C-N 118.121 0.419 . . . . 0.0 110.355 -177.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.756 ' HD3' ' N ' ' A' ' 71' ' ' ARG . 54.5 Cg_endo -105.85 114.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.324 -0.737 0 C-N-CA 121.922 1.748 . . . . 0.0 112.85 -176.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.85 -39.46 15.82 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.196 -1.002 . . . . 0.0 108.956 177.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.509 ' CD1' ' N ' ' A' ' 74' ' ' TRP . 6.4 m95 -89.7 -38.19 14.04 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.331 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.449 ' HB2' ' O ' ' A' ' 74' ' ' TRP . 7.1 ttm -179.58 146.02 0.44 Allowed Pre-proline 0 N--CA 1.51 2.549 0 O-C-N 121.746 -0.596 . . . . 0.0 111.485 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.644 ' HB2' ' HB1' ' A' ' 67' ' ' ALA . 48.3 Cg_endo -94.54 174.7 1.29 Allowed 'Trans proline' 0 N--CA 1.486 1.087 0 C-N-CA 122.113 1.875 . . . . 0.0 111.041 178.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.757 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 3.8 mt-10 -95.26 16.02 17.75 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 117.892 -1.523 . . . . 0.0 110.812 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.629 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 0.3 OUTLIER -98.28 80.83 2.69 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.22 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.637 HG13 ' N ' ' A' ' 80' ' ' SER . 0.6 OUTLIER 178.59 170.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 C-N-CA 118.128 -1.429 . . . . 0.0 112.122 -177.706 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.669 ' HA ' ' CG1' ' A' ' 64' ' ' ILE . 1.4 m -70.77 109.77 5.16 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 175.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.814 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -169.09 -156.88 0.0 OUTLIER Pre-proline 0 C--O 1.192 -1.973 0 C-N-CA 118.882 -1.127 . . . . 0.0 108.651 -174.916 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.814 ' HD2' ' HB3' ' A' ' 81' ' ' LYS . 43.7 Cg_endo -74.7 127.22 10.72 Favored 'Trans proline' 0 C--N 1.299 -2.052 0 N-CA-C 108.905 -1.229 . . . . 0.0 108.905 178.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.922 ' CZ ' ' HB3' ' A' ' 63' ' ' GLU . 0.8 OUTLIER -58.9 151.64 21.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.506 -1.371 . . . . 0.0 108.087 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.774 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 9.8 p -149.64 95.49 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.508 0 CA-C-O 122.015 0.912 . . . . 0.0 109.764 -178.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.697 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -78.53 119.0 21.19 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 179.611 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.626 ' HB3' ' CZ ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -85.71 94.37 9.08 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 122.716 1.246 . . . . 0.0 113.845 -176.157 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.631 ' HB3' ' CG1' ' A' ' 57' ' ' VAL . 0.0 OUTLIER -99.47 176.96 5.32 Favored 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 114.584 -1.189 . . . . 0.0 108.733 175.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.04 133.39 5.13 Favored 'General case' 0 N--CA 1.514 2.769 0 O-C-N 120.613 -1.304 . . . . 0.0 113.627 -175.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.468 HG12 ' HA ' ' A' ' 56' ' ' HIS . 40.8 mt . . . . . 0 N--CA 1.499 2.01 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.995 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.516 ' O ' ' HA ' ' A' ' 20' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.882 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.59 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 51.0 t30 -77.17 143.19 39.25 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.606 -0.684 . . . . 0.0 110.581 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -138.98 148.72 43.84 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.119 0.485 . . . . 0.0 109.737 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.9 m -125.97 140.04 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 O-C-N 121.331 -0.855 . . . . 0.0 112.504 -177.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.568 ' CB ' HG12 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -161.91 167.36 24.77 Favored 'General case' 0 N--CA 1.511 2.621 0 O-C-N 121.408 -0.807 . . . . 0.0 111.836 179.485 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.549 ' O ' ' N ' ' A' ' 14' ' ' ASN . 3.4 ttm-85 -134.82 107.95 7.68 Favored 'General case' 0 N--CA 1.526 3.328 0 O-C-N 121.15 -0.969 . . . . 0.0 112.856 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.822 ' HB2' ' CB ' ' A' ' 16' ' ' HIS . 0.7 OUTLIER -74.55 -158.18 0.07 Allowed 'General case' 0 N--CA 1.513 2.688 0 O-C-N 120.998 -1.064 . . . . 0.0 111.878 -179.611 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.613 ' HA ' ' HB3' ' A' ' 41' ' ' ASN . 0.2 OUTLIER 70.9 48.94 0.38 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 -177.366 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.619 ' HA ' ' O ' ' A' ' 42' ' ' PRO . 97.8 m-20 58.63 8.37 0.89 Allowed 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 112.498 -2.137 . . . . 0.0 113.216 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.16 -75.89 1.27 Allowed Glycine 0 N--CA 1.49 2.299 0 C-N-CA 117.88 -2.105 . . . . 0.0 108.368 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.549 ' N ' ' O ' ' A' ' 9' ' ' ARG . 0.8 OUTLIER -119.25 -78.72 0.59 Allowed 'General case' 0 C--N 1.293 -1.862 0 CA-C-O 122.261 1.029 . . . . 0.0 108.316 177.388 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.576 ' HB2' ' CG2' ' A' ' 45' ' ' ILE . 1.7 tp10 -177.01 140.55 0.31 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 178.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.822 ' CB ' ' HB2' ' A' ' 10' ' ' ASP . 0.3 OUTLIER -87.29 122.67 31.37 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 116.286 -2.166 . . . . 0.0 112.324 -179.608 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.538 ' HA2' ' CZ ' ' A' ' 19' ' ' PHE . . . -177.25 120.13 0.72 Allowed Glycine 0 C--N 1.28 -2.542 0 CA-C-N 113.496 -1.684 . . . . 0.0 110.019 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.9 82.69 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.61 ' N ' ' CD1' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -174.23 -173.43 0.79 Allowed 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.226 -179.165 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.59 ' HA ' ' HA ' ' A' ' 5' ' ' ASN . 39.0 p -102.12 150.62 23.08 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.421 -0.8 . . . . 0.0 112.441 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -130.25 121.29 3.3 Favored Glycine 0 N--CA 1.499 2.846 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 178.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.67 -45.01 70.13 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.49 -1.006 . . . . 0.0 109.823 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -118.02 135.4 23.42 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.452 ' O ' ' HB1' ' A' ' 28' ' ' ALA . 41.1 Cg_endo -69.29 -45.23 1.93 Allowed 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.384 1.202 . . . . 0.0 110.74 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 40.3 mtt180 -82.3 -64.93 1.08 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.652 -0.655 . . . . 0.0 111.208 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.588 ' HG3' ' HA ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -47.0 -45.09 20.82 Favored 'General case' 0 N--CA 1.51 2.569 0 O-C-N 121.187 -0.946 . . . . 0.0 111.861 -179.374 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.466 ' O ' ' CB ' ' A' ' 31' ' ' ALA . . . -73.41 -17.79 61.22 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.181 -1.007 . . . . 0.0 110.642 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.452 ' HB1' ' O ' ' A' ' 24' ' ' PRO . . . -71.93 -52.51 16.86 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.847 -1.158 . . . . 0.0 111.759 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.552 ' CD1' HG21 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -52.64 -57.24 10.67 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.849 0.833 . . . . 0.0 109.66 -179.073 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.409 ' NZ ' ' OE1' ' A' ' 26' ' ' GLN . 30.7 mtmt -69.68 -34.4 73.91 Favored 'General case' 0 N--CA 1.511 2.592 0 O-C-N 121.284 -0.885 . . . . 0.0 113.151 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.646 ' C ' ' HB2' ' A' ' 36' ' ' SER . . . -59.29 -43.58 92.58 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.757 -1.214 . . . . 0.0 112.129 -178.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.643 ' HA ' ' CB ' ' A' ' 36' ' ' SER . . . -65.49 -32.75 74.53 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 118.621 -1.232 . . . . 0.0 110.062 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.493 ' HB2' ' HG3' ' A' ' 82' ' ' PRO . 46.8 t30 -40.04 -50.01 2.56 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.0 mtm105 -94.65 -74.76 0.53 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.196 -1.002 . . . . 0.0 113.097 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.498 ' O ' ' CD2' ' A' ' 16' ' ' HIS . . . -113.53 -0.06 24.8 Favored Glycine 0 N--CA 1.504 3.2 0 N-CA-C 116.758 1.463 . . . . 0.0 116.758 -175.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.646 ' HB2' ' C ' ' A' ' 31' ' ' ALA . 0.3 OUTLIER -87.64 4.05 45.39 Favored 'General case' 0 N--CA 1.506 2.34 0 CA-C-N 122.248 3.024 . . . . 0.0 110.843 -177.272 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -166.58 117.68 0.75 Allowed Glycine 0 N--CA 1.482 1.739 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.493 ' O ' ' HB3' ' A' ' 39' ' ' LYS . 28.2 m -78.29 -17.28 56.82 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 120.525 2.163 . . . . 0.0 109.691 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.804 ' CA ' ' HG3' ' A' ' 42' ' ' PRO . 4.6 tttm 73.27 -56.8 0.65 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -178.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.9 -19.36 65.71 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 175.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.613 ' HB3' ' HA ' ' A' ' 11' ' ' GLU 0.278 0.2 OUTLIER -160.23 68.08 2.78 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.845 -0.535 . . . . 0.0 111.332 179.108 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.804 ' HG3' ' CA ' ' A' ' 39' ' ' LYS . 76.8 Cg_endo -116.95 -175.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.411 2.074 . . . . 0.0 109.369 178.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.444 ' HB3' ' O ' ' A' ' 14' ' ' ASN . 1.7 t70 -168.54 -173.98 2.07 Favored 'General case' 0 N--CA 1.514 2.775 0 C-N-CA 116.988 -1.885 . . . . 0.0 113.431 176.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.616 HG21 ' HD3' ' A' ' 59' ' ' LYS . 1.6 pp -81.52 136.28 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.576 ' CG2' ' HB2' ' A' ' 15' ' ' GLU . 3.1 tp -147.94 139.53 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 117.634 -1.626 . . . . 0.0 114.184 -177.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 49.4 mtt-85 -88.75 95.28 10.21 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 173.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.734 ' HB2' ' CD2' ' A' ' 56' ' ' HIS . 0.3 OUTLIER -66.52 93.16 0.23 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -178.357 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.296 -1.754 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.214 -176.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.429 ' O ' ' HB2' ' A' ' 48' ' ' ARG . 9.2 mttp . . . . . 0 N--CA 1.495 1.806 0 CA-C-O 120.695 0.284 . . . . 0.0 110.675 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 71.7 t -153.82 96.35 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.613 -0.679 . . . . 0.0 111.028 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.734 ' CD2' ' HB2' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -88.44 137.15 32.58 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 177.237 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.535 ' HB ' ' CB ' ' A' ' 87' ' ' GLU . 2.2 t -116.79 116.12 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 O-C-N 119.755 -1.841 . . . . 0.0 110.381 -178.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.708 ' HA ' ' O ' ' A' ' 85' ' ' LYS . 0.5 OUTLIER -157.51 174.95 14.6 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.289 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.702 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 16.8 mttm -132.04 127.33 35.93 Favored 'General case' 0 N--CA 1.505 2.296 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 177.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.608 ' CB ' ' HB1' ' A' ' 32' ' ' ALA . . . -115.67 110.29 18.94 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 120.747 -1.221 . . . . 0.0 113.198 -175.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.715 ' CD1' ' HG2' ' A' ' 42' ' ' PRO . 14.1 m0 -126.49 -167.21 1.69 Allowed 'General case' 0 N--CA 1.512 2.675 0 O-C-N 121.943 -0.473 . . . . 0.0 110.307 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.699 ' HB2' ' HB2' ' A' ' 39' ' ' LYS . 0.7 OUTLIER -123.45 88.13 2.86 Favored 'General case' 0 N--CA 1.507 2.382 0 CA-C-N 120.158 1.345 . . . . 0.0 112.569 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.844 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 3.6 mt-10 -165.97 172.34 11.6 Favored 'General case' 0 N--CA 1.51 2.573 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.283 176.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.655 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 9.2 tt -73.61 101.42 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.523 3.186 0 N-CA-C 116.824 2.157 . . . . 0.0 116.824 -174.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.718 ' CG2' ' HA ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -88.29 -166.57 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.406 -1.434 . . . . 0.0 109.883 176.63 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.654 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 9.2 t0 -124.43 129.08 50.01 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.824 ' HA ' ' CB ' ' A' ' 77' ' ' GLU . . . -64.3 99.3 0.18 Allowed Pre-proline 0 N--CA 1.507 2.396 0 CA-C-O 117.79 -1.1 . . . . 0.0 111.784 -178.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.654 ' HD3' ' O ' ' A' ' 66' ' ' ASP . 52.1 Cg_endo -88.9 -160.33 0.1 OUTLIER 'Trans proline' 0 C--N 1.316 -1.141 0 O-C-N 124.105 1.581 . . . . 0.0 110.528 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.3 mttt -70.11 64.57 0.24 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.292 -0.88 . . . . 0.0 109.092 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.521 ' O ' ' HG2' ' A' ' 71' ' ' ARG . 5.4 m-20 -102.37 -12.4 17.93 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.473 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.733 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER 59.8 44.69 0.98 Allowed Pre-proline 0 N--CA 1.506 2.358 0 C-N-CA 122.796 0.439 . . . . 0.0 111.209 -177.528 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.733 ' HD3' ' N ' ' A' ' 71' ' ' ARG . 48.9 Cg_endo -92.89 99.89 0.16 Allowed 'Trans proline' 0 C--N 1.323 -0.797 0 C-N-CA 121.152 1.234 . . . . 0.0 110.495 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.19 -34.07 24.05 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.365 -0.834 . . . . 0.0 112.065 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.465 ' CD1' ' N ' ' A' ' 74' ' ' TRP . 32.2 m95 -81.55 -31.46 32.68 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.444 -0.785 . . . . 0.0 110.514 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.429 ' O ' ' HB2' ' A' ' 72' ' ' PRO . 12.5 tpt -164.75 110.38 0.85 Allowed Pre-proline 0 N--CA 1.496 1.861 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.681 ' HB2' ' HB1' ' A' ' 67' ' ' ALA . 48.2 Cg_endo -79.28 -178.91 4.96 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.898 1.473 . . . . 0.0 112.693 -178.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.824 ' CB ' ' HA ' ' A' ' 67' ' ' ALA . 3.1 tt0 -90.21 6.61 42.03 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 118.429 -1.308 . . . . 0.0 110.09 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.656 ' C ' ' CG2' ' A' ' 79' ' ' ILE . 1.5 tppm? -92.28 77.05 5.22 Favored 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.686 ' CG1' ' HB2' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -168.08 158.63 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 C-N-CA 118.272 -1.371 . . . . 0.0 112.146 -177.711 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.569 ' HA ' ' HA ' ' A' ' 64' ' ' ILE . 1.7 m -77.09 103.35 6.97 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 175.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.856 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -173.17 -152.18 0.0 OUTLIER Pre-proline 0 C--O 1.196 -1.711 0 O-C-N 121.302 -0.874 . . . . 0.0 108.759 -175.757 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.856 ' HD2' ' HB3' ' A' ' 81' ' ' LYS . 43.4 Cg_endo -68.34 123.7 10.84 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 117.808 -0.995 . . . . 0.0 111.639 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.844 ' CZ ' ' HB3' ' A' ' 63' ' ' GLU . 0.7 OUTLIER -63.43 159.4 18.44 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.184 -0.947 . . . . 0.0 109.382 178.83 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.702 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -153.16 93.94 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 C-N-CA 120.034 -0.666 . . . . 0.0 109.62 178.376 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.708 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 3.1 tptt -73.5 125.59 28.29 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 177.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.57 ' HB3' ' CZ ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -94.05 90.64 6.5 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 122.337 1.065 . . . . 0.0 113.783 -175.257 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.535 ' CB ' ' HB ' ' A' ' 57' ' ' VAL . 4.2 mt-10 -86.35 150.63 24.2 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 115.293 -0.867 . . . . 0.0 108.755 176.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -56.89 122.14 11.54 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.363 -0.836 . . . . 0.0 111.911 -177.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.432 HG12 ' HA ' ' A' ' 56' ' ' HIS . 88.1 mt . . . . . 0 N--CA 1.492 1.673 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.521 ' HB3' ' HD2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 120.853 0.359 . . . . 0.0 110.104 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.522 ' HA ' ' CG2' ' A' ' 20' ' ' THR . 43.9 t30 -74.35 137.49 42.83 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.496 -0.752 . . . . 0.0 110.58 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.409 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 25.7 m-85 -145.01 151.1 38.04 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.347 0.594 . . . . 0.0 111.057 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.598 HG21 ' HG3' ' A' ' 48' ' ' ARG . 11.7 m -111.21 146.55 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.665 -0.647 . . . . 0.0 111.173 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.67 ' HG ' ' HG ' ' A' ' 47' ' ' LEU . 4.6 mp -152.33 145.08 24.3 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.422 -0.799 . . . . 0.0 111.862 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.561 ' O ' ' N ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -134.11 91.56 2.83 Favored 'General case' 0 N--CA 1.514 2.756 0 O-C-N 121.073 -1.017 . . . . 0.0 111.243 176.647 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.746 ' HB2' ' N ' ' A' ' 16' ' ' HIS . 1.7 t70 -69.63 -159.4 0.03 OUTLIER 'General case' 0 N--CA 1.51 2.565 0 C-N-CA 123.932 0.893 . . . . 0.0 112.007 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.609 ' HA ' ' HB3' ' A' ' 41' ' ' ASN . 0.1 OUTLIER 72.23 52.56 0.19 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 -176.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.58 ' HA ' ' O ' ' A' ' 42' ' ' PRO . 92.4 m-20 61.28 6.91 1.49 Allowed 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 112.539 -2.118 . . . . 0.0 112.783 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.402 ' O ' ' HB3' ' A' ' 43' ' ' ASP . . . -90.17 -75.43 1.3 Allowed Glycine 0 N--CA 1.485 1.95 0 C-N-CA 117.98 -2.057 . . . . 0.0 108.82 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.66 ' CB ' ' HB ' ' A' ' 45' ' ' ILE . 8.2 m120 -125.22 -76.77 0.59 Allowed 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.596 0.713 . . . . 0.0 111.337 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.592 ' HB2' HG22 ' A' ' 45' ' ' ILE . 8.1 mt-10 -169.31 151.42 4.57 Favored 'General case' 0 N--CA 1.511 2.582 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.746 ' N ' ' HB2' ' A' ' 10' ' ' ASP . 0.4 OUTLIER -99.1 118.68 36.39 Favored 'General case' 0 N--CA 1.507 2.388 0 C-N-CA 115.021 -2.672 . . . . 0.0 113.125 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.549 ' HA2' ' CZ ' ' A' ' 19' ' ' PHE . . . 175.21 132.07 1.53 Allowed Glycine 0 C--N 1.285 -2.292 0 C-N-CA 119.493 -1.336 . . . . 0.0 112.251 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.6 86.78 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 175.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.623 ' N ' ' CD1' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -172.54 -172.26 0.89 Allowed 'General case' 0 N--CA 1.5 2.073 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.733 -178.132 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.522 ' CG2' ' HA ' ' A' ' 5' ' ' ASN . 57.2 p -107.62 158.46 17.23 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.493 -0.755 . . . . 0.0 111.703 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -130.69 130.97 6.31 Favored Glycine 0 N--CA 1.501 3.02 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.4 ttpt -60.84 -47.82 84.64 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.309 -1.113 . . . . 0.0 108.765 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.64 ' HB3' ' HB3' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -115.7 114.13 42.22 Favored Pre-proline 0 N--CA 1.486 1.362 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.403 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.417 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 38.1 Cg_endo -64.94 -35.86 41.66 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.65 1.342 . . . . 0.0 110.823 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.551 ' HB3' ' HA ' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -83.08 -62.92 1.47 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.209 -0.932 . . . . 0.0 109.862 179.419 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.64 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 1.0 OUTLIER -53.44 -41.97 66.65 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.129 -0.982 . . . . 0.0 111.886 -179.683 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -74.57 -15.69 60.84 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 120.593 -1.317 . . . . 0.0 110.42 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 24' ' ' PRO . . . -63.61 -51.89 63.29 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.79 -1.194 . . . . 0.0 110.642 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.623 HD13 HG23 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -61.9 -50.46 72.1 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 121.558 0.694 . . . . 0.0 109.559 -179.555 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -69.41 -37.87 77.65 Favored 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -178.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.405 ' C ' ' HB2' ' A' ' 36' ' ' SER . . . -60.5 -43.73 96.75 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 120.719 -1.238 . . . . 0.0 112.461 -177.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.711 ' HA ' ' CB ' ' A' ' 36' ' ' SER . . . -64.51 -33.34 75.67 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 118.77 -1.172 . . . . 0.0 110.15 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.543 ' CA ' ' HG3' ' A' ' 82' ' ' PRO . 0.2 OUTLIER -42.74 -46.34 5.1 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.802 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.5 mtp85 -95.51 -72.83 0.61 Allowed 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.269 -0.972 . . . . 0.0 112.254 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.548 ' O ' ' CD2' ' A' ' 16' ' ' HIS . . . -115.72 -0.72 21.47 Favored Glycine 0 N--CA 1.499 2.877 0 N-CA-C 117.48 1.752 . . . . 0.0 117.48 -175.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.711 ' CB ' ' HA ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -82.03 -2.29 51.21 Favored 'General case' 0 N--CA 1.514 2.73 0 CA-C-N 123.615 3.708 . . . . 0.0 110.94 -176.744 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -163.49 120.84 0.97 Allowed Glycine 0 C--N 1.297 -1.637 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -178.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.519 ' O ' ' HB3' ' A' ' 39' ' ' LYS . 23.5 m -77.73 -15.61 59.01 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 119.825 1.813 . . . . 0.0 109.494 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.811 ' CA ' ' HG3' ' A' ' 42' ' ' PRO . 7.6 tttm 75.21 -56.27 0.62 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -178.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.43 -18.89 65.62 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 175.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.609 ' HB3' ' HA ' ' A' ' 11' ' ' GLU 0.27 0.4 OUTLIER -160.44 67.31 2.62 Favored Pre-proline 0 C--O 1.202 -1.446 0 O-C-N 121.661 -0.649 . . . . 0.0 111.147 179.097 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.811 ' HG3' ' CA ' ' A' ' 39' ' ' LYS . 82.9 Cg_endo -118.0 -176.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.3 -2.012 0 C-N-CA 122.019 1.813 . . . . 0.0 109.615 178.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.447 ' HB2' ' C ' ' A' ' 12' ' ' ASP . 0.7 OUTLIER -168.04 -169.49 1.14 Allowed 'General case' 0 N--CA 1.512 2.643 0 O-C-N 119.826 -1.796 . . . . 0.0 113.902 177.036 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.669 ' CG2' ' HD3' ' A' ' 59' ' ' LYS . 1.6 pp -91.5 142.6 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.66 ' HB ' ' CB ' ' A' ' 14' ' ' ASN . 1.1 tp -161.59 142.67 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 117.958 -1.497 . . . . 0.0 113.422 -178.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.473 ' HG3' HG12 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -87.03 96.23 10.21 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 174.184 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.698 ' HB2' ' CD2' ' A' ' 56' ' ' HIS . 9.0 mp -63.21 95.77 0.09 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 -178.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.598 ' HG3' HG21 ' A' ' 7' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.296 -1.747 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.704 -177.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 48' ' ' ARG . 5.3 mtmm . . . . . 0 N--CA 1.487 1.382 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . 6.7 t -137.03 100.2 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 CA-C-O 121.399 0.618 . . . . 0.0 110.338 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.703 ' NE2' ' HB2' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -91.61 138.09 31.85 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.926 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.53 ' HB ' ' CB ' ' A' ' 87' ' ' GLU . 2.5 t -114.59 104.09 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 O-C-N 119.91 -1.744 . . . . 0.0 109.258 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.711 ' HA ' ' O ' ' A' ' 85' ' ' LYS . 0.6 OUTLIER -146.62 175.58 10.49 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.376 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.744 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 24.5 mttm -130.04 128.12 41.3 Favored 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 177.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.502 ' O ' ' CD1' ' A' ' 61' ' ' TRP . . . -114.18 113.26 24.43 Favored 'General case' 0 N--CA 1.505 2.312 0 C-N-CA 118.199 -1.4 . . . . 0.0 113.605 -176.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.788 ' HB2' ' HB2' ' A' ' 83' ' ' PHE . 13.6 m0 -130.26 -168.42 1.97 Allowed 'General case' 0 N--CA 1.516 2.841 0 O-C-N 121.713 -0.617 . . . . 0.0 110.802 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.639 ' HB2' ' HB2' ' A' ' 39' ' ' LYS . 1.3 tmtm? -120.68 89.02 3.05 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.696 -1.253 . . . . 0.0 111.283 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.809 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 2.1 mt-10 -165.79 168.67 15.81 Favored 'General case' 0 N--CA 1.508 2.456 0 CA-C-O 121.354 0.597 . . . . 0.0 109.994 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.646 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 4.7 tt -72.56 101.15 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.522 3.138 0 O-C-N 119.612 -1.93 . . . . 0.0 115.68 -176.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.693 ' CG2' ' HA ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -91.86 -166.58 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.501 -1.375 . . . . 0.0 110.838 177.948 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.682 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 7.5 t70 -120.39 130.19 54.26 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.825 ' HA ' ' CB ' ' A' ' 77' ' ' GLU . . . -65.64 100.47 0.23 Allowed Pre-proline 0 N--CA 1.509 2.505 0 CA-C-O 118.061 -0.971 . . . . 0.0 113.308 -177.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.682 ' HD3' ' O ' ' A' ' 66' ' ' ASP . 55.8 Cg_endo -84.01 -163.48 0.2 Allowed 'Trans proline' 0 N--CA 1.485 1.019 0 O-C-N 123.625 1.329 . . . . 0.0 110.502 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.2 mmpp? -69.83 64.87 0.22 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.158 -0.964 . . . . 0.0 109.841 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.566 ' O ' ' HG2' ' A' ' 71' ' ' ARG . 3.8 m-20 -97.94 -12.6 21.84 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.986 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.697 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER 44.87 51.08 8.21 Favored Pre-proline 0 N--CA 1.504 2.271 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.374 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.787 ' HG2' ' HA ' ' A' ' 76' ' ' PRO . 55.1 Cg_endo -99.97 112.0 0.07 OUTLIER 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 121.861 1.707 . . . . 0.0 109.518 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.78 -19.98 47.32 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.766 -1.209 . . . . 0.0 112.106 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.435 ' CD1' ' N ' ' A' ' 74' ' ' TRP . 44.5 m95 -81.96 -37.75 26.22 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.308 -0.87 . . . . 0.0 110.46 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.444 ' O ' ' HB2' ' A' ' 72' ' ' PRO . 20.9 ttm -168.89 130.75 1.12 Allowed Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.673 -0.642 . . . . 0.0 109.665 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.787 ' HA ' ' HG2' ' A' ' 72' ' ' PRO . 47.5 Cg_endo -88.59 179.82 2.47 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.662 1.349 . . . . 0.0 111.803 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.825 ' CB ' ' HA ' ' A' ' 67' ' ' ALA . 3.7 tt0 -88.71 9.23 25.09 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 118.005 -1.478 . . . . 0.0 110.1 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.578 ' N ' ' HB3' ' A' ' 67' ' ' ALA . 40.6 tptt -93.74 82.49 4.32 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.646 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -179.82 163.21 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 C-N-CA 118.006 -1.478 . . . . 0.0 112.501 -178.51 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.568 ' HA ' ' HB ' ' A' ' 64' ' ' ILE . 1.1 m -72.01 105.35 3.86 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 175.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.68 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 11.2 pttp -167.81 -154.92 0.0 OUTLIER Pre-proline 0 C--O 1.196 -1.729 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -175.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.68 ' HD2' ' HB2' ' A' ' 81' ' ' LYS . 49.7 Cg_endo -75.59 128.99 11.44 Favored 'Trans proline' 0 C--N 1.299 -2.066 0 N-CA-C 109.761 -0.899 . . . . 0.0 109.761 178.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.809 ' CZ ' ' HB3' ' A' ' 63' ' ' GLU . 1.1 m-30 -64.73 157.15 28.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.217 -0.927 . . . . 0.0 109.423 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.744 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -152.15 95.66 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.153 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.711 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -74.01 130.15 39.28 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 105.917 -1.882 . . . . 0.0 105.917 178.16 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.614 ' HB3' ' CZ ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -99.36 92.24 5.32 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 122.615 1.197 . . . . 0.0 113.908 -175.338 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.53 ' CB ' ' HB ' ' A' ' 57' ' ' VAL . 24.0 mt-10 -88.75 151.94 22.1 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 175.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -55.4 116.69 2.99 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-O 122.316 1.055 . . . . 0.0 112.77 -176.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.506 ' CG2' ' HA ' ' A' ' 56' ' ' HIS . 23.7 mt . . . . . 0 N--CA 1.491 1.611 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.428 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.496 ' O ' ' HA ' ' A' ' 20' ' ' THR . 5.1 mmp_? . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 120.79 0.329 . . . . 0.0 110.213 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.546 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 19.5 t-20 -74.54 140.88 44.78 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.557 -0.714 . . . . 0.0 110.228 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.531 ' HB3' HD22 ' A' ' 47' ' ' LEU . 8.5 m-85 -152.57 168.29 26.07 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.476 -0.765 . . . . 0.0 110.421 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.562 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -150.24 141.52 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 O-C-N 121.444 -0.785 . . . . 0.0 111.591 -178.007 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.671 ' CD2' ' HG ' ' A' ' 47' ' ' LEU . 1.5 mp -148.12 167.68 24.39 Favored 'General case' 0 N--CA 1.52 3.052 0 O-C-N 121.287 -0.883 . . . . 0.0 112.942 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.539 ' N ' ' O ' ' A' ' 15' ' ' GLU . 9.3 ptt-85 -136.3 95.37 3.17 Favored 'General case' 0 N--CA 1.517 2.908 0 O-C-N 121.488 -0.757 . . . . 0.0 111.28 176.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.797 ' HB2' ' N ' ' A' ' 16' ' ' HIS . 5.1 t0 -82.46 -150.93 0.09 Allowed 'General case' 0 N--CA 1.509 2.508 0 C-N-CA 124.136 0.974 . . . . 0.0 113.081 -178.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.558 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 0.8 OUTLIER 73.56 53.63 0.11 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 104.048 -2.575 . . . . 0.0 104.048 -175.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.558 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 1.9 m-20 63.98 3.96 1.85 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 112.683 -2.053 . . . . 0.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -89.52 -76.54 1.31 Allowed Glycine 0 N--CA 1.479 1.55 0 C-N-CA 117.795 -2.145 . . . . 0.0 107.795 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.637 ' HB3' ' HB ' ' A' ' 45' ' ' ILE . 3.5 m120 -126.74 -77.03 0.58 Allowed 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.452 0.644 . . . . 0.0 111.576 178.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.617 ' HB2' ' CG2' ' A' ' 45' ' ' ILE . 4.6 mt-10 -171.28 154.84 4.08 Favored 'General case' 0 N--CA 1.512 2.626 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.797 ' N ' ' HB2' ' A' ' 10' ' ' ASP . 0.2 OUTLIER -119.62 120.29 36.23 Favored 'General case' 0 N--CA 1.511 2.615 0 C-N-CA 114.848 -2.741 . . . . 0.0 115.047 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.419 ' CA ' ' CE1' ' A' ' 19' ' ' PHE . . . -176.45 128.35 1.34 Allowed Glycine 0 C--N 1.29 -1.999 0 CA-C-N 113.561 -1.654 . . . . 0.0 110.113 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.418 ' C ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -134.78 92.05 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 177.449 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.671 ' N ' ' CD1' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -175.25 -173.3 0.65 Allowed 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 121.283 0.563 . . . . 0.0 110.281 -178.743 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 5' ' ' ASN . 22.2 p -106.1 126.56 52.36 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.289 -0.882 . . . . 0.0 110.953 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -97.68 131.15 10.49 Favored Glycine 0 N--CA 1.501 3.001 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.1 mtmp? -59.54 -39.2 83.17 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.55 -0.971 . . . . 0.0 109.57 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.449 ' HB3' ' HB3' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -127.42 125.35 23.89 Favored Pre-proline 0 N--CA 1.489 1.493 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.112 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.42 ' O ' ' HB1' ' A' ' 28' ' ' ALA . 37.0 Cg_endo -63.06 -40.82 31.65 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 O-C-N 123.493 1.26 . . . . 0.0 110.924 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -87.47 -61.19 1.78 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.499 -0.751 . . . . 0.0 111.46 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.449 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 14.5 tt0 -55.76 -40.94 73.28 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 120.938 -1.101 . . . . 0.0 111.71 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 23' ' ' GLN . . . -79.8 -18.92 49.75 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.828 -1.149 . . . . 0.0 109.446 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.42 ' HB1' ' O ' ' A' ' 24' ' ' PRO . . . -62.74 -57.7 10.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.358 -0.839 . . . . 0.0 110.808 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.462 ' O ' ' HG2' ' A' ' 82' ' ' PRO . 2.4 pp -58.38 -44.37 88.87 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.354 -178.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.47 ' HB2' ' HE3' ' A' ' 30' ' ' LYS . 1.0 OUTLIER -70.46 -35.47 73.35 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 120.793 -1.192 . . . . 0.0 111.689 179.249 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.425 ' C ' ' HB2' ' A' ' 36' ' ' SER . . . -56.59 -42.01 77.97 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.187 -0.946 . . . . 0.0 113.079 -177.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.733 ' HA ' ' HB2' ' A' ' 36' ' ' SER . . . -73.03 -29.92 63.36 Favored 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 118.865 -1.134 . . . . 0.0 110.096 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.568 ' CB ' ' HG3' ' A' ' 82' ' ' PRO . 6.3 t-20 -41.37 -46.89 3.45 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.371 0.605 . . . . 0.0 109.369 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.8 mmm-85 -92.97 -74.57 0.52 Allowed 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 118.884 -1.126 . . . . 0.0 112.938 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.474 ' O ' ' CD2' ' A' ' 16' ' ' HIS . . . -115.93 -3.96 19.34 Favored Glycine 0 N--CA 1.499 2.855 0 N-CA-C 117.065 1.586 . . . . 0.0 117.065 -175.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.733 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 0.6 OUTLIER -79.02 -4.27 49.26 Favored 'General case' 0 N--CA 1.51 2.558 0 CA-C-N 122.633 3.216 . . . . 0.0 110.573 -176.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.525 ' O ' ' HG3' ' A' ' 39' ' ' LYS . . . -154.31 117.72 0.81 Allowed Glycine 0 C--N 1.292 -1.873 0 N-CA-C 108.579 -1.809 . . . . 0.0 108.579 -178.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.447 ' HB ' ' C ' ' A' ' 41' ' ' ASN . 90.2 m -68.9 -17.12 63.92 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 119.348 1.574 . . . . 0.0 108.107 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.779 ' CA ' ' HG3' ' A' ' 42' ' ' PRO . 10.0 mtmt 71.36 -59.64 0.54 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.72 -20.02 61.97 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 175.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.517 ' HB3' ' HA ' ' A' ' 11' ' ' GLU 0.279 0.1 OUTLIER -149.66 65.25 7.59 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.722 -0.612 . . . . 0.0 110.638 178.628 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.779 ' HG3' ' CA ' ' A' ' 39' ' ' LYS . 75.1 Cg_endo -117.03 -174.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 121.167 1.245 . . . . 0.0 111.322 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -167.13 -168.23 1.05 Allowed 'General case' 0 N--CA 1.512 2.672 0 C-N-CA 118.07 -1.452 . . . . 0.0 112.887 177.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.662 ' CG2' ' HD3' ' A' ' 59' ' ' LYS . 1.2 pp -95.85 149.62 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.637 ' HB ' ' HB3' ' A' ' 14' ' ' ASN . 1.8 tp -163.09 144.05 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 C-N-CA 117.773 -1.571 . . . . 0.0 113.883 -178.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.441 ' HG2' HG11 ' A' ' 57' ' ' VAL . 32.8 mtt180 -85.35 95.63 9.29 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 174.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.671 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -70.15 94.88 0.93 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.448 -0.782 . . . . 0.0 109.361 -178.063 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.428 ' O ' HG12 ' A' ' 7' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.563 -0.711 . . . . 0.0 110.078 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.483 ' HD3' ' O ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.937 0 CA-C-O 121.187 0.518 . . . . 0.0 110.364 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.455 ' O ' HG23 ' A' ' 89' ' ' ILE . 2.4 t -155.76 142.84 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 CA-C-O 122.002 0.906 . . . . 0.0 111.216 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.639 ' NE2' ' HB2' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -162.78 129.89 3.61 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 179.598 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.555 ' CG1' ' CB ' ' A' ' 87' ' ' GLU . 11.5 t -118.31 115.88 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 117.311 -1.756 . . . . 0.0 109.23 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.71 ' HA ' ' O ' ' A' ' 85' ' ' LYS . 0.8 OUTLIER -153.76 -176.63 5.92 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 -179.817 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.765 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 30.2 mttt -137.39 133.97 35.4 Favored 'General case' 0 N--CA 1.51 2.566 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 177.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.578 ' O ' ' CD1' ' A' ' 61' ' ' TRP . . . -117.04 112.69 21.28 Favored 'General case' 0 N--CA 1.51 2.557 0 CA-C-N 120.662 1.574 . . . . 0.0 113.653 -176.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.75 ' HB2' ' HB2' ' A' ' 83' ' ' PHE . 11.7 m0 -133.59 -165.51 1.64 Allowed 'General case' 0 N--CA 1.514 2.726 0 O-C-N 122.036 -0.415 . . . . 0.0 111.344 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.638 ' HB2' ' HB3' ' A' ' 39' ' ' LYS . 1.6 tptp -123.78 91.4 3.46 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.643 -1.285 . . . . 0.0 111.776 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.86 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 1.1 mt-10 -165.37 -173.0 2.65 Favored 'General case' 0 N--CA 1.51 2.573 0 CA-C-O 121.223 0.535 . . . . 0.0 110.452 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.591 ' C ' ' HE1' ' A' ' 83' ' ' PHE . 12.6 tt -94.86 98.68 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.117 0 O-C-N 118.977 -2.327 . . . . 0.0 116.081 -176.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.611 HG23 ' HG2' ' A' ' 77' ' ' GLU . 0.3 OUTLIER -103.65 -168.54 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 120.137 -1.602 . . . . 0.0 108.706 176.329 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.702 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 5.9 t0 -114.23 145.63 41.47 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.663 -0.648 . . . . 0.0 111.379 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.809 ' HA ' ' HB3' ' A' ' 77' ' ' GLU 0.25 . . -66.25 101.38 0.28 Allowed Pre-proline 0 N--CA 1.511 2.6 0 CA-C-O 118.075 -0.964 . . . . 0.0 113.167 -178.772 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.779 ' HG3' ' HG2' ' A' ' 86' ' ' LYS . 55.0 Cg_endo -70.81 64.53 2.42 Favored 'Trans proline' 0 N--CA 1.5 1.906 0 O-C-N 123.85 1.448 . . . . 0.0 110.961 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 50.2 40.94 23.23 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 120.994 -1.066 . . . . 0.0 108.69 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.669 ' HB3' ' HG3' ' A' ' 72' ' ' PRO . 6.3 m120 -55.37 -18.83 7.36 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.489 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.779 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER 49.99 43.22 1.55 Allowed Pre-proline 0 N--CA 1.495 1.809 0 CA-C-O 120.484 0.183 . . . . 0.0 110.784 -176.642 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.779 ' HD3' ' N ' ' A' ' 71' ' ' ARG . 57.8 Cg_endo -100.05 135.09 0.22 Allowed 'Trans proline' 0 C--O 1.219 -0.446 0 C-N-CA 121.481 1.454 . . . . 0.0 109.435 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.27 -28.55 25.25 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 120.892 -1.13 . . . . 0.0 111.105 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.447 ' CD1' ' N ' ' A' ' 74' ' ' TRP . 41.0 m95 -84.71 -35.94 22.17 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.542 -0.724 . . . . 0.0 111.424 -178.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.469 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 2.4 tpt -175.06 132.11 0.45 Allowed Pre-proline 0 N--CA 1.51 2.55 0 O-C-N 121.23 -0.919 . . . . 0.0 111.689 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.746 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 44.3 Cg_endo -93.55 -178.21 0.71 Allowed 'Trans proline' 0 N--CA 1.489 1.264 0 C-N-CA 122.401 2.067 . . . . 0.0 111.455 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.809 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 7.8 tt0 -86.12 9.24 17.97 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 117.729 -1.588 . . . . 0.0 110.82 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.702 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -88.05 82.2 7.25 Favored 'General case' 0 N--CA 1.507 2.406 0 C-N-CA 118.861 -1.136 . . . . 0.0 108.292 178.786 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.559 HG13 ' N ' ' A' ' 80' ' ' SER . 0.1 OUTLIER 179.02 165.89 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.382 0 C-N-CA 118.384 -1.326 . . . . 0.0 112.673 -178.105 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.585 ' HA ' ' HA ' ' A' ' 64' ' ' ILE . 13.3 m -77.69 107.13 9.96 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 175.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.862 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -171.54 -152.86 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.331 0 O-C-N 121.107 -0.995 . . . . 0.0 108.644 -176.106 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.862 ' HD2' ' HB2' ' A' ' 81' ' ' LYS . 44.2 Cg_endo -71.86 123.66 9.53 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 117.316 -1.323 . . . . 0.0 110.005 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.86 ' CZ ' ' HB3' ' A' ' 63' ' ' GLU . 0.5 OUTLIER -61.74 161.0 10.75 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.226 -0.921 . . . . 0.0 110.601 -179.665 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.765 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -155.6 95.55 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.083 178.081 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.71 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 0.9 OUTLIER -71.16 133.92 46.55 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 178.131 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.779 ' HG2' ' HG3' ' A' ' 68' ' ' PRO . 0.0 OUTLIER -101.91 92.3 4.75 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -173.795 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.555 ' CB ' ' CG1' ' A' ' 57' ' ' VAL . 2.6 mp0 -93.47 163.58 13.52 Favored 'General case' 0 C--N 1.28 -2.431 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 174.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -54.88 146.53 17.24 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 120.959 -1.088 . . . . 0.0 113.448 -176.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.535 HG23 ' HA ' ' A' ' 56' ' ' HIS . 97.8 mt . . . . . 0 N--CA 1.496 1.854 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.538 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 20' ' ' THR . 11.1 mmt85 . . . . . 0 N--CA 1.496 1.875 0 CA-C-O 120.917 0.389 . . . . 0.0 110.035 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.585 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 3.7 t30 -76.96 144.52 38.74 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.593 -0.692 . . . . 0.0 111.158 -179.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.595 ' HB3' ' CD2' ' A' ' 47' ' ' LEU . 18.2 m-85 -140.8 170.53 15.58 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.5 m -138.93 130.53 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.421 0 O-C-N 121.141 -0.974 . . . . 0.0 112.177 -177.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.541 HD11 ' CG ' ' A' ' 15' ' ' GLU . 0.2 OUTLIER -149.39 161.86 41.25 Favored 'General case' 0 N--CA 1.511 2.604 0 O-C-N 121.071 -1.018 . . . . 0.0 112.222 -179.884 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.511 ' O ' ' N ' ' A' ' 14' ' ' ASN . 12.6 tpt180 -142.72 99.2 3.43 Favored 'General case' 0 N--CA 1.511 2.619 0 O-C-N 121.192 -0.943 . . . . 0.0 111.554 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.781 ' HB2' ' N ' ' A' ' 16' ' ' HIS . 19.1 t70 -80.71 -146.53 0.05 Allowed 'General case' 0 N--CA 1.507 2.399 0 C-N-CA 123.662 0.785 . . . . 0.0 110.167 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.705 ' HA ' ' HB3' ' A' ' 41' ' ' ASN . 0.3 OUTLIER 71.0 55.44 0.23 Allowed 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 104.109 -2.552 . . . . 0.0 104.109 -176.057 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.58 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 0.7 OUTLIER 67.04 1.26 2.28 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-N 112.985 -1.916 . . . . 0.0 111.706 -178.848 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 43' ' ' ASP . . . -94.98 -77.52 1.37 Allowed Glycine 0 N--CA 1.477 1.369 0 C-N-CA 118.136 -1.983 . . . . 0.0 109.086 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.674 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 2.4 m-80 -126.25 -80.3 0.61 Allowed 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.67 ' C ' ' HB2' ' A' ' 10' ' ' ASP . 28.3 tt0 -168.44 139.8 2.7 Favored 'General case' 0 N--CA 1.509 2.524 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 -178.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.781 ' N ' ' HB2' ' A' ' 10' ' ' ASP . 0.9 OUTLIER -109.56 120.98 44.16 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 116.065 -2.254 . . . . 0.0 115.361 -176.318 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.534 ' HA3' ' CE1' ' A' ' 19' ' ' PHE . . . -179.62 129.64 1.39 Allowed Glycine 0 C--N 1.288 -2.109 0 CA-C-N 112.96 -1.927 . . . . 0.0 109.555 178.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.82 94.37 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 177.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.624 ' N ' ' CD1' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -175.74 -169.29 0.34 Allowed 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 121.286 0.565 . . . . 0.0 110.591 -178.388 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.585 ' HA ' ' HA ' ' A' ' 5' ' ' ASN . 2.7 p -105.59 150.64 25.22 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.431 -0.793 . . . . 0.0 111.508 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -130.1 128.55 5.66 Favored Glycine 0 N--CA 1.5 2.945 0 N-CA-C 108.669 -1.773 . . . . 0.0 108.669 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -60.9 -52.82 63.41 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.41 -1.053 . . . . 0.0 108.823 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.53 ' HB3' ' HB3' ' A' ' 26' ' ' GLN . 5.0 mp0 -106.47 99.32 23.79 Favored Pre-proline 0 N--CA 1.487 1.392 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.452 ' O ' ' HB1' ' A' ' 28' ' ' ALA . 36.8 Cg_endo -59.74 -29.18 89.06 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.508 1.267 . . . . 0.0 110.398 -179.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.563 ' O ' HD22 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -84.61 -61.15 1.86 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.363 -0.836 . . . . 0.0 109.919 178.475 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.669 ' HG3' ' HA ' ' A' ' 72' ' ' PRO . 16.6 tm0? -65.84 -42.9 89.93 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 120.871 -1.143 . . . . 0.0 112.397 -179.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -73.07 -17.36 61.42 Favored 'General case' 0 N--CA 1.482 1.138 0 O-C-N 120.69 -1.257 . . . . 0.0 109.885 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 25' ' ' ARG . . . -61.07 -53.05 61.94 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.237 -0.914 . . . . 0.0 111.592 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.714 ' HG ' ' CG ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -63.48 -56.84 12.91 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 -179.082 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.17 -44.13 32.25 Favored 'General case' 0 N--CA 1.506 2.347 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.93 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.518 ' C ' ' HB2' ' A' ' 36' ' ' SER . . . -54.83 -43.1 72.67 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.455 -0.778 . . . . 0.0 111.965 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.725 ' HA ' ' CB ' ' A' ' 36' ' ' SER . . . -72.86 -28.25 62.4 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.701 -1.25 . . . . 0.0 110.807 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.578 ' HB2' ' HG3' ' A' ' 82' ' ' PRO . 2.0 t30 -39.59 -46.95 1.86 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -95.11 -74.59 0.54 Allowed 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.154 -1.018 . . . . 0.0 112.91 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.47 ' O ' ' CD2' ' A' ' 16' ' ' HIS . . . -113.81 -4.96 22.59 Favored Glycine 0 N--CA 1.502 3.039 0 N-CA-C 116.798 1.479 . . . . 0.0 116.798 -175.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.725 ' CB ' ' HA ' ' A' ' 32' ' ' ALA . 0.4 OUTLIER -82.44 -7.13 59.64 Favored 'General case' 0 N--CA 1.506 2.363 0 CA-C-N 122.166 2.983 . . . . 0.0 110.157 -177.353 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' A' ' 60' ' ' ALA . . . -141.44 111.74 0.72 Allowed Glycine 0 C--N 1.289 -2.028 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.504 ' O ' ' HB3' ' A' ' 39' ' ' LYS . 5.2 m -69.05 -20.94 64.12 Favored 'General case' 0 C--N 1.312 -1.054 0 O-C-N 120.672 -1.487 . . . . 0.0 109.4 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.669 ' HA ' ' HG3' ' A' ' 42' ' ' PRO . 5.6 ttpt 67.64 -52.04 0.51 Allowed 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.65 -27.95 64.44 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 174.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.705 ' HB3' ' HA ' ' A' ' 11' ' ' GLU 0.274 0.2 OUTLIER -142.41 71.19 21.57 Favored Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.468 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.956 ' HB2' ' CD1' ' A' ' 61' ' ' TRP . 72.2 Cg_endo -112.89 169.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 121.75 1.633 . . . . 0.0 112.208 -178.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.512 ' HB2' ' C ' ' A' ' 12' ' ' ASP . 0.7 OUTLIER -167.82 -167.47 0.86 Allowed 'General case' 0 N--CA 1.517 2.891 0 C-N-CA 117.692 -1.603 . . . . 0.0 113.949 177.091 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.674 ' O ' ' HA ' ' A' ' 14' ' ' ASN . 0.2 OUTLIER -84.09 123.58 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -178.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.662 ' CD1' ' HB3' ' A' ' 14' ' ' ASN . 0.7 OUTLIER -108.1 117.52 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.846 -1.159 . . . . 0.0 113.648 -177.856 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.49 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 0.3 OUTLIER -87.73 88.14 7.57 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 103.492 -2.781 . . . . 0.0 103.492 173.249 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.634 ' HB2' ' CD2' ' A' ' 56' ' ' HIS . 0.1 OUTLIER -79.14 94.43 5.37 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -177.62 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.53 ' HD2' ' C ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.478 0 O-C-N 121.589 -0.694 . . . . 0.0 111.431 -178.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.523 ' HG2' ' CZ ' ' A' ' 6' ' ' PHE . 5.7 mtmt . . . . . 0 N--CA 1.484 1.238 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.545 ' O ' HG22 ' A' ' 89' ' ' ILE . 2.8 t -154.05 149.75 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.698 0.761 . . . . 0.0 110.522 -178.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.634 ' CD2' ' HB2' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -160.81 122.67 3.07 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 179.276 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.596 ' O ' ' HB2' ' A' ' 87' ' ' GLU . 12.9 t -113.32 100.55 10.92 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 C-N-CA 117.722 -1.591 . . . . 0.0 108.188 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.699 ' HA ' ' O ' ' A' ' 85' ' ' LYS . 0.3 OUTLIER -144.72 178.79 7.74 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 179.601 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.786 ' HB3' ' CZ2' ' A' ' 61' ' ' TRP . 44.2 mttt -131.62 134.56 46.13 Favored 'General case' 0 C--N 1.274 -2.715 0 N-CA-C 104.245 -2.502 . . . . 0.0 104.245 176.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.626 ' CB ' ' HB2' ' A' ' 32' ' ' ALA . . . -123.54 109.72 14.15 Favored 'General case' 0 N--CA 1.495 1.825 0 C-N-CA 117.593 -1.643 . . . . 0.0 112.599 -175.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.956 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 5.3 m0 -124.91 -163.07 1.15 Allowed 'General case' 0 N--CA 1.508 2.442 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.426 -178.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.633 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -124.51 88.55 2.92 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.042 -1.036 . . . . 0.0 111.015 179.541 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.878 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 4.4 mt-10 -167.15 171.64 10.71 Favored 'General case' 0 N--CA 1.507 2.397 0 CA-C-O 121.745 0.783 . . . . 0.0 110.449 177.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.654 ' CG1' ' HA ' ' A' ' 80' ' ' SER . 2.3 mt -72.47 98.37 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.519 2.989 0 O-C-N 119.594 -1.942 . . . . 0.0 115.478 -176.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.696 ' CG2' ' HA ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -94.27 -164.54 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.296 -1.503 . . . . 0.0 109.288 176.101 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.677 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 14.2 t70 -120.13 136.93 54.43 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 178.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.772 ' HA ' ' HB2' ' A' ' 77' ' ' GLU 0.251 . . -68.72 100.6 0.26 Allowed Pre-proline 0 N--CA 1.503 2.177 0 CA-C-O 117.799 -1.096 . . . . 0.0 111.615 -177.924 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.677 ' HD3' ' O ' ' A' ' 66' ' ' ASP . 49.3 Cg_endo -88.52 -153.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.319 -1.003 0 O-C-N 124.086 1.572 . . . . 0.0 111.241 -179.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.04 61.7 0.08 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.128 -0.983 . . . . 0.0 110.102 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.53 ' ND2' HD22 ' A' ' 29' ' ' LEU . 0.7 OUTLIER -99.63 -14.88 18.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.622 -0.673 . . . . 0.0 110.989 -179.583 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.708 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER 49.72 52.6 12.91 Favored Pre-proline 0 N--CA 1.488 1.429 0 O-C-N 121.892 -0.505 . . . . 0.0 109.992 -178.096 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.708 ' HD3' ' N ' ' A' ' 71' ' ' ARG . 53.2 Cg_endo -98.74 108.01 0.07 OUTLIER 'Trans proline' 0 C--N 1.317 -1.124 0 C-N-CA 122.05 1.834 . . . . 0.0 110.831 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.81 -31.32 23.93 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.966 -1.084 . . . . 0.0 111.447 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.453 ' CD1' ' N ' ' A' ' 74' ' ' TRP . 41.8 m95 -83.65 -32.63 25.55 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.688 -0.633 . . . . 0.0 110.907 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.3 mtm -167.98 106.76 0.56 Allowed Pre-proline 0 N--CA 1.499 2.003 0 O-C-N 121.467 -0.771 . . . . 0.0 111.08 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.74 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 51.0 Cg_endo -79.59 -179.93 5.78 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.696 1.366 . . . . 0.0 110.929 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.772 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 14.0 mm-40 -96.46 18.87 13.1 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 117.193 -1.803 . . . . 0.0 111.634 -178.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.594 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 5.8 tttm -90.39 76.27 6.72 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 177.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.542 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 0.3 OUTLIER -179.98 171.48 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 C-N-CA 118.095 -1.442 . . . . 0.0 112.326 -176.294 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.654 ' HA ' ' CG1' ' A' ' 64' ' ' ILE . 29.4 t -71.31 110.37 5.9 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 175.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.812 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . 3.5 mttm -164.83 -154.49 0.0 OUTLIER Pre-proline 0 C--O 1.191 -2.003 0 C-N-CA 119.093 -1.043 . . . . 0.0 108.761 -174.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.812 ' HD2' ' HB3' ' A' ' 81' ' ' LYS . 50.6 Cg_endo -81.94 130.66 6.68 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 N-CA-C 109.336 -1.063 . . . . 0.0 109.336 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.878 ' CZ ' ' HB3' ' A' ' 63' ' ' GLU . 1.5 m-30 -62.13 152.37 33.16 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 118.233 -1.387 . . . . 0.0 108.568 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.718 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 15.5 m -147.21 96.81 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.241 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.647 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.699 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -74.57 129.26 37.42 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 104.751 -2.314 . . . . 0.0 104.751 177.117 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.503 ' CB ' ' CZ ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -102.67 88.19 3.16 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -173.694 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.596 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 4.3 mp0 -91.81 161.56 14.81 Favored 'General case' 0 C--N 1.283 -2.311 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 174.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.49 ' HD2' ' HA ' ' A' ' 88' ' ' ARG . 0.9 OUTLIER -53.0 151.7 4.54 Favored 'General case' 0 N--CA 1.51 2.535 0 O-C-N 120.521 -1.362 . . . . 0.0 113.933 -175.241 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.549 HG12 ' HA ' ' A' ' 56' ' ' HIS . 74.7 mt . . . . . 0 N--CA 1.494 1.739 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.039 -178.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.496 1.837 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -131.34 113.99 14.45 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.523 -0.736 . . . . 0.0 109.751 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 1.7 m -139.95 131.54 27.16 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.414 -0.804 . . . . 0.0 109.8 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.59 ' HG3' ' O ' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -120.1 121.96 39.99 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.417 -0.802 . . . . 0.0 111.379 -179.169 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.61 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 19.4 t-20 -84.99 148.03 26.4 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.593 -0.692 . . . . 0.0 110.284 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -144.03 156.25 44.31 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.604 ' CG2' ' HG2' ' A' ' 49' ' ' GLU . 32.9 m -129.62 132.21 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 120.867 -1.146 . . . . 0.0 111.9 -178.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.605 HD11 ' HB3' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -162.7 164.91 26.22 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.602 -0.686 . . . . 0.0 110.86 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.532 ' O ' ' N ' ' A' ' 14' ' ' ASN . 15.0 mtt85 -130.96 114.51 15.32 Favored 'General case' 0 N--CA 1.514 2.728 0 O-C-N 121.041 -1.037 . . . . 0.0 113.27 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.753 ' HB2' ' CB ' ' A' ' 16' ' ' HIS . 0.8 OUTLIER -75.07 -155.14 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 124.581 1.153 . . . . 0.0 111.216 179.471 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.648 ' HA ' ' HB3' ' A' ' 41' ' ' ASN . 3.4 mp0 69.03 52.3 0.51 Allowed 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 -177.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.635 ' HA ' ' O ' ' A' ' 42' ' ' PRO . 33.5 m-20 58.07 8.8 0.82 Allowed 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 112.101 -2.318 . . . . 0.0 113.286 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.18 -75.65 1.3 Allowed Glycine 0 N--CA 1.487 2.092 0 C-N-CA 118.034 -2.032 . . . . 0.0 109.279 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.596 ' O ' ' HB3' ' A' ' 43' ' ' ASP . 1.0 OUTLIER -118.4 -78.06 0.58 Allowed 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.876 1.322 . . . . 0.0 108.991 178.853 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.605 ' HB3' HD11 ' A' ' 8' ' ' LEU . 2.2 mt-10 -179.23 133.82 0.12 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.753 ' CB ' ' HB2' ' A' ' 10' ' ' ASP . 0.2 OUTLIER -79.72 123.58 27.8 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 115.712 -2.395 . . . . 0.0 111.376 -178.532 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.682 ' HA2' ' CZ ' ' A' ' 19' ' ' PHE . . . -168.89 109.2 0.32 Allowed Glycine 0 C--N 1.285 -2.287 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.872 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.31 81.32 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 176.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.682 ' CZ ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -176.24 -173.32 0.54 Allowed 'General case' 0 N--CA 1.507 2.396 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.032 -178.487 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.61 ' HA ' ' HA ' ' A' ' 5' ' ' ASN . 37.5 p -106.97 137.0 45.87 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.508 -0.745 . . . . 0.0 111.967 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.59 ' O ' ' HG3' ' A' ' 4' ' ' ARG . . . -115.58 128.3 7.98 Favored Glycine 0 N--CA 1.499 2.854 0 N-CA-C 108.172 -1.971 . . . . 0.0 108.172 178.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 10.7 pttp -57.29 -40.0 76.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.936 -1.332 . . . . 0.0 110.266 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.56 ' HG2' ' HB3' ' A' ' 26' ' ' GLN . 2.4 tp-100 -121.49 136.36 25.86 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 120.975 -1.078 . . . . 0.0 109.311 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.512 ' HB3' ' HD3' ' A' ' 4' ' ' ARG . 38.5 Cg_endo -67.29 -52.84 0.55 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.365 1.192 . . . . 0.0 111.422 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.606 ' HB3' ' HA ' ' A' ' 70' ' ' ASN . 26.8 mtt180 -82.28 -57.55 3.33 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.498 -0.751 . . . . 0.0 111.036 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.56 ' HB3' ' HG2' ' A' ' 23' ' ' GLN . 9.0 tt0 -52.87 -43.21 65.95 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.209 -0.932 . . . . 0.0 111.393 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.455 ' CB ' ' O ' ' A' ' 23' ' ' GLN . . . -77.74 -13.59 59.85 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 120.908 -1.12 . . . . 0.0 109.719 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 24' ' ' PRO . . . -62.1 -51.51 67.63 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.189 -0.944 . . . . 0.0 109.866 178.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.714 ' HB2' ' HG2' ' A' ' 77' ' ' GLU . 3.0 pp -69.2 -42.9 75.16 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.317 -0.953 . . . . 0.0 109.657 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.433 ' H ' ' HG ' ' A' ' 29' ' ' LEU . 11.4 mmtt -61.78 -42.97 99.68 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.43 -0.794 . . . . 0.0 111.305 178.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.413 ' C ' ' HB2' ' A' ' 36' ' ' SER . . . -59.81 -48.43 81.73 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -177.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.642 ' HA ' ' CB ' ' A' ' 36' ' ' SER . . . -62.5 -33.24 74.49 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 118.707 -1.197 . . . . 0.0 109.958 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -44.96 -45.3 10.43 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.7 -70.84 0.72 Allowed 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.346 -0.942 . . . . 0.0 112.441 178.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.546 ' O ' ' CD2' ' A' ' 16' ' ' HIS . . . -114.67 2.07 23.25 Favored Glycine 0 N--CA 1.502 3.079 0 N-CA-C 117.529 1.771 . . . . 0.0 117.529 -175.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.642 ' CB ' ' HA ' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -88.3 -2.51 58.64 Favored 'General case' 0 N--CA 1.511 2.62 0 CA-C-N 123.401 3.6 . . . . 0.0 111.081 -177.238 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 60' ' ' ALA . . . -164.34 117.11 0.74 Allowed Glycine 0 N--CA 1.482 1.759 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -178.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.521 ' O ' ' HB3' ' A' ' 39' ' ' LYS . 50.9 m -76.74 -20.22 56.77 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 119.898 1.849 . . . . 0.0 110.234 -178.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.807 ' CA ' ' HG3' ' A' ' 42' ' ' PRO . 0.3 OUTLIER 76.59 -56.6 0.56 Allowed 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -178.514 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.89 -19.36 65.01 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 175.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.648 ' HB3' ' HA ' ' A' ' 11' ' ' GLU 0.282 0.3 OUTLIER -158.43 68.49 3.61 Favored Pre-proline 0 C--O 1.202 -1.412 0 O-C-N 121.738 -0.602 . . . . 0.0 110.408 179.144 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.807 ' HG3' ' CA ' ' A' ' 39' ' ' LYS 0.251 81.6 Cg_endo -119.1 -173.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.301 -1.955 0 C-N-CA 122.084 1.856 . . . . 0.0 110.442 178.866 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.596 ' HB3' ' O ' ' A' ' 14' ' ' ASN . 4.6 t70 -162.51 -173.44 3.56 Favored 'General case' 0 N--CA 1.507 2.388 0 O-C-N 120.367 -1.458 . . . . 0.0 111.817 176.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.703 ' CD1' ' HG2' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -127.65 123.8 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.546 HG23 HD12 ' A' ' 47' ' ' LEU . 7.7 tt -166.23 170.68 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 119.267 -0.973 . . . . 0.0 110.221 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.531 ' HG3' HG12 ' A' ' 57' ' ' VAL . 2.3 mtp180 -78.21 98.7 5.95 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.554 ' HB2' ' CD2' ' A' ' 56' ' ' HIS . 10.8 mp -70.14 97.04 1.14 Allowed 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.407 ' O ' HG23 ' A' ' 7' ' ' VAL . 6.7 ptt180 -123.61 -178.94 4.17 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.125 -0.984 . . . . 0.0 111.87 -178.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.604 ' HG2' ' CG2' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -150.1 132.5 15.61 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 178.58 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -88.54 -178.3 5.8 Favored 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 118.124 -1.43 . . . . 0.0 111.134 -177.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.93 -58.63 3.9 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 -178.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.559 ' OG1' ' NZ ' ' A' ' 54' ' ' LYS . 4.7 p -105.24 -179.24 3.89 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.543 -0.975 . . . . 0.0 109.273 178.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.61 ' O ' ' N ' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -89.64 99.14 12.2 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 120.972 -1.08 . . . . 0.0 108.211 179.277 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.559 ' NZ ' ' OG1' ' A' ' 52' ' ' THR . 0.0 OUTLIER -144.35 106.51 4.35 Favored 'General case' 0 C--N 1.281 -2.394 0 O-C-N 120.964 -1.085 . . . . 0.0 110.048 -179.28 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.44 ' O ' HG21 ' A' ' 89' ' ' ILE . 42.8 t -150.59 118.73 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.7 -0.625 . . . . 0.0 110.078 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.637 ' NE2' ' HB2' ' A' ' 58' ' ' PHE . 0.3 OUTLIER -131.04 117.58 19.35 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 178.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.665 ' CG1' ' HB3' ' A' ' 87' ' ' GLU . 7.9 t -105.99 115.86 48.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 C-N-CA 117.571 -1.652 . . . . 0.0 108.377 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.637 ' HB2' ' NE2' ' A' ' 56' ' ' HIS . 0.2 OUTLIER -162.22 -177.19 5.56 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 -178.876 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.703 ' HG2' ' CD1' ' A' ' 44' ' ' ILE . 30.0 mttt -129.98 132.75 46.4 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 177.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.497 ' O ' ' CD1' ' A' ' 61' ' ' TRP . . . -121.62 109.55 14.9 Favored 'General case' 0 N--CA 1.504 2.242 0 CA-C-N 120.429 1.468 . . . . 0.0 112.575 -177.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.773 ' HB2' ' HB2' ' A' ' 83' ' ' PHE . 10.6 m0 -131.24 -173.85 3.22 Favored 'General case' 0 N--CA 1.512 2.638 0 O-C-N 121.673 -0.642 . . . . 0.0 111.1 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.666 ' HB3' ' HG3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -114.52 91.85 3.76 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.157 -0.964 . . . . 0.0 109.876 178.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.893 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 3.4 tp10 -171.04 163.91 7.42 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.561 0.696 . . . . 0.0 110.373 178.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.689 ' HB ' ' HA ' ' A' ' 80' ' ' SER . 6.0 tt -70.2 93.94 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.52 3.038 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 -175.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.611 ' HB ' ' HD1' ' A' ' 83' ' ' PHE . 1.4 p -97.86 -161.08 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 O-C-N 120.096 -1.627 . . . . 0.0 109.067 176.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.672 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 1.0 OUTLIER -115.95 140.4 49.28 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.296 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.797 ' HA ' ' CB ' ' A' ' 77' ' ' GLU 0.254 . . -58.39 100.41 0.22 Allowed Pre-proline 0 N--CA 1.502 2.171 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.297 -178.111 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.641 ' HD3' ' O ' ' A' ' 66' ' ' ASP . 54.5 Cg_endo -76.38 83.82 1.96 Allowed 'Trans proline' 0 N--CA 1.492 1.391 0 O-C-N 124.166 1.614 . . . . 0.0 112.366 -177.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.6 mttt 41.3 38.94 0.87 Allowed 'General case' 0 N--CA 1.507 2.413 0 CA-C-O 121.3 0.571 . . . . 0.0 111.476 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.643 ' ND2' ' HB3' ' A' ' 29' ' ' LEU . 20.0 m-20 -77.81 -19.18 55.42 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.476 -0.765 . . . . 0.0 111.406 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.702 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER 41.77 50.77 5.05 Favored Pre-proline 0 N--CA 1.507 2.412 0 CA-C-O 121.028 0.442 . . . . 0.0 112.02 -178.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.736 ' HG2' ' HA ' ' A' ' 76' ' ' PRO . 55.5 Cg_endo -99.22 99.68 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.591 1.528 . . . . 0.0 108.76 179.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.89 -19.17 16.21 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.191 -0.943 . . . . 0.0 111.829 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.446 ' CD1' ' N ' ' A' ' 74' ' ' TRP . 41.0 m95 -79.41 -42.59 25.15 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 121.443 -0.786 . . . . 0.0 109.808 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 6.6 ttm -176.21 123.55 0.31 Allowed Pre-proline 0 N--CA 1.503 2.177 0 O-C-N 121.581 -0.699 . . . . 0.0 110.487 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.746 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 51.8 Cg_endo -83.18 176.84 7.06 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 O-C-N 124.091 1.574 . . . . 0.0 111.101 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.797 ' CB ' ' HA ' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -87.87 12.67 12.5 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 117.697 -1.601 . . . . 0.0 110.726 -179.645 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.672 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 4.6 tttm -82.63 79.88 8.91 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.597 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 0.3 OUTLIER 177.87 170.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 C-N-CA 118.388 -1.325 . . . . 0.0 111.903 -177.643 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.689 ' HA ' ' HB ' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -69.08 106.29 2.74 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 104.207 -2.516 . . . . 0.0 104.207 175.243 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.825 ' HB3' ' HD2' ' A' ' 82' ' ' PRO 0.26 0.7 OUTLIER -165.02 -155.54 0.01 OUTLIER Pre-proline 0 C--O 1.194 -1.867 0 C-N-CA 119.143 -1.023 . . . . 0.0 108.847 -173.402 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.825 ' HD2' ' HB3' ' A' ' 81' ' ' LYS . 51.2 Cg_endo -78.15 125.01 6.9 Favored 'Trans proline' 0 C--N 1.302 -1.876 0 N-CA-C 108.792 -1.272 . . . . 0.0 108.792 178.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.893 ' CZ ' ' HB3' ' A' ' 63' ' ' GLU . 2.0 m-30 -61.38 145.81 50.35 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.288 -1.508 . . . . 0.0 108.158 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.696 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 2.1 t -143.21 94.84 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.466 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.635 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 2.7 mmtm -88.18 117.08 26.83 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.622 ' HB3' ' CZ ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -72.97 162.36 29.58 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 124.344 2.021 . . . . 0.0 114.091 -175.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.665 ' HB3' ' CG1' ' A' ' 57' ' ' VAL . 5.0 mt-10 -165.53 155.66 13.05 Favored 'General case' 0 C--N 1.271 -2.846 0 CA-C-N 110.544 -3.025 . . . . 0.0 107.857 177.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.45 ' O ' HG21 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -47.01 132.45 11.88 Favored 'General case' 0 N--CA 1.507 2.423 0 CA-C-O 122.194 0.997 . . . . 0.0 113.031 -175.666 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.521 HG21 ' HA ' ' A' ' 56' ' ' HIS . 5.2 mt -121.68 142.36 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.335 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -141.71 122.99 14.81 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.411 ' NZ ' ' O ' ' A' ' 92' ' ' LEU . 0.7 OUTLIER -138.5 174.3 10.69 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.467 -1.396 . . . . 0.0 111.784 -179.458 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.61 ' N ' ' O ' ' A' ' 53' ' ' LYS . 2.1 pp -70.85 131.26 43.51 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.593 0.711 . . . . 0.0 109.737 -179.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 . . . . . 0 C--N 1.293 -1.852 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.027 -179.886 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.2 t . . . . . 0 N--CA 1.497 1.899 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.405 ' OD1' ' NZ ' ' A' ' 22' ' ' LYS . 37.4 p-10 -116.44 145.71 43.07 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.421 -0.799 . . . . 0.0 110.163 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.1 m -153.94 158.89 41.36 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.97 -1.081 . . . . 0.0 109.859 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.475 ' HD3' ' N ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -97.68 126.16 42.85 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.238 -0.913 . . . . 0.0 109.924 -179.724 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.512 ' HA ' ' CG2' ' A' ' 20' ' ' THR . 0.1 OUTLIER -78.17 121.53 24.46 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.695 -0.628 . . . . 0.0 110.849 -179.3 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.713 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 39.5 m-85 -109.6 167.45 10.13 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.426 -0.796 . . . . 0.0 110.549 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.478 HG21 ' HG2' ' A' ' 48' ' ' ARG . 29.8 m -139.72 129.83 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 O-C-N 121.527 -0.733 . . . . 0.0 111.695 -178.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.646 ' HB3' ' HG ' ' A' ' 47' ' ' LEU . 0.3 OUTLIER -164.98 159.49 18.08 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.118 -0.989 . . . . 0.0 111.746 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.512 ' O ' ' N ' ' A' ' 14' ' ' ASN . 2.5 ttm-85 -140.12 114.91 9.52 Favored 'General case' 0 N--CA 1.511 2.577 0 O-C-N 121.083 -1.011 . . . . 0.0 112.755 178.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.779 ' HB2' ' CB ' ' A' ' 16' ' ' HIS . 0.7 OUTLIER -73.49 -153.19 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 125.154 1.381 . . . . 0.0 111.444 179.647 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.587 ' HA ' ' HB3' ' A' ' 41' ' ' ASN . 0.6 OUTLIER 71.9 50.95 0.23 Allowed 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 -177.594 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.595 ' HA ' ' O ' ' A' ' 42' ' ' PRO . 86.5 m-20 59.14 6.6 0.72 Allowed 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 112.539 -2.118 . . . . 0.0 112.591 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.04 -77.33 1.34 Allowed Glycine 0 N--CA 1.485 1.903 0 C-N-CA 117.937 -2.078 . . . . 0.0 109.77 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.692 ' CA ' HG12 ' A' ' 45' ' ' ILE . 6.1 m-20 -117.49 -81.67 0.62 Allowed 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 122.183 0.992 . . . . 0.0 111.566 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.556 ' HB3' HD11 ' A' ' 8' ' ' LEU . 7.8 mt-10 -170.12 129.84 0.93 Allowed 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.779 ' CB ' ' HB2' ' A' ' 10' ' ' ASP . 0.2 OUTLIER -81.25 121.51 26.25 Favored 'General case' 0 N--CA 1.505 2.281 0 C-N-CA 115.273 -2.571 . . . . 0.0 112.17 -178.086 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.67 ' HA2' ' CZ ' ' A' ' 19' ' ' PHE . . . -176.89 122.84 0.86 Allowed Glycine 0 C--N 1.284 -2.322 0 CA-C-N 114.149 -1.387 . . . . 0.0 111.977 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.27 86.46 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 176.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.67 ' CZ ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -175.42 -172.11 0.54 Allowed 'General case' 0 N--CA 1.504 2.228 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.022 -178.08 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.512 ' CG2' ' HA ' ' A' ' 5' ' ' ASN . 42.8 p -108.56 153.74 22.94 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.121 -0.987 . . . . 0.0 111.885 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -135.89 131.55 5.78 Favored Glycine 0 N--CA 1.507 3.367 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.405 ' NZ ' ' OD1' ' A' ' 2' ' ' ASN . 0.7 OUTLIER -56.14 -50.88 69.89 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.149 -1.206 . . . . 0.0 109.225 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.487 ' HB2' ' HG2' ' A' ' 26' ' ' GLN . 37.2 mm-40 -126.71 124.71 24.22 Favored Pre-proline 0 N--CA 1.492 1.641 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.417 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 42.5 Cg_endo -67.9 -19.67 46.11 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 123.614 1.323 . . . . 0.0 112.085 -178.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.485 ' HD2' ' HA ' ' A' ' 70' ' ' ASN . 8.5 mtt180 -82.84 -68.03 0.74 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.298 -0.877 . . . . 0.0 110.739 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.614 ' HB2' ' HA ' ' A' ' 72' ' ' PRO . 13.6 pt20 -58.93 -37.57 77.01 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.982 -1.073 . . . . 0.0 112.148 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.0 -22.85 63.09 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 120.765 -1.21 . . . . 0.0 109.661 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 24' ' ' PRO . . . -58.77 -58.17 9.8 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.112 -0.992 . . . . 0.0 111.688 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.519 ' HB2' ' NZ ' ' A' ' 81' ' ' LYS . 2.6 pp -56.26 -50.27 71.81 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 119.041 -1.064 . . . . 0.0 110.709 -178.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.426 ' HD3' ' CD1' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -69.79 -37.68 76.42 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 120.582 -1.324 . . . . 0.0 112.892 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.01 -45.09 95.12 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.723 -1.235 . . . . 0.0 112.306 -177.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.622 ' HA ' ' CB ' ' A' ' 36' ' ' SER . . . -62.42 -34.52 76.93 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 118.694 -1.202 . . . . 0.0 109.535 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.606 ' CA ' ' HG3' ' A' ' 82' ' ' PRO . 0.2 OUTLIER -40.88 -48.1 3.06 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.185 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 -97.04 -72.31 0.65 Allowed 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.212 -0.995 . . . . 0.0 112.086 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.532 ' O ' ' CD2' ' A' ' 16' ' ' HIS . . . -114.52 -1.23 23.22 Favored Glycine 0 N--CA 1.501 2.991 0 N-CA-C 117.401 1.72 . . . . 0.0 117.401 -175.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.622 ' CB ' ' HA ' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -86.04 -1.71 57.62 Favored 'General case' 0 N--CA 1.514 2.75 0 CA-C-N 123.255 3.527 . . . . 0.0 110.941 -177.017 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -162.4 119.56 0.89 Allowed Glycine 0 C--N 1.299 -1.521 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.483 ' O ' ' HB3' ' A' ' 39' ' ' LYS . 12.9 m -81.08 -15.2 56.67 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 120.417 -1.637 . . . . 0.0 109.665 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.806 ' CA ' ' HG3' ' A' ' 42' ' ' PRO . 7.6 tttp 72.84 -59.16 0.58 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.45 -18.02 65.12 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.121 -1.436 . . . . 0.0 107.121 175.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.587 ' HB3' ' HA ' ' A' ' 11' ' ' GLU 0.285 0.3 OUTLIER -159.05 67.77 3.2 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.678 -0.639 . . . . 0.0 110.87 179.233 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.806 ' HG3' ' CA ' ' A' ' 39' ' ' LYS . 78.2 Cg_endo -119.13 -174.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.472 2.115 . . . . 0.0 110.927 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -166.47 -172.83 2.3 Favored 'General case' 0 N--CA 1.513 2.716 0 O-C-N 120.156 -1.59 . . . . 0.0 113.029 176.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.642 ' HB ' ' CG ' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -126.02 124.34 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.692 HG12 ' CA ' ' A' ' 14' ' ' ASN . 1.6 pp -157.32 -176.43 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.435 -0.791 . . . . 0.0 110.336 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.552 ' HB3' HG11 ' A' ' 55' ' ' VAL . 16.7 mtt85 -85.56 94.56 9.07 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.646 ' HG ' ' HB3' ' A' ' 8' ' ' LEU . 5.3 tt -73.55 94.41 2.14 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.478 ' HG2' HG21 ' A' ' 7' ' ' VAL . 4.2 ptp180 -81.66 -176.76 6.23 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 119.478 -0.889 . . . . 0.0 112.282 -177.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.713 ' HA ' ' HA ' ' A' ' 6' ' ' PHE . 0.4 OUTLIER -137.94 161.54 36.39 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 -179.27 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.659 ' N ' ' HG2' ' A' ' 49' ' ' GLU . 4.5 mtt180 -102.48 154.53 19.01 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 117.512 -1.675 . . . . 0.0 110.318 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.83 -76.93 0.23 Allowed Glycine 0 N--CA 1.495 2.596 0 N-CA-C 107.569 -2.213 . . . . 0.0 107.569 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.593 ' OG1' ' NZ ' ' A' ' 54' ' ' LYS . 21.7 p -98.38 -170.47 1.96 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 177.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.516 ' CB ' ' O ' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -105.71 91.14 3.63 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 120.382 -1.449 . . . . 0.0 109.346 179.712 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.631 ' HB3' ' HB3' ' A' ' 49' ' ' GLU . 0.1 OUTLIER -114.45 149.44 36.27 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.382 179.638 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.552 HG11 ' HB3' ' A' ' 46' ' ' ARG . 35.2 t -149.26 94.25 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.637 ' NE2' ' HB2' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -79.92 124.92 29.11 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 179.189 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.618 ' CB ' ' HB2' ' A' ' 87' ' ' GLU . 2.9 t -109.37 106.46 20.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 C-N-CA 117.362 -1.735 . . . . 0.0 107.152 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.745 ' HA ' ' O ' ' A' ' 85' ' ' LYS . 0.3 OUTLIER -150.03 167.74 25.87 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.699 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 8.3 mttm -121.17 118.96 31.0 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.458 ' O ' ' CD1' ' A' ' 61' ' ' TRP . . . -106.69 107.33 18.29 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 118.609 -1.236 . . . . 0.0 112.484 -176.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.763 ' HB2' ' HB2' ' A' ' 83' ' ' PHE . 18.5 m0 -128.49 -166.13 1.59 Allowed 'General case' 0 N--CA 1.512 2.635 0 O-C-N 121.842 -0.536 . . . . 0.0 111.021 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.728 ' HB2' ' HB2' ' A' ' 39' ' ' LYS . 0.3 OUTLIER -123.2 86.53 2.59 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 120.967 -1.083 . . . . 0.0 110.966 179.747 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.757 ' CB ' ' CZ ' ' A' ' 83' ' ' PHE . 19.7 mp0 -161.19 171.14 18.98 Favored 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.639 ' HB ' ' HA ' ' A' ' 80' ' ' SER . 2.8 tt -78.48 98.04 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.136 0 O-C-N 119.301 -2.124 . . . . 0.0 115.49 -177.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.635 HG23 ' HA ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -89.85 -168.41 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.309 -1.495 . . . . 0.0 110.342 177.739 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.632 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 10.9 t70 -119.66 133.85 55.47 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.779 ' HA ' ' CB ' ' A' ' 77' ' ' GLU . . . -66.01 101.33 0.27 Allowed Pre-proline 0 N--CA 1.504 2.273 0 CA-C-O 117.93 -1.033 . . . . 0.0 111.902 -178.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.656 ' CB ' ' HD2' ' A' ' 86' ' ' LYS . 52.5 Cg_endo -86.93 -166.66 0.31 Allowed 'Trans proline' 0 C--N 1.315 -1.221 0 O-C-N 123.875 1.461 . . . . 0.0 111.467 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.0 mmmt -69.44 62.02 0.15 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.447 -0.783 . . . . 0.0 110.295 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.497 ' O ' ' CG ' ' A' ' 71' ' ' ARG . 1.0 OUTLIER -101.65 -9.35 20.99 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.653 -0.654 . . . . 0.0 111.213 -179.842 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.74 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER 56.52 44.06 1.33 Allowed Pre-proline 0 N--CA 1.508 2.441 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -179.244 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.744 ' HG2' ' HA ' ' A' ' 76' ' ' PRO . 49.0 Cg_endo -94.06 98.99 0.13 Allowed 'Trans proline' 0 C--N 1.316 -1.183 0 C-N-CA 120.84 1.026 . . . . 0.0 110.015 178.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.9 -18.33 50.86 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.15 -0.968 . . . . 0.0 111.444 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.519 ' CD1' ' N ' ' A' ' 74' ' ' TRP . 6.9 m0 -80.29 -37.82 32.01 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.154 -0.966 . . . . 0.0 109.579 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.439 ' O ' ' HB2' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -167.64 122.57 0.82 Allowed Pre-proline 0 N--CA 1.496 1.83 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.612 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.744 ' HA ' ' HG2' ' A' ' 72' ' ' PRO . 49.5 Cg_endo -81.92 -179.8 5.06 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.589 1.31 . . . . 0.0 112.62 -178.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.779 ' CB ' ' HA ' ' A' ' 67' ' ' ALA . 1.3 mt-10 -92.2 11.0 27.12 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 118.315 -1.354 . . . . 0.0 110.684 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.61 ' HB2' ' HB1' ' A' ' 67' ' ' ALA . 0.6 OUTLIER -92.46 82.83 4.89 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.94 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.608 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -176.87 161.55 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 C-N-CA 118.146 -1.422 . . . . 0.0 112.392 -177.837 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.639 ' HA ' ' HB ' ' A' ' 64' ' ' ILE . 0.3 OUTLIER -75.07 104.94 5.85 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 175.501 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.727 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 11.5 pttp -169.81 -152.58 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.784 0 C-N-CA 118.843 -1.143 . . . . 0.0 108.393 -174.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.727 ' HD2' ' HB2' ' A' ' 81' ' ' LYS . 51.0 Cg_endo -74.83 127.33 10.72 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 N-CA-C 109.547 -0.982 . . . . 0.0 109.547 178.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.763 ' HB2' ' HB2' ' A' ' 61' ' ' TRP . 0.8 OUTLIER -65.16 160.19 21.84 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.987 -1.071 . . . . 0.0 109.737 179.502 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.699 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -154.64 92.7 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 177.25 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.745 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -77.51 122.35 25.11 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 178.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.656 ' HD2' ' CB ' ' A' ' 68' ' ' PRO . 0.0 OUTLIER -85.24 92.2 8.36 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 122.864 1.316 . . . . 0.0 113.29 -175.783 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.637 ' HG3' HD12 ' A' ' 44' ' ' ILE . 3.2 mm-40 -88.5 153.94 20.75 Favored 'General case' 0 C--N 1.28 -2.448 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.459 176.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -53.38 111.11 0.64 Allowed 'General case' 0 N--CA 1.51 2.557 0 CA-C-O 122.092 0.949 . . . . 0.0 113.087 -176.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.537 ' CG2' ' HA ' ' A' ' 56' ' ' HIS . 10.4 mt -84.55 131.75 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.085 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -101.82 152.3 21.06 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.577 -0.702 . . . . 0.0 109.158 178.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.565 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -163.69 95.23 0.8 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.554 -1.341 . . . . 0.0 112.702 -179.481 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.516 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 1.1 pp -170.0 124.07 0.75 Allowed 'General case' 0 N--CA 1.506 2.371 0 C-N-CA 119.563 -0.855 . . . . 0.0 112.497 177.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.565 ' HG3' ' HA ' ' A' ' 52' ' ' THR . 18.9 tt0 . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 118.184 -0.912 . . . . 0.0 109.823 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 120.809 0.338 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.26 148.1 34.05 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.205 -0.934 . . . . 0.0 110.515 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 1.5 m -78.25 151.18 33.21 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.189 0.519 . . . . 0.0 111.313 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.477 ' O ' ' HA ' ' A' ' 20' ' ' THR . 3.0 mpt_? -113.54 136.27 52.98 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.306 -0.871 . . . . 0.0 110.068 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 6.7 t-20 -77.43 143.55 38.5 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.65 -0.657 . . . . 0.0 110.417 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -142.65 137.56 30.05 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.576 -0.702 . . . . 0.0 110.264 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.463 HG22 ' O ' ' A' ' 7' ' ' VAL . 17.0 m -119.39 132.78 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.516 -0.74 . . . . 0.0 111.599 -178.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.572 ' CD2' ' HG ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -163.39 161.45 24.42 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.107 -0.995 . . . . 0.0 111.291 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.472 ' O ' ' N ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -131.99 110.58 10.85 Favored 'General case' 0 N--CA 1.513 2.718 0 O-C-N 121.13 -0.981 . . . . 0.0 113.154 -179.375 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.798 ' HB2' ' CB ' ' A' ' 16' ' ' HIS . 0.9 OUTLIER -73.48 -156.16 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 C-N-CA 124.274 1.03 . . . . 0.0 111.101 179.337 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.695 ' HA ' ' HB3' ' A' ' 41' ' ' ASN . 3.0 mp0 70.92 51.66 0.3 Allowed 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 -177.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.607 ' HA ' ' O ' ' A' ' 42' ' ' PRO . 86.4 m-20 59.45 7.95 1.09 Allowed 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 112.306 -2.224 . . . . 0.0 113.027 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.28 -77.69 1.33 Allowed Glycine 0 N--CA 1.486 1.992 0 C-N-CA 117.954 -2.07 . . . . 0.0 109.061 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.626 ' O ' ' HB3' ' A' ' 43' ' ' ASP . 8.0 m-20 -117.11 -77.24 0.57 Allowed 'General case' 0 C--N 1.296 -1.753 0 CA-C-O 122.606 1.193 . . . . 0.0 109.909 178.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.54 ' HA ' ' OD1' ' A' ' 10' ' ' ASP . 1.3 mt-10 -178.05 138.08 0.19 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 178.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.798 ' CB ' ' HB2' ' A' ' 10' ' ' ASP . 0.2 OUTLIER -87.37 122.45 31.14 Favored 'General case' 0 N--CA 1.501 2.119 0 C-N-CA 115.672 -2.411 . . . . 0.0 112.22 -178.623 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.649 ' HA2' ' CE1' ' A' ' 19' ' ' PHE . . . -174.43 110.16 0.32 Allowed Glycine 0 C--N 1.283 -2.375 0 CA-C-N 113.804 -1.543 . . . . 0.0 110.834 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.449 ' C ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -130.96 81.87 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.2 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.649 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -175.17 -173.49 0.67 Allowed 'General case' 0 N--CA 1.502 2.161 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.077 -179.682 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 4' ' ' ARG . 57.3 p -103.23 144.8 30.86 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.418 -0.801 . . . . 0.0 111.809 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -124.29 133.58 8.76 Favored Glycine 0 N--CA 1.503 3.111 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 5.4 mttt -66.46 -58.64 4.83 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.241 -1.153 . . . . 0.0 108.752 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.497 ' HB3' ' HB3' ' A' ' 26' ' ' GLN . 0.9 OUTLIER -109.45 106.05 58.02 Favored Pre-proline 0 C--N 1.303 -1.424 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 177.9 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.557 ' HB2' HD13 ' A' ' 89' ' ' ILE . 36.9 Cg_endo -60.04 -26.46 82.49 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.945 1.498 . . . . 0.0 111.309 -178.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.586 ' HD3' ' HA ' ' A' ' 70' ' ' ASN . 3.6 mtt-85 -85.23 -58.39 2.7 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.268 -0.895 . . . . 0.0 109.239 178.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.76 ' HG3' ' HA ' ' A' ' 72' ' ' PRO . 1.0 OUTLIER -59.01 -43.53 91.54 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.921 -1.112 . . . . 0.0 110.807 179.552 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.41 -18.15 63.73 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 118.993 -1.083 . . . . 0.0 109.78 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.474 ' HB2' ' O ' ' A' ' 24' ' ' PRO . . . -59.76 -60.11 4.36 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.436 -0.79 . . . . 0.0 111.703 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.552 ' HB3' ' HG3' ' A' ' 77' ' ' GLU . 1.8 pp -63.89 -44.13 93.93 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 118.933 -1.107 . . . . 0.0 110.524 -179.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.6 mtmt -66.48 -43.7 84.67 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 120.781 -1.199 . . . . 0.0 112.476 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.23 -45.46 88.07 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.929 -1.107 . . . . 0.0 112.864 -177.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.663 ' HA ' ' CB ' ' A' ' 36' ' ' SER . . . -56.64 -37.52 70.87 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 118.781 -1.167 . . . . 0.0 109.493 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.488 ' CB ' ' HG3' ' A' ' 82' ' ' PRO . 4.4 t-20 -42.39 -47.05 4.87 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.98 -73.44 0.58 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 119.035 -1.066 . . . . 0.0 112.545 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.512 ' O ' ' CD2' ' A' ' 16' ' ' HIS . . . -116.76 1.63 19.92 Favored Glycine 0 N--CA 1.502 3.092 0 N-CA-C 117.213 1.645 . . . . 0.0 117.213 -175.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.663 ' CB ' ' HA ' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -85.17 -4.85 59.3 Favored 'General case' 0 N--CA 1.51 2.545 0 CA-C-N 122.929 3.364 . . . . 0.0 110.99 -176.917 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -165.37 120.89 0.96 Allowed Glycine 0 N--CA 1.478 1.494 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.56 ' O ' ' HB3' ' A' ' 39' ' ' LYS . 32.4 m -77.66 -14.81 59.52 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 120.359 -1.671 . . . . 0.0 110.195 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.803 ' CA ' ' HG3' ' A' ' 42' ' ' PRO . 1.2 tmtt? 72.01 -56.57 0.64 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -178.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.97 -18.73 63.36 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 176.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.695 ' HB3' ' HA ' ' A' ' 11' ' ' GLU 0.278 0.4 OUTLIER -156.75 67.73 4.34 Favored Pre-proline 0 C--O 1.199 -1.581 0 O-C-N 121.819 -0.55 . . . . 0.0 109.98 179.083 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.803 ' HG3' ' CA ' ' A' ' 39' ' ' LYS . 80.0 Cg_endo -119.61 -174.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 122.382 2.054 . . . . 0.0 111.075 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.626 ' HB3' ' O ' ' A' ' 14' ' ' ASN . 3.2 t70 -165.11 -168.71 1.47 Allowed 'General case' 0 N--CA 1.51 2.565 0 O-C-N 120.357 -1.464 . . . . 0.0 111.963 176.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.689 ' CD1' ' HG2' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -129.93 120.76 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.715 -0.616 . . . . 0.0 109.778 -179.043 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.529 ' CG2' ' HA ' ' A' ' 14' ' ' ASN . 1.3 pp -157.98 -177.96 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-O 121.829 0.823 . . . . 0.0 109.876 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.505 ' HG2' ' HB ' ' A' ' 57' ' ' VAL . 0.5 OUTLIER -91.19 100.26 13.12 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.102 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.572 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 9.4 mp -69.71 93.32 0.72 Allowed 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.555 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 8.2 ptp85 -113.12 -165.41 0.99 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.722 -0.791 . . . . 0.0 113.059 -175.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -147.36 164.55 32.94 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -111.68 172.63 6.78 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 117.894 -1.522 . . . . 0.0 110.9 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.98 -43.31 2.96 Favored Glycine 0 N--CA 1.498 2.825 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.0 p -126.8 178.84 5.69 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.254 -1.145 . . . . 0.0 109.337 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.596 ' O ' ' N ' ' A' ' 92' ' ' LEU . 2.1 mttm -92.91 105.69 17.77 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 122.684 1.23 . . . . 0.0 108.866 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 48' ' ' ARG . 0.8 OUTLIER -149.53 99.7 2.92 Favored 'General case' 0 C--N 1.279 -2.479 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.814 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.538 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . 3.9 t -138.78 107.58 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 CA-C-O 121.245 0.545 . . . . 0.0 110.547 -178.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.593 ' NE2' ' HB2' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -101.04 127.4 47.58 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 178.54 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.729 ' CG1' ' HB3' ' A' ' 87' ' ' GLU . 2.2 p -117.6 123.84 72.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 C-N-CA 116.611 -2.036 . . . . 0.0 108.852 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.632 ' HA ' ' O ' ' A' ' 85' ' ' LYS . 0.3 OUTLIER -162.75 -176.35 4.92 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 -178.681 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.724 ' CG ' ' HB2' ' A' ' 85' ' ' LYS . 38.2 mttt -133.42 124.48 27.18 Favored 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.522 ' O ' ' CD1' ' A' ' 61' ' ' TRP . . . -110.75 109.29 19.46 Favored 'General case' 0 N--CA 1.505 2.287 0 C-N-CA 118.595 -1.242 . . . . 0.0 113.424 -176.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.796 ' HB2' ' HB2' ' A' ' 83' ' ' PHE . 11.2 m0 -132.38 -163.46 1.34 Allowed 'General case' 0 N--CA 1.515 2.822 0 O-C-N 121.86 -0.525 . . . . 0.0 110.589 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.691 ' CB ' ' HG3' ' A' ' 39' ' ' LYS . 0.5 OUTLIER -125.26 89.04 2.98 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 120.423 -1.423 . . . . 0.0 112.217 179.93 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.85 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 4.3 mt-10 -167.17 -179.44 4.57 Favored 'General case' 0 N--CA 1.514 2.752 0 CA-C-O 121.514 0.674 . . . . 0.0 111.064 177.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.574 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 2.1 mt -78.26 99.88 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.086 0 O-C-N 119.429 -2.045 . . . . 0.0 115.012 -176.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.679 ' CG2' ' HA ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -90.92 -168.91 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 120.586 -1.321 . . . . 0.0 110.317 177.51 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.632 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 12.1 t70 -124.72 129.86 51.3 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.798 ' HA ' ' CB ' ' A' ' 77' ' ' GLU 0.253 . . -66.18 98.6 0.16 Allowed Pre-proline 0 N--CA 1.511 2.623 0 CA-C-O 117.51 -1.233 . . . . 0.0 111.862 -177.542 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.632 ' HD3' ' O ' ' A' ' 66' ' ' ASP . 48.9 Cg_endo -92.95 85.68 0.19 Allowed 'Trans proline' 0 N--CA 1.483 0.893 0 O-C-N 123.818 1.43 . . . . 0.0 112.994 -178.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.5 mttm 38.99 54.03 2.07 Favored 'General case' 0 N--CA 1.511 2.597 0 CA-C-O 121.71 0.767 . . . . 0.0 111.538 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.586 ' HA ' ' HD3' ' A' ' 25' ' ' ARG . 0.9 OUTLIER -91.8 -9.7 42.56 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.289 -0.882 . . . . 0.0 112.216 -179.083 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.742 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER 62.67 35.46 0.21 Allowed Pre-proline 0 N--CA 1.508 2.432 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -179.649 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.794 ' HG2' ' HA ' ' A' ' 76' ' ' PRO . 56.8 Cg_endo -93.41 115.13 0.27 Allowed 'Trans proline' 0 C--N 1.315 -1.193 0 N-CA-C 109.822 -0.876 . . . . 0.0 109.822 178.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.0 -19.75 39.85 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.951 -1.093 . . . . 0.0 111.715 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.457 ' CD1' ' N ' ' A' ' 74' ' ' TRP . 37.8 m95 -82.28 -39.21 23.27 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.398 -0.814 . . . . 0.0 110.137 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.539 ' SD ' ' HE3' ' A' ' 81' ' ' LYS . 2.1 mtm -170.42 132.2 0.96 Allowed Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.708 -0.62 . . . . 0.0 109.556 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.794 ' HA ' ' HG2' ' A' ' 72' ' ' PRO . 46.4 Cg_endo -87.33 -178.16 2.34 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.682 1.359 . . . . 0.0 112.129 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.798 ' CB ' ' HA ' ' A' ' 67' ' ' ALA . 0.3 OUTLIER -88.94 11.39 18.27 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 118.092 -1.443 . . . . 0.0 110.321 -179.328 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.604 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -94.18 81.6 4.08 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.229 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.587 HG12 ' HE2' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -177.97 164.44 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 118.145 -1.422 . . . . 0.0 112.57 -177.462 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.567 ' HA ' ' HA ' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -73.84 104.32 4.68 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 104.556 -2.387 . . . . 0.0 104.556 175.218 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.776 ' HB3' ' HD2' ' A' ' 82' ' ' PRO 0.262 2.8 mttm -164.16 -162.41 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.682 0 C-N-CA 118.857 -1.137 . . . . 0.0 110.112 -174.267 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.776 ' HD2' ' HB3' ' A' ' 81' ' ' LYS . 43.4 Cg_endo -69.87 121.65 8.31 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 N-CA-C 107.529 -1.758 . . . . 0.0 107.529 176.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.85 ' CZ ' ' HB3' ' A' ' 63' ' ' GLU . 0.4 OUTLIER -57.37 151.51 16.12 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.878 -1.139 . . . . 0.0 109.892 -178.734 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.669 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -148.04 88.8 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.51 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.388 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.724 ' HB2' ' CG ' ' A' ' 59' ' ' LYS . 14.6 mmtp -79.93 118.16 21.43 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.557 ' HA ' ' CE1' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -72.67 156.55 38.84 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 124.256 1.979 . . . . 0.0 114.3 -175.419 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.729 ' HB3' ' CG1' ' A' ' 57' ' ' VAL . 0.5 OUTLIER -163.34 143.7 8.98 Favored 'General case' 0 C--N 1.271 -2.817 0 CA-C-N 111.096 -2.774 . . . . 0.0 108.828 177.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.528 ' O ' HG12 ' A' ' 57' ' ' VAL . 1.0 OUTLIER -55.0 117.49 3.49 Favored 'General case' 0 N--CA 1.506 2.351 0 CA-C-O 122.13 0.967 . . . . 0.0 113.38 -176.487 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.593 HG22 ' HD3' ' A' ' 91' ' ' LYS . 42.8 mt -83.12 106.08 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.34 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -84.55 122.75 29.46 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.455 -0.778 . . . . 0.0 109.132 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.593 ' HD3' HG22 ' A' ' 89' ' ' ILE . 16.7 mtmm -140.44 -179.72 6.18 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.813 -1.179 . . . . 0.0 112.063 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.596 ' N ' ' O ' ' A' ' 53' ' ' LYS . 2.7 pp -78.08 -176.62 4.65 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 115.383 -0.826 . . . . 0.0 108.848 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 . . . . . 0 N--CA 1.494 1.774 0 CA-C-O 118.367 -0.825 . . . . 0.0 109.484 178.878 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.968 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -152.49 158.5 42.66 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.175 -0.953 . . . . 0.0 110.476 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.4 t -153.86 146.89 24.52 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.464 -0.773 . . . . 0.0 109.583 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.494 ' O ' ' HA ' ' A' ' 20' ' ' THR . 22.3 mmt180 -116.94 124.52 49.62 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.28 -0.888 . . . . 0.0 110.052 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.465 ' HA ' ' CG2' ' A' ' 20' ' ' THR . 6.1 t-20 -72.55 135.86 45.7 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.512 -0.742 . . . . 0.0 109.582 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.688 ' CD1' HD23 ' A' ' 47' ' ' LEU . 4.3 m-85 -142.22 166.81 23.67 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.603 -0.839 . . . . 0.0 111.355 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.45 ' O ' HD22 ' A' ' 47' ' ' LEU . 10.8 m -136.62 131.77 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.808 -0.557 . . . . 0.0 111.143 -178.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.599 ' HB3' ' HG ' ' A' ' 47' ' ' LEU . 0.4 OUTLIER -159.07 161.97 36.53 Favored 'General case' 0 N--CA 1.512 2.641 0 O-C-N 120.922 -1.111 . . . . 0.0 111.877 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.475 ' O ' ' N ' ' A' ' 14' ' ' ASN . 10.7 tpt180 -148.81 112.51 5.08 Favored 'General case' 0 N--CA 1.512 2.647 0 O-C-N 121.012 -1.055 . . . . 0.0 112.832 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.869 ' HB3' ' CD2' ' A' ' 16' ' ' HIS . 5.8 t0 -98.61 -144.09 0.32 Allowed 'General case' 0 N--CA 1.508 2.428 0 O-C-N 121.273 -0.892 . . . . 0.0 109.405 177.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.75 ' HA ' ' HB3' ' A' ' 41' ' ' ASN . 2.4 mt-10 72.63 57.54 0.13 Allowed 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 102.576 -3.12 . . . . 0.0 102.576 -174.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.661 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 69.8 m-20 74.14 -5.15 2.12 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 112.272 -2.24 . . . . 0.0 111.844 -177.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.07 -83.53 1.42 Allowed Glycine 0 N--CA 1.482 1.764 0 C-N-CA 118.25 -1.928 . . . . 0.0 109.729 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.708 ' HB3' ' CD1' ' A' ' 45' ' ' ILE . 0.7 OUTLIER -129.19 -74.49 0.56 Allowed 'General case' 0 N--CA 1.51 2.529 0 O-C-N 121.634 -0.921 . . . . 0.0 112.744 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.747 ' CA ' ' HB2' ' A' ' 10' ' ' ASP . 35.2 tt0 -164.89 127.89 2.3 Favored 'General case' 0 N--CA 1.522 3.136 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.869 ' CD2' ' HB3' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -99.37 124.4 44.45 Favored 'General case' 0 N--CA 1.512 2.671 0 C-N-CA 116.208 -2.197 . . . . 0.0 115.415 -176.377 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.484 ' CA ' ' CE1' ' A' ' 19' ' ' PHE . . . -178.09 134.62 2.45 Favored Glycine 0 N--CA 1.48 1.586 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.212 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.423 ' C ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -132.88 91.07 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 120.87 -1.37 . . . . 0.0 108.112 177.254 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.671 ' N ' ' CD1' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -174.81 -170.65 0.49 Allowed 'General case' 0 N--CA 1.504 2.251 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.727 -178.667 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 4' ' ' ARG . 18.1 p -106.09 151.46 24.66 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.033 -1.042 . . . . 0.0 111.24 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -129.62 142.07 13.25 Favored Glycine 0 N--CA 1.504 3.195 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -71.49 -61.8 1.64 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.158 -1.201 . . . . 0.0 108.564 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.463 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -99.96 115.37 65.6 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.102 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.487 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 36.9 Cg_endo -61.65 -32.63 87.14 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.318 1.167 . . . . 0.0 111.1 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 43.1 mtt180 -83.25 -64.7 1.12 Allowed 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.384 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.654 ' HG3' ' HA ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -57.43 -39.49 76.35 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.967 -1.083 . . . . 0.0 111.528 -179.661 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 23' ' ' GLN . . . -74.57 -16.38 60.81 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 120.396 -1.44 . . . . 0.0 109.669 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 24' ' ' PRO . . . -57.21 -60.05 4.19 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.442 -0.786 . . . . 0.0 110.301 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.608 ' HG ' ' N ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -62.04 -46.08 90.75 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 118.512 -1.275 . . . . 0.0 108.145 179.199 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.608 ' N ' ' HG ' ' A' ' 29' ' ' LEU . 2.8 mmpt? -49.51 -48.07 48.34 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.224 -0.922 . . . . 0.0 110.741 179.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.505 ' C ' ' HB2' ' A' ' 36' ' ' SER . . . -62.13 -49.58 75.31 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.308 -0.87 . . . . 0.0 110.856 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.646 ' HA ' ' CB ' ' A' ' 36' ' ' SER . . . -59.17 -35.32 73.34 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.306 -0.871 . . . . 0.0 109.807 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.439 ' CA ' ' HG3' ' A' ' 82' ' ' PRO . 1.1 t-20 -38.89 -48.43 1.56 Allowed 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.6 mmt180 -92.47 -75.16 0.49 Allowed 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 118.593 -1.243 . . . . 0.0 112.235 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.582 ' O ' ' CG ' ' A' ' 16' ' ' HIS . . . -117.11 -3.03 18.01 Favored Glycine 0 N--CA 1.5 2.946 0 CA-C-O 118.078 -1.401 . . . . 0.0 116.527 -176.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.646 ' CB ' ' HA ' ' A' ' 32' ' ' ALA . 0.4 OUTLIER -82.32 -4.14 56.67 Favored 'General case' 0 N--CA 1.508 2.428 0 CA-C-N 122.358 3.079 . . . . 0.0 111.154 -176.684 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.486 ' CA ' ' O ' ' A' ' 60' ' ' ALA . . . -145.99 109.53 0.5 Allowed Glycine 0 C--N 1.287 -2.145 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.42 ' O ' ' N ' ' A' ' 40' ' ' ALA . 0.3 OUTLIER -76.56 -23.17 53.55 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 117.965 -1.494 . . . . 0.0 109.828 -179.745 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.678 ' HG3' ' HB2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER 67.67 -55.87 0.47 Allowed 'General case' 0 N--CA 1.51 2.564 0 CA-C-O 121.53 0.681 . . . . 0.0 109.188 -179.566 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 38' ' ' THR . . . -65.65 -29.09 69.61 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 104.49 -2.411 . . . . 0.0 104.49 174.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.75 ' HB3' ' HA ' ' A' ' 11' ' ' GLU 0.282 0.7 OUTLIER -140.59 71.94 30.75 Favored Pre-proline 0 N--CA 1.485 1.288 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 176.986 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.944 ' HB2' ' CD1' ' A' ' 61' ' ' TRP . 93.8 Cg_endo -110.71 167.5 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 121.166 1.244 . . . . 0.0 111.779 -177.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -164.96 -170.63 2.0 Favored 'General case' 0 N--CA 1.511 2.59 0 C-N-CA 118.021 -1.472 . . . . 0.0 112.707 177.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.573 ' CG2' ' HD3' ' A' ' 59' ' ' LYS . 0.2 OUTLIER -93.99 134.42 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.708 ' CD1' ' HB3' ' A' ' 14' ' ' ASN . 2.2 tp -120.06 129.96 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.673 -1.267 . . . . 0.0 113.749 -177.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.1 mtm180 -92.3 84.27 5.16 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 104.023 -2.584 . . . . 0.0 104.023 173.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.688 HD23 ' CD1' ' A' ' 6' ' ' PHE . 0.1 OUTLIER -76.03 94.38 3.42 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -177.871 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.433 ' HB2' HG21 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -139.81 177.0 8.27 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.178 -1.009 . . . . 0.0 111.929 -178.569 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.452 ' CB ' ' HE2' ' A' ' 54' ' ' LYS . 0.3 OUTLIER -147.82 -176.14 5.15 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 177.914 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.22 179.57 4.65 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 117.92 -1.512 . . . . 0.0 110.584 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.01 -71.93 0.72 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.3 p -82.21 169.44 16.58 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.728 -0.866 . . . . 0.0 109.569 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.581 ' O ' ' N ' ' A' ' 92' ' ' LEU . 11.6 mttt -83.15 89.6 6.97 Favored 'General case' 0 C--O 1.204 -1.34 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.452 ' HE2' ' CB ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -127.89 100.72 6.03 Favored 'General case' 0 C--N 1.282 -2.334 0 O-C-N 120.85 -1.156 . . . . 0.0 109.702 -178.74 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.433 HG21 ' HB2' ' A' ' 48' ' ' ARG . 52.8 t -151.07 129.04 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-O 121.832 0.825 . . . . 0.0 110.797 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.559 ' NE2' ' HB2' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -146.24 110.64 5.09 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 179.334 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.631 ' CG1' ' HB3' ' A' ' 87' ' ' GLU . 21.9 t -105.82 99.95 9.59 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.305 0 C-N-CA 117.497 -1.681 . . . . 0.0 107.735 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.697 ' HA ' ' O ' ' A' ' 85' ' ' LYS . 0.2 OUTLIER -135.03 179.54 6.26 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 179.563 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.774 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 39.7 mttt -133.06 135.07 45.13 Favored 'General case' 0 C--N 1.275 -2.658 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 177.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.681 ' HB3' ' HG3' ' A' ' 15' ' ' GLU . . . -122.85 111.29 16.48 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-N 120.8 1.636 . . . . 0.0 112.911 -175.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.944 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 2.7 m0 -128.11 -165.07 1.44 Allowed 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.708 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 7.3 mmtp -122.25 92.2 3.67 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 120.669 -1.27 . . . . 0.0 111.083 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.922 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 4.5 tp10 -173.51 169.74 4.28 Favored 'General case' 0 N--CA 1.502 2.175 0 CA-C-O 121.469 0.652 . . . . 0.0 110.955 178.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.669 ' CG1' ' HA ' ' A' ' 80' ' ' SER . 2.1 mt -71.71 102.14 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.533 3.679 0 O-C-N 119.421 -2.049 . . . . 0.0 116.305 -175.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.617 ' CG2' ' HA ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -102.0 -167.94 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 120.449 -1.407 . . . . 0.0 110.858 177.09 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.684 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 11.6 t70 -116.1 134.58 54.79 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.509 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.757 ' HA ' ' HB2' ' A' ' 77' ' ' GLU 0.28 . . -72.46 97.57 0.15 Allowed Pre-proline 0 N--CA 1.511 2.595 0 CA-C-O 117.466 -1.254 . . . . 0.0 112.761 -178.242 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.684 ' HD3' ' O ' ' A' ' 66' ' ' ASP . 53.6 Cg_endo -73.35 123.81 8.98 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 O-C-N 123.273 1.144 . . . . 0.0 111.315 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER 53.25 37.9 26.34 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.313 -0.867 . . . . 0.0 109.044 -179.307 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.588 ' HB3' ' HD3' ' A' ' 72' ' ' PRO . 6.6 m-80 2.07 -75.57 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.756 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 11.8 ptm180 34.63 44.22 0.29 Allowed Pre-proline 0 N--CA 1.513 2.707 0 CA-C-N 118.121 0.419 . . . . 0.0 110.355 -177.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.756 ' HD3' ' N ' ' A' ' 71' ' ' ARG . 54.5 Cg_endo -105.85 114.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.324 -0.737 0 C-N-CA 121.922 1.748 . . . . 0.0 112.85 -176.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.85 -39.46 15.82 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.196 -1.002 . . . . 0.0 108.956 177.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.509 ' CD1' ' N ' ' A' ' 74' ' ' TRP . 6.4 m95 -89.7 -38.19 14.04 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.331 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.449 ' HB2' ' O ' ' A' ' 74' ' ' TRP . 7.1 ttm -179.58 146.02 0.44 Allowed Pre-proline 0 N--CA 1.51 2.549 0 O-C-N 121.746 -0.596 . . . . 0.0 111.485 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.644 ' HB2' ' HB1' ' A' ' 67' ' ' ALA . 48.3 Cg_endo -94.54 174.7 1.29 Allowed 'Trans proline' 0 N--CA 1.486 1.087 0 C-N-CA 122.113 1.875 . . . . 0.0 111.041 178.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.757 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 3.8 mt-10 -95.26 16.02 17.75 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 117.892 -1.523 . . . . 0.0 110.812 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.629 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 0.3 OUTLIER -98.28 80.83 2.69 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.22 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.637 HG13 ' N ' ' A' ' 80' ' ' SER . 0.6 OUTLIER 178.59 170.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 C-N-CA 118.128 -1.429 . . . . 0.0 112.122 -177.706 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.669 ' HA ' ' CG1' ' A' ' 64' ' ' ILE . 1.4 m -70.77 109.77 5.16 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 175.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.814 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -169.09 -156.88 0.0 OUTLIER Pre-proline 0 C--O 1.192 -1.973 0 C-N-CA 118.882 -1.127 . . . . 0.0 108.651 -174.916 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.814 ' HD2' ' HB3' ' A' ' 81' ' ' LYS . 43.7 Cg_endo -74.7 127.22 10.72 Favored 'Trans proline' 0 C--N 1.299 -2.052 0 N-CA-C 108.905 -1.229 . . . . 0.0 108.905 178.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.922 ' CZ ' ' HB3' ' A' ' 63' ' ' GLU . 0.8 OUTLIER -58.9 151.64 21.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.506 -1.371 . . . . 0.0 108.087 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.774 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 9.8 p -149.64 95.49 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.508 0 CA-C-O 122.015 0.912 . . . . 0.0 109.764 -178.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.697 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -78.53 119.0 21.19 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 179.611 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.626 ' HB3' ' CZ ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -85.71 94.37 9.08 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 122.716 1.246 . . . . 0.0 113.845 -176.157 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.631 ' HB3' ' CG1' ' A' ' 57' ' ' VAL . 0.0 OUTLIER -99.47 176.96 5.32 Favored 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 114.584 -1.189 . . . . 0.0 108.733 175.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.04 133.39 5.13 Favored 'General case' 0 N--CA 1.514 2.769 0 O-C-N 120.613 -1.304 . . . . 0.0 113.627 -175.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.468 HG12 ' HA ' ' A' ' 56' ' ' HIS . 40.8 mt -139.22 119.03 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.995 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -135.71 108.74 7.66 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.605 -0.684 . . . . 0.0 109.442 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -114.44 150.44 34.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.179 -0.951 . . . . 0.0 110.355 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.581 ' N ' ' O ' ' A' ' 53' ' ' LYS . 1.2 pp -65.46 178.51 0.94 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.117 0.96 . . . . 0.0 111.405 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.448 ' HA ' ' NH1' ' A' ' 4' ' ' ARG . 3.5 tp10 . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.844 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 41.0 t . . . . . 0 N--CA 1.494 1.763 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -145.95 106.36 4.06 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.537 -0.727 . . . . 0.0 110.096 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.457 ' HB ' ' CB ' ' A' ' 20' ' ' THR . 0.8 OUTLIER -86.3 110.71 19.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.34 -0.85 . . . . 0.0 109.569 179.729 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.516 ' O ' ' HA ' ' A' ' 20' ' ' THR . 0.1 OUTLIER -78.43 122.01 25.27 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.367 -0.833 . . . . 0.0 109.578 -179.789 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.59 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 51.0 t30 -77.17 143.19 39.25 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.606 -0.684 . . . . 0.0 110.581 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -138.98 148.72 43.84 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.119 0.485 . . . . 0.0 109.737 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.494 HG22 ' HA ' ' A' ' 49' ' ' GLU . 29.9 m -125.97 140.04 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 O-C-N 121.331 -0.855 . . . . 0.0 112.504 -177.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.568 ' CB ' HG12 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -161.91 167.36 24.77 Favored 'General case' 0 N--CA 1.511 2.621 0 O-C-N 121.408 -0.807 . . . . 0.0 111.836 179.485 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.549 ' O ' ' N ' ' A' ' 14' ' ' ASN . 3.4 ttm-85 -134.82 107.95 7.68 Favored 'General case' 0 N--CA 1.526 3.328 0 O-C-N 121.15 -0.969 . . . . 0.0 112.856 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.822 ' HB2' ' CB ' ' A' ' 16' ' ' HIS . 0.7 OUTLIER -74.55 -158.18 0.07 Allowed 'General case' 0 N--CA 1.513 2.688 0 O-C-N 120.998 -1.064 . . . . 0.0 111.878 -179.611 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.613 ' HA ' ' HB3' ' A' ' 41' ' ' ASN . 0.2 OUTLIER 70.9 48.94 0.38 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 -177.366 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.619 ' HA ' ' O ' ' A' ' 42' ' ' PRO . 97.8 m-20 58.63 8.37 0.89 Allowed 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 112.498 -2.137 . . . . 0.0 113.216 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.16 -75.89 1.27 Allowed Glycine 0 N--CA 1.49 2.299 0 C-N-CA 117.88 -2.105 . . . . 0.0 108.368 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.549 ' N ' ' O ' ' A' ' 9' ' ' ARG . 0.8 OUTLIER -119.25 -78.72 0.59 Allowed 'General case' 0 C--N 1.293 -1.862 0 CA-C-O 122.261 1.029 . . . . 0.0 108.316 177.388 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.576 ' HB2' ' CG2' ' A' ' 45' ' ' ILE . 1.7 tp10 -177.01 140.55 0.31 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 178.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.822 ' CB ' ' HB2' ' A' ' 10' ' ' ASP . 0.3 OUTLIER -87.29 122.67 31.37 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 116.286 -2.166 . . . . 0.0 112.324 -179.608 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.538 ' HA2' ' CZ ' ' A' ' 19' ' ' PHE . . . -177.25 120.13 0.72 Allowed Glycine 0 C--N 1.28 -2.542 0 CA-C-N 113.496 -1.684 . . . . 0.0 110.019 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.9 82.69 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.61 ' N ' ' CD1' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -174.23 -173.43 0.79 Allowed 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.226 -179.165 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.59 ' HA ' ' HA ' ' A' ' 5' ' ' ASN . 39.0 p -102.12 150.62 23.08 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.421 -0.8 . . . . 0.0 112.441 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -130.25 121.29 3.3 Favored Glycine 0 N--CA 1.499 2.846 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 178.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.67 -45.01 70.13 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.49 -1.006 . . . . 0.0 109.823 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -118.02 135.4 23.42 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.452 ' O ' ' HB1' ' A' ' 28' ' ' ALA . 41.1 Cg_endo -69.29 -45.23 1.93 Allowed 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.384 1.202 . . . . 0.0 110.74 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 40.3 mtt180 -82.3 -64.93 1.08 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.652 -0.655 . . . . 0.0 111.208 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.588 ' HG3' ' HA ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -47.0 -45.09 20.82 Favored 'General case' 0 N--CA 1.51 2.569 0 O-C-N 121.187 -0.946 . . . . 0.0 111.861 -179.374 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.466 ' O ' ' CB ' ' A' ' 31' ' ' ALA . . . -73.41 -17.79 61.22 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.181 -1.007 . . . . 0.0 110.642 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.452 ' HB1' ' O ' ' A' ' 24' ' ' PRO . . . -71.93 -52.51 16.86 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.847 -1.158 . . . . 0.0 111.759 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.552 ' CD1' HG21 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -52.64 -57.24 10.67 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.849 0.833 . . . . 0.0 109.66 -179.073 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.409 ' NZ ' ' OE1' ' A' ' 26' ' ' GLN . 30.7 mtmt -69.68 -34.4 73.91 Favored 'General case' 0 N--CA 1.511 2.592 0 O-C-N 121.284 -0.885 . . . . 0.0 113.151 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.646 ' C ' ' HB2' ' A' ' 36' ' ' SER . . . -59.29 -43.58 92.58 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.757 -1.214 . . . . 0.0 112.129 -178.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.643 ' HA ' ' CB ' ' A' ' 36' ' ' SER . . . -65.49 -32.75 74.53 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 118.621 -1.232 . . . . 0.0 110.062 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.493 ' HB2' ' HG3' ' A' ' 82' ' ' PRO . 46.8 t30 -40.04 -50.01 2.56 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.0 mtm105 -94.65 -74.76 0.53 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.196 -1.002 . . . . 0.0 113.097 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.498 ' O ' ' CD2' ' A' ' 16' ' ' HIS . . . -113.53 -0.06 24.8 Favored Glycine 0 N--CA 1.504 3.2 0 N-CA-C 116.758 1.463 . . . . 0.0 116.758 -175.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.646 ' HB2' ' C ' ' A' ' 31' ' ' ALA . 0.3 OUTLIER -87.64 4.05 45.39 Favored 'General case' 0 N--CA 1.506 2.34 0 CA-C-N 122.248 3.024 . . . . 0.0 110.843 -177.272 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -166.58 117.68 0.75 Allowed Glycine 0 N--CA 1.482 1.739 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.493 ' O ' ' HB3' ' A' ' 39' ' ' LYS . 28.2 m -78.29 -17.28 56.82 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 120.525 2.163 . . . . 0.0 109.691 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.804 ' CA ' ' HG3' ' A' ' 42' ' ' PRO . 4.6 tttm 73.27 -56.8 0.65 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -178.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.9 -19.36 65.71 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 175.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.613 ' HB3' ' HA ' ' A' ' 11' ' ' GLU 0.278 0.2 OUTLIER -160.23 68.08 2.78 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.845 -0.535 . . . . 0.0 111.332 179.108 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.804 ' HG3' ' CA ' ' A' ' 39' ' ' LYS . 76.8 Cg_endo -116.95 -175.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.411 2.074 . . . . 0.0 109.369 178.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.444 ' HB3' ' O ' ' A' ' 14' ' ' ASN . 1.7 t70 -168.54 -173.98 2.07 Favored 'General case' 0 N--CA 1.514 2.775 0 C-N-CA 116.988 -1.885 . . . . 0.0 113.431 176.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.616 HG21 ' HD3' ' A' ' 59' ' ' LYS . 1.6 pp -81.52 136.28 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.576 ' CG2' ' HB2' ' A' ' 15' ' ' GLU . 3.1 tp -147.94 139.53 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 117.634 -1.626 . . . . 0.0 114.184 -177.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 49.4 mtt-85 -88.75 95.28 10.21 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 173.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.734 ' HB2' ' CD2' ' A' ' 56' ' ' HIS . 0.3 OUTLIER -66.52 93.16 0.23 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -178.357 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -117.29 -169.01 1.58 Allowed 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.214 -176.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.494 ' HA ' HG22 ' A' ' 7' ' ' VAL . 2.1 tp10 -160.23 118.92 2.68 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -73.37 152.3 40.9 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 118.437 -1.305 . . . . 0.0 111.244 -177.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.4 -43.24 1.72 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 107.521 -2.231 . . . . 0.0 107.521 -178.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 68.2 p -125.52 140.5 52.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.836 -0.802 . . . . 0.0 109.033 178.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.611 ' CB ' ' HA ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -64.58 90.92 0.08 Allowed 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 122.484 1.135 . . . . 0.0 110.207 -179.29 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.429 ' O ' ' HB2' ' A' ' 48' ' ' ARG . 9.2 mttp -136.98 123.87 21.36 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.675 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.429 HG22 HD12 ' A' ' 92' ' ' LEU . 71.7 t -153.82 96.35 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.613 -0.679 . . . . 0.0 111.028 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.734 ' CD2' ' HB2' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -88.44 137.15 32.58 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 177.237 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.535 ' HB ' ' CB ' ' A' ' 87' ' ' GLU . 2.2 t -116.79 116.12 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 O-C-N 119.755 -1.841 . . . . 0.0 110.381 -178.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.708 ' HA ' ' O ' ' A' ' 85' ' ' LYS . 0.5 OUTLIER -157.51 174.95 14.6 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.289 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.702 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 16.8 mttm -132.04 127.33 35.93 Favored 'General case' 0 N--CA 1.505 2.296 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 177.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.608 ' CB ' ' HB1' ' A' ' 32' ' ' ALA . . . -115.67 110.29 18.94 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 120.747 -1.221 . . . . 0.0 113.198 -175.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.715 ' CD1' ' HG2' ' A' ' 42' ' ' PRO . 14.1 m0 -126.49 -167.21 1.69 Allowed 'General case' 0 N--CA 1.512 2.675 0 O-C-N 121.943 -0.473 . . . . 0.0 110.307 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.699 ' HB2' ' HB2' ' A' ' 39' ' ' LYS . 0.7 OUTLIER -123.45 88.13 2.86 Favored 'General case' 0 N--CA 1.507 2.382 0 CA-C-N 120.158 1.345 . . . . 0.0 112.569 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.844 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 3.6 mt-10 -165.97 172.34 11.6 Favored 'General case' 0 N--CA 1.51 2.573 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.283 176.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.655 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 9.2 tt -73.61 101.42 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.523 3.186 0 N-CA-C 116.824 2.157 . . . . 0.0 116.824 -174.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.718 ' CG2' ' HA ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -88.29 -166.57 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.406 -1.434 . . . . 0.0 109.883 176.63 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.654 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 9.2 t0 -124.43 129.08 50.01 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.824 ' HA ' ' CB ' ' A' ' 77' ' ' GLU . . . -64.3 99.3 0.18 Allowed Pre-proline 0 N--CA 1.507 2.396 0 CA-C-O 117.79 -1.1 . . . . 0.0 111.784 -178.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.654 ' HD3' ' O ' ' A' ' 66' ' ' ASP . 52.1 Cg_endo -88.9 -160.33 0.1 OUTLIER 'Trans proline' 0 C--N 1.316 -1.141 0 O-C-N 124.105 1.581 . . . . 0.0 110.528 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.3 mttt -70.11 64.57 0.24 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.292 -0.88 . . . . 0.0 109.092 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.521 ' O ' ' HG2' ' A' ' 71' ' ' ARG . 5.4 m-20 -102.37 -12.4 17.93 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.473 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.733 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER 59.8 44.69 0.98 Allowed Pre-proline 0 N--CA 1.506 2.358 0 C-N-CA 122.796 0.439 . . . . 0.0 111.209 -177.528 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.733 ' HD3' ' N ' ' A' ' 71' ' ' ARG . 48.9 Cg_endo -92.89 99.89 0.16 Allowed 'Trans proline' 0 C--N 1.323 -0.797 0 C-N-CA 121.152 1.234 . . . . 0.0 110.495 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.19 -34.07 24.05 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.365 -0.834 . . . . 0.0 112.065 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.465 ' CD1' ' N ' ' A' ' 74' ' ' TRP . 32.2 m95 -81.55 -31.46 32.68 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.444 -0.785 . . . . 0.0 110.514 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.429 ' O ' ' HB2' ' A' ' 72' ' ' PRO . 12.5 tpt -164.75 110.38 0.85 Allowed Pre-proline 0 N--CA 1.496 1.861 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.681 ' HB2' ' HB1' ' A' ' 67' ' ' ALA . 48.2 Cg_endo -79.28 -178.91 4.96 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.898 1.473 . . . . 0.0 112.693 -178.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.824 ' CB ' ' HA ' ' A' ' 67' ' ' ALA . 3.1 tt0 -90.21 6.61 42.03 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 118.429 -1.308 . . . . 0.0 110.09 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.656 ' C ' ' CG2' ' A' ' 79' ' ' ILE . 1.5 tppm? -92.28 77.05 5.22 Favored 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.686 ' CG1' ' HB2' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -168.08 158.63 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 C-N-CA 118.272 -1.371 . . . . 0.0 112.146 -177.711 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.569 ' HA ' ' HA ' ' A' ' 64' ' ' ILE . 1.7 m -77.09 103.35 6.97 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 175.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.856 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -173.17 -152.18 0.0 OUTLIER Pre-proline 0 C--O 1.196 -1.711 0 O-C-N 121.302 -0.874 . . . . 0.0 108.759 -175.757 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.856 ' HD2' ' HB3' ' A' ' 81' ' ' LYS . 43.4 Cg_endo -68.34 123.7 10.84 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 117.808 -0.995 . . . . 0.0 111.639 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.844 ' CZ ' ' HB3' ' A' ' 63' ' ' GLU . 0.7 OUTLIER -63.43 159.4 18.44 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.184 -0.947 . . . . 0.0 109.382 178.83 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.702 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -153.16 93.94 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 C-N-CA 120.034 -0.666 . . . . 0.0 109.62 178.376 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.708 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 3.1 tptt -73.5 125.59 28.29 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 177.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.57 ' HB3' ' CZ ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -94.05 90.64 6.5 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 122.337 1.065 . . . . 0.0 113.783 -175.257 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.535 ' CB ' ' HB ' ' A' ' 57' ' ' VAL . 4.2 mt-10 -86.35 150.63 24.2 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 115.293 -0.867 . . . . 0.0 108.755 176.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -56.89 122.14 11.54 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.363 -0.836 . . . . 0.0 111.911 -177.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.432 HG12 ' HA ' ' A' ' 56' ' ' HIS . 88.1 mt -73.79 125.13 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -106.06 -179.52 3.96 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.47 0.652 . . . . 0.0 109.637 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.595 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -133.86 95.99 3.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.894 -1.129 . . . . 0.0 109.889 179.723 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.611 ' HA ' ' CB ' ' A' ' 53' ' ' LYS . 2.7 pp -177.31 -175.78 0.58 Allowed 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.633 -0.667 . . . . 0.0 111.181 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.605 ' HB2' HD12 ' A' ' 92' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.497 1.883 0 CA-C-O 118.584 -0.722 . . . . 0.0 111.733 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.497 1.889 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -160.17 137.01 9.14 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.417 -0.802 . . . . 0.0 110.779 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.0 p -79.22 151.97 30.9 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.529 -0.732 . . . . 0.0 109.919 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.521 ' HB3' ' HD2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -84.44 127.17 33.86 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.126 -0.984 . . . . 0.0 110.104 179.705 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.522 ' HA ' ' CG2' ' A' ' 20' ' ' THR . 43.9 t30 -74.35 137.49 42.83 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.496 -0.752 . . . . 0.0 110.58 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.409 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 25.7 m-85 -145.01 151.1 38.04 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.347 0.594 . . . . 0.0 111.057 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.598 HG21 ' HG3' ' A' ' 48' ' ' ARG . 11.7 m -111.21 146.55 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.665 -0.647 . . . . 0.0 111.173 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.67 ' HG ' ' HG ' ' A' ' 47' ' ' LEU . 4.6 mp -152.33 145.08 24.3 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.422 -0.799 . . . . 0.0 111.862 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.561 ' O ' ' N ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -134.11 91.56 2.83 Favored 'General case' 0 N--CA 1.514 2.756 0 O-C-N 121.073 -1.017 . . . . 0.0 111.243 176.647 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.746 ' HB2' ' N ' ' A' ' 16' ' ' HIS . 1.7 t70 -69.63 -159.4 0.03 OUTLIER 'General case' 0 N--CA 1.51 2.565 0 C-N-CA 123.932 0.893 . . . . 0.0 112.007 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.609 ' HA ' ' HB3' ' A' ' 41' ' ' ASN . 0.1 OUTLIER 72.23 52.56 0.19 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 -176.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.58 ' HA ' ' O ' ' A' ' 42' ' ' PRO . 92.4 m-20 61.28 6.91 1.49 Allowed 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 112.539 -2.118 . . . . 0.0 112.783 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.402 ' O ' ' HB3' ' A' ' 43' ' ' ASP . . . -90.17 -75.43 1.3 Allowed Glycine 0 N--CA 1.485 1.95 0 C-N-CA 117.98 -2.057 . . . . 0.0 108.82 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.66 ' CB ' ' HB ' ' A' ' 45' ' ' ILE . 8.2 m120 -125.22 -76.77 0.59 Allowed 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.596 0.713 . . . . 0.0 111.337 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.592 ' HB2' HG22 ' A' ' 45' ' ' ILE . 8.1 mt-10 -169.31 151.42 4.57 Favored 'General case' 0 N--CA 1.511 2.582 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.746 ' N ' ' HB2' ' A' ' 10' ' ' ASP . 0.4 OUTLIER -99.1 118.68 36.39 Favored 'General case' 0 N--CA 1.507 2.388 0 C-N-CA 115.021 -2.672 . . . . 0.0 113.125 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.549 ' HA2' ' CZ ' ' A' ' 19' ' ' PHE . . . 175.21 132.07 1.53 Allowed Glycine 0 C--N 1.285 -2.292 0 C-N-CA 119.493 -1.336 . . . . 0.0 112.251 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.6 86.78 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 175.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.623 ' N ' ' CD1' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -172.54 -172.26 0.89 Allowed 'General case' 0 N--CA 1.5 2.073 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.733 -178.132 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.522 ' CG2' ' HA ' ' A' ' 5' ' ' ASN . 57.2 p -107.62 158.46 17.23 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.493 -0.755 . . . . 0.0 111.703 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -130.69 130.97 6.31 Favored Glycine 0 N--CA 1.501 3.02 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.4 ttpt -60.84 -47.82 84.64 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.309 -1.113 . . . . 0.0 108.765 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.64 ' HB3' ' HB3' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -115.7 114.13 42.22 Favored Pre-proline 0 N--CA 1.486 1.362 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.403 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.417 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 38.1 Cg_endo -64.94 -35.86 41.66 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.65 1.342 . . . . 0.0 110.823 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.551 ' HB3' ' HA ' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -83.08 -62.92 1.47 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.209 -0.932 . . . . 0.0 109.862 179.419 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.64 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 1.0 OUTLIER -53.44 -41.97 66.65 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.129 -0.982 . . . . 0.0 111.886 -179.683 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -74.57 -15.69 60.84 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 120.593 -1.317 . . . . 0.0 110.42 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 24' ' ' PRO . . . -63.61 -51.89 63.29 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.79 -1.194 . . . . 0.0 110.642 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.623 HD13 HG23 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -61.9 -50.46 72.1 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 121.558 0.694 . . . . 0.0 109.559 -179.555 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -69.41 -37.87 77.65 Favored 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -178.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.405 ' C ' ' HB2' ' A' ' 36' ' ' SER . . . -60.5 -43.73 96.75 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 120.719 -1.238 . . . . 0.0 112.461 -177.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.711 ' HA ' ' CB ' ' A' ' 36' ' ' SER . . . -64.51 -33.34 75.67 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 118.77 -1.172 . . . . 0.0 110.15 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.543 ' CA ' ' HG3' ' A' ' 82' ' ' PRO . 0.2 OUTLIER -42.74 -46.34 5.1 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.802 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.5 mtp85 -95.51 -72.83 0.61 Allowed 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.269 -0.972 . . . . 0.0 112.254 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.548 ' O ' ' CD2' ' A' ' 16' ' ' HIS . . . -115.72 -0.72 21.47 Favored Glycine 0 N--CA 1.499 2.877 0 N-CA-C 117.48 1.752 . . . . 0.0 117.48 -175.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.711 ' CB ' ' HA ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -82.03 -2.29 51.21 Favored 'General case' 0 N--CA 1.514 2.73 0 CA-C-N 123.615 3.708 . . . . 0.0 110.94 -176.744 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -163.49 120.84 0.97 Allowed Glycine 0 C--N 1.297 -1.637 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -178.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.519 ' O ' ' HB3' ' A' ' 39' ' ' LYS . 23.5 m -77.73 -15.61 59.01 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 119.825 1.813 . . . . 0.0 109.494 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.811 ' CA ' ' HG3' ' A' ' 42' ' ' PRO . 7.6 tttm 75.21 -56.27 0.62 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -178.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.43 -18.89 65.62 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 175.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.609 ' HB3' ' HA ' ' A' ' 11' ' ' GLU 0.27 0.4 OUTLIER -160.44 67.31 2.62 Favored Pre-proline 0 C--O 1.202 -1.446 0 O-C-N 121.661 -0.649 . . . . 0.0 111.147 179.097 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.811 ' HG3' ' CA ' ' A' ' 39' ' ' LYS . 82.9 Cg_endo -118.0 -176.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.3 -2.012 0 C-N-CA 122.019 1.813 . . . . 0.0 109.615 178.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.447 ' HB2' ' C ' ' A' ' 12' ' ' ASP . 0.7 OUTLIER -168.04 -169.49 1.14 Allowed 'General case' 0 N--CA 1.512 2.643 0 O-C-N 119.826 -1.796 . . . . 0.0 113.902 177.036 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.669 ' CG2' ' HD3' ' A' ' 59' ' ' LYS . 1.6 pp -91.5 142.6 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.66 ' HB ' ' CB ' ' A' ' 14' ' ' ASN . 1.1 tp -161.59 142.67 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 117.958 -1.497 . . . . 0.0 113.422 -178.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.473 ' HG3' HG12 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -87.03 96.23 10.21 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 174.184 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.698 ' HB2' ' CD2' ' A' ' 56' ' ' HIS . 9.0 mp -63.21 95.77 0.09 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 -178.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.598 ' HG3' HG21 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -103.2 -172.88 2.19 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.704 -177.603 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -159.45 142.98 14.6 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -97.56 139.63 33.18 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.701 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.71 -56.43 0.53 Allowed Glycine 0 N--CA 1.494 2.563 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.556 ' OG1' ' NZ ' ' A' ' 54' ' ' LYS . 7.1 p -115.27 -175.6 2.73 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.424 -1.045 . . . . 0.0 109.007 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.639 ' O ' ' N ' ' A' ' 92' ' ' LEU . 3.0 mmtt -97.45 99.07 10.49 Favored 'General case' 0 C--O 1.203 -1.365 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.556 ' NZ ' ' OG1' ' A' ' 52' ' ' THR . 5.3 mtmm -146.4 98.8 3.13 Favored 'General case' 0 C--N 1.281 -2.395 0 O-C-N 120.495 -1.378 . . . . 0.0 109.816 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . 6.7 t -137.03 100.2 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 CA-C-O 121.399 0.618 . . . . 0.0 110.338 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.703 ' NE2' ' HB2' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -91.61 138.09 31.85 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.926 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.53 ' HB ' ' CB ' ' A' ' 87' ' ' GLU . 2.5 t -114.59 104.09 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 O-C-N 119.91 -1.744 . . . . 0.0 109.258 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.711 ' HA ' ' O ' ' A' ' 85' ' ' LYS . 0.6 OUTLIER -146.62 175.58 10.49 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.376 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.744 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 24.5 mttm -130.04 128.12 41.3 Favored 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 177.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.502 ' O ' ' CD1' ' A' ' 61' ' ' TRP . . . -114.18 113.26 24.43 Favored 'General case' 0 N--CA 1.505 2.312 0 C-N-CA 118.199 -1.4 . . . . 0.0 113.605 -176.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.788 ' HB2' ' HB2' ' A' ' 83' ' ' PHE . 13.6 m0 -130.26 -168.42 1.97 Allowed 'General case' 0 N--CA 1.516 2.841 0 O-C-N 121.713 -0.617 . . . . 0.0 110.802 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.639 ' HB2' ' HB2' ' A' ' 39' ' ' LYS . 1.3 tmtm? -120.68 89.02 3.05 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.696 -1.253 . . . . 0.0 111.283 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.809 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 2.1 mt-10 -165.79 168.67 15.81 Favored 'General case' 0 N--CA 1.508 2.456 0 CA-C-O 121.354 0.597 . . . . 0.0 109.994 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.646 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 4.7 tt -72.56 101.15 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.522 3.138 0 O-C-N 119.612 -1.93 . . . . 0.0 115.68 -176.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.693 ' CG2' ' HA ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -91.86 -166.58 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.501 -1.375 . . . . 0.0 110.838 177.948 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.682 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 7.5 t70 -120.39 130.19 54.26 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.825 ' HA ' ' CB ' ' A' ' 77' ' ' GLU . . . -65.64 100.47 0.23 Allowed Pre-proline 0 N--CA 1.509 2.505 0 CA-C-O 118.061 -0.971 . . . . 0.0 113.308 -177.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.682 ' HD3' ' O ' ' A' ' 66' ' ' ASP . 55.8 Cg_endo -84.01 -163.48 0.2 Allowed 'Trans proline' 0 N--CA 1.485 1.019 0 O-C-N 123.625 1.329 . . . . 0.0 110.502 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.2 mmpp? -69.83 64.87 0.22 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.158 -0.964 . . . . 0.0 109.841 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.566 ' O ' ' HG2' ' A' ' 71' ' ' ARG . 3.8 m-20 -97.94 -12.6 21.84 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.986 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.697 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER 44.87 51.08 8.21 Favored Pre-proline 0 N--CA 1.504 2.271 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.374 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.787 ' HG2' ' HA ' ' A' ' 76' ' ' PRO . 55.1 Cg_endo -99.97 112.0 0.07 OUTLIER 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 121.861 1.707 . . . . 0.0 109.518 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.78 -19.98 47.32 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.766 -1.209 . . . . 0.0 112.106 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.435 ' CD1' ' N ' ' A' ' 74' ' ' TRP . 44.5 m95 -81.96 -37.75 26.22 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.308 -0.87 . . . . 0.0 110.46 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.444 ' O ' ' HB2' ' A' ' 72' ' ' PRO . 20.9 ttm -168.89 130.75 1.12 Allowed Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.673 -0.642 . . . . 0.0 109.665 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.787 ' HA ' ' HG2' ' A' ' 72' ' ' PRO . 47.5 Cg_endo -88.59 179.82 2.47 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.662 1.349 . . . . 0.0 111.803 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.825 ' CB ' ' HA ' ' A' ' 67' ' ' ALA . 3.7 tt0 -88.71 9.23 25.09 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 118.005 -1.478 . . . . 0.0 110.1 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.578 ' N ' ' HB3' ' A' ' 67' ' ' ALA . 40.6 tptt -93.74 82.49 4.32 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.646 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -179.82 163.21 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 C-N-CA 118.006 -1.478 . . . . 0.0 112.501 -178.51 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.568 ' HA ' ' HB ' ' A' ' 64' ' ' ILE . 1.1 m -72.01 105.35 3.86 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 175.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.68 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 11.2 pttp -167.81 -154.92 0.0 OUTLIER Pre-proline 0 C--O 1.196 -1.729 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -175.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.68 ' HD2' ' HB2' ' A' ' 81' ' ' LYS . 49.7 Cg_endo -75.59 128.99 11.44 Favored 'Trans proline' 0 C--N 1.299 -2.066 0 N-CA-C 109.761 -0.899 . . . . 0.0 109.761 178.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.809 ' CZ ' ' HB3' ' A' ' 63' ' ' GLU . 1.1 m-30 -64.73 157.15 28.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.217 -0.927 . . . . 0.0 109.423 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.744 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -152.15 95.66 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.153 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.711 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -74.01 130.15 39.28 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 105.917 -1.882 . . . . 0.0 105.917 178.16 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.614 ' HB3' ' CZ ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -99.36 92.24 5.32 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 122.615 1.197 . . . . 0.0 113.908 -175.338 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.53 ' CB ' ' HB ' ' A' ' 57' ' ' VAL . 24.0 mt-10 -88.75 151.94 22.1 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 175.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -55.4 116.69 2.99 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-O 122.316 1.055 . . . . 0.0 112.77 -176.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.506 ' CG2' ' HA ' ' A' ' 56' ' ' HIS . 23.7 mt -83.84 140.54 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.428 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.24 144.14 48.77 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 177.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.524 ' HE3' ' O ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -159.96 175.57 12.87 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.571 -1.331 . . . . 0.0 112.607 -178.732 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.639 ' N ' ' O ' ' A' ' 53' ' ' LYS . 1.9 pp -74.26 -178.59 3.49 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.529 0.681 . . . . 0.0 110.369 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 . . . . . 0 N--CA 1.493 1.721 0 O-C-N 121.339 -0.851 . . . . 0.0 109.896 179.334 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 120.774 0.321 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -126.37 114.68 18.54 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.296 -0.877 . . . . 0.0 109.947 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.401 ' OG1' ' HB ' ' A' ' 20' ' ' THR . 5.2 t -162.84 173.34 13.86 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.444 -0.785 . . . . 0.0 110.342 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.496 ' O ' ' HA ' ' A' ' 20' ' ' THR . 5.1 mmp_? -121.93 119.58 31.96 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.423 -0.798 . . . . 0.0 110.213 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.546 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 19.5 t-20 -74.54 140.88 44.78 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.557 -0.714 . . . . 0.0 110.228 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.531 ' HB3' HD22 ' A' ' 47' ' ' LEU . 8.5 m-85 -152.57 168.29 26.07 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.476 -0.765 . . . . 0.0 110.421 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.562 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -150.24 141.52 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 O-C-N 121.444 -0.785 . . . . 0.0 111.591 -178.007 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.671 ' CD2' ' HG ' ' A' ' 47' ' ' LEU . 1.5 mp -148.12 167.68 24.39 Favored 'General case' 0 N--CA 1.52 3.052 0 O-C-N 121.287 -0.883 . . . . 0.0 112.942 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.539 ' N ' ' O ' ' A' ' 15' ' ' GLU . 9.3 ptt-85 -136.3 95.37 3.17 Favored 'General case' 0 N--CA 1.517 2.908 0 O-C-N 121.488 -0.757 . . . . 0.0 111.28 176.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.797 ' HB2' ' N ' ' A' ' 16' ' ' HIS . 5.1 t0 -82.46 -150.93 0.09 Allowed 'General case' 0 N--CA 1.509 2.508 0 C-N-CA 124.136 0.974 . . . . 0.0 113.081 -178.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.558 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 0.8 OUTLIER 73.56 53.63 0.11 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 104.048 -2.575 . . . . 0.0 104.048 -175.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.558 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 1.9 m-20 63.98 3.96 1.85 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 112.683 -2.053 . . . . 0.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -89.52 -76.54 1.31 Allowed Glycine 0 N--CA 1.479 1.55 0 C-N-CA 117.795 -2.145 . . . . 0.0 107.795 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.637 ' HB3' ' HB ' ' A' ' 45' ' ' ILE . 3.5 m120 -126.74 -77.03 0.58 Allowed 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.452 0.644 . . . . 0.0 111.576 178.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.617 ' HB2' ' CG2' ' A' ' 45' ' ' ILE . 4.6 mt-10 -171.28 154.84 4.08 Favored 'General case' 0 N--CA 1.512 2.626 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.797 ' N ' ' HB2' ' A' ' 10' ' ' ASP . 0.2 OUTLIER -119.62 120.29 36.23 Favored 'General case' 0 N--CA 1.511 2.615 0 C-N-CA 114.848 -2.741 . . . . 0.0 115.047 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.419 ' CA ' ' CE1' ' A' ' 19' ' ' PHE . . . -176.45 128.35 1.34 Allowed Glycine 0 C--N 1.29 -1.999 0 CA-C-N 113.561 -1.654 . . . . 0.0 110.113 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.418 ' C ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -134.78 92.05 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 177.449 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.671 ' N ' ' CD1' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -175.25 -173.3 0.65 Allowed 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 121.283 0.563 . . . . 0.0 110.281 -178.743 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 5' ' ' ASN . 22.2 p -106.1 126.56 52.36 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.289 -0.882 . . . . 0.0 110.953 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -97.68 131.15 10.49 Favored Glycine 0 N--CA 1.501 3.001 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.1 mtmp? -59.54 -39.2 83.17 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.55 -0.971 . . . . 0.0 109.57 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.449 ' HB3' ' HB3' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -127.42 125.35 23.89 Favored Pre-proline 0 N--CA 1.489 1.493 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.112 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.42 ' O ' ' HB1' ' A' ' 28' ' ' ALA . 37.0 Cg_endo -63.06 -40.82 31.65 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 O-C-N 123.493 1.26 . . . . 0.0 110.924 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -87.47 -61.19 1.78 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.499 -0.751 . . . . 0.0 111.46 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.449 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 14.5 tt0 -55.76 -40.94 73.28 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 120.938 -1.101 . . . . 0.0 111.71 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 23' ' ' GLN . . . -79.8 -18.92 49.75 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.828 -1.149 . . . . 0.0 109.446 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.42 ' HB1' ' O ' ' A' ' 24' ' ' PRO . . . -62.74 -57.7 10.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.358 -0.839 . . . . 0.0 110.808 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.462 ' O ' ' HG2' ' A' ' 82' ' ' PRO . 2.4 pp -58.38 -44.37 88.87 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.354 -178.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.47 ' HB2' ' HE3' ' A' ' 30' ' ' LYS . 1.0 OUTLIER -70.46 -35.47 73.35 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 120.793 -1.192 . . . . 0.0 111.689 179.249 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.425 ' C ' ' HB2' ' A' ' 36' ' ' SER . . . -56.59 -42.01 77.97 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.187 -0.946 . . . . 0.0 113.079 -177.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.733 ' HA ' ' HB2' ' A' ' 36' ' ' SER . . . -73.03 -29.92 63.36 Favored 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 118.865 -1.134 . . . . 0.0 110.096 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.568 ' CB ' ' HG3' ' A' ' 82' ' ' PRO . 6.3 t-20 -41.37 -46.89 3.45 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.371 0.605 . . . . 0.0 109.369 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.8 mmm-85 -92.97 -74.57 0.52 Allowed 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 118.884 -1.126 . . . . 0.0 112.938 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.474 ' O ' ' CD2' ' A' ' 16' ' ' HIS . . . -115.93 -3.96 19.34 Favored Glycine 0 N--CA 1.499 2.855 0 N-CA-C 117.065 1.586 . . . . 0.0 117.065 -175.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.733 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 0.6 OUTLIER -79.02 -4.27 49.26 Favored 'General case' 0 N--CA 1.51 2.558 0 CA-C-N 122.633 3.216 . . . . 0.0 110.573 -176.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.525 ' O ' ' HG3' ' A' ' 39' ' ' LYS . . . -154.31 117.72 0.81 Allowed Glycine 0 C--N 1.292 -1.873 0 N-CA-C 108.579 -1.809 . . . . 0.0 108.579 -178.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.447 ' HB ' ' C ' ' A' ' 41' ' ' ASN . 90.2 m -68.9 -17.12 63.92 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 119.348 1.574 . . . . 0.0 108.107 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.779 ' CA ' ' HG3' ' A' ' 42' ' ' PRO . 10.0 mtmt 71.36 -59.64 0.54 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.72 -20.02 61.97 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 175.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.517 ' HB3' ' HA ' ' A' ' 11' ' ' GLU 0.279 0.1 OUTLIER -149.66 65.25 7.59 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.722 -0.612 . . . . 0.0 110.638 178.628 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.779 ' HG3' ' CA ' ' A' ' 39' ' ' LYS . 75.1 Cg_endo -117.03 -174.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 121.167 1.245 . . . . 0.0 111.322 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -167.13 -168.23 1.05 Allowed 'General case' 0 N--CA 1.512 2.672 0 C-N-CA 118.07 -1.452 . . . . 0.0 112.887 177.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.662 ' CG2' ' HD3' ' A' ' 59' ' ' LYS . 1.2 pp -95.85 149.62 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.637 ' HB ' ' HB3' ' A' ' 14' ' ' ASN . 1.8 tp -163.09 144.05 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 C-N-CA 117.773 -1.571 . . . . 0.0 113.883 -178.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.441 ' HG2' HG11 ' A' ' 57' ' ' VAL . 32.8 mtt180 -85.35 95.63 9.29 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 174.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.671 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -70.15 94.88 0.93 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.448 -0.782 . . . . 0.0 109.361 -178.063 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.428 ' O ' HG12 ' A' ' 7' ' ' VAL . 0.4 OUTLIER -129.18 -177.32 4.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.563 -0.711 . . . . 0.0 110.078 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -150.13 117.72 6.15 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.98 152.28 38.76 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 118.597 -1.241 . . . . 0.0 110.358 -177.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.86 -32.33 7.36 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.5 p -146.4 176.78 9.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.401 -1.058 . . . . 0.0 110.656 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.758 ' HA ' ' CA ' ' A' ' 92' ' ' LEU . 5.1 mttm -75.36 92.57 2.81 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.789 0.804 . . . . 0.0 110.094 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.483 ' HD3' ' O ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -141.93 115.21 8.87 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.364 179.482 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.455 ' O ' HG23 ' A' ' 89' ' ' ILE . 2.4 t -155.76 142.84 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 CA-C-O 122.002 0.906 . . . . 0.0 111.216 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.639 ' NE2' ' HB2' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -162.78 129.89 3.61 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 179.598 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.555 ' CG1' ' CB ' ' A' ' 87' ' ' GLU . 11.5 t -118.31 115.88 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 117.311 -1.756 . . . . 0.0 109.23 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.71 ' HA ' ' O ' ' A' ' 85' ' ' LYS . 0.8 OUTLIER -153.76 -176.63 5.92 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 -179.817 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.765 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 30.2 mttt -137.39 133.97 35.4 Favored 'General case' 0 N--CA 1.51 2.566 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 177.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.578 ' O ' ' CD1' ' A' ' 61' ' ' TRP . . . -117.04 112.69 21.28 Favored 'General case' 0 N--CA 1.51 2.557 0 CA-C-N 120.662 1.574 . . . . 0.0 113.653 -176.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.75 ' HB2' ' HB2' ' A' ' 83' ' ' PHE . 11.7 m0 -133.59 -165.51 1.64 Allowed 'General case' 0 N--CA 1.514 2.726 0 O-C-N 122.036 -0.415 . . . . 0.0 111.344 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.638 ' HB2' ' HB3' ' A' ' 39' ' ' LYS . 1.6 tptp -123.78 91.4 3.46 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.643 -1.285 . . . . 0.0 111.776 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.86 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 1.1 mt-10 -165.37 -173.0 2.65 Favored 'General case' 0 N--CA 1.51 2.573 0 CA-C-O 121.223 0.535 . . . . 0.0 110.452 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.591 ' C ' ' HE1' ' A' ' 83' ' ' PHE . 12.6 tt -94.86 98.68 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.117 0 O-C-N 118.977 -2.327 . . . . 0.0 116.081 -176.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.611 HG23 ' HG2' ' A' ' 77' ' ' GLU . 0.3 OUTLIER -103.65 -168.54 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 120.137 -1.602 . . . . 0.0 108.706 176.329 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.702 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 5.9 t0 -114.23 145.63 41.47 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.663 -0.648 . . . . 0.0 111.379 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.809 ' HA ' ' HB3' ' A' ' 77' ' ' GLU 0.25 . . -66.25 101.38 0.28 Allowed Pre-proline 0 N--CA 1.511 2.6 0 CA-C-O 118.075 -0.964 . . . . 0.0 113.167 -178.772 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.779 ' HG3' ' HG2' ' A' ' 86' ' ' LYS . 55.0 Cg_endo -70.81 64.53 2.42 Favored 'Trans proline' 0 N--CA 1.5 1.906 0 O-C-N 123.85 1.448 . . . . 0.0 110.961 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 50.2 40.94 23.23 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 120.994 -1.066 . . . . 0.0 108.69 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.669 ' HB3' ' HG3' ' A' ' 72' ' ' PRO . 6.3 m120 -55.37 -18.83 7.36 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.489 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.779 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER 49.99 43.22 1.55 Allowed Pre-proline 0 N--CA 1.495 1.809 0 CA-C-O 120.484 0.183 . . . . 0.0 110.784 -176.642 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.779 ' HD3' ' N ' ' A' ' 71' ' ' ARG . 57.8 Cg_endo -100.05 135.09 0.22 Allowed 'Trans proline' 0 C--O 1.219 -0.446 0 C-N-CA 121.481 1.454 . . . . 0.0 109.435 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.27 -28.55 25.25 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 120.892 -1.13 . . . . 0.0 111.105 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.447 ' CD1' ' N ' ' A' ' 74' ' ' TRP . 41.0 m95 -84.71 -35.94 22.17 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.542 -0.724 . . . . 0.0 111.424 -178.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.469 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 2.4 tpt -175.06 132.11 0.45 Allowed Pre-proline 0 N--CA 1.51 2.55 0 O-C-N 121.23 -0.919 . . . . 0.0 111.689 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.746 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 44.3 Cg_endo -93.55 -178.21 0.71 Allowed 'Trans proline' 0 N--CA 1.489 1.264 0 C-N-CA 122.401 2.067 . . . . 0.0 111.455 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.809 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 7.8 tt0 -86.12 9.24 17.97 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 117.729 -1.588 . . . . 0.0 110.82 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.702 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -88.05 82.2 7.25 Favored 'General case' 0 N--CA 1.507 2.406 0 C-N-CA 118.861 -1.136 . . . . 0.0 108.292 178.786 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.559 HG13 ' N ' ' A' ' 80' ' ' SER . 0.1 OUTLIER 179.02 165.89 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.382 0 C-N-CA 118.384 -1.326 . . . . 0.0 112.673 -178.105 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.585 ' HA ' ' HA ' ' A' ' 64' ' ' ILE . 13.3 m -77.69 107.13 9.96 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 175.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.862 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -171.54 -152.86 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.331 0 O-C-N 121.107 -0.995 . . . . 0.0 108.644 -176.106 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.862 ' HD2' ' HB2' ' A' ' 81' ' ' LYS . 44.2 Cg_endo -71.86 123.66 9.53 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 117.316 -1.323 . . . . 0.0 110.005 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.86 ' CZ ' ' HB3' ' A' ' 63' ' ' GLU . 0.5 OUTLIER -61.74 161.0 10.75 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.226 -0.921 . . . . 0.0 110.601 -179.665 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.765 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -155.6 95.55 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.083 178.081 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.71 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 0.9 OUTLIER -71.16 133.92 46.55 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 178.131 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.779 ' HG2' ' HG3' ' A' ' 68' ' ' PRO . 0.0 OUTLIER -101.91 92.3 4.75 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -173.795 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.555 ' CB ' ' CG1' ' A' ' 57' ' ' VAL . 2.6 mp0 -93.47 163.58 13.52 Favored 'General case' 0 C--N 1.28 -2.431 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 174.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -54.88 146.53 17.24 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 120.959 -1.088 . . . . 0.0 113.448 -176.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.535 HG23 ' HA ' ' A' ' 56' ' ' HIS . 97.8 mt -128.76 149.51 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.538 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.486 ' HB3' ' CD2' ' A' ' 92' ' ' LEU . 1.8 tm-20 -163.33 -175.12 4.09 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.402 -0.811 . . . . 0.0 110.348 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.551 ' C ' ' HB3' ' A' ' 53' ' ' LYS . 9.2 mtmm -114.39 97.18 6.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.938 -1.101 . . . . 0.0 109.743 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.758 ' CA ' ' HA ' ' A' ' 53' ' ' LYS . 0.6 OUTLIER -170.47 -176.93 2.27 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.33 -0.856 . . . . 0.0 110.937 179.167 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 . . . . . 0 N--CA 1.497 1.922 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.796 179.905 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.6 p . . . . . 0 N--CA 1.494 1.752 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -118.23 160.93 20.73 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.257 -0.902 . . . . 0.0 109.468 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.0 t -79.09 175.02 10.97 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.385 -0.822 . . . . 0.0 110.271 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 20' ' ' THR . 11.1 mmt85 -136.55 126.02 25.13 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.24 -0.912 . . . . 0.0 110.035 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.585 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 3.7 t30 -76.96 144.52 38.74 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.593 -0.692 . . . . 0.0 111.158 -179.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.595 ' HB3' ' CD2' ' A' ' 47' ' ' LEU . 18.2 m-85 -140.8 170.53 15.58 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.5 m -138.93 130.53 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.421 0 O-C-N 121.141 -0.974 . . . . 0.0 112.177 -177.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.541 HD11 ' CG ' ' A' ' 15' ' ' GLU . 0.2 OUTLIER -149.39 161.86 41.25 Favored 'General case' 0 N--CA 1.511 2.604 0 O-C-N 121.071 -1.018 . . . . 0.0 112.222 -179.884 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.511 ' O ' ' N ' ' A' ' 14' ' ' ASN . 12.6 tpt180 -142.72 99.2 3.43 Favored 'General case' 0 N--CA 1.511 2.619 0 O-C-N 121.192 -0.943 . . . . 0.0 111.554 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.781 ' HB2' ' N ' ' A' ' 16' ' ' HIS . 19.1 t70 -80.71 -146.53 0.05 Allowed 'General case' 0 N--CA 1.507 2.399 0 C-N-CA 123.662 0.785 . . . . 0.0 110.167 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.705 ' HA ' ' HB3' ' A' ' 41' ' ' ASN . 0.3 OUTLIER 71.0 55.44 0.23 Allowed 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 104.109 -2.552 . . . . 0.0 104.109 -176.057 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.58 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 0.7 OUTLIER 67.04 1.26 2.28 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-N 112.985 -1.916 . . . . 0.0 111.706 -178.848 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 43' ' ' ASP . . . -94.98 -77.52 1.37 Allowed Glycine 0 N--CA 1.477 1.369 0 C-N-CA 118.136 -1.983 . . . . 0.0 109.086 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.674 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 2.4 m-80 -126.25 -80.3 0.61 Allowed 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.67 ' C ' ' HB2' ' A' ' 10' ' ' ASP . 28.3 tt0 -168.44 139.8 2.7 Favored 'General case' 0 N--CA 1.509 2.524 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 -178.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.781 ' N ' ' HB2' ' A' ' 10' ' ' ASP . 0.9 OUTLIER -109.56 120.98 44.16 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 116.065 -2.254 . . . . 0.0 115.361 -176.318 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.534 ' HA3' ' CE1' ' A' ' 19' ' ' PHE . . . -179.62 129.64 1.39 Allowed Glycine 0 C--N 1.288 -2.109 0 CA-C-N 112.96 -1.927 . . . . 0.0 109.555 178.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.82 94.37 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 177.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.624 ' N ' ' CD1' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -175.74 -169.29 0.34 Allowed 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 121.286 0.565 . . . . 0.0 110.591 -178.388 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.585 ' HA ' ' HA ' ' A' ' 5' ' ' ASN . 2.7 p -105.59 150.64 25.22 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.431 -0.793 . . . . 0.0 111.508 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -130.1 128.55 5.66 Favored Glycine 0 N--CA 1.5 2.945 0 N-CA-C 108.669 -1.773 . . . . 0.0 108.669 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -60.9 -52.82 63.41 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.41 -1.053 . . . . 0.0 108.823 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.53 ' HB3' ' HB3' ' A' ' 26' ' ' GLN . 5.0 mp0 -106.47 99.32 23.79 Favored Pre-proline 0 N--CA 1.487 1.392 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.452 ' O ' ' HB1' ' A' ' 28' ' ' ALA . 36.8 Cg_endo -59.74 -29.18 89.06 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.508 1.267 . . . . 0.0 110.398 -179.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.563 ' O ' HD22 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -84.61 -61.15 1.86 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.363 -0.836 . . . . 0.0 109.919 178.475 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.669 ' HG3' ' HA ' ' A' ' 72' ' ' PRO . 16.6 tm0? -65.84 -42.9 89.93 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 120.871 -1.143 . . . . 0.0 112.397 -179.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -73.07 -17.36 61.42 Favored 'General case' 0 N--CA 1.482 1.138 0 O-C-N 120.69 -1.257 . . . . 0.0 109.885 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 25' ' ' ARG . . . -61.07 -53.05 61.94 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.237 -0.914 . . . . 0.0 111.592 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.714 ' HG ' ' CG ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -63.48 -56.84 12.91 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 -179.082 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.17 -44.13 32.25 Favored 'General case' 0 N--CA 1.506 2.347 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.93 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.518 ' C ' ' HB2' ' A' ' 36' ' ' SER . . . -54.83 -43.1 72.67 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.455 -0.778 . . . . 0.0 111.965 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.725 ' HA ' ' CB ' ' A' ' 36' ' ' SER . . . -72.86 -28.25 62.4 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.701 -1.25 . . . . 0.0 110.807 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.578 ' HB2' ' HG3' ' A' ' 82' ' ' PRO . 2.0 t30 -39.59 -46.95 1.86 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -95.11 -74.59 0.54 Allowed 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.154 -1.018 . . . . 0.0 112.91 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.47 ' O ' ' CD2' ' A' ' 16' ' ' HIS . . . -113.81 -4.96 22.59 Favored Glycine 0 N--CA 1.502 3.039 0 N-CA-C 116.798 1.479 . . . . 0.0 116.798 -175.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.725 ' CB ' ' HA ' ' A' ' 32' ' ' ALA . 0.4 OUTLIER -82.44 -7.13 59.64 Favored 'General case' 0 N--CA 1.506 2.363 0 CA-C-N 122.166 2.983 . . . . 0.0 110.157 -177.353 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' A' ' 60' ' ' ALA . . . -141.44 111.74 0.72 Allowed Glycine 0 C--N 1.289 -2.028 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.504 ' O ' ' HB3' ' A' ' 39' ' ' LYS . 5.2 m -69.05 -20.94 64.12 Favored 'General case' 0 C--N 1.312 -1.054 0 O-C-N 120.672 -1.487 . . . . 0.0 109.4 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.669 ' HA ' ' HG3' ' A' ' 42' ' ' PRO . 5.6 ttpt 67.64 -52.04 0.51 Allowed 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.65 -27.95 64.44 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 174.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.705 ' HB3' ' HA ' ' A' ' 11' ' ' GLU 0.274 0.2 OUTLIER -142.41 71.19 21.57 Favored Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.468 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.956 ' HB2' ' CD1' ' A' ' 61' ' ' TRP . 72.2 Cg_endo -112.89 169.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 121.75 1.633 . . . . 0.0 112.208 -178.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.512 ' HB2' ' C ' ' A' ' 12' ' ' ASP . 0.7 OUTLIER -167.82 -167.47 0.86 Allowed 'General case' 0 N--CA 1.517 2.891 0 C-N-CA 117.692 -1.603 . . . . 0.0 113.949 177.091 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.674 ' O ' ' HA ' ' A' ' 14' ' ' ASN . 0.2 OUTLIER -84.09 123.58 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -178.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.662 ' CD1' ' HB3' ' A' ' 14' ' ' ASN . 0.7 OUTLIER -108.1 117.52 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.846 -1.159 . . . . 0.0 113.648 -177.856 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.49 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 0.3 OUTLIER -87.73 88.14 7.57 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 103.492 -2.781 . . . . 0.0 103.492 173.249 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.634 ' HB2' ' CD2' ' A' ' 56' ' ' HIS . 0.1 OUTLIER -79.14 94.43 5.37 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -177.62 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.53 ' HD2' ' C ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -135.9 178.45 7.04 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.589 -0.694 . . . . 0.0 111.431 -178.666 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -157.22 117.56 3.51 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 178.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -75.14 172.58 12.13 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.207 -177.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.2 -56.18 3.22 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 107.883 -2.087 . . . . 0.0 107.883 -178.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.9 p -111.52 -177.12 3.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.865 -0.785 . . . . 0.0 109.17 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.617 ' O ' ' N ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -89.71 97.04 10.97 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 122.506 1.146 . . . . 0.0 108.581 179.109 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.523 ' HG2' ' CZ ' ' A' ' 6' ' ' PHE . 5.7 mtmt -146.63 109.55 4.65 Favored 'General case' 0 C--N 1.28 -2.453 0 O-C-N 120.912 -1.118 . . . . 0.0 109.604 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.545 ' O ' HG22 ' A' ' 89' ' ' ILE . 2.8 t -154.05 149.75 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.698 0.761 . . . . 0.0 110.522 -178.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.634 ' CD2' ' HB2' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -160.81 122.67 3.07 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 179.276 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.596 ' O ' ' HB2' ' A' ' 87' ' ' GLU . 12.9 t -113.32 100.55 10.92 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 C-N-CA 117.722 -1.591 . . . . 0.0 108.188 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.699 ' HA ' ' O ' ' A' ' 85' ' ' LYS . 0.3 OUTLIER -144.72 178.79 7.74 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 179.601 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.786 ' HB3' ' CZ2' ' A' ' 61' ' ' TRP . 44.2 mttt -131.62 134.56 46.13 Favored 'General case' 0 C--N 1.274 -2.715 0 N-CA-C 104.245 -2.502 . . . . 0.0 104.245 176.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.626 ' CB ' ' HB2' ' A' ' 32' ' ' ALA . . . -123.54 109.72 14.15 Favored 'General case' 0 N--CA 1.495 1.825 0 C-N-CA 117.593 -1.643 . . . . 0.0 112.599 -175.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.956 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 5.3 m0 -124.91 -163.07 1.15 Allowed 'General case' 0 N--CA 1.508 2.442 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.426 -178.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.633 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -124.51 88.55 2.92 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.042 -1.036 . . . . 0.0 111.015 179.541 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.878 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 4.4 mt-10 -167.15 171.64 10.71 Favored 'General case' 0 N--CA 1.507 2.397 0 CA-C-O 121.745 0.783 . . . . 0.0 110.449 177.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.654 ' CG1' ' HA ' ' A' ' 80' ' ' SER . 2.3 mt -72.47 98.37 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.519 2.989 0 O-C-N 119.594 -1.942 . . . . 0.0 115.478 -176.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.696 ' CG2' ' HA ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -94.27 -164.54 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.296 -1.503 . . . . 0.0 109.288 176.101 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.677 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 14.2 t70 -120.13 136.93 54.43 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 178.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.772 ' HA ' ' HB2' ' A' ' 77' ' ' GLU 0.251 . . -68.72 100.6 0.26 Allowed Pre-proline 0 N--CA 1.503 2.177 0 CA-C-O 117.799 -1.096 . . . . 0.0 111.615 -177.924 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.677 ' HD3' ' O ' ' A' ' 66' ' ' ASP . 49.3 Cg_endo -88.52 -153.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.319 -1.003 0 O-C-N 124.086 1.572 . . . . 0.0 111.241 -179.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.04 61.7 0.08 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.128 -0.983 . . . . 0.0 110.102 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.53 ' ND2' HD22 ' A' ' 29' ' ' LEU . 0.7 OUTLIER -99.63 -14.88 18.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.622 -0.673 . . . . 0.0 110.989 -179.583 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.708 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER 49.72 52.6 12.91 Favored Pre-proline 0 N--CA 1.488 1.429 0 O-C-N 121.892 -0.505 . . . . 0.0 109.992 -178.096 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.708 ' HD3' ' N ' ' A' ' 71' ' ' ARG . 53.2 Cg_endo -98.74 108.01 0.07 OUTLIER 'Trans proline' 0 C--N 1.317 -1.124 0 C-N-CA 122.05 1.834 . . . . 0.0 110.831 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.81 -31.32 23.93 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.966 -1.084 . . . . 0.0 111.447 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.453 ' CD1' ' N ' ' A' ' 74' ' ' TRP . 41.8 m95 -83.65 -32.63 25.55 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.688 -0.633 . . . . 0.0 110.907 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.3 mtm -167.98 106.76 0.56 Allowed Pre-proline 0 N--CA 1.499 2.003 0 O-C-N 121.467 -0.771 . . . . 0.0 111.08 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.74 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 51.0 Cg_endo -79.59 -179.93 5.78 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.696 1.366 . . . . 0.0 110.929 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.772 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 14.0 mm-40 -96.46 18.87 13.1 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 117.193 -1.803 . . . . 0.0 111.634 -178.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.594 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 5.8 tttm -90.39 76.27 6.72 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 177.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.542 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 0.3 OUTLIER -179.98 171.48 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 C-N-CA 118.095 -1.442 . . . . 0.0 112.326 -176.294 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.654 ' HA ' ' CG1' ' A' ' 64' ' ' ILE . 29.4 t -71.31 110.37 5.9 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 175.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.812 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . 3.5 mttm -164.83 -154.49 0.0 OUTLIER Pre-proline 0 C--O 1.191 -2.003 0 C-N-CA 119.093 -1.043 . . . . 0.0 108.761 -174.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.812 ' HD2' ' HB3' ' A' ' 81' ' ' LYS . 50.6 Cg_endo -81.94 130.66 6.68 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 N-CA-C 109.336 -1.063 . . . . 0.0 109.336 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.878 ' CZ ' ' HB3' ' A' ' 63' ' ' GLU . 1.5 m-30 -62.13 152.37 33.16 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 118.233 -1.387 . . . . 0.0 108.568 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.718 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 15.5 m -147.21 96.81 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.241 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.647 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.699 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -74.57 129.26 37.42 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 104.751 -2.314 . . . . 0.0 104.751 177.117 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.503 ' CB ' ' CZ ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -102.67 88.19 3.16 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -173.694 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.596 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 4.3 mp0 -91.81 161.56 14.81 Favored 'General case' 0 C--N 1.283 -2.311 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 174.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.49 ' HD2' ' HA ' ' A' ' 88' ' ' ARG . 0.9 OUTLIER -53.0 151.7 4.54 Favored 'General case' 0 N--CA 1.51 2.535 0 O-C-N 120.521 -1.362 . . . . 0.0 113.933 -175.241 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.549 HG12 ' HA ' ' A' ' 56' ' ' HIS . 74.7 mt -130.36 158.3 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.039 -178.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -145.9 148.16 32.53 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.583 -0.698 . . . . 0.0 109.964 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.417 ' HE3' ' HB3' ' A' ' 91' ' ' LYS . 0.2 OUTLIER -149.08 145.85 27.44 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.689 -1.257 . . . . 0.0 112.243 -178.866 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.617 ' N ' ' O ' ' A' ' 53' ' ' LYS . 0.3 OUTLIER -72.44 -178.08 2.44 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.673 -0.642 . . . . 0.0 109.571 179.243 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 118.325 -0.845 . . . . 0.0 109.807 179.349 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.625 ' HG3' ' O ' ' A' ' 21' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.505 2.301 0 CA-C-O 121.259 0.552 . . . . 0.0 111.379 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.737 ' HB2' HG22 ' A' ' 20' ' ' THR . 19.4 t-20 -84.99 148.03 26.4 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.593 -0.692 . . . . 0.0 110.284 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -144.03 156.25 44.31 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.734 ' C ' HD23 ' A' ' 8' ' ' LEU . 32.9 m -129.62 132.21 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 120.867 -1.146 . . . . 0.0 111.9 -178.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.85 HD13 ' CD2' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -162.7 164.91 26.22 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.602 -0.686 . . . . 0.0 110.86 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.417 ' H ' ' HB2' ' A' ' 14' ' ' ASN . 15.0 mtt85 -130.96 114.51 15.32 Favored 'General case' 0 N--CA 1.514 2.728 0 O-C-N 121.041 -1.037 . . . . 0.0 113.27 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.781 ' HB2' ' CB ' ' A' ' 16' ' ' HIS . 0.8 OUTLIER -75.07 -155.14 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 124.581 1.153 . . . . 0.0 111.216 179.471 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.613 ' HB2' ' O ' ' A' ' 10' ' ' ASP . 3.4 mp0 69.03 52.3 0.51 Allowed 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 -177.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.65 ' HA ' ' O ' ' A' ' 42' ' ' PRO . 33.5 m-20 58.07 8.8 0.82 Allowed 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 112.101 -2.318 . . . . 0.0 113.286 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.18 -75.65 1.3 Allowed Glycine 0 N--CA 1.487 2.092 0 C-N-CA 118.034 -2.032 . . . . 0.0 109.279 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.756 ' CG ' HD13 ' A' ' 45' ' ' ILE . 2.9 m-20 -118.4 -78.06 0.58 Allowed 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.876 1.322 . . . . 0.0 108.991 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.548 ' HA ' ' OD1' ' A' ' 10' ' ' ASP . 2.2 mt-10 -179.23 133.82 0.12 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.781 ' CB ' ' HB2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -79.72 123.58 27.8 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 115.712 -2.395 . . . . 0.0 111.376 -178.532 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.701 ' HA2' ' CZ ' ' A' ' 19' ' ' PHE . . . -168.89 109.2 0.32 Allowed Glycine 0 C--N 1.285 -2.287 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.872 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.31 81.32 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 176.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.701 ' CZ ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -176.24 -173.32 0.54 Allowed 'General case' 0 N--CA 1.507 2.396 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.032 -178.487 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.737 HG22 ' HB2' ' A' ' 5' ' ' ASN . 37.5 p -106.97 137.0 45.87 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.508 -0.745 . . . . 0.0 111.967 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.625 ' O ' ' HG3' ' A' ' 4' ' ' ARG . . . -115.58 128.3 7.98 Favored Glycine 0 N--CA 1.499 2.854 0 N-CA-C 108.172 -1.971 . . . . 0.0 108.172 178.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.7 pttp -57.29 -40.0 76.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.936 -1.332 . . . . 0.0 110.266 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.832 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 2.4 tp-100 -121.49 136.36 25.86 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 120.975 -1.078 . . . . 0.0 109.311 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.52 ' HB3' ' HD3' ' A' ' 4' ' ' ARG . 38.5 Cg_endo -67.29 -52.84 0.55 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.365 1.192 . . . . 0.0 111.422 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.662 ' HB3' ' HA ' ' A' ' 70' ' ' ASN . 26.8 mtt180 -82.28 -57.55 3.33 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.498 -0.751 . . . . 0.0 111.036 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.592 ' HB3' ' HG2' ' A' ' 23' ' ' GLN . 9.0 tt0 -52.87 -43.21 65.95 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.209 -0.932 . . . . 0.0 111.393 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.832 ' HB3' ' O ' ' A' ' 23' ' ' GLN . . . -77.74 -13.59 59.85 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 120.908 -1.12 . . . . 0.0 109.719 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 25' ' ' ARG . . . -62.1 -51.51 67.63 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.189 -0.944 . . . . 0.0 109.866 178.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.745 ' HB2' ' HG2' ' A' ' 77' ' ' GLU . 3.0 pp -69.2 -42.9 75.16 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.317 -0.953 . . . . 0.0 109.657 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.738 ' HE2' HD11 ' A' ' 29' ' ' LEU . 11.4 mmtt -61.78 -42.97 99.68 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.43 -0.794 . . . . 0.0 111.305 178.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.44 ' C ' ' HB2' ' A' ' 36' ' ' SER . . . -59.81 -48.43 81.73 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -177.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.623 ' HA ' ' CB ' ' A' ' 36' ' ' SER . . . -62.5 -33.24 74.49 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 118.707 -1.197 . . . . 0.0 109.958 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -44.96 -45.3 10.43 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.7 -70.84 0.72 Allowed 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.346 -0.942 . . . . 0.0 112.441 178.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -114.67 2.07 23.25 Favored Glycine 0 N--CA 1.502 3.079 0 N-CA-C 117.529 1.771 . . . . 0.0 117.529 -175.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.623 ' CB ' ' HA ' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -88.3 -2.51 58.64 Favored 'General case' 0 N--CA 1.511 2.62 0 CA-C-N 123.401 3.6 . . . . 0.0 111.081 -177.238 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 60' ' ' ALA . . . -164.34 117.11 0.74 Allowed Glycine 0 N--CA 1.482 1.759 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -178.179 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.536 ' O ' ' HB3' ' A' ' 39' ' ' LYS . 50.9 m -76.74 -20.22 56.77 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 119.898 1.849 . . . . 0.0 110.234 -178.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.834 ' CA ' ' HG3' ' A' ' 42' ' ' PRO . 0.3 OUTLIER 76.59 -56.6 0.56 Allowed 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -178.514 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.89 -19.36 65.01 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 175.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.605 ' HB3' ' HA ' ' A' ' 11' ' ' GLU 0.282 0.3 OUTLIER -158.43 68.49 3.61 Favored Pre-proline 0 C--O 1.202 -1.412 0 O-C-N 121.738 -0.602 . . . . 0.0 110.408 179.144 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.834 ' HG3' ' CA ' ' A' ' 39' ' ' LYS 0.251 81.6 Cg_endo -119.1 -173.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.301 -1.955 0 C-N-CA 122.084 1.856 . . . . 0.0 110.442 178.866 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.61 ' HB3' ' O ' ' A' ' 14' ' ' ASN . 4.6 t70 -162.51 -173.44 3.56 Favored 'General case' 0 N--CA 1.507 2.388 0 O-C-N 120.367 -1.458 . . . . 0.0 111.817 176.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.017 HD13 ' HG2' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -127.65 123.8 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.782 ' N ' HD12 ' A' ' 44' ' ' ILE . 7.7 tt -166.23 170.68 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 119.267 -0.973 . . . . 0.0 110.221 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.498 ' HG3' HG13 ' A' ' 57' ' ' VAL . 2.3 mtp180 -78.21 98.7 5.95 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.85 ' CD2' HD13 ' A' ' 8' ' ' LEU . 10.8 mp -70.14 97.04 1.14 Allowed 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 . . . . . 0 N--CA 1.489 1.525 0 O-C-N 121.125 -0.984 . . . . 0.0 111.87 -178.048 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.415 ' C ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 120.995 0.426 . . . . 0.0 110.048 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.421 ' O ' HG23 ' A' ' 89' ' ' ILE . 42.8 t -150.59 118.73 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.7 -0.625 . . . . 0.0 110.078 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.867 ' CE1' ' HB2' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -131.04 117.58 19.35 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 178.964 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.697 ' CG1' ' HB3' ' A' ' 87' ' ' GLU . 7.9 t -105.99 115.86 48.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 C-N-CA 117.571 -1.652 . . . . 0.0 108.377 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.97 ' CD1' HG12 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -162.22 -177.19 5.56 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 -178.876 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 1.017 ' HG2' HD13 ' A' ' 44' ' ' ILE . 30.0 mttt -129.98 132.75 46.4 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 177.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.497 ' O ' ' CD1' ' A' ' 61' ' ' TRP . . . -121.62 109.55 14.9 Favored 'General case' 0 N--CA 1.504 2.242 0 CA-C-N 120.429 1.468 . . . . 0.0 112.575 -177.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.803 ' HB2' ' HB2' ' A' ' 83' ' ' PHE . 10.6 m0 -131.24 -173.85 3.22 Favored 'General case' 0 N--CA 1.512 2.638 0 O-C-N 121.673 -0.642 . . . . 0.0 111.1 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.676 ' HB3' ' HG3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -114.52 91.85 3.76 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.157 -0.964 . . . . 0.0 109.876 178.931 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.916 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 3.4 tp10 -171.04 163.91 7.42 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.561 0.696 . . . . 0.0 110.373 178.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.713 ' HB ' ' HA ' ' A' ' 80' ' ' SER . 6.0 tt -70.2 93.94 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.52 3.038 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 -175.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.709 HG22 ' H ' ' A' ' 66' ' ' ASP . 1.4 p -97.86 -161.08 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 O-C-N 120.096 -1.627 . . . . 0.0 109.067 176.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.709 ' H ' HG22 ' A' ' 65' ' ' VAL . 1.0 OUTLIER -115.95 140.4 49.28 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.296 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.838 ' HB2' ' HB2' ' A' ' 76' ' ' PRO 0.254 . . -58.39 100.41 0.22 Allowed Pre-proline 0 N--CA 1.502 2.171 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.297 -178.111 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.653 ' HD2' ' HB2' ' A' ' 77' ' ' GLU . 54.5 Cg_endo -76.38 83.82 1.96 Allowed 'Trans proline' 0 N--CA 1.492 1.391 0 O-C-N 124.166 1.614 . . . . 0.0 112.366 -177.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.6 mttt 41.3 38.94 0.87 Allowed 'General case' 0 N--CA 1.507 2.413 0 CA-C-O 121.3 0.571 . . . . 0.0 111.476 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.662 ' HA ' ' HB3' ' A' ' 25' ' ' ARG . 0.8 OUTLIER -77.81 -19.18 55.42 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.476 -0.765 . . . . 0.0 111.406 -179.679 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.699 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER 41.77 50.77 5.05 Favored Pre-proline 0 N--CA 1.507 2.412 0 CA-C-O 121.028 0.442 . . . . 0.0 112.02 -178.984 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.74 ' HG2' ' HA ' ' A' ' 76' ' ' PRO . 55.5 Cg_endo -99.22 99.68 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.591 1.528 . . . . 0.0 108.76 179.075 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.89 -19.17 16.21 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.191 -0.943 . . . . 0.0 111.829 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.446 ' CD1' ' N ' ' A' ' 74' ' ' TRP . 41.0 m95 -79.41 -42.59 25.15 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 121.443 -0.786 . . . . 0.0 109.808 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.404 ' O ' ' HG2' ' A' ' 72' ' ' PRO . 6.6 ttm -176.21 123.55 0.31 Allowed Pre-proline 0 N--CA 1.503 2.177 0 O-C-N 121.581 -0.699 . . . . 0.0 110.487 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.838 ' HB2' ' HB2' ' A' ' 67' ' ' ALA . 51.8 Cg_endo -83.18 176.84 7.06 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 O-C-N 124.091 1.574 . . . . 0.0 111.101 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.817 ' CB ' ' HA ' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -87.87 12.67 12.5 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 117.697 -1.601 . . . . 0.0 110.726 -179.645 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.694 ' C ' HG22 ' A' ' 79' ' ' ILE . 4.6 tttm -82.63 79.88 8.91 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.694 HG22 ' C ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER 177.87 170.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 C-N-CA 118.388 -1.325 . . . . 0.0 111.903 -177.643 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.713 ' HA ' ' HB ' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -69.08 106.29 2.74 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 104.207 -2.516 . . . . 0.0 104.207 175.243 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.846 ' HB3' ' HD2' ' A' ' 82' ' ' PRO 0.26 0.7 OUTLIER -165.02 -155.54 0.01 OUTLIER Pre-proline 0 C--O 1.194 -1.867 0 C-N-CA 119.143 -1.023 . . . . 0.0 108.847 -173.402 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.846 ' HD2' ' HB3' ' A' ' 81' ' ' LYS . 51.2 Cg_endo -78.15 125.01 6.9 Favored 'Trans proline' 0 C--N 1.302 -1.876 0 N-CA-C 108.792 -1.272 . . . . 0.0 108.792 178.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.916 ' CZ ' ' HB3' ' A' ' 63' ' ' GLU . 2.0 m-30 -61.38 145.81 50.35 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.288 -1.508 . . . . 0.0 108.158 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.97 HG12 ' CD1' ' A' ' 58' ' ' PHE . 2.1 t -143.21 94.84 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.466 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.673 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 2.7 mmtm -88.18 117.08 26.83 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.638 ' HB3' ' CZ ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -72.97 162.36 29.58 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 124.344 2.021 . . . . 0.0 114.091 -175.839 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.697 ' HB3' ' CG1' ' A' ' 57' ' ' VAL . 5.0 mt-10 -165.53 155.66 13.05 Favored 'General case' 0 C--N 1.271 -2.846 0 CA-C-N 110.544 -3.025 . . . . 0.0 107.857 177.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.462 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -47.01 132.45 11.88 Favored 'General case' 0 N--CA 1.507 2.423 0 CA-C-O 122.194 0.997 . . . . 0.0 113.031 -175.666 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.515 HG23 ' HA ' ' A' ' 56' ' ' HIS . 5.2 mt . . . . . 0 N--CA 1.492 1.665 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.335 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.485 ' O ' ' HA ' ' A' ' 20' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.893 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.804 ' HA ' HG22 ' A' ' 20' ' ' THR . 0.1 OUTLIER -78.17 121.53 24.46 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.695 -0.628 . . . . 0.0 110.849 -179.3 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.607 ' HB3' HD21 ' A' ' 47' ' ' LEU . 39.5 m-85 -109.6 167.45 10.13 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.426 -0.796 . . . . 0.0 110.549 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.695 ' C ' HD23 ' A' ' 8' ' ' LEU . 29.8 m -139.72 129.83 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 O-C-N 121.527 -0.733 . . . . 0.0 111.695 -178.15 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.845 HD13 HD11 ' A' ' 47' ' ' LEU . 0.3 OUTLIER -164.98 159.49 18.08 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.118 -0.989 . . . . 0.0 111.746 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.512 ' O ' ' N ' ' A' ' 14' ' ' ASN . 2.5 ttm-85 -140.12 114.91 9.52 Favored 'General case' 0 N--CA 1.511 2.577 0 O-C-N 121.083 -1.011 . . . . 0.0 112.755 178.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.81 ' HB2' ' CB ' ' A' ' 16' ' ' HIS . 0.7 OUTLIER -73.49 -153.19 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 125.154 1.381 . . . . 0.0 111.444 179.647 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.566 ' HB2' ' O ' ' A' ' 10' ' ' ASP . 0.6 OUTLIER 71.9 50.95 0.23 Allowed 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 -177.594 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.624 ' HA ' ' O ' ' A' ' 42' ' ' PRO . 86.5 m-20 59.14 6.6 0.72 Allowed 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 112.539 -2.118 . . . . 0.0 112.591 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.04 -77.33 1.34 Allowed Glycine 0 N--CA 1.485 1.903 0 C-N-CA 117.937 -2.078 . . . . 0.0 109.77 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.707 ' CA ' HG12 ' A' ' 45' ' ' ILE . 6.1 m-20 -117.49 -81.67 0.62 Allowed 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 122.183 0.992 . . . . 0.0 111.566 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.588 ' HB3' HD12 ' A' ' 8' ' ' LEU . 7.8 mt-10 -170.12 129.84 0.93 Allowed 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.81 ' CB ' ' HB2' ' A' ' 10' ' ' ASP . 1.1 p-80 -81.25 121.51 26.25 Favored 'General case' 0 N--CA 1.505 2.281 0 C-N-CA 115.273 -2.571 . . . . 0.0 112.17 -178.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.695 ' HA2' ' CZ ' ' A' ' 19' ' ' PHE . . . -176.89 122.84 0.86 Allowed Glycine 0 C--N 1.284 -2.322 0 CA-C-N 114.149 -1.387 . . . . 0.0 111.977 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.27 86.46 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 176.065 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.695 ' CZ ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -175.42 -172.11 0.54 Allowed 'General case' 0 N--CA 1.504 2.228 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.022 -178.08 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.804 HG22 ' HA ' ' A' ' 5' ' ' ASN . 42.8 p -108.56 153.74 22.94 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.121 -0.987 . . . . 0.0 111.885 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -135.89 131.55 5.78 Favored Glycine 0 N--CA 1.507 3.367 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.14 -50.88 69.89 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.149 -1.206 . . . . 0.0 109.225 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.513 ' HB2' ' HG2' ' A' ' 26' ' ' GLN . 37.2 mm-40 -126.71 124.71 24.22 Favored Pre-proline 0 N--CA 1.492 1.641 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.9 -19.67 46.11 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 123.614 1.323 . . . . 0.0 112.085 -178.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.55 ' HD2' ' HA ' ' A' ' 70' ' ' ASN . 8.5 mtt180 -82.84 -68.03 0.74 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.298 -0.877 . . . . 0.0 110.739 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.607 ' HB2' ' HA ' ' A' ' 72' ' ' PRO . 13.6 pt20 -58.93 -37.57 77.01 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.982 -1.073 . . . . 0.0 112.148 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.0 -22.85 63.09 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 120.765 -1.21 . . . . 0.0 109.661 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.77 -58.17 9.8 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.112 -0.992 . . . . 0.0 111.688 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.569 HD21 ' HB3' ' A' ' 72' ' ' PRO . 2.6 pp -56.26 -50.27 71.81 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 119.041 -1.064 . . . . 0.0 110.709 -178.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.532 ' N ' HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -69.79 -37.68 76.42 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 120.582 -1.324 . . . . 0.0 112.892 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.413 ' C ' ' HB2' ' A' ' 36' ' ' SER . . . -62.01 -45.09 95.12 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.723 -1.235 . . . . 0.0 112.306 -177.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.781 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -62.42 -34.52 76.93 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 118.694 -1.202 . . . . 0.0 109.535 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.606 ' CA ' ' HG3' ' A' ' 82' ' ' PRO . 0.2 OUTLIER -40.88 -48.1 3.06 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.185 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 -97.04 -72.31 0.65 Allowed 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.212 -0.995 . . . . 0.0 112.086 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -114.52 -1.23 23.22 Favored Glycine 0 N--CA 1.501 2.991 0 N-CA-C 117.401 1.72 . . . . 0.0 117.401 -175.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.604 ' CB ' ' HA ' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -86.04 -1.71 57.62 Favored 'General case' 0 N--CA 1.514 2.75 0 CA-C-N 123.255 3.527 . . . . 0.0 110.941 -177.017 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.438 ' C ' ' HE1' ' A' ' 16' ' ' HIS . . . -162.4 119.56 0.89 Allowed Glycine 0 C--N 1.299 -1.521 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -178.048 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.496 ' O ' ' HB3' ' A' ' 39' ' ' LYS . 12.9 m -81.08 -15.2 56.67 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 120.417 -1.637 . . . . 0.0 109.665 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.834 ' CA ' ' HG3' ' A' ' 42' ' ' PRO . 7.6 tttp 72.84 -59.16 0.58 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.45 -18.02 65.12 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.121 -1.436 . . . . 0.0 107.121 175.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.549 ' HB3' ' HA ' ' A' ' 11' ' ' GLU 0.285 0.3 OUTLIER -159.05 67.77 3.2 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.678 -0.639 . . . . 0.0 110.87 179.233 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.834 ' HG3' ' CA ' ' A' ' 39' ' ' LYS . 78.2 Cg_endo -119.13 -174.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.472 2.115 . . . . 0.0 110.927 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -166.47 -172.83 2.3 Favored 'General case' 0 N--CA 1.513 2.716 0 O-C-N 120.156 -1.59 . . . . 0.0 113.029 176.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.866 HD13 ' HG2' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -126.02 124.34 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.713 ' N ' HD12 ' A' ' 44' ' ' ILE . 1.6 pp -157.32 -176.43 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.435 -0.791 . . . . 0.0 110.336 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.887 ' HB3' HG13 ' A' ' 55' ' ' VAL . 16.7 mtt85 -85.56 94.56 9.07 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.845 HD11 HD13 ' A' ' 8' ' ' LEU . 5.3 tt -73.55 94.41 2.14 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.497 ' HG2' HG23 ' A' ' 7' ' ' VAL . 4.2 ptp180 . . . . . 0 N--CA 1.496 1.839 0 C-N-CA 119.478 -0.889 . . . . 0.0 112.282 -177.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 48' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 121.647 0.737 . . . . 0.0 110.382 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.887 HG13 ' HB3' ' A' ' 46' ' ' ARG . 35.2 t -149.26 94.25 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.899 ' HA ' HG23 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -79.92 124.92 29.11 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 179.189 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.661 HG12 ' HB2' ' A' ' 87' ' ' GLU . 2.9 t -109.37 106.46 20.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 C-N-CA 117.362 -1.735 . . . . 0.0 107.152 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.859 ' HB2' ' CE1' ' A' ' 56' ' ' HIS . 0.3 OUTLIER -150.03 167.74 25.87 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.866 ' HG2' HD13 ' A' ' 44' ' ' ILE . 8.3 mttm -121.17 118.96 31.0 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.781 ' HB1' ' HB2' ' A' ' 32' ' ' ALA . . . -106.69 107.33 18.29 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 118.609 -1.236 . . . . 0.0 112.484 -176.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.794 ' HB2' ' HB2' ' A' ' 83' ' ' PHE . 18.5 m0 -128.49 -166.13 1.59 Allowed 'General case' 0 N--CA 1.512 2.635 0 O-C-N 121.842 -0.536 . . . . 0.0 111.021 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.748 ' HB2' ' HB2' ' A' ' 39' ' ' LYS . 0.3 OUTLIER -123.2 86.53 2.59 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 120.967 -1.083 . . . . 0.0 110.966 179.747 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.757 ' CB ' ' CZ ' ' A' ' 83' ' ' PHE . 19.7 mp0 -161.19 171.14 18.98 Favored 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.646 ' HB ' ' HA ' ' A' ' 80' ' ' SER . 2.8 tt -78.48 98.04 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.136 0 O-C-N 119.301 -2.124 . . . . 0.0 115.49 -177.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 1.122 HG13 ' CD1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -89.85 -168.41 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.309 -1.495 . . . . 0.0 110.342 177.739 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.62 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 10.9 t70 -119.66 133.85 55.47 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.806 ' HA ' ' CB ' ' A' ' 77' ' ' GLU . . . -66.01 101.33 0.27 Allowed Pre-proline 0 N--CA 1.504 2.273 0 CA-C-O 117.93 -1.033 . . . . 0.0 111.902 -178.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.681 ' CB ' ' HD2' ' A' ' 86' ' ' LYS . 52.5 Cg_endo -86.93 -166.66 0.31 Allowed 'Trans proline' 0 C--N 1.315 -1.221 0 O-C-N 123.875 1.461 . . . . 0.0 111.467 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.0 mmmt -69.44 62.02 0.15 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.447 -0.783 . . . . 0.0 110.295 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.55 ' HA ' ' HD2' ' A' ' 25' ' ' ARG . 1.0 OUTLIER -101.65 -9.35 20.99 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.653 -0.654 . . . . 0.0 111.213 -179.842 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.755 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER 56.52 44.06 1.33 Allowed Pre-proline 0 N--CA 1.508 2.441 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -179.244 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.755 ' HD3' ' N ' ' A' ' 71' ' ' ARG . 49.0 Cg_endo -94.06 98.99 0.13 Allowed 'Trans proline' 0 C--N 1.316 -1.183 0 C-N-CA 120.84 1.026 . . . . 0.0 110.015 178.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.9 -18.33 50.86 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.15 -0.968 . . . . 0.0 111.444 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.519 ' CD1' ' N ' ' A' ' 74' ' ' TRP . 6.9 m0 -80.29 -37.82 32.01 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.154 -0.966 . . . . 0.0 109.579 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.457 ' O ' ' HB2' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -167.64 122.57 0.82 Allowed Pre-proline 0 N--CA 1.496 1.83 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.612 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.766 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 49.5 Cg_endo -81.92 -179.8 5.06 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.589 1.31 . . . . 0.0 112.62 -178.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.806 ' CB ' ' HA ' ' A' ' 67' ' ' ALA . 1.3 mt-10 -92.2 11.0 27.12 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 118.315 -1.354 . . . . 0.0 110.684 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.691 ' C ' HG22 ' A' ' 79' ' ' ILE . 0.6 OUTLIER -92.46 82.83 4.89 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.94 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.691 HG22 ' C ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -176.87 161.55 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 C-N-CA 118.146 -1.422 . . . . 0.0 112.392 -177.837 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.646 ' HA ' ' HB ' ' A' ' 64' ' ' ILE . 0.3 OUTLIER -75.07 104.94 5.85 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 175.501 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.768 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 11.5 pttp -169.81 -152.58 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.784 0 C-N-CA 118.843 -1.143 . . . . 0.0 108.393 -174.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.768 ' HD2' ' HB2' ' A' ' 81' ' ' LYS . 51.0 Cg_endo -74.83 127.33 10.72 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 N-CA-C 109.547 -0.982 . . . . 0.0 109.547 178.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 1.122 ' CD1' HG13 ' A' ' 65' ' ' VAL . 0.8 OUTLIER -65.16 160.19 21.84 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.987 -1.071 . . . . 0.0 109.737 179.502 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.704 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -154.64 92.7 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 177.25 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.783 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -77.51 122.35 25.11 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 178.946 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.681 ' HD2' ' CB ' ' A' ' 68' ' ' PRO . 0.0 OUTLIER -85.24 92.2 8.36 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 122.864 1.316 . . . . 0.0 113.29 -175.783 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.661 ' HB2' HG12 ' A' ' 57' ' ' VAL . 3.2 mm-40 -88.5 153.94 20.75 Favored 'General case' 0 C--N 1.28 -2.448 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.459 176.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -53.38 111.11 0.64 Allowed 'General case' 0 N--CA 1.51 2.557 0 CA-C-O 122.092 0.949 . . . . 0.0 113.087 -176.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.899 HG23 ' HA ' ' A' ' 56' ' ' HIS . 10.4 mt . . . . . 0 N--CA 1.5 2.029 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.085 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.495 ' O ' ' HA ' ' A' ' 20' ' ' THR . 3.0 mpt_? . . . . . 0 N--CA 1.5 2.057 0 CA-C-O 120.834 0.349 . . . . 0.0 110.068 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.49 ' CA ' HG22 ' A' ' 20' ' ' THR . 6.7 t-20 -77.43 143.55 38.5 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.65 -0.657 . . . . 0.0 110.417 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -142.65 137.56 30.05 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.576 -0.702 . . . . 0.0 110.264 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.917 HG22 ' O ' ' A' ' 48' ' ' ARG . 17.0 m -119.39 132.78 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.516 -0.74 . . . . 0.0 111.599 -178.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.805 HD22 ' HG ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -163.39 161.45 24.42 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.107 -0.995 . . . . 0.0 111.291 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.433 ' H ' ' HB2' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -131.99 110.58 10.85 Favored 'General case' 0 N--CA 1.513 2.718 0 O-C-N 121.13 -0.981 . . . . 0.0 113.154 -179.375 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.83 ' HB2' ' CB ' ' A' ' 16' ' ' HIS . 0.9 OUTLIER -73.48 -156.16 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 C-N-CA 124.274 1.03 . . . . 0.0 111.101 179.337 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.665 ' HA ' ' HB3' ' A' ' 41' ' ' ASN . 3.0 mp0 70.92 51.66 0.3 Allowed 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 -177.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.615 ' HA ' ' O ' ' A' ' 42' ' ' PRO . 86.4 m-20 59.45 7.95 1.09 Allowed 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 112.306 -2.224 . . . . 0.0 113.027 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.28 -77.69 1.33 Allowed Glycine 0 N--CA 1.486 1.992 0 C-N-CA 117.954 -2.07 . . . . 0.0 109.061 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.639 ' O ' ' HB3' ' A' ' 43' ' ' ASP . 8.0 m-20 -117.11 -77.24 0.57 Allowed 'General case' 0 C--N 1.296 -1.753 0 CA-C-O 122.606 1.193 . . . . 0.0 109.909 178.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.569 ' HA ' ' OD1' ' A' ' 10' ' ' ASP . 1.3 mt-10 -178.05 138.08 0.19 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 178.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.83 ' CB ' ' HB2' ' A' ' 10' ' ' ASP . 0.1 OUTLIER -87.37 122.45 31.14 Favored 'General case' 0 N--CA 1.501 2.119 0 C-N-CA 115.672 -2.411 . . . . 0.0 112.22 -178.623 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.669 ' HA2' ' CE1' ' A' ' 19' ' ' PHE . . . -174.43 110.16 0.32 Allowed Glycine 0 C--N 1.283 -2.375 0 CA-C-N 113.804 -1.543 . . . . 0.0 110.834 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.449 ' C ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -130.96 81.87 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.2 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.669 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -175.17 -173.49 0.67 Allowed 'General case' 0 N--CA 1.502 2.161 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.077 -179.682 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 4' ' ' ARG . 57.3 p -103.23 144.8 30.86 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.418 -0.801 . . . . 0.0 111.809 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -124.29 133.58 8.76 Favored Glycine 0 N--CA 1.503 3.111 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.4 mttt -66.46 -58.64 4.83 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.241 -1.153 . . . . 0.0 108.752 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.545 ' HB3' ' HB3' ' A' ' 26' ' ' GLN . 0.9 OUTLIER -109.45 106.05 58.02 Favored Pre-proline 0 C--N 1.303 -1.424 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 177.9 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.608 ' HB2' HD13 ' A' ' 89' ' ' ILE . 36.9 Cg_endo -60.04 -26.46 82.49 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.945 1.498 . . . . 0.0 111.309 -178.064 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.622 ' HD3' ' HA ' ' A' ' 70' ' ' ASN . 3.6 mtt-85 -85.23 -58.39 2.7 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.268 -0.895 . . . . 0.0 109.239 178.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.758 ' HG3' ' HA ' ' A' ' 72' ' ' PRO . 1.0 OUTLIER -59.01 -43.53 91.54 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.921 -1.112 . . . . 0.0 110.807 179.552 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.41 -18.15 63.73 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 118.993 -1.083 . . . . 0.0 109.78 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 25' ' ' ARG . . . -59.76 -60.11 4.36 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.436 -0.79 . . . . 0.0 111.703 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.567 ' HB3' ' HG3' ' A' ' 77' ' ' GLU . 1.8 pp -63.89 -44.13 93.93 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 118.933 -1.107 . . . . 0.0 110.524 -179.066 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.401 ' HG3' ' CD1' ' A' ' 29' ' ' LEU . 37.6 mtmt -66.48 -43.7 84.67 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 120.781 -1.199 . . . . 0.0 112.476 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.23 -45.46 88.07 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.929 -1.107 . . . . 0.0 112.864 -177.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.646 ' HA ' ' CB ' ' A' ' 36' ' ' SER . . . -56.64 -37.52 70.87 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 118.781 -1.167 . . . . 0.0 109.493 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.494 ' CB ' ' HG3' ' A' ' 82' ' ' PRO . 4.4 t-20 -42.39 -47.05 4.87 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.98 -73.44 0.58 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 119.035 -1.066 . . . . 0.0 112.545 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.76 1.63 19.92 Favored Glycine 0 N--CA 1.502 3.092 0 N-CA-C 117.213 1.645 . . . . 0.0 117.213 -175.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.646 ' CB ' ' HA ' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -85.17 -4.85 59.3 Favored 'General case' 0 N--CA 1.51 2.545 0 CA-C-N 122.929 3.364 . . . . 0.0 110.99 -176.917 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.442 ' C ' ' HE1' ' A' ' 16' ' ' HIS . . . -165.37 120.89 0.96 Allowed Glycine 0 N--CA 1.478 1.494 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -177.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.57 ' O ' ' HB3' ' A' ' 39' ' ' LYS . 32.4 m -77.66 -14.81 59.52 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 120.359 -1.671 . . . . 0.0 110.195 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.828 ' CA ' ' HG3' ' A' ' 42' ' ' PRO . 1.2 tmtt? 72.01 -56.57 0.64 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -178.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.97 -18.73 63.36 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 176.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.665 ' HB3' ' HA ' ' A' ' 11' ' ' GLU 0.278 0.4 OUTLIER -156.75 67.73 4.34 Favored Pre-proline 0 C--O 1.199 -1.581 0 O-C-N 121.819 -0.55 . . . . 0.0 109.98 179.083 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.828 ' HG3' ' CA ' ' A' ' 39' ' ' LYS . 80.0 Cg_endo -119.61 -174.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 122.382 2.054 . . . . 0.0 111.075 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.639 ' HB3' ' O ' ' A' ' 14' ' ' ASN . 3.2 t70 -165.11 -168.71 1.47 Allowed 'General case' 0 N--CA 1.51 2.565 0 O-C-N 120.357 -1.464 . . . . 0.0 111.963 176.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.03 HD13 ' HG2' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -129.93 120.76 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.715 -0.616 . . . . 0.0 109.778 -179.043 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.715 ' N ' HD12 ' A' ' 44' ' ' ILE . 1.3 pp -157.98 -177.96 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-O 121.829 0.823 . . . . 0.0 109.876 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.608 ' NH1' HG21 ' A' ' 57' ' ' VAL . 0.5 OUTLIER -91.19 100.26 13.12 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.102 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.805 ' HG ' HD22 ' A' ' 8' ' ' LEU . 9.4 mp -69.71 93.32 0.72 Allowed 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.917 ' O ' HG22 ' A' ' 7' ' ' VAL . 8.2 ptp85 . . . . . 0 N--CA 1.49 1.547 0 C-N-CA 119.722 -0.791 . . . . 0.0 113.059 -175.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.584 ' O ' ' HA ' ' A' ' 48' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.404 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.839 HG13 ' HB3' ' A' ' 48' ' ' ARG . 3.9 t -138.78 107.58 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 CA-C-O 121.245 0.545 . . . . 0.0 110.547 -178.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.819 ' CE1' ' HB2' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -101.04 127.4 47.58 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 178.54 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.861 HG22 ' CB ' ' A' ' 87' ' ' GLU . 2.2 p -117.6 123.84 72.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 C-N-CA 116.611 -2.036 . . . . 0.0 108.852 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.819 ' HB2' ' CE1' ' A' ' 56' ' ' HIS . 0.3 OUTLIER -162.75 -176.35 4.92 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 -178.681 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 1.03 ' HG2' HD13 ' A' ' 44' ' ' ILE . 38.2 mttt -133.42 124.48 27.18 Favored 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.617 ' HB1' ' CB ' ' A' ' 32' ' ' ALA . . . -110.75 109.29 19.46 Favored 'General case' 0 N--CA 1.505 2.287 0 C-N-CA 118.595 -1.242 . . . . 0.0 113.424 -176.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.845 ' HB2' ' HB2' ' A' ' 83' ' ' PHE . 11.2 m0 -132.38 -163.46 1.34 Allowed 'General case' 0 N--CA 1.515 2.822 0 O-C-N 121.86 -0.525 . . . . 0.0 110.589 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.698 ' CB ' ' HG3' ' A' ' 39' ' ' LYS . 0.5 OUTLIER -125.26 89.04 2.98 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 120.423 -1.423 . . . . 0.0 112.217 179.93 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.885 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 4.3 mt-10 -167.17 -179.44 4.57 Favored 'General case' 0 N--CA 1.514 2.752 0 CA-C-O 121.514 0.674 . . . . 0.0 111.064 177.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.597 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 2.1 mt -78.26 99.88 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.086 0 O-C-N 119.429 -2.045 . . . . 0.0 115.012 -176.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.859 HG13 ' CD1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -90.92 -168.91 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 120.586 -1.321 . . . . 0.0 110.317 177.51 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.618 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 12.1 t70 -124.72 129.86 51.3 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.822 ' HA ' ' CB ' ' A' ' 77' ' ' GLU 0.253 . . -66.18 98.6 0.16 Allowed Pre-proline 0 N--CA 1.511 2.623 0 CA-C-O 117.51 -1.233 . . . . 0.0 111.862 -177.542 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.615 ' HD3' ' O ' ' A' ' 66' ' ' ASP . 48.9 Cg_endo -92.95 85.68 0.19 Allowed 'Trans proline' 0 N--CA 1.483 0.893 0 O-C-N 123.818 1.43 . . . . 0.0 112.994 -178.266 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.5 mttm 38.99 54.03 2.07 Favored 'General case' 0 N--CA 1.511 2.597 0 CA-C-O 121.71 0.767 . . . . 0.0 111.538 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.622 ' HA ' ' HD3' ' A' ' 25' ' ' ARG . 0.9 OUTLIER -91.8 -9.7 42.56 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.289 -0.882 . . . . 0.0 112.216 -179.083 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.765 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER 62.67 35.46 0.21 Allowed Pre-proline 0 N--CA 1.508 2.432 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -179.649 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.795 ' HG2' ' HA ' ' A' ' 76' ' ' PRO . 56.8 Cg_endo -93.41 115.13 0.27 Allowed 'Trans proline' 0 C--N 1.315 -1.193 0 N-CA-C 109.822 -0.876 . . . . 0.0 109.822 178.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.0 -19.75 39.85 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.951 -1.093 . . . . 0.0 111.715 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.457 ' CD1' ' N ' ' A' ' 74' ' ' TRP . 37.8 m95 -82.28 -39.21 23.27 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.398 -0.814 . . . . 0.0 110.137 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.551 ' SD ' ' HE3' ' A' ' 81' ' ' LYS . 2.1 mtm -170.42 132.2 0.96 Allowed Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.708 -0.62 . . . . 0.0 109.556 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.795 ' HA ' ' HG2' ' A' ' 72' ' ' PRO . 46.4 Cg_endo -87.33 -178.16 2.34 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.682 1.359 . . . . 0.0 112.129 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.822 ' CB ' ' HA ' ' A' ' 67' ' ' ALA . 0.3 OUTLIER -88.94 11.39 18.27 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 118.092 -1.443 . . . . 0.0 110.321 -179.328 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.702 ' C ' HG22 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -94.18 81.6 4.08 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.229 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.702 HG22 ' C ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -177.97 164.44 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 118.145 -1.422 . . . . 0.0 112.57 -177.462 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.54 ' N ' HG13 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -73.84 104.32 4.68 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 104.556 -2.387 . . . . 0.0 104.556 175.218 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.79 ' HB3' ' HD2' ' A' ' 82' ' ' PRO 0.262 2.8 mttm -164.16 -162.41 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.682 0 C-N-CA 118.857 -1.137 . . . . 0.0 110.112 -174.267 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.79 ' HD2' ' HB3' ' A' ' 81' ' ' LYS . 43.4 Cg_endo -69.87 121.65 8.31 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 N-CA-C 107.529 -1.758 . . . . 0.0 107.529 176.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.885 ' CZ ' ' HB3' ' A' ' 63' ' ' GLU . 0.4 OUTLIER -57.37 151.51 16.12 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.878 -1.139 . . . . 0.0 109.892 -178.734 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.733 ' H ' HG11 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -148.04 88.8 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.51 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.388 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.748 ' HB2' ' CG ' ' A' ' 59' ' ' LYS . 14.6 mmtp -79.93 118.16 21.43 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.523 ' CE ' ' O ' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -72.67 156.55 38.84 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 124.256 1.979 . . . . 0.0 114.3 -175.419 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.861 ' CB ' HG22 ' A' ' 57' ' ' VAL . 0.5 OUTLIER -163.34 143.7 8.98 Favored 'General case' 0 C--N 1.271 -2.817 0 CA-C-N 111.096 -2.774 . . . . 0.0 108.828 177.865 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.4 ' O ' HG12 ' A' ' 57' ' ' VAL . 1.0 OUTLIER -55.0 117.49 3.49 Favored 'General case' 0 N--CA 1.506 2.351 0 CA-C-O 122.13 0.967 . . . . 0.0 113.38 -176.487 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.781 HG23 ' HA ' ' A' ' 56' ' ' HIS . 42.8 mt . . . . . 0 N--CA 1.494 1.747 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.34 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 20' ' ' THR . 22.3 mmt180 . . . . . 0 N--CA 1.499 2.001 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.77 ' HA ' HG22 ' A' ' 20' ' ' THR . 6.1 t-20 -72.55 135.86 45.7 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.512 -0.742 . . . . 0.0 109.582 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.687 ' CD1' HD22 ' A' ' 47' ' ' LEU . 4.3 m-85 -142.22 166.81 23.67 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.603 -0.839 . . . . 0.0 111.355 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.504 ' O ' HD23 ' A' ' 47' ' ' LEU . 10.8 m -136.62 131.77 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.808 -0.557 . . . . 0.0 111.143 -178.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.717 HD13 ' OE1' ' A' ' 15' ' ' GLU . 0.4 OUTLIER -159.07 161.97 36.53 Favored 'General case' 0 N--CA 1.512 2.641 0 O-C-N 120.922 -1.111 . . . . 0.0 111.877 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.466 ' N ' ' O ' ' A' ' 15' ' ' GLU . 10.7 tpt180 -148.81 112.51 5.08 Favored 'General case' 0 N--CA 1.512 2.647 0 O-C-N 121.012 -1.055 . . . . 0.0 112.832 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.929 ' HB3' ' CD2' ' A' ' 16' ' ' HIS . 5.8 t0 -98.61 -144.09 0.32 Allowed 'General case' 0 N--CA 1.508 2.428 0 O-C-N 121.273 -0.892 . . . . 0.0 109.405 177.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.755 ' HA ' ' HB3' ' A' ' 41' ' ' ASN . 2.4 mt-10 72.63 57.54 0.13 Allowed 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 102.576 -3.12 . . . . 0.0 102.576 -174.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.654 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 69.8 m-20 74.14 -5.15 2.12 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 112.272 -2.24 . . . . 0.0 111.844 -177.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.07 -83.53 1.42 Allowed Glycine 0 N--CA 1.482 1.764 0 C-N-CA 118.25 -1.928 . . . . 0.0 109.729 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.731 ' HB3' ' CD1' ' A' ' 45' ' ' ILE . 0.7 OUTLIER -129.19 -74.49 0.56 Allowed 'General case' 0 N--CA 1.51 2.529 0 O-C-N 121.634 -0.921 . . . . 0.0 112.744 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.773 ' CA ' ' HB2' ' A' ' 10' ' ' ASP . 35.2 tt0 -164.89 127.89 2.3 Favored 'General case' 0 N--CA 1.522 3.136 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.929 ' CD2' ' HB3' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -99.37 124.4 44.45 Favored 'General case' 0 N--CA 1.512 2.671 0 C-N-CA 116.208 -2.197 . . . . 0.0 115.415 -176.377 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.484 ' CA ' ' CE1' ' A' ' 19' ' ' PHE . . . -178.09 134.62 2.45 Favored Glycine 0 N--CA 1.48 1.586 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.212 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.423 ' C ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -132.88 91.07 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 120.87 -1.37 . . . . 0.0 108.112 177.254 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.671 ' N ' ' CD1' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -174.81 -170.65 0.49 Allowed 'General case' 0 N--CA 1.504 2.251 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.727 -178.667 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.77 HG22 ' HA ' ' A' ' 5' ' ' ASN . 18.1 p -106.09 151.46 24.66 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.033 -1.042 . . . . 0.0 111.24 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -129.62 142.07 13.25 Favored Glycine 0 N--CA 1.504 3.195 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -71.49 -61.8 1.64 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.158 -1.201 . . . . 0.0 108.564 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.691 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -99.96 115.37 65.6 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.102 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.473 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 36.9 Cg_endo -61.65 -32.63 87.14 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.318 1.167 . . . . 0.0 111.1 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.499 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 43.1 mtt180 -83.25 -64.7 1.12 Allowed 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.384 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.639 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -57.43 -39.49 76.35 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.967 -1.083 . . . . 0.0 111.528 -179.661 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' A' ' 23' ' ' GLN . . . -74.57 -16.38 60.81 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 120.396 -1.44 . . . . 0.0 109.669 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 25' ' ' ARG . . . -57.21 -60.05 4.19 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.442 -0.786 . . . . 0.0 110.301 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.712 HD22 ' HG2' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -62.04 -46.08 90.75 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 118.512 -1.275 . . . . 0.0 108.145 179.199 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.626 ' N ' ' HG ' ' A' ' 29' ' ' LEU . 2.8 mmpt? -49.51 -48.07 48.34 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.224 -0.922 . . . . 0.0 110.741 179.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.522 ' C ' ' HB2' ' A' ' 36' ' ' SER . . . -62.13 -49.58 75.31 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.308 -0.87 . . . . 0.0 110.856 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.982 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -59.17 -35.32 73.34 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.306 -0.871 . . . . 0.0 109.807 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.433 ' CA ' ' HG3' ' A' ' 82' ' ' PRO . 0.1 OUTLIER -38.89 -48.43 1.56 Allowed 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.6 mmt180 -92.47 -75.16 0.49 Allowed 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 118.593 -1.243 . . . . 0.0 112.235 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.582 ' O ' ' CG ' ' A' ' 16' ' ' HIS . . . -117.11 -3.03 18.01 Favored Glycine 0 N--CA 1.5 2.946 0 CA-C-O 118.078 -1.401 . . . . 0.0 116.527 -176.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.661 ' HB2' ' CA ' ' A' ' 32' ' ' ALA . 0.4 OUTLIER -82.32 -4.14 56.67 Favored 'General case' 0 N--CA 1.508 2.428 0 CA-C-N 122.358 3.079 . . . . 0.0 111.154 -176.684 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 60' ' ' ALA . . . -145.99 109.53 0.5 Allowed Glycine 0 C--N 1.287 -2.145 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.42 ' O ' ' N ' ' A' ' 40' ' ' ALA . 0.3 OUTLIER -76.56 -23.17 53.55 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 117.965 -1.494 . . . . 0.0 109.828 -179.745 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.692 ' HG3' ' HB2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER 67.67 -55.87 0.47 Allowed 'General case' 0 N--CA 1.51 2.564 0 CA-C-O 121.53 0.681 . . . . 0.0 109.188 -179.566 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 38' ' ' THR . . . -65.65 -29.09 69.61 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 104.49 -2.411 . . . . 0.0 104.49 174.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.755 ' HB3' ' HA ' ' A' ' 11' ' ' GLU 0.282 0.4 OUTLIER -140.59 71.94 30.75 Favored Pre-proline 0 N--CA 1.485 1.288 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 176.986 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.995 ' HB2' ' CD1' ' A' ' 61' ' ' TRP . 93.8 Cg_endo -110.71 167.5 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 121.166 1.244 . . . . 0.0 111.779 -177.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -164.96 -170.63 2.0 Favored 'General case' 0 N--CA 1.511 2.59 0 C-N-CA 118.021 -1.472 . . . . 0.0 112.707 177.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.731 HG22 ' HD3' ' A' ' 59' ' ' LYS . 0.2 OUTLIER -93.99 134.42 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.731 ' CD1' ' HB3' ' A' ' 14' ' ' ASN . 2.2 tp -120.06 129.96 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.673 -1.267 . . . . 0.0 113.749 -177.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.1 mtm180 -92.3 84.27 5.16 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 104.023 -2.584 . . . . 0.0 104.023 173.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.687 HD22 ' CD1' ' A' ' 6' ' ' PHE . 0.1 OUTLIER -76.03 94.38 3.42 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -177.871 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 C-N-CA 119.178 -1.009 . . . . 0.0 111.929 -178.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 121.146 0.498 . . . . 0.0 109.702 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 52.8 t -151.07 129.04 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-O 121.832 0.825 . . . . 0.0 110.797 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.779 ' CE1' ' HB2' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -146.24 110.64 5.09 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 179.334 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.661 ' CG1' ' HB3' ' A' ' 87' ' ' GLU . 21.9 t -105.82 99.95 9.59 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.305 0 C-N-CA 117.497 -1.681 . . . . 0.0 107.735 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 1.016 ' CD1' HG22 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -135.03 179.54 6.26 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 179.563 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.809 ' HB3' ' CZ2' ' A' ' 61' ' ' TRP . 39.7 mttt -133.06 135.07 45.13 Favored 'General case' 0 C--N 1.275 -2.658 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 177.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.982 ' HB1' ' HB2' ' A' ' 32' ' ' ALA . . . -122.85 111.29 16.48 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-N 120.8 1.636 . . . . 0.0 112.911 -175.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.995 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 2.7 m0 -128.11 -165.07 1.44 Allowed 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.739 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 7.3 mmtp -122.25 92.2 3.67 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 120.669 -1.27 . . . . 0.0 111.083 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.952 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 4.5 tp10 -173.51 169.74 4.28 Favored 'General case' 0 N--CA 1.502 2.175 0 CA-C-O 121.469 0.652 . . . . 0.0 110.955 178.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.687 ' CG1' ' HA ' ' A' ' 80' ' ' SER . 2.1 mt -71.71 102.14 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.533 3.679 0 O-C-N 119.421 -2.049 . . . . 0.0 116.305 -175.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 1.061 HG13 ' CD1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -102.0 -167.94 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 120.449 -1.407 . . . . 0.0 110.858 177.09 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.705 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 11.6 t70 -116.1 134.58 54.79 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.509 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.819 ' HA ' ' HB2' ' A' ' 77' ' ' GLU 0.28 . . -72.46 97.57 0.15 Allowed Pre-proline 0 N--CA 1.511 2.595 0 CA-C-O 117.466 -1.254 . . . . 0.0 112.761 -178.242 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.705 ' HD3' ' O ' ' A' ' 66' ' ' ASP . 53.6 Cg_endo -73.35 123.81 8.98 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 O-C-N 123.273 1.144 . . . . 0.0 111.315 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER 53.25 37.9 26.34 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.313 -0.867 . . . . 0.0 109.044 -179.307 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.606 ' HB3' ' HD3' ' A' ' 72' ' ' PRO . 6.6 m-80 2.07 -75.57 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.75 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 11.8 ptm180 34.63 44.22 0.29 Allowed Pre-proline 0 N--CA 1.513 2.707 0 CA-C-N 118.121 0.419 . . . . 0.0 110.355 -177.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.75 ' HD3' ' N ' ' A' ' 71' ' ' ARG . 54.5 Cg_endo -105.85 114.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.324 -0.737 0 C-N-CA 121.922 1.748 . . . . 0.0 112.85 -176.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.85 -39.46 15.82 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.196 -1.002 . . . . 0.0 108.956 177.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.509 ' CD1' ' N ' ' A' ' 74' ' ' TRP . 6.4 m95 -89.7 -38.19 14.04 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.331 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.444 ' HB2' ' O ' ' A' ' 74' ' ' TRP . 7.1 ttm -179.58 146.02 0.44 Allowed Pre-proline 0 N--CA 1.51 2.549 0 O-C-N 121.746 -0.596 . . . . 0.0 111.485 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.598 ' HB3' ' HG3' ' A' ' 72' ' ' PRO . 48.3 Cg_endo -94.54 174.7 1.29 Allowed 'Trans proline' 0 N--CA 1.486 1.087 0 C-N-CA 122.113 1.875 . . . . 0.0 111.041 178.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.819 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 3.8 mt-10 -95.26 16.02 17.75 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 117.892 -1.523 . . . . 0.0 110.812 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.697 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 0.3 OUTLIER -98.28 80.83 2.69 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.22 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.647 ' CG1' ' HD2' ' A' ' 81' ' ' LYS . 0.6 OUTLIER 178.59 170.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 C-N-CA 118.128 -1.429 . . . . 0.0 112.122 -177.706 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.687 ' HA ' ' CG1' ' A' ' 64' ' ' ILE . 1.4 m -70.77 109.77 5.16 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 175.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.83 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -169.09 -156.88 0.0 OUTLIER Pre-proline 0 C--O 1.192 -1.973 0 C-N-CA 118.882 -1.127 . . . . 0.0 108.651 -174.916 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.83 ' HD2' ' HB3' ' A' ' 81' ' ' LYS . 43.7 Cg_endo -74.7 127.22 10.72 Favored 'Trans proline' 0 C--N 1.299 -2.052 0 N-CA-C 108.905 -1.229 . . . . 0.0 108.905 178.024 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 1.061 ' CD1' HG13 ' A' ' 65' ' ' VAL . 0.8 OUTLIER -58.9 151.64 21.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.506 -1.371 . . . . 0.0 108.087 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 1.016 HG22 ' CD1' ' A' ' 58' ' ' PHE . 9.8 p -149.64 95.49 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.508 0 CA-C-O 122.015 0.912 . . . . 0.0 109.764 -178.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.748 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -78.53 119.0 21.19 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 179.611 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.638 ' HB3' ' CZ ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -85.71 94.37 9.08 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 122.716 1.246 . . . . 0.0 113.845 -176.157 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.661 ' HB3' ' CG1' ' A' ' 57' ' ' VAL . 0.0 OUTLIER -99.47 176.96 5.32 Favored 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 114.584 -1.189 . . . . 0.0 108.733 175.985 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.508 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -44.04 133.39 5.13 Favored 'General case' 0 N--CA 1.514 2.769 0 O-C-N 120.613 -1.304 . . . . 0.0 113.627 -175.81 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.81 HD11 ' CD2' ' A' ' 58' ' ' PHE . 40.8 mt . . . . . 0 N--CA 1.499 2.01 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.995 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.526 ' O ' ' HA ' ' A' ' 20' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.882 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.778 ' CA ' HG22 ' A' ' 20' ' ' THR . 51.0 t30 -77.17 143.19 39.25 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.606 -0.684 . . . . 0.0 110.581 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.402 ' HE2' ' HB2' ' A' ' 4' ' ' ARG . 45.9 m-85 -138.98 148.72 43.84 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.119 0.485 . . . . 0.0 109.737 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.868 HG22 ' O ' ' A' ' 48' ' ' ARG . 29.9 m -125.97 140.04 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 O-C-N 121.331 -0.855 . . . . 0.0 112.504 -177.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.829 HD22 ' HG ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -161.91 167.36 24.77 Favored 'General case' 0 N--CA 1.511 2.621 0 O-C-N 121.408 -0.807 . . . . 0.0 111.836 179.485 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.549 ' O ' ' N ' ' A' ' 14' ' ' ASN . 3.4 ttm-85 -134.82 107.95 7.68 Favored 'General case' 0 N--CA 1.526 3.328 0 O-C-N 121.15 -0.969 . . . . 0.0 112.856 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.858 ' HB2' ' CB ' ' A' ' 16' ' ' HIS . 0.7 OUTLIER -74.55 -158.18 0.07 Allowed 'General case' 0 N--CA 1.513 2.688 0 O-C-N 120.998 -1.064 . . . . 0.0 111.878 -179.611 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.593 ' HA ' ' HB3' ' A' ' 41' ' ' ASN . 0.2 OUTLIER 70.9 48.94 0.38 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 -177.366 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.623 ' HA ' ' O ' ' A' ' 42' ' ' PRO . 97.8 m-20 58.63 8.37 0.89 Allowed 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 112.498 -2.137 . . . . 0.0 113.216 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.16 -75.89 1.27 Allowed Glycine 0 N--CA 1.49 2.299 0 C-N-CA 117.88 -2.105 . . . . 0.0 108.368 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.949 ' HB3' HD13 ' A' ' 45' ' ' ILE . 0.8 OUTLIER -119.25 -78.72 0.59 Allowed 'General case' 0 C--N 1.293 -1.862 0 CA-C-O 122.261 1.029 . . . . 0.0 108.316 177.388 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.7 ' CB ' HG21 ' A' ' 45' ' ' ILE . 1.7 tp10 -177.01 140.55 0.31 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 178.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.858 ' CB ' ' HB2' ' A' ' 10' ' ' ASP . 0.1 OUTLIER -87.29 122.67 31.37 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 116.286 -2.166 . . . . 0.0 112.324 -179.608 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.557 ' HA2' ' CZ ' ' A' ' 19' ' ' PHE . . . -177.25 120.13 0.72 Allowed Glycine 0 C--N 1.28 -2.542 0 CA-C-N 113.496 -1.684 . . . . 0.0 110.019 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.9 82.69 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.61 ' N ' ' CD1' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -174.23 -173.43 0.79 Allowed 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.226 -179.165 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.778 HG22 ' CA ' ' A' ' 5' ' ' ASN . 39.0 p -102.12 150.62 23.08 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.421 -0.8 . . . . 0.0 112.441 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -130.25 121.29 3.3 Favored Glycine 0 N--CA 1.499 2.846 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 178.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.67 -45.01 70.13 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.49 -1.006 . . . . 0.0 109.823 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.689 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -118.02 135.4 23.42 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.034 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -69.29 -45.23 1.93 Allowed 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.384 1.202 . . . . 0.0 110.74 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.576 ' O ' HD22 ' A' ' 29' ' ' LEU . 40.3 mtt180 -82.3 -64.93 1.08 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.652 -0.655 . . . . 0.0 111.208 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.625 ' HG3' ' HA ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -47.0 -45.09 20.82 Favored 'General case' 0 N--CA 1.51 2.569 0 O-C-N 121.187 -0.946 . . . . 0.0 111.861 -179.374 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.689 ' HB3' ' O ' ' A' ' 23' ' ' GLN . . . -73.41 -17.79 61.22 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.181 -1.007 . . . . 0.0 110.642 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.93 -52.51 16.86 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.847 -1.158 . . . . 0.0 111.759 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.995 HD12 HG21 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -52.64 -57.24 10.67 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.849 0.833 . . . . 0.0 109.66 -179.073 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.409 ' NZ ' ' OE1' ' A' ' 26' ' ' GLN . 30.7 mtmt -69.68 -34.4 73.91 Favored 'General case' 0 N--CA 1.511 2.592 0 O-C-N 121.284 -0.885 . . . . 0.0 113.151 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.675 ' C ' ' HB2' ' A' ' 36' ' ' SER . . . -59.29 -43.58 92.58 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.757 -1.214 . . . . 0.0 112.129 -178.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.891 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -65.49 -32.75 74.53 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 118.621 -1.232 . . . . 0.0 110.062 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.497 ' HB2' ' HG3' ' A' ' 82' ' ' PRO . 46.8 t30 -40.04 -50.01 2.56 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.0 mtm105 -94.65 -74.76 0.53 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.196 -1.002 . . . . 0.0 113.097 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.425 ' O ' ' CE1' ' A' ' 16' ' ' HIS . . . -113.53 -0.06 24.8 Favored Glycine 0 N--CA 1.504 3.2 0 N-CA-C 116.758 1.463 . . . . 0.0 116.758 -175.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.675 ' HB2' ' C ' ' A' ' 31' ' ' ALA . 0.3 OUTLIER -87.64 4.05 45.39 Favored 'General case' 0 N--CA 1.506 2.34 0 CA-C-N 122.248 3.024 . . . . 0.0 110.843 -177.272 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.468 ' C ' ' HE1' ' A' ' 16' ' ' HIS . . . -166.58 117.68 0.75 Allowed Glycine 0 N--CA 1.482 1.739 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.506 ' O ' ' HB3' ' A' ' 39' ' ' LYS . 28.2 m -78.29 -17.28 56.82 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 120.525 2.163 . . . . 0.0 109.691 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.829 ' CA ' ' HG3' ' A' ' 42' ' ' PRO . 4.6 tttm 73.27 -56.8 0.65 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -178.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.9 -19.36 65.71 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 175.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.593 ' HB3' ' HA ' ' A' ' 11' ' ' GLU 0.278 0.2 OUTLIER -160.23 68.08 2.78 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.845 -0.535 . . . . 0.0 111.332 179.108 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.829 ' HG3' ' CA ' ' A' ' 39' ' ' LYS . 76.8 Cg_endo -116.95 -175.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.411 2.074 . . . . 0.0 109.369 178.033 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.452 ' HB3' ' O ' ' A' ' 14' ' ' ASN . 1.7 t70 -168.54 -173.98 2.07 Favored 'General case' 0 N--CA 1.514 2.775 0 C-N-CA 116.988 -1.885 . . . . 0.0 113.431 176.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.873 HG22 ' HD3' ' A' ' 59' ' ' LYS . 1.6 pp -81.52 136.28 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.949 HD13 ' HB3' ' A' ' 14' ' ' ASN . 3.1 tp -147.94 139.53 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 117.634 -1.626 . . . . 0.0 114.184 -177.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.505 ' H ' HD12 ' A' ' 45' ' ' ILE . 49.4 mtt-85 -88.75 95.28 10.21 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 173.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.829 ' HG ' HD22 ' A' ' 8' ' ' LEU . 0.3 OUTLIER -66.52 93.16 0.23 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -178.357 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.868 ' O ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.296 -1.754 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.214 -176.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 48' ' ' ARG . 9.2 mttp . . . . . 0 N--CA 1.495 1.806 0 CA-C-O 120.695 0.284 . . . . 0.0 110.675 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.426 HG23 ' C ' ' A' ' 54' ' ' LYS . 71.7 t -153.82 96.35 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.613 -0.679 . . . . 0.0 111.028 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.796 ' CE1' ' HB2' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -88.44 137.15 32.58 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 177.237 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.529 ' HB ' ' CB ' ' A' ' 87' ' ' GLU . 2.2 t -116.79 116.12 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 O-C-N 119.755 -1.841 . . . . 0.0 110.381 -178.185 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.796 ' HB2' ' CE1' ' A' ' 56' ' ' HIS . 0.5 OUTLIER -157.51 174.95 14.6 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.289 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.873 ' HD3' HG22 ' A' ' 44' ' ' ILE . 16.8 mttm -132.04 127.33 35.93 Favored 'General case' 0 N--CA 1.505 2.296 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 177.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.891 ' HB1' ' HB2' ' A' ' 32' ' ' ALA . . . -115.67 110.29 18.94 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 120.747 -1.221 . . . . 0.0 113.198 -175.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.762 ' O ' ' HA ' ' A' ' 82' ' ' PRO . 14.1 m0 -126.49 -167.21 1.69 Allowed 'General case' 0 N--CA 1.512 2.675 0 O-C-N 121.943 -0.473 . . . . 0.0 110.307 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.718 ' HB2' ' HB2' ' A' ' 39' ' ' LYS . 0.7 OUTLIER -123.45 88.13 2.86 Favored 'General case' 0 N--CA 1.507 2.382 0 CA-C-N 120.158 1.345 . . . . 0.0 112.569 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.879 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 3.6 mt-10 -165.97 172.34 11.6 Favored 'General case' 0 N--CA 1.51 2.573 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.283 176.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.668 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 9.2 tt -73.61 101.42 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.523 3.186 0 N-CA-C 116.824 2.157 . . . . 0.0 116.824 -174.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.902 HG13 ' CD1' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -88.29 -166.57 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.406 -1.434 . . . . 0.0 109.883 176.63 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.643 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 9.2 t0 -124.43 129.08 50.01 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.843 ' HA ' ' CB ' ' A' ' 77' ' ' GLU . . . -64.3 99.3 0.18 Allowed Pre-proline 0 N--CA 1.507 2.396 0 CA-C-O 117.79 -1.1 . . . . 0.0 111.784 -178.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.694 ' HD3' ' HB3' ' A' ' 77' ' ' GLU . 52.1 Cg_endo -88.9 -160.33 0.1 OUTLIER 'Trans proline' 0 C--N 1.316 -1.141 0 O-C-N 124.105 1.581 . . . . 0.0 110.528 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.3 mttt -70.11 64.57 0.24 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.292 -0.88 . . . . 0.0 109.092 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.762 ' ND2' HD11 ' A' ' 29' ' ' LEU . 5.4 m-20 -102.37 -12.4 17.93 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.473 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.743 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER 59.8 44.69 0.98 Allowed Pre-proline 0 N--CA 1.506 2.358 0 C-N-CA 122.796 0.439 . . . . 0.0 111.209 -177.528 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.743 ' HD3' ' N ' ' A' ' 71' ' ' ARG . 48.9 Cg_endo -92.89 99.89 0.16 Allowed 'Trans proline' 0 C--N 1.323 -0.797 0 C-N-CA 121.152 1.234 . . . . 0.0 110.495 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.19 -34.07 24.05 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.365 -0.834 . . . . 0.0 112.065 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.465 ' CD1' ' N ' ' A' ' 74' ' ' TRP . 32.2 m95 -81.55 -31.46 32.68 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.444 -0.785 . . . . 0.0 110.514 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.456 ' O ' ' HB2' ' A' ' 72' ' ' PRO . 12.5 tpt -164.75 110.38 0.85 Allowed Pre-proline 0 N--CA 1.496 1.861 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.703 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 48.2 Cg_endo -79.28 -178.91 4.96 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.898 1.473 . . . . 0.0 112.693 -178.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.843 ' CB ' ' HA ' ' A' ' 67' ' ' ALA . 3.1 tt0 -90.21 6.61 42.03 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 118.429 -1.308 . . . . 0.0 110.09 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.736 ' O ' HG22 ' A' ' 79' ' ' ILE . 1.5 tppm? -92.28 77.05 5.22 Favored 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.778 HD11 ' CB ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -168.08 158.63 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 C-N-CA 118.272 -1.371 . . . . 0.0 112.146 -177.711 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.578 ' HA ' ' HB ' ' A' ' 64' ' ' ILE . 1.7 m -77.09 103.35 6.97 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 175.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.875 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -173.17 -152.18 0.0 OUTLIER Pre-proline 0 C--O 1.196 -1.711 0 O-C-N 121.302 -0.874 . . . . 0.0 108.759 -175.757 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.875 ' HD2' ' HB3' ' A' ' 81' ' ' LYS . 43.4 Cg_endo -68.34 123.7 10.84 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 117.808 -0.995 . . . . 0.0 111.639 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.902 ' CD1' HG13 ' A' ' 65' ' ' VAL . 0.7 OUTLIER -63.43 159.4 18.44 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.184 -0.947 . . . . 0.0 109.382 178.83 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.995 HG21 HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -153.16 93.94 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 C-N-CA 120.034 -0.666 . . . . 0.0 109.62 178.376 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.734 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 3.1 tptt -73.5 125.59 28.29 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 177.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.586 ' HB3' ' CZ ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -94.05 90.64 6.5 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 122.337 1.065 . . . . 0.0 113.783 -175.257 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.529 ' CB ' ' HB ' ' A' ' 57' ' ' VAL . 4.2 mt-10 -86.35 150.63 24.2 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 115.293 -0.867 . . . . 0.0 108.755 176.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -56.89 122.14 11.54 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.363 -0.836 . . . . 0.0 111.911 -177.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.664 HG23 ' HA ' ' A' ' 56' ' ' HIS . 88.1 mt . . . . . 0 N--CA 1.492 1.673 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.543 ' HB3' ' HD2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 120.853 0.359 . . . . 0.0 110.104 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.831 ' CA ' HG22 ' A' ' 20' ' ' THR . 43.9 t30 -74.35 137.49 42.83 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.496 -0.752 . . . . 0.0 110.58 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.437 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 25.7 m-85 -145.01 151.1 38.04 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.347 0.594 . . . . 0.0 111.057 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.708 HG22 ' O ' ' A' ' 48' ' ' ARG . 11.7 m -111.21 146.55 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.665 -0.647 . . . . 0.0 111.173 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.1 HD21 HD21 ' A' ' 47' ' ' LEU . 4.6 mp -152.33 145.08 24.3 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.422 -0.799 . . . . 0.0 111.862 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -134.11 91.56 2.83 Favored 'General case' 0 N--CA 1.514 2.756 0 O-C-N 121.073 -1.017 . . . . 0.0 111.243 176.647 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.762 ' HB2' ' N ' ' A' ' 16' ' ' HIS . 1.7 t70 -69.63 -159.4 0.03 OUTLIER 'General case' 0 N--CA 1.51 2.565 0 C-N-CA 123.932 0.893 . . . . 0.0 112.007 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.578 ' HA ' ' HB3' ' A' ' 41' ' ' ASN . 0.1 OUTLIER 72.23 52.56 0.19 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 -176.957 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.599 ' HA ' ' O ' ' A' ' 42' ' ' PRO . 92.4 m-20 61.28 6.91 1.49 Allowed 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 112.539 -2.118 . . . . 0.0 112.783 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.421 ' O ' ' HB3' ' A' ' 43' ' ' ASP . . . -90.17 -75.43 1.3 Allowed Glycine 0 N--CA 1.485 1.95 0 C-N-CA 117.98 -2.057 . . . . 0.0 108.82 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.872 ' CG ' HD13 ' A' ' 45' ' ' ILE . 8.2 m120 -125.22 -76.77 0.59 Allowed 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.596 0.713 . . . . 0.0 111.337 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.733 ' HB2' HG21 ' A' ' 45' ' ' ILE . 8.1 mt-10 -169.31 151.42 4.57 Favored 'General case' 0 N--CA 1.511 2.582 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.762 ' N ' ' HB2' ' A' ' 10' ' ' ASP . 2.6 p-80 -99.1 118.68 36.39 Favored 'General case' 0 N--CA 1.507 2.388 0 C-N-CA 115.021 -2.672 . . . . 0.0 113.125 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.57 ' HA2' ' CZ ' ' A' ' 19' ' ' PHE . . . 175.21 132.07 1.53 Allowed Glycine 0 C--N 1.285 -2.292 0 C-N-CA 119.493 -1.336 . . . . 0.0 112.251 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.6 86.78 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 175.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.623 ' N ' ' CD1' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -172.54 -172.26 0.89 Allowed 'General case' 0 N--CA 1.5 2.073 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.733 -178.132 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.831 HG22 ' CA ' ' A' ' 5' ' ' ASN . 57.2 p -107.62 158.46 17.23 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.493 -0.755 . . . . 0.0 111.703 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -130.69 130.97 6.31 Favored Glycine 0 N--CA 1.501 3.02 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.4 ttpt -60.84 -47.82 84.64 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.309 -1.113 . . . . 0.0 108.765 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.665 ' HB3' ' HB3' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -115.7 114.13 42.22 Favored Pre-proline 0 N--CA 1.486 1.362 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.403 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.94 -35.86 41.66 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.65 1.342 . . . . 0.0 110.823 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.593 ' HB3' ' HA ' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -83.08 -62.92 1.47 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.209 -0.932 . . . . 0.0 109.862 179.419 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.665 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 1.0 OUTLIER -53.44 -41.97 66.65 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.129 -0.982 . . . . 0.0 111.886 -179.683 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' A' ' 23' ' ' GLN . . . -74.57 -15.69 60.84 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 120.593 -1.317 . . . . 0.0 110.42 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.61 -51.89 63.29 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.79 -1.194 . . . . 0.0 110.642 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.064 HD12 HG21 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -61.9 -50.46 72.1 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 121.558 0.694 . . . . 0.0 109.559 -179.555 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -69.41 -37.87 77.65 Favored 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -178.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.43 ' C ' ' HB2' ' A' ' 36' ' ' SER . . . -60.5 -43.73 96.75 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 120.719 -1.238 . . . . 0.0 112.461 -177.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.724 ' CB ' ' HB1' ' A' ' 60' ' ' ALA . . . -64.51 -33.34 75.67 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 118.77 -1.172 . . . . 0.0 110.15 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.545 ' N ' ' HG3' ' A' ' 82' ' ' PRO . 0.2 OUTLIER -42.74 -46.34 5.1 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.802 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.5 mtp85 -95.51 -72.83 0.61 Allowed 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.269 -0.972 . . . . 0.0 112.254 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.443 ' O ' ' CG ' ' A' ' 16' ' ' HIS . . . -115.72 -0.72 21.47 Favored Glycine 0 N--CA 1.499 2.877 0 N-CA-C 117.48 1.752 . . . . 0.0 117.48 -175.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.693 ' CB ' ' HA ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -82.03 -2.29 51.21 Favored 'General case' 0 N--CA 1.514 2.73 0 CA-C-N 123.615 3.708 . . . . 0.0 110.94 -176.744 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.414 ' C ' ' HE1' ' A' ' 16' ' ' HIS . . . -163.49 120.84 0.97 Allowed Glycine 0 C--N 1.297 -1.637 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -178.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.532 ' O ' ' HB3' ' A' ' 39' ' ' LYS . 23.5 m -77.73 -15.61 59.01 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 119.825 1.813 . . . . 0.0 109.494 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.84 ' CA ' ' HG3' ' A' ' 42' ' ' PRO . 7.6 tttm 75.21 -56.27 0.62 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -178.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.43 -18.89 65.62 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 175.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.578 ' HB3' ' HA ' ' A' ' 11' ' ' GLU 0.27 0.4 OUTLIER -160.44 67.31 2.62 Favored Pre-proline 0 C--O 1.202 -1.446 0 O-C-N 121.661 -0.649 . . . . 0.0 111.147 179.097 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.84 ' HG3' ' CA ' ' A' ' 39' ' ' LYS . 82.9 Cg_endo -118.0 -176.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.3 -2.012 0 C-N-CA 122.019 1.813 . . . . 0.0 109.615 178.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.459 ' HB2' ' C ' ' A' ' 12' ' ' ASP . 0.7 OUTLIER -168.04 -169.49 1.14 Allowed 'General case' 0 N--CA 1.512 2.643 0 O-C-N 119.826 -1.796 . . . . 0.0 113.902 177.036 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.868 HG22 ' HD3' ' A' ' 59' ' ' LYS . 1.6 pp -91.5 142.6 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.872 HD13 ' CG ' ' A' ' 14' ' ' ASN . 1.1 tp -161.59 142.67 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 117.958 -1.497 . . . . 0.0 113.422 -178.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.508 ' HG3' HG13 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -87.03 96.23 10.21 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 174.184 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 1.1 HD21 HD21 ' A' ' 8' ' ' LEU . 9.0 mp -63.21 95.77 0.09 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 -178.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.708 ' O ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.296 -1.747 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.704 -177.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.626 ' O ' ' HA ' ' A' ' 48' ' ' ARG . 5.3 mtmm . . . . . 0 N--CA 1.487 1.382 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 6.7 t -137.03 100.2 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 CA-C-O 121.399 0.618 . . . . 0.0 110.338 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.932 ' CE1' ' HB2' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -91.61 138.09 31.85 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.926 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.52 ' HB ' ' CB ' ' A' ' 87' ' ' GLU . 2.5 t -114.59 104.09 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 O-C-N 119.91 -1.744 . . . . 0.0 109.258 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.932 ' HB2' ' CE1' ' A' ' 56' ' ' HIS . 0.6 OUTLIER -146.62 175.58 10.49 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.376 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.868 ' HD3' HG22 ' A' ' 44' ' ' ILE . 24.5 mttm -130.04 128.12 41.3 Favored 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 177.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.724 ' HB1' ' CB ' ' A' ' 32' ' ' ALA . . . -114.18 113.26 24.43 Favored 'General case' 0 N--CA 1.505 2.312 0 C-N-CA 118.199 -1.4 . . . . 0.0 113.605 -176.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.814 ' HB2' ' HB2' ' A' ' 83' ' ' PHE . 13.6 m0 -130.26 -168.42 1.97 Allowed 'General case' 0 N--CA 1.516 2.841 0 O-C-N 121.713 -0.617 . . . . 0.0 110.802 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.668 ' HB2' ' HB2' ' A' ' 39' ' ' LYS . 1.3 tmtm? -120.68 89.02 3.05 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.696 -1.253 . . . . 0.0 111.283 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.84 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 2.1 mt-10 -165.79 168.67 15.81 Favored 'General case' 0 N--CA 1.508 2.456 0 CA-C-O 121.354 0.597 . . . . 0.0 109.994 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.676 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 4.7 tt -72.56 101.15 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.522 3.138 0 O-C-N 119.612 -1.93 . . . . 0.0 115.68 -176.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.985 HG13 ' CD1' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -91.86 -166.58 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.501 -1.375 . . . . 0.0 110.838 177.948 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.681 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 7.5 t70 -120.39 130.19 54.26 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.862 ' HA ' ' CB ' ' A' ' 77' ' ' GLU . . . -65.64 100.47 0.23 Allowed Pre-proline 0 N--CA 1.509 2.505 0 CA-C-O 118.061 -0.971 . . . . 0.0 113.308 -177.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.681 ' HD3' ' O ' ' A' ' 66' ' ' ASP . 55.8 Cg_endo -84.01 -163.48 0.2 Allowed 'Trans proline' 0 N--CA 1.485 1.019 0 O-C-N 123.625 1.329 . . . . 0.0 110.502 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.2 mmpp? -69.83 64.87 0.22 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.158 -0.964 . . . . 0.0 109.841 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.808 ' ND2' HD11 ' A' ' 29' ' ' LEU . 3.8 m-20 -97.94 -12.6 21.84 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.986 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.704 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER 44.87 51.08 8.21 Favored Pre-proline 0 N--CA 1.504 2.271 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.374 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.798 ' HG2' ' HA ' ' A' ' 76' ' ' PRO . 55.1 Cg_endo -99.97 112.0 0.07 OUTLIER 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 121.861 1.707 . . . . 0.0 109.518 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.78 -19.98 47.32 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.766 -1.209 . . . . 0.0 112.106 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.435 ' CD1' ' N ' ' A' ' 74' ' ' TRP . 44.5 m95 -81.96 -37.75 26.22 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.308 -0.87 . . . . 0.0 110.46 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.461 ' O ' ' HB2' ' A' ' 72' ' ' PRO . 20.9 ttm -168.89 130.75 1.12 Allowed Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.673 -0.642 . . . . 0.0 109.665 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.798 ' HA ' ' HG2' ' A' ' 72' ' ' PRO . 47.5 Cg_endo -88.59 179.82 2.47 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.662 1.349 . . . . 0.0 111.803 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.862 ' CB ' ' HA ' ' A' ' 67' ' ' ALA . 3.7 tt0 -88.71 9.23 25.09 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 118.005 -1.478 . . . . 0.0 110.1 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.707 ' H ' ' HB2' ' A' ' 67' ' ' ALA . 40.6 tptt -93.74 82.49 4.32 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.678 HG22 ' C ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -179.82 163.21 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 C-N-CA 118.006 -1.478 . . . . 0.0 112.501 -178.51 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.591 ' HA ' ' HB ' ' A' ' 64' ' ' ILE . 1.1 m -72.01 105.35 3.86 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 175.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.711 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 11.2 pttp -167.81 -154.92 0.0 OUTLIER Pre-proline 0 C--O 1.196 -1.729 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -175.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.743 ' HA ' ' O ' ' A' ' 61' ' ' TRP . 49.7 Cg_endo -75.59 128.99 11.44 Favored 'Trans proline' 0 C--N 1.299 -2.066 0 N-CA-C 109.761 -0.899 . . . . 0.0 109.761 178.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.985 ' CD1' HG13 ' A' ' 65' ' ' VAL . 1.1 m-30 -64.73 157.15 28.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.217 -0.927 . . . . 0.0 109.423 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 1.064 HG21 HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -152.15 95.66 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.153 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.748 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -74.01 130.15 39.28 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 105.917 -1.882 . . . . 0.0 105.917 178.16 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.632 ' HB3' ' CZ ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -99.36 92.24 5.32 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 122.615 1.197 . . . . 0.0 113.908 -175.338 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.52 ' CB ' ' HB ' ' A' ' 57' ' ' VAL . 24.0 mt-10 -88.75 151.94 22.1 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 175.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -55.4 116.69 2.99 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-O 122.316 1.055 . . . . 0.0 112.77 -176.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.846 HG23 ' HA ' ' A' ' 56' ' ' HIS . 23.7 mt . . . . . 0 N--CA 1.491 1.611 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.428 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.55 ' O ' ' HA ' ' A' ' 20' ' ' THR . 5.1 mmp_? . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 120.79 0.329 . . . . 0.0 110.213 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.698 ' CA ' HG22 ' A' ' 20' ' ' THR . 19.5 t-20 -74.54 140.88 44.78 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.557 -0.714 . . . . 0.0 110.228 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.557 ' HD1' HD22 ' A' ' 47' ' ' LEU . 8.5 m-85 -152.57 168.29 26.07 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.476 -0.765 . . . . 0.0 110.421 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.573 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -150.24 141.52 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 O-C-N 121.444 -0.785 . . . . 0.0 111.591 -178.007 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.967 HD21 ' HG ' ' A' ' 47' ' ' LEU . 1.5 mp -148.12 167.68 24.39 Favored 'General case' 0 N--CA 1.52 3.052 0 O-C-N 121.287 -0.883 . . . . 0.0 112.942 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.539 ' N ' ' O ' ' A' ' 15' ' ' GLU . 9.3 ptt-85 -136.3 95.37 3.17 Favored 'General case' 0 N--CA 1.517 2.908 0 O-C-N 121.488 -0.757 . . . . 0.0 111.28 176.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.82 ' HB2' ' N ' ' A' ' 16' ' ' HIS . 5.1 t0 -82.46 -150.93 0.09 Allowed 'General case' 0 N--CA 1.509 2.508 0 C-N-CA 124.136 0.974 . . . . 0.0 113.081 -178.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.55 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 0.8 OUTLIER 73.56 53.63 0.11 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 104.048 -2.575 . . . . 0.0 104.048 -175.936 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.55 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 1.9 m-20 63.98 3.96 1.85 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 112.683 -2.053 . . . . 0.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -89.52 -76.54 1.31 Allowed Glycine 0 N--CA 1.479 1.55 0 C-N-CA 117.795 -2.145 . . . . 0.0 107.795 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.886 ' CG ' HD13 ' A' ' 45' ' ' ILE . 3.5 m120 -126.74 -77.03 0.58 Allowed 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.452 0.644 . . . . 0.0 111.576 178.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 1.109 ' HB2' HG21 ' A' ' 45' ' ' ILE . 4.6 mt-10 -171.28 154.84 4.08 Favored 'General case' 0 N--CA 1.512 2.626 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.82 ' N ' ' HB2' ' A' ' 10' ' ' ASP . 0.2 OUTLIER -119.62 120.29 36.23 Favored 'General case' 0 N--CA 1.511 2.615 0 C-N-CA 114.848 -2.741 . . . . 0.0 115.047 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.42 ' HA2' ' CZ ' ' A' ' 19' ' ' PHE . . . -176.45 128.35 1.34 Allowed Glycine 0 C--N 1.29 -1.999 0 CA-C-N 113.561 -1.654 . . . . 0.0 110.113 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.418 ' C ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -134.78 92.05 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 177.449 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.671 ' N ' ' CD1' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -175.25 -173.3 0.65 Allowed 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 121.283 0.563 . . . . 0.0 110.281 -178.743 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.698 HG22 ' CA ' ' A' ' 5' ' ' ASN . 22.2 p -106.1 126.56 52.36 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.289 -0.882 . . . . 0.0 110.953 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -97.68 131.15 10.49 Favored Glycine 0 N--CA 1.501 3.001 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.1 mtmp? -59.54 -39.2 83.17 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.55 -0.971 . . . . 0.0 109.57 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.813 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -127.42 125.35 23.89 Favored Pre-proline 0 N--CA 1.489 1.493 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.112 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.856 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 37.0 Cg_endo -63.06 -40.82 31.65 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 O-C-N 123.493 1.26 . . . . 0.0 110.924 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.411 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 2.8 ttt180 -87.47 -61.19 1.78 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.499 -0.751 . . . . 0.0 111.46 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.471 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 14.5 tt0 -55.76 -40.94 73.28 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 120.938 -1.101 . . . . 0.0 111.71 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.813 ' HB3' ' O ' ' A' ' 23' ' ' GLN . . . -79.8 -18.92 49.75 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.828 -1.149 . . . . 0.0 109.446 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.856 ' HB2' ' O ' ' A' ' 24' ' ' PRO . . . -62.74 -57.7 10.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.358 -0.839 . . . . 0.0 110.808 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.492 ' O ' ' HG2' ' A' ' 82' ' ' PRO . 2.4 pp -58.38 -44.37 88.87 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.354 -178.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.476 ' HB2' ' HE3' ' A' ' 30' ' ' LYS . 1.0 OUTLIER -70.46 -35.47 73.35 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 120.793 -1.192 . . . . 0.0 111.689 179.249 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 27' ' ' ALA . . . -56.59 -42.01 77.97 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.187 -0.946 . . . . 0.0 113.079 -177.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.843 ' CB ' ' HB1' ' A' ' 60' ' ' ALA . . . -73.03 -29.92 63.36 Favored 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 118.865 -1.134 . . . . 0.0 110.096 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.577 ' CB ' ' HG3' ' A' ' 82' ' ' PRO . 6.3 t-20 -41.37 -46.89 3.45 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.371 0.605 . . . . 0.0 109.369 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.8 mmm-85 -92.97 -74.57 0.52 Allowed 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 118.884 -1.126 . . . . 0.0 112.938 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.474 ' O ' ' CD2' ' A' ' 16' ' ' HIS . . . -115.93 -3.96 19.34 Favored Glycine 0 N--CA 1.499 2.855 0 N-CA-C 117.065 1.586 . . . . 0.0 117.065 -175.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.757 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 0.6 OUTLIER -79.02 -4.27 49.26 Favored 'General case' 0 N--CA 1.51 2.558 0 CA-C-N 122.633 3.216 . . . . 0.0 110.573 -176.948 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.54 ' O ' ' HG3' ' A' ' 39' ' ' LYS . . . -154.31 117.72 0.81 Allowed Glycine 0 C--N 1.292 -1.873 0 N-CA-C 108.579 -1.809 . . . . 0.0 108.579 -178.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.459 ' HB ' ' C ' ' A' ' 41' ' ' ASN . 90.2 m -68.9 -17.12 63.92 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 119.348 1.574 . . . . 0.0 108.107 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.8 ' CA ' ' HG3' ' A' ' 42' ' ' PRO . 10.0 mtmt 71.36 -59.64 0.54 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.72 -20.02 61.97 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 175.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.505 ' HB3' ' HA ' ' A' ' 11' ' ' GLU 0.279 0.6 OUTLIER -149.66 65.25 7.59 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.722 -0.612 . . . . 0.0 110.638 178.628 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.8 ' HG3' ' CA ' ' A' ' 39' ' ' LYS . 75.1 Cg_endo -117.03 -174.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 121.167 1.245 . . . . 0.0 111.322 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.406 ' N ' ' HE1' ' A' ' 61' ' ' TRP . 1.3 t70 -167.13 -168.23 1.05 Allowed 'General case' 0 N--CA 1.512 2.672 0 C-N-CA 118.07 -1.452 . . . . 0.0 112.887 177.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.876 HG22 ' HD3' ' A' ' 59' ' ' LYS . 1.2 pp -95.85 149.62 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 1.109 HG21 ' HB2' ' A' ' 15' ' ' GLU . 1.8 tp -163.09 144.05 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 C-N-CA 117.773 -1.571 . . . . 0.0 113.883 -178.105 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.565 ' H ' HD12 ' A' ' 45' ' ' ILE . 32.8 mtt180 -85.35 95.63 9.29 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 174.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.967 ' HG ' HD21 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -70.15 94.88 0.93 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.448 -0.782 . . . . 0.0 109.361 -178.063 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.563 -0.711 . . . . 0.0 110.078 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.515 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.937 0 CA-C-O 121.187 0.518 . . . . 0.0 110.364 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 54' ' ' LYS . 2.4 t -155.76 142.84 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 CA-C-O 122.002 0.906 . . . . 0.0 111.216 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.866 ' CE1' ' HB2' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -162.78 129.89 3.61 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 179.598 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.595 HG12 ' HB2' ' A' ' 87' ' ' GLU . 11.5 t -118.31 115.88 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 117.311 -1.756 . . . . 0.0 109.23 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.866 ' HB2' ' CE1' ' A' ' 56' ' ' HIS . 0.8 OUTLIER -153.76 -176.63 5.92 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 -179.817 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.876 ' HD3' HG22 ' A' ' 44' ' ' ILE . 30.2 mttt -137.39 133.97 35.4 Favored 'General case' 0 N--CA 1.51 2.566 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 177.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.843 ' HB1' ' CB ' ' A' ' 32' ' ' ALA . . . -117.04 112.69 21.28 Favored 'General case' 0 N--CA 1.51 2.557 0 CA-C-N 120.662 1.574 . . . . 0.0 113.653 -176.095 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.779 ' HB2' ' HB2' ' A' ' 83' ' ' PHE . 11.7 m0 -133.59 -165.51 1.64 Allowed 'General case' 0 N--CA 1.514 2.726 0 O-C-N 122.036 -0.415 . . . . 0.0 111.344 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.66 ' HB2' ' HB3' ' A' ' 39' ' ' LYS . 1.6 tptp -123.78 91.4 3.46 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.643 -1.285 . . . . 0.0 111.776 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.899 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 1.1 mt-10 -165.37 -173.0 2.65 Favored 'General case' 0 N--CA 1.51 2.573 0 CA-C-O 121.223 0.535 . . . . 0.0 110.452 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.606 ' C ' ' HE1' ' A' ' 83' ' ' PHE . 12.6 tt -94.86 98.68 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.117 0 O-C-N 118.977 -2.327 . . . . 0.0 116.081 -176.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.998 HG13 ' CD1' ' A' ' 83' ' ' PHE . 0.3 OUTLIER -103.65 -168.54 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 120.137 -1.602 . . . . 0.0 108.706 176.329 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.784 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 5.9 t0 -114.23 145.63 41.47 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.663 -0.648 . . . . 0.0 111.379 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.91 ' HA ' ' HB3' ' A' ' 77' ' ' GLU 0.25 . . -66.25 101.38 0.28 Allowed Pre-proline 0 N--CA 1.511 2.6 0 CA-C-O 118.075 -0.964 . . . . 0.0 113.167 -178.772 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.803 ' HG3' ' HG2' ' A' ' 86' ' ' LYS . 55.0 Cg_endo -70.81 64.53 2.42 Favored 'Trans proline' 0 N--CA 1.5 1.906 0 O-C-N 123.85 1.448 . . . . 0.0 110.961 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 50.2 40.94 23.23 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 120.994 -1.066 . . . . 0.0 108.69 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.694 ' HB3' ' HG3' ' A' ' 72' ' ' PRO . 6.3 m120 -55.37 -18.83 7.36 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.489 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.792 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER 49.99 43.22 1.55 Allowed Pre-proline 0 N--CA 1.495 1.809 0 CA-C-O 120.484 0.183 . . . . 0.0 110.784 -176.642 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.792 ' HD3' ' N ' ' A' ' 71' ' ' ARG . 57.8 Cg_endo -100.05 135.09 0.22 Allowed 'Trans proline' 0 C--O 1.219 -0.446 0 C-N-CA 121.481 1.454 . . . . 0.0 109.435 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.27 -28.55 25.25 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 120.892 -1.13 . . . . 0.0 111.105 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.447 ' CD1' ' N ' ' A' ' 74' ' ' TRP . 41.0 m95 -84.71 -35.94 22.17 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.542 -0.724 . . . . 0.0 111.424 -178.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.522 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 2.4 tpt -175.06 132.11 0.45 Allowed Pre-proline 0 N--CA 1.51 2.55 0 O-C-N 121.23 -0.919 . . . . 0.0 111.689 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.769 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 44.3 Cg_endo -93.55 -178.21 0.71 Allowed 'Trans proline' 0 N--CA 1.489 1.264 0 C-N-CA 122.401 2.067 . . . . 0.0 111.455 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.91 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 7.8 tt0 -86.12 9.24 17.97 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 117.729 -1.588 . . . . 0.0 110.82 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.784 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -88.05 82.2 7.25 Favored 'General case' 0 N--CA 1.507 2.406 0 C-N-CA 118.861 -1.136 . . . . 0.0 108.292 178.786 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.776 HG22 ' C ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER 179.02 165.89 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.382 0 C-N-CA 118.384 -1.326 . . . . 0.0 112.673 -178.105 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.56 ' N ' HG13 ' A' ' 79' ' ' ILE . 13.3 m -77.69 107.13 9.96 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 175.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.938 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -171.54 -152.86 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.331 0 O-C-N 121.107 -0.995 . . . . 0.0 108.644 -176.106 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.938 ' HD2' ' HB2' ' A' ' 81' ' ' LYS . 44.2 Cg_endo -71.86 123.66 9.53 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 117.316 -1.323 . . . . 0.0 110.005 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.998 ' CD1' HG13 ' A' ' 65' ' ' VAL . 0.5 OUTLIER -61.74 161.0 10.75 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.226 -0.921 . . . . 0.0 110.601 -179.665 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.787 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -155.6 95.55 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.083 178.081 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.744 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 0.9 OUTLIER -71.16 133.92 46.55 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 178.131 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.803 ' HG2' ' HG3' ' A' ' 68' ' ' PRO . 0.0 OUTLIER -101.91 92.3 4.75 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -173.795 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.595 ' HB2' HG12 ' A' ' 57' ' ' VAL . 2.6 mp0 -93.47 163.58 13.52 Favored 'General case' 0 C--N 1.28 -2.431 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 174.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.444 ' O ' HG23 ' A' ' 57' ' ' VAL . 1.4 mtt-85 -54.88 146.53 17.24 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 120.959 -1.088 . . . . 0.0 113.448 -176.169 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.658 HD11 ' CE2' ' A' ' 58' ' ' PHE . 97.8 mt . . . . . 0 N--CA 1.496 1.854 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.538 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 20' ' ' THR . 11.1 mmt85 . . . . . 0 N--CA 1.496 1.875 0 CA-C-O 120.917 0.389 . . . . 0.0 110.035 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.58 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 3.7 t30 -76.96 144.52 38.74 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.593 -0.692 . . . . 0.0 111.158 -179.058 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.603 ' HB3' ' CD2' ' A' ' 47' ' ' LEU . 18.2 m-85 -140.8 170.53 15.58 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.411 ' O ' HD23 ' A' ' 47' ' ' LEU . 3.5 m -138.93 130.53 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.421 0 O-C-N 121.141 -0.974 . . . . 0.0 112.177 -177.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.689 HD12 ' C ' ' A' ' 15' ' ' GLU . 0.2 OUTLIER -149.39 161.86 41.25 Favored 'General case' 0 N--CA 1.511 2.604 0 O-C-N 121.071 -1.018 . . . . 0.0 112.222 -179.884 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.511 ' O ' ' N ' ' A' ' 14' ' ' ASN . 12.6 tpt180 -142.72 99.2 3.43 Favored 'General case' 0 N--CA 1.511 2.619 0 O-C-N 121.192 -0.943 . . . . 0.0 111.554 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.823 ' HB2' ' N ' ' A' ' 16' ' ' HIS . 19.1 t70 -80.71 -146.53 0.05 Allowed 'General case' 0 N--CA 1.507 2.399 0 C-N-CA 123.662 0.785 . . . . 0.0 110.167 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.722 ' HA ' ' HB3' ' A' ' 41' ' ' ASN . 0.3 OUTLIER 71.0 55.44 0.23 Allowed 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 104.109 -2.552 . . . . 0.0 104.109 -176.057 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.568 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 0.7 OUTLIER 67.04 1.26 2.28 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-N 112.985 -1.916 . . . . 0.0 111.706 -178.848 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.474 ' O ' ' HB3' ' A' ' 43' ' ' ASP . . . -94.98 -77.52 1.37 Allowed Glycine 0 N--CA 1.477 1.369 0 C-N-CA 118.136 -1.983 . . . . 0.0 109.086 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.83 ' HB3' HD13 ' A' ' 45' ' ' ILE . 2.4 m-80 -126.25 -80.3 0.61 Allowed 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.7 ' C ' ' HB2' ' A' ' 10' ' ' ASP . 28.3 tt0 -168.44 139.8 2.7 Favored 'General case' 0 N--CA 1.509 2.524 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 -178.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.823 ' N ' ' HB2' ' A' ' 10' ' ' ASP . 0.9 OUTLIER -109.56 120.98 44.16 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 116.065 -2.254 . . . . 0.0 115.361 -176.318 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.542 ' HA3' ' CE1' ' A' ' 19' ' ' PHE . . . -179.62 129.64 1.39 Allowed Glycine 0 C--N 1.288 -2.109 0 CA-C-N 112.96 -1.927 . . . . 0.0 109.555 178.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.82 94.37 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 177.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.624 ' N ' ' CD1' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -175.74 -169.29 0.34 Allowed 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 121.286 0.565 . . . . 0.0 110.591 -178.388 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.58 ' HA ' ' HA ' ' A' ' 5' ' ' ASN . 2.7 p -105.59 150.64 25.22 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.431 -0.793 . . . . 0.0 111.508 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -130.1 128.55 5.66 Favored Glycine 0 N--CA 1.5 2.945 0 N-CA-C 108.669 -1.773 . . . . 0.0 108.669 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -60.9 -52.82 63.41 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.41 -1.053 . . . . 0.0 108.823 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.616 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 5.0 mp0 -106.47 99.32 23.79 Favored Pre-proline 0 N--CA 1.487 1.392 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.774 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 36.8 Cg_endo -59.74 -29.18 89.06 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.508 1.267 . . . . 0.0 110.398 -179.129 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.61 -61.15 1.86 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.363 -0.836 . . . . 0.0 109.919 178.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.679 ' HG3' ' HA ' ' A' ' 72' ' ' PRO . 16.6 tm0? -65.84 -42.9 89.93 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 120.871 -1.143 . . . . 0.0 112.397 -179.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.616 ' HB3' ' O ' ' A' ' 23' ' ' GLN . . . -73.07 -17.36 61.42 Favored 'General case' 0 N--CA 1.482 1.138 0 O-C-N 120.69 -1.257 . . . . 0.0 109.885 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.774 ' HB2' ' O ' ' A' ' 24' ' ' PRO . . . -61.07 -53.05 61.94 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.237 -0.914 . . . . 0.0 111.592 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.905 HD13 ' N ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -63.48 -56.84 12.91 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 -179.082 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.448 ' NZ ' ' O ' ' A' ' 75' ' ' MET . 0.1 OUTLIER -48.17 -44.13 32.25 Favored 'General case' 0 N--CA 1.506 2.347 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.93 179.121 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.537 ' C ' ' HB2' ' A' ' 36' ' ' SER . . . -54.83 -43.1 72.67 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.455 -0.778 . . . . 0.0 111.965 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 1.147 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -72.86 -28.25 62.4 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.701 -1.25 . . . . 0.0 110.807 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.575 ' HB2' ' HG3' ' A' ' 82' ' ' PRO . 2.0 t30 -39.59 -46.95 1.86 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -95.11 -74.59 0.54 Allowed 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.154 -1.018 . . . . 0.0 112.91 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.47 ' O ' ' CD2' ' A' ' 16' ' ' HIS . . . -113.81 -4.96 22.59 Favored Glycine 0 N--CA 1.502 3.039 0 N-CA-C 116.798 1.479 . . . . 0.0 116.798 -175.345 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.701 ' CB ' ' HA ' ' A' ' 32' ' ' ALA . 0.4 OUTLIER -82.44 -7.13 59.64 Favored 'General case' 0 N--CA 1.506 2.363 0 CA-C-N 122.166 2.983 . . . . 0.0 110.157 -177.353 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.512 ' HA3' ' O ' ' A' ' 60' ' ' ALA . . . -141.44 111.74 0.72 Allowed Glycine 0 C--N 1.289 -2.028 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.509 ' O ' ' HB3' ' A' ' 39' ' ' LYS . 5.2 m -69.05 -20.94 64.12 Favored 'General case' 0 C--N 1.312 -1.054 0 O-C-N 120.672 -1.487 . . . . 0.0 109.4 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.693 ' HA ' ' HG3' ' A' ' 42' ' ' PRO . 5.6 ttpt 67.64 -52.04 0.51 Allowed 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 38' ' ' THR . . . -70.65 -27.95 64.44 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 174.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.722 ' HB3' ' HA ' ' A' ' 11' ' ' GLU 0.274 0.7 OUTLIER -142.41 71.19 21.57 Favored Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.468 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 1.013 ' HB2' ' CD1' ' A' ' 61' ' ' TRP . 72.2 Cg_endo -112.89 169.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 121.75 1.633 . . . . 0.0 112.208 -178.034 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.53 ' HB2' ' C ' ' A' ' 12' ' ' ASP . 0.7 OUTLIER -167.82 -167.47 0.86 Allowed 'General case' 0 N--CA 1.517 2.891 0 C-N-CA 117.692 -1.603 . . . . 0.0 113.949 177.091 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.809 HG22 ' HD3' ' A' ' 59' ' ' LYS . 0.2 OUTLIER -84.09 123.58 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -178.995 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.83 HD13 ' HB3' ' A' ' 14' ' ' ASN . 0.7 OUTLIER -108.1 117.52 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.846 -1.159 . . . . 0.0 113.648 -177.856 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.505 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 0.3 OUTLIER -87.73 88.14 7.57 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 103.492 -2.781 . . . . 0.0 103.492 173.249 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.603 ' CD2' ' HB3' ' A' ' 6' ' ' PHE . 0.1 OUTLIER -79.14 94.43 5.37 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -177.62 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.532 ' HB3' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.478 0 O-C-N 121.589 -0.694 . . . . 0.0 111.431 -178.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.523 ' HG2' ' CZ ' ' A' ' 6' ' ' PHE . 5.7 mtmt . . . . . 0 N--CA 1.484 1.238 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.532 HG22 ' HB3' ' A' ' 48' ' ' ARG . 2.8 t -154.05 149.75 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.698 0.761 . . . . 0.0 110.522 -178.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.769 ' CE1' ' HB2' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -160.81 122.67 3.07 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 179.276 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.642 HG12 ' HB2' ' A' ' 87' ' ' GLU . 12.9 t -113.32 100.55 10.92 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 C-N-CA 117.722 -1.591 . . . . 0.0 108.188 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.769 ' HB2' ' CE1' ' A' ' 56' ' ' HIS . 0.3 OUTLIER -144.72 178.79 7.74 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 179.601 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.829 ' HB3' ' CZ2' ' A' ' 61' ' ' TRP . 44.2 mttt -131.62 134.56 46.13 Favored 'General case' 0 C--N 1.274 -2.715 0 N-CA-C 104.245 -2.502 . . . . 0.0 104.245 176.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 1.147 ' HB1' ' HB2' ' A' ' 32' ' ' ALA . . . -123.54 109.72 14.15 Favored 'General case' 0 N--CA 1.495 1.825 0 C-N-CA 117.593 -1.643 . . . . 0.0 112.599 -175.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 1.013 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 5.3 m0 -124.91 -163.07 1.15 Allowed 'General case' 0 N--CA 1.508 2.442 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.426 -178.273 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.646 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -124.51 88.55 2.92 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.042 -1.036 . . . . 0.0 111.015 179.541 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.921 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 4.4 mt-10 -167.15 171.64 10.71 Favored 'General case' 0 N--CA 1.507 2.397 0 CA-C-O 121.745 0.783 . . . . 0.0 110.449 177.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.677 ' CG1' ' HA ' ' A' ' 80' ' ' SER . 2.3 mt -72.47 98.37 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.519 2.989 0 O-C-N 119.594 -1.942 . . . . 0.0 115.478 -176.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.863 HG13 ' CD1' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -94.27 -164.54 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.296 -1.503 . . . . 0.0 109.288 176.101 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.672 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 14.2 t70 -120.13 136.93 54.43 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 178.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.797 ' HA ' ' HB2' ' A' ' 77' ' ' GLU 0.251 . . -68.72 100.6 0.26 Allowed Pre-proline 0 N--CA 1.503 2.177 0 CA-C-O 117.799 -1.096 . . . . 0.0 111.615 -177.924 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.672 ' HD3' ' O ' ' A' ' 66' ' ' ASP . 49.3 Cg_endo -88.52 -153.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.319 -1.003 0 O-C-N 124.086 1.572 . . . . 0.0 111.241 -179.076 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.04 61.7 0.08 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.128 -0.983 . . . . 0.0 110.102 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.743 ' CG ' HD21 ' A' ' 29' ' ' LEU . 0.7 OUTLIER -99.63 -14.88 18.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.622 -0.673 . . . . 0.0 110.989 -179.583 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.716 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER 49.72 52.6 12.91 Favored Pre-proline 0 N--CA 1.488 1.429 0 O-C-N 121.892 -0.505 . . . . 0.0 109.992 -178.096 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.716 ' HD3' ' N ' ' A' ' 71' ' ' ARG . 53.2 Cg_endo -98.74 108.01 0.07 OUTLIER 'Trans proline' 0 C--N 1.317 -1.124 0 C-N-CA 122.05 1.834 . . . . 0.0 110.831 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.81 -31.32 23.93 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.966 -1.084 . . . . 0.0 111.447 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.453 ' CD1' ' N ' ' A' ' 74' ' ' TRP . 41.8 m95 -83.65 -32.63 25.55 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.688 -0.633 . . . . 0.0 110.907 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.448 ' O ' ' NZ ' ' A' ' 30' ' ' LYS . 2.3 mtm -167.98 106.76 0.56 Allowed Pre-proline 0 N--CA 1.499 2.003 0 O-C-N 121.467 -0.771 . . . . 0.0 111.08 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.765 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 51.0 Cg_endo -79.59 -179.93 5.78 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.696 1.366 . . . . 0.0 110.929 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 1.002 ' HG3' HG21 ' A' ' 84' ' ' VAL . 14.0 mm-40 -96.46 18.87 13.1 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 117.193 -1.803 . . . . 0.0 111.634 -178.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.667 ' C ' HG22 ' A' ' 79' ' ' ILE . 5.8 tttm -90.39 76.27 6.72 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 177.048 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.667 HG22 ' C ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -179.98 171.48 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 C-N-CA 118.095 -1.442 . . . . 0.0 112.326 -176.294 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.677 ' HA ' ' CG1' ' A' ' 64' ' ' ILE . 29.4 t -71.31 110.37 5.9 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 175.144 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.854 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . 3.5 mttm -164.83 -154.49 0.0 OUTLIER Pre-proline 0 C--O 1.191 -2.003 0 C-N-CA 119.093 -1.043 . . . . 0.0 108.761 -174.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.854 ' HD2' ' HB3' ' A' ' 81' ' ' LYS . 50.6 Cg_endo -81.94 130.66 6.68 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 N-CA-C 109.336 -1.063 . . . . 0.0 109.336 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.921 ' CZ ' ' HB3' ' A' ' 63' ' ' GLU . 1.5 m-30 -62.13 152.37 33.16 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 118.233 -1.387 . . . . 0.0 108.568 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 1.002 HG21 ' HG3' ' A' ' 77' ' ' GLU . 15.5 m -147.21 96.81 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.241 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.647 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.743 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -74.57 129.26 37.42 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 104.751 -2.314 . . . . 0.0 104.751 177.117 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.503 ' CB ' ' CZ ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -102.67 88.19 3.16 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -173.694 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.642 ' HB2' HG12 ' A' ' 57' ' ' VAL . 4.3 mp0 -91.81 161.56 14.81 Favored 'General case' 0 C--N 1.283 -2.311 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 174.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.464 ' HD2' ' HA ' ' A' ' 88' ' ' ARG . 0.9 OUTLIER -53.0 151.7 4.54 Favored 'General case' 0 N--CA 1.51 2.535 0 O-C-N 120.521 -1.362 . . . . 0.0 113.933 -175.241 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.628 HG12 ' HA ' ' A' ' 56' ' ' HIS . 74.7 mt . . . . . 0 N--CA 1.494 1.739 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.039 -178.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.496 1.837 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.428 ' O ' ' HA ' ' A' ' 22' ' ' LYS . 11.3 m120 -131.34 113.99 14.45 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.523 -0.736 . . . . 0.0 109.751 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.787 HG22 ' HB ' ' A' ' 20' ' ' THR . 1.7 m -139.95 131.54 27.16 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.414 -0.804 . . . . 0.0 109.8 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.625 ' HG3' ' O ' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -120.1 121.96 39.99 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.417 -0.802 . . . . 0.0 111.379 -179.169 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.737 ' HB2' HG22 ' A' ' 20' ' ' THR . 19.4 t-20 -84.99 148.03 26.4 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.593 -0.692 . . . . 0.0 110.284 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -144.03 156.25 44.31 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.734 ' C ' HD23 ' A' ' 8' ' ' LEU . 32.9 m -129.62 132.21 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 120.867 -1.146 . . . . 0.0 111.9 -178.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.85 HD13 ' CD2' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -162.7 164.91 26.22 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.602 -0.686 . . . . 0.0 110.86 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.417 ' H ' ' HB2' ' A' ' 14' ' ' ASN . 15.0 mtt85 -130.96 114.51 15.32 Favored 'General case' 0 N--CA 1.514 2.728 0 O-C-N 121.041 -1.037 . . . . 0.0 113.27 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.781 ' HB2' ' CB ' ' A' ' 16' ' ' HIS . 0.8 OUTLIER -75.07 -155.14 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 124.581 1.153 . . . . 0.0 111.216 179.471 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.613 ' HB2' ' O ' ' A' ' 10' ' ' ASP . 3.4 mp0 69.03 52.3 0.51 Allowed 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 -177.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.65 ' HA ' ' O ' ' A' ' 42' ' ' PRO . 33.5 m-20 58.07 8.8 0.82 Allowed 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 112.101 -2.318 . . . . 0.0 113.286 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.18 -75.65 1.3 Allowed Glycine 0 N--CA 1.487 2.092 0 C-N-CA 118.034 -2.032 . . . . 0.0 109.279 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.756 ' CG ' HD13 ' A' ' 45' ' ' ILE . 2.9 m-20 -118.4 -78.06 0.58 Allowed 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.876 1.322 . . . . 0.0 108.991 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.548 ' HA ' ' OD1' ' A' ' 10' ' ' ASP . 2.2 mt-10 -179.23 133.82 0.12 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.781 ' CB ' ' HB2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -79.72 123.58 27.8 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 115.712 -2.395 . . . . 0.0 111.376 -178.532 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.701 ' HA2' ' CZ ' ' A' ' 19' ' ' PHE . . . -168.89 109.2 0.32 Allowed Glycine 0 C--N 1.285 -2.287 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.872 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.31 81.32 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 176.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.701 ' CZ ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -176.24 -173.32 0.54 Allowed 'General case' 0 N--CA 1.507 2.396 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.032 -178.487 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.787 ' HB ' HG22 ' A' ' 3' ' ' THR . 37.5 p -106.97 137.0 45.87 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.508 -0.745 . . . . 0.0 111.967 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.625 ' O ' ' HG3' ' A' ' 4' ' ' ARG . . . -115.58 128.3 7.98 Favored Glycine 0 N--CA 1.499 2.854 0 N-CA-C 108.172 -1.971 . . . . 0.0 108.172 178.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 10.7 pttp -57.29 -40.0 76.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.936 -1.332 . . . . 0.0 110.266 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.832 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 2.4 tp-100 -121.49 136.36 25.86 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 120.975 -1.078 . . . . 0.0 109.311 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.52 ' HB3' ' HD3' ' A' ' 4' ' ' ARG . 38.5 Cg_endo -67.29 -52.84 0.55 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.365 1.192 . . . . 0.0 111.422 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.662 ' HB3' ' HA ' ' A' ' 70' ' ' ASN . 26.8 mtt180 -82.28 -57.55 3.33 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.498 -0.751 . . . . 0.0 111.036 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.592 ' HB3' ' HG2' ' A' ' 23' ' ' GLN . 9.0 tt0 -52.87 -43.21 65.95 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.209 -0.932 . . . . 0.0 111.393 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.832 ' HB3' ' O ' ' A' ' 23' ' ' GLN . . . -77.74 -13.59 59.85 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 120.908 -1.12 . . . . 0.0 109.719 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 25' ' ' ARG . . . -62.1 -51.51 67.63 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.189 -0.944 . . . . 0.0 109.866 178.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.745 ' HB2' ' HG2' ' A' ' 77' ' ' GLU . 3.0 pp -69.2 -42.9 75.16 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.317 -0.953 . . . . 0.0 109.657 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.738 ' HE2' HD11 ' A' ' 29' ' ' LEU . 11.4 mmtt -61.78 -42.97 99.68 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.43 -0.794 . . . . 0.0 111.305 178.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.44 ' C ' ' HB2' ' A' ' 36' ' ' SER . . . -59.81 -48.43 81.73 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -177.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.623 ' HA ' ' CB ' ' A' ' 36' ' ' SER . . . -62.5 -33.24 74.49 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 118.707 -1.197 . . . . 0.0 109.958 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -44.96 -45.3 10.43 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.7 -70.84 0.72 Allowed 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.346 -0.942 . . . . 0.0 112.441 178.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -114.67 2.07 23.25 Favored Glycine 0 N--CA 1.502 3.079 0 N-CA-C 117.529 1.771 . . . . 0.0 117.529 -175.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.623 ' CB ' ' HA ' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -88.3 -2.51 58.64 Favored 'General case' 0 N--CA 1.511 2.62 0 CA-C-N 123.401 3.6 . . . . 0.0 111.081 -177.238 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 60' ' ' ALA . . . -164.34 117.11 0.74 Allowed Glycine 0 N--CA 1.482 1.759 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -178.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.536 ' O ' ' HB3' ' A' ' 39' ' ' LYS . 50.9 m -76.74 -20.22 56.77 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 119.898 1.849 . . . . 0.0 110.234 -178.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.834 ' CA ' ' HG3' ' A' ' 42' ' ' PRO . 0.3 OUTLIER 76.59 -56.6 0.56 Allowed 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -178.514 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.89 -19.36 65.01 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 175.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.605 ' HB3' ' HA ' ' A' ' 11' ' ' GLU 0.282 0.3 OUTLIER -158.43 68.49 3.61 Favored Pre-proline 0 C--O 1.202 -1.412 0 O-C-N 121.738 -0.602 . . . . 0.0 110.408 179.144 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.834 ' HG3' ' CA ' ' A' ' 39' ' ' LYS 0.251 81.6 Cg_endo -119.1 -173.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.301 -1.955 0 C-N-CA 122.084 1.856 . . . . 0.0 110.442 178.866 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.61 ' HB3' ' O ' ' A' ' 14' ' ' ASN . 4.6 t70 -162.51 -173.44 3.56 Favored 'General case' 0 N--CA 1.507 2.388 0 O-C-N 120.367 -1.458 . . . . 0.0 111.817 176.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.017 HD13 ' HG2' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -127.65 123.8 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.782 ' N ' HD12 ' A' ' 44' ' ' ILE . 7.7 tt -166.23 170.68 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 119.267 -0.973 . . . . 0.0 110.221 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.498 ' HG3' HG13 ' A' ' 57' ' ' VAL . 2.3 mtp180 -78.21 98.7 5.95 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.85 ' CD2' HD13 ' A' ' 8' ' ' LEU . 10.8 mp -70.14 97.04 1.14 Allowed 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -123.61 -178.94 4.17 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.125 -0.984 . . . . 0.0 111.87 -178.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.622 ' HG2' ' CG2' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -150.1 132.5 15.61 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 178.58 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -88.54 -178.3 5.8 Favored 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 118.124 -1.43 . . . . 0.0 111.134 -177.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.93 -58.63 3.9 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 -178.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.559 ' OG1' ' NZ ' ' A' ' 54' ' ' LYS . 4.7 p -105.24 -179.24 3.89 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.543 -0.975 . . . . 0.0 109.273 178.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.61 ' O ' ' N ' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -89.64 99.14 12.2 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 120.972 -1.08 . . . . 0.0 108.211 179.277 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.569 ' HB3' ' HB2' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -144.35 106.51 4.35 Favored 'General case' 0 C--N 1.281 -2.394 0 O-C-N 120.964 -1.085 . . . . 0.0 110.048 -179.28 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.421 ' O ' HG23 ' A' ' 89' ' ' ILE . 42.8 t -150.59 118.73 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.7 -0.625 . . . . 0.0 110.078 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.867 ' CE1' ' HB2' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -131.04 117.58 19.35 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 178.964 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.697 ' CG1' ' HB3' ' A' ' 87' ' ' GLU . 7.9 t -105.99 115.86 48.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 C-N-CA 117.571 -1.652 . . . . 0.0 108.377 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.97 ' CD1' HG12 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -162.22 -177.19 5.56 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 -178.876 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 1.017 ' HG2' HD13 ' A' ' 44' ' ' ILE . 30.0 mttt -129.98 132.75 46.4 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 177.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.497 ' O ' ' CD1' ' A' ' 61' ' ' TRP . . . -121.62 109.55 14.9 Favored 'General case' 0 N--CA 1.504 2.242 0 CA-C-N 120.429 1.468 . . . . 0.0 112.575 -177.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.803 ' HB2' ' HB2' ' A' ' 83' ' ' PHE . 10.6 m0 -131.24 -173.85 3.22 Favored 'General case' 0 N--CA 1.512 2.638 0 O-C-N 121.673 -0.642 . . . . 0.0 111.1 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.676 ' HB3' ' HG3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -114.52 91.85 3.76 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.157 -0.964 . . . . 0.0 109.876 178.931 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.916 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 3.4 tp10 -171.04 163.91 7.42 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.561 0.696 . . . . 0.0 110.373 178.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.713 ' HB ' ' HA ' ' A' ' 80' ' ' SER . 6.0 tt -70.2 93.94 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.52 3.038 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 -175.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.709 HG22 ' H ' ' A' ' 66' ' ' ASP . 1.4 p -97.86 -161.08 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 O-C-N 120.096 -1.627 . . . . 0.0 109.067 176.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.709 ' H ' HG22 ' A' ' 65' ' ' VAL . 1.0 OUTLIER -115.95 140.4 49.28 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.296 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.838 ' HB2' ' HB2' ' A' ' 76' ' ' PRO 0.254 . . -58.39 100.41 0.22 Allowed Pre-proline 0 N--CA 1.502 2.171 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.297 -178.111 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.653 ' HD2' ' HB2' ' A' ' 77' ' ' GLU . 54.5 Cg_endo -76.38 83.82 1.96 Allowed 'Trans proline' 0 N--CA 1.492 1.391 0 O-C-N 124.166 1.614 . . . . 0.0 112.366 -177.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.6 mttt 41.3 38.94 0.87 Allowed 'General case' 0 N--CA 1.507 2.413 0 CA-C-O 121.3 0.571 . . . . 0.0 111.476 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.662 ' HA ' ' HB3' ' A' ' 25' ' ' ARG . 0.8 OUTLIER -77.81 -19.18 55.42 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.476 -0.765 . . . . 0.0 111.406 -179.679 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.699 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER 41.77 50.77 5.05 Favored Pre-proline 0 N--CA 1.507 2.412 0 CA-C-O 121.028 0.442 . . . . 0.0 112.02 -178.984 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.74 ' HG2' ' HA ' ' A' ' 76' ' ' PRO . 55.5 Cg_endo -99.22 99.68 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.591 1.528 . . . . 0.0 108.76 179.075 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.89 -19.17 16.21 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.191 -0.943 . . . . 0.0 111.829 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.446 ' CD1' ' N ' ' A' ' 74' ' ' TRP . 41.0 m95 -79.41 -42.59 25.15 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 121.443 -0.786 . . . . 0.0 109.808 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.404 ' O ' ' HG2' ' A' ' 72' ' ' PRO . 6.6 ttm -176.21 123.55 0.31 Allowed Pre-proline 0 N--CA 1.503 2.177 0 O-C-N 121.581 -0.699 . . . . 0.0 110.487 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.838 ' HB2' ' HB2' ' A' ' 67' ' ' ALA . 51.8 Cg_endo -83.18 176.84 7.06 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 O-C-N 124.091 1.574 . . . . 0.0 111.101 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.817 ' CB ' ' HA ' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -87.87 12.67 12.5 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 117.697 -1.601 . . . . 0.0 110.726 -179.645 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.694 ' C ' HG22 ' A' ' 79' ' ' ILE . 4.6 tttm -82.63 79.88 8.91 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.694 HG22 ' C ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER 177.87 170.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 C-N-CA 118.388 -1.325 . . . . 0.0 111.903 -177.643 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.713 ' HA ' ' HB ' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -69.08 106.29 2.74 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 104.207 -2.516 . . . . 0.0 104.207 175.243 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.846 ' HB3' ' HD2' ' A' ' 82' ' ' PRO 0.26 0.7 OUTLIER -165.02 -155.54 0.01 OUTLIER Pre-proline 0 C--O 1.194 -1.867 0 C-N-CA 119.143 -1.023 . . . . 0.0 108.847 -173.402 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.846 ' HD2' ' HB3' ' A' ' 81' ' ' LYS . 51.2 Cg_endo -78.15 125.01 6.9 Favored 'Trans proline' 0 C--N 1.302 -1.876 0 N-CA-C 108.792 -1.272 . . . . 0.0 108.792 178.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.916 ' CZ ' ' HB3' ' A' ' 63' ' ' GLU . 2.0 m-30 -61.38 145.81 50.35 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.288 -1.508 . . . . 0.0 108.158 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.97 HG12 ' CD1' ' A' ' 58' ' ' PHE . 2.1 t -143.21 94.84 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.466 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.673 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 2.7 mmtm -88.18 117.08 26.83 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.638 ' HB3' ' CZ ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -72.97 162.36 29.58 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 124.344 2.021 . . . . 0.0 114.091 -175.839 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.697 ' HB3' ' CG1' ' A' ' 57' ' ' VAL . 5.0 mt-10 -165.53 155.66 13.05 Favored 'General case' 0 C--N 1.271 -2.846 0 CA-C-N 110.544 -3.025 . . . . 0.0 107.857 177.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.462 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -47.01 132.45 11.88 Favored 'General case' 0 N--CA 1.507 2.423 0 CA-C-O 122.194 0.997 . . . . 0.0 113.031 -175.666 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.515 HG23 ' HA ' ' A' ' 56' ' ' HIS . 5.2 mt -121.68 142.36 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.335 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.408 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 44.1 mt-10 -141.71 122.99 14.81 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.411 ' NZ ' ' O ' ' A' ' 92' ' ' LEU . 0.7 OUTLIER -138.5 174.3 10.69 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.467 -1.396 . . . . 0.0 111.784 -179.458 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.61 ' N ' ' O ' ' A' ' 53' ' ' LYS . 2.1 pp -70.85 131.26 43.51 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.593 0.711 . . . . 0.0 109.737 -179.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 . . . . . 0 C--N 1.293 -1.852 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.027 -179.886 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.2 t . . . . . 0 N--CA 1.497 1.899 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 37.4 p-10 -116.44 145.71 43.07 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.421 -0.799 . . . . 0.0 110.163 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.1 m -153.94 158.89 41.36 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.97 -1.081 . . . . 0.0 109.859 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.485 ' O ' ' HA ' ' A' ' 20' ' ' THR . 0.0 OUTLIER -97.68 126.16 42.85 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.238 -0.913 . . . . 0.0 109.924 -179.724 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.804 ' HA ' HG22 ' A' ' 20' ' ' THR . 0.1 OUTLIER -78.17 121.53 24.46 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.695 -0.628 . . . . 0.0 110.849 -179.3 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.736 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 39.5 m-85 -109.6 167.45 10.13 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.426 -0.796 . . . . 0.0 110.549 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.695 ' C ' HD23 ' A' ' 8' ' ' LEU . 29.8 m -139.72 129.83 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 O-C-N 121.527 -0.733 . . . . 0.0 111.695 -178.15 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.845 HD13 HD11 ' A' ' 47' ' ' LEU . 0.3 OUTLIER -164.98 159.49 18.08 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.118 -0.989 . . . . 0.0 111.746 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.512 ' O ' ' N ' ' A' ' 14' ' ' ASN . 2.5 ttm-85 -140.12 114.91 9.52 Favored 'General case' 0 N--CA 1.511 2.577 0 O-C-N 121.083 -1.011 . . . . 0.0 112.755 178.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.81 ' HB2' ' CB ' ' A' ' 16' ' ' HIS . 0.7 OUTLIER -73.49 -153.19 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 125.154 1.381 . . . . 0.0 111.444 179.647 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.566 ' HB2' ' O ' ' A' ' 10' ' ' ASP . 0.6 OUTLIER 71.9 50.95 0.23 Allowed 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 -177.594 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.624 ' HA ' ' O ' ' A' ' 42' ' ' PRO . 86.5 m-20 59.14 6.6 0.72 Allowed 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 112.539 -2.118 . . . . 0.0 112.591 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.04 -77.33 1.34 Allowed Glycine 0 N--CA 1.485 1.903 0 C-N-CA 117.937 -2.078 . . . . 0.0 109.77 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.707 ' CA ' HG12 ' A' ' 45' ' ' ILE . 6.1 m-20 -117.49 -81.67 0.62 Allowed 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 122.183 0.992 . . . . 0.0 111.566 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.588 ' HB3' HD12 ' A' ' 8' ' ' LEU . 7.8 mt-10 -170.12 129.84 0.93 Allowed 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.81 ' CB ' ' HB2' ' A' ' 10' ' ' ASP . 1.1 p-80 -81.25 121.51 26.25 Favored 'General case' 0 N--CA 1.505 2.281 0 C-N-CA 115.273 -2.571 . . . . 0.0 112.17 -178.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.695 ' HA2' ' CZ ' ' A' ' 19' ' ' PHE . . . -176.89 122.84 0.86 Allowed Glycine 0 C--N 1.284 -2.322 0 CA-C-N 114.149 -1.387 . . . . 0.0 111.977 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.27 86.46 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 176.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.695 ' CZ ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -175.42 -172.11 0.54 Allowed 'General case' 0 N--CA 1.504 2.228 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.022 -178.08 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.804 HG22 ' HA ' ' A' ' 5' ' ' ASN . 42.8 p -108.56 153.74 22.94 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.121 -0.987 . . . . 0.0 111.885 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -135.89 131.55 5.78 Favored Glycine 0 N--CA 1.507 3.367 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.14 -50.88 69.89 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.149 -1.206 . . . . 0.0 109.225 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.513 ' HB2' ' HG2' ' A' ' 26' ' ' GLN . 37.2 mm-40 -126.71 124.71 24.22 Favored Pre-proline 0 N--CA 1.492 1.641 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.9 -19.67 46.11 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 123.614 1.323 . . . . 0.0 112.085 -178.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.55 ' HD2' ' HA ' ' A' ' 70' ' ' ASN . 8.5 mtt180 -82.84 -68.03 0.74 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.298 -0.877 . . . . 0.0 110.739 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.607 ' HB2' ' HA ' ' A' ' 72' ' ' PRO . 13.6 pt20 -58.93 -37.57 77.01 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.982 -1.073 . . . . 0.0 112.148 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.0 -22.85 63.09 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 120.765 -1.21 . . . . 0.0 109.661 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.77 -58.17 9.8 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.112 -0.992 . . . . 0.0 111.688 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.569 HD21 ' HB3' ' A' ' 72' ' ' PRO . 2.6 pp -56.26 -50.27 71.81 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 119.041 -1.064 . . . . 0.0 110.709 -178.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.532 ' N ' HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -69.79 -37.68 76.42 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 120.582 -1.324 . . . . 0.0 112.892 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.413 ' C ' ' HB2' ' A' ' 36' ' ' SER . . . -62.01 -45.09 95.12 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.723 -1.235 . . . . 0.0 112.306 -177.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.781 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -62.42 -34.52 76.93 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 118.694 -1.202 . . . . 0.0 109.535 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.606 ' CA ' ' HG3' ' A' ' 82' ' ' PRO . 0.2 OUTLIER -40.88 -48.1 3.06 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.185 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 -97.04 -72.31 0.65 Allowed 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.212 -0.995 . . . . 0.0 112.086 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -114.52 -1.23 23.22 Favored Glycine 0 N--CA 1.501 2.991 0 N-CA-C 117.401 1.72 . . . . 0.0 117.401 -175.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.604 ' CB ' ' HA ' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -86.04 -1.71 57.62 Favored 'General case' 0 N--CA 1.514 2.75 0 CA-C-N 123.255 3.527 . . . . 0.0 110.941 -177.017 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.438 ' C ' ' HE1' ' A' ' 16' ' ' HIS . . . -162.4 119.56 0.89 Allowed Glycine 0 C--N 1.299 -1.521 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -178.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.496 ' O ' ' HB3' ' A' ' 39' ' ' LYS . 12.9 m -81.08 -15.2 56.67 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 120.417 -1.637 . . . . 0.0 109.665 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.834 ' CA ' ' HG3' ' A' ' 42' ' ' PRO . 7.6 tttp 72.84 -59.16 0.58 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.45 -18.02 65.12 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.121 -1.436 . . . . 0.0 107.121 175.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.549 ' HB3' ' HA ' ' A' ' 11' ' ' GLU 0.285 0.3 OUTLIER -159.05 67.77 3.2 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.678 -0.639 . . . . 0.0 110.87 179.233 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.834 ' HG3' ' CA ' ' A' ' 39' ' ' LYS . 78.2 Cg_endo -119.13 -174.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.472 2.115 . . . . 0.0 110.927 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -166.47 -172.83 2.3 Favored 'General case' 0 N--CA 1.513 2.716 0 O-C-N 120.156 -1.59 . . . . 0.0 113.029 176.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.866 HD13 ' HG2' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -126.02 124.34 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.713 ' N ' HD12 ' A' ' 44' ' ' ILE . 1.6 pp -157.32 -176.43 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.435 -0.791 . . . . 0.0 110.336 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.887 ' HB3' HG13 ' A' ' 55' ' ' VAL . 16.7 mtt85 -85.56 94.56 9.07 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.845 HD11 HD13 ' A' ' 8' ' ' LEU . 5.3 tt -73.55 94.41 2.14 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.497 ' HG2' HG23 ' A' ' 7' ' ' VAL . 4.2 ptp180 -81.66 -176.76 6.23 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 119.478 -0.889 . . . . 0.0 112.282 -177.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.736 ' HA ' ' HA ' ' A' ' 6' ' ' PHE . 0.4 OUTLIER -137.94 161.54 36.39 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 -179.27 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.668 ' N ' ' HG2' ' A' ' 49' ' ' GLU . 4.5 mtt180 -102.48 154.53 19.01 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 117.512 -1.675 . . . . 0.0 110.318 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.83 -76.93 0.23 Allowed Glycine 0 N--CA 1.495 2.596 0 N-CA-C 107.569 -2.213 . . . . 0.0 107.569 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.577 ' HA ' ' HG3' ' A' ' 93' ' ' GLU . 21.7 p -98.38 -170.47 1.96 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 177.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.516 ' CB ' ' O ' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -105.71 91.14 3.63 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 120.382 -1.449 . . . . 0.0 109.346 179.712 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.683 ' HB3' ' HB3' ' A' ' 49' ' ' GLU . 0.1 OUTLIER -114.45 149.44 36.27 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.382 179.638 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.887 HG13 ' HB3' ' A' ' 46' ' ' ARG . 35.2 t -149.26 94.25 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.899 ' HA ' HG23 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -79.92 124.92 29.11 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 179.189 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.661 HG12 ' HB2' ' A' ' 87' ' ' GLU . 2.9 t -109.37 106.46 20.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 C-N-CA 117.362 -1.735 . . . . 0.0 107.152 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.859 ' HB2' ' CE1' ' A' ' 56' ' ' HIS . 0.3 OUTLIER -150.03 167.74 25.87 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.866 ' HG2' HD13 ' A' ' 44' ' ' ILE . 8.3 mttm -121.17 118.96 31.0 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.781 ' HB1' ' HB2' ' A' ' 32' ' ' ALA . . . -106.69 107.33 18.29 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 118.609 -1.236 . . . . 0.0 112.484 -176.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.794 ' HB2' ' HB2' ' A' ' 83' ' ' PHE . 18.5 m0 -128.49 -166.13 1.59 Allowed 'General case' 0 N--CA 1.512 2.635 0 O-C-N 121.842 -0.536 . . . . 0.0 111.021 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.748 ' HB2' ' HB2' ' A' ' 39' ' ' LYS . 0.3 OUTLIER -123.2 86.53 2.59 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 120.967 -1.083 . . . . 0.0 110.966 179.747 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.757 ' CB ' ' CZ ' ' A' ' 83' ' ' PHE . 19.7 mp0 -161.19 171.14 18.98 Favored 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.646 ' HB ' ' HA ' ' A' ' 80' ' ' SER . 2.8 tt -78.48 98.04 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.136 0 O-C-N 119.301 -2.124 . . . . 0.0 115.49 -177.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 1.122 HG13 ' CD1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -89.85 -168.41 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.309 -1.495 . . . . 0.0 110.342 177.739 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.62 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 10.9 t70 -119.66 133.85 55.47 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.806 ' HA ' ' CB ' ' A' ' 77' ' ' GLU . . . -66.01 101.33 0.27 Allowed Pre-proline 0 N--CA 1.504 2.273 0 CA-C-O 117.93 -1.033 . . . . 0.0 111.902 -178.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.681 ' CB ' ' HD2' ' A' ' 86' ' ' LYS . 52.5 Cg_endo -86.93 -166.66 0.31 Allowed 'Trans proline' 0 C--N 1.315 -1.221 0 O-C-N 123.875 1.461 . . . . 0.0 111.467 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.0 mmmt -69.44 62.02 0.15 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.447 -0.783 . . . . 0.0 110.295 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.55 ' HA ' ' HD2' ' A' ' 25' ' ' ARG . 1.0 OUTLIER -101.65 -9.35 20.99 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.653 -0.654 . . . . 0.0 111.213 -179.842 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.755 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER 56.52 44.06 1.33 Allowed Pre-proline 0 N--CA 1.508 2.441 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -179.244 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.755 ' HD3' ' N ' ' A' ' 71' ' ' ARG . 49.0 Cg_endo -94.06 98.99 0.13 Allowed 'Trans proline' 0 C--N 1.316 -1.183 0 C-N-CA 120.84 1.026 . . . . 0.0 110.015 178.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.9 -18.33 50.86 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.15 -0.968 . . . . 0.0 111.444 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.519 ' CD1' ' N ' ' A' ' 74' ' ' TRP . 6.9 m0 -80.29 -37.82 32.01 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.154 -0.966 . . . . 0.0 109.579 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.457 ' O ' ' HB2' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -167.64 122.57 0.82 Allowed Pre-proline 0 N--CA 1.496 1.83 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.612 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.766 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 49.5 Cg_endo -81.92 -179.8 5.06 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.589 1.31 . . . . 0.0 112.62 -178.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.806 ' CB ' ' HA ' ' A' ' 67' ' ' ALA . 1.3 mt-10 -92.2 11.0 27.12 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 118.315 -1.354 . . . . 0.0 110.684 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.691 ' C ' HG22 ' A' ' 79' ' ' ILE . 0.6 OUTLIER -92.46 82.83 4.89 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.94 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.691 HG22 ' C ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -176.87 161.55 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 C-N-CA 118.146 -1.422 . . . . 0.0 112.392 -177.837 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.646 ' HA ' ' HB ' ' A' ' 64' ' ' ILE . 0.3 OUTLIER -75.07 104.94 5.85 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 175.501 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.768 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 11.5 pttp -169.81 -152.58 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.784 0 C-N-CA 118.843 -1.143 . . . . 0.0 108.393 -174.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.768 ' HD2' ' HB2' ' A' ' 81' ' ' LYS . 51.0 Cg_endo -74.83 127.33 10.72 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 N-CA-C 109.547 -0.982 . . . . 0.0 109.547 178.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 1.122 ' CD1' HG13 ' A' ' 65' ' ' VAL . 0.8 OUTLIER -65.16 160.19 21.84 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.987 -1.071 . . . . 0.0 109.737 179.502 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.704 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -154.64 92.7 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 177.25 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.783 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -77.51 122.35 25.11 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 178.946 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.681 ' HD2' ' CB ' ' A' ' 68' ' ' PRO . 0.0 OUTLIER -85.24 92.2 8.36 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 122.864 1.316 . . . . 0.0 113.29 -175.783 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.661 ' HB2' HG12 ' A' ' 57' ' ' VAL . 3.2 mm-40 -88.5 153.94 20.75 Favored 'General case' 0 C--N 1.28 -2.448 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.459 176.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -53.38 111.11 0.64 Allowed 'General case' 0 N--CA 1.51 2.557 0 CA-C-O 122.092 0.949 . . . . 0.0 113.087 -176.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.899 HG23 ' HA ' ' A' ' 56' ' ' HIS . 10.4 mt -84.55 131.75 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.085 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -101.82 152.3 21.06 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.577 -0.702 . . . . 0.0 109.158 178.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -163.69 95.23 0.8 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.554 -1.341 . . . . 0.0 112.702 -179.481 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.516 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 1.1 pp -170.0 124.07 0.75 Allowed 'General case' 0 N--CA 1.506 2.371 0 C-N-CA 119.563 -0.855 . . . . 0.0 112.497 177.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.577 ' HG3' ' HA ' ' A' ' 52' ' ' THR . 18.9 tt0 . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 118.184 -0.912 . . . . 0.0 109.823 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 120.809 0.338 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.26 148.1 34.05 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.205 -0.934 . . . . 0.0 110.515 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 1.5 m -78.25 151.18 33.21 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.189 0.519 . . . . 0.0 111.313 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.495 ' O ' ' HA ' ' A' ' 20' ' ' THR . 3.0 mpt_? -113.54 136.27 52.98 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.306 -0.871 . . . . 0.0 110.068 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.49 ' CA ' HG22 ' A' ' 20' ' ' THR . 6.7 t-20 -77.43 143.55 38.5 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.65 -0.657 . . . . 0.0 110.417 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -142.65 137.56 30.05 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.576 -0.702 . . . . 0.0 110.264 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.917 HG22 ' O ' ' A' ' 48' ' ' ARG . 17.0 m -119.39 132.78 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.516 -0.74 . . . . 0.0 111.599 -178.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.805 HD22 ' HG ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -163.39 161.45 24.42 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.107 -0.995 . . . . 0.0 111.291 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.433 ' H ' ' HB2' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -131.99 110.58 10.85 Favored 'General case' 0 N--CA 1.513 2.718 0 O-C-N 121.13 -0.981 . . . . 0.0 113.154 -179.375 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.83 ' HB2' ' CB ' ' A' ' 16' ' ' HIS . 0.9 OUTLIER -73.48 -156.16 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 C-N-CA 124.274 1.03 . . . . 0.0 111.101 179.337 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.665 ' HA ' ' HB3' ' A' ' 41' ' ' ASN . 3.0 mp0 70.92 51.66 0.3 Allowed 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 -177.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.615 ' HA ' ' O ' ' A' ' 42' ' ' PRO . 86.4 m-20 59.45 7.95 1.09 Allowed 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 112.306 -2.224 . . . . 0.0 113.027 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.28 -77.69 1.33 Allowed Glycine 0 N--CA 1.486 1.992 0 C-N-CA 117.954 -2.07 . . . . 0.0 109.061 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.639 ' O ' ' HB3' ' A' ' 43' ' ' ASP . 8.0 m-20 -117.11 -77.24 0.57 Allowed 'General case' 0 C--N 1.296 -1.753 0 CA-C-O 122.606 1.193 . . . . 0.0 109.909 178.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.569 ' HA ' ' OD1' ' A' ' 10' ' ' ASP . 1.3 mt-10 -178.05 138.08 0.19 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 178.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.83 ' CB ' ' HB2' ' A' ' 10' ' ' ASP . 0.1 OUTLIER -87.37 122.45 31.14 Favored 'General case' 0 N--CA 1.501 2.119 0 C-N-CA 115.672 -2.411 . . . . 0.0 112.22 -178.623 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.669 ' HA2' ' CE1' ' A' ' 19' ' ' PHE . . . -174.43 110.16 0.32 Allowed Glycine 0 C--N 1.283 -2.375 0 CA-C-N 113.804 -1.543 . . . . 0.0 110.834 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.449 ' C ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -130.96 81.87 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.2 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.669 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -175.17 -173.49 0.67 Allowed 'General case' 0 N--CA 1.502 2.161 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.077 -179.682 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 4' ' ' ARG . 57.3 p -103.23 144.8 30.86 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.418 -0.801 . . . . 0.0 111.809 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -124.29 133.58 8.76 Favored Glycine 0 N--CA 1.503 3.111 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 5.4 mttt -66.46 -58.64 4.83 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.241 -1.153 . . . . 0.0 108.752 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.545 ' HB3' ' HB3' ' A' ' 26' ' ' GLN . 0.9 OUTLIER -109.45 106.05 58.02 Favored Pre-proline 0 C--N 1.303 -1.424 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 177.9 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.608 ' HB2' HD13 ' A' ' 89' ' ' ILE . 36.9 Cg_endo -60.04 -26.46 82.49 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.945 1.498 . . . . 0.0 111.309 -178.064 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.622 ' HD3' ' HA ' ' A' ' 70' ' ' ASN . 3.6 mtt-85 -85.23 -58.39 2.7 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.268 -0.895 . . . . 0.0 109.239 178.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.758 ' HG3' ' HA ' ' A' ' 72' ' ' PRO . 1.0 OUTLIER -59.01 -43.53 91.54 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.921 -1.112 . . . . 0.0 110.807 179.552 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.41 -18.15 63.73 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 118.993 -1.083 . . . . 0.0 109.78 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 25' ' ' ARG . . . -59.76 -60.11 4.36 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.436 -0.79 . . . . 0.0 111.703 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.567 ' HB3' ' HG3' ' A' ' 77' ' ' GLU . 1.8 pp -63.89 -44.13 93.93 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 118.933 -1.107 . . . . 0.0 110.524 -179.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.401 ' HG3' ' CD1' ' A' ' 29' ' ' LEU . 37.6 mtmt -66.48 -43.7 84.67 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 120.781 -1.199 . . . . 0.0 112.476 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.23 -45.46 88.07 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.929 -1.107 . . . . 0.0 112.864 -177.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.646 ' HA ' ' CB ' ' A' ' 36' ' ' SER . . . -56.64 -37.52 70.87 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 118.781 -1.167 . . . . 0.0 109.493 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.494 ' CB ' ' HG3' ' A' ' 82' ' ' PRO . 4.4 t-20 -42.39 -47.05 4.87 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.98 -73.44 0.58 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 119.035 -1.066 . . . . 0.0 112.545 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.76 1.63 19.92 Favored Glycine 0 N--CA 1.502 3.092 0 N-CA-C 117.213 1.645 . . . . 0.0 117.213 -175.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.646 ' CB ' ' HA ' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -85.17 -4.85 59.3 Favored 'General case' 0 N--CA 1.51 2.545 0 CA-C-N 122.929 3.364 . . . . 0.0 110.99 -176.917 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.442 ' C ' ' HE1' ' A' ' 16' ' ' HIS . . . -165.37 120.89 0.96 Allowed Glycine 0 N--CA 1.478 1.494 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -177.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.57 ' O ' ' HB3' ' A' ' 39' ' ' LYS . 32.4 m -77.66 -14.81 59.52 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 120.359 -1.671 . . . . 0.0 110.195 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.828 ' CA ' ' HG3' ' A' ' 42' ' ' PRO . 1.2 tmtt? 72.01 -56.57 0.64 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -178.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.97 -18.73 63.36 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 176.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.665 ' HB3' ' HA ' ' A' ' 11' ' ' GLU 0.278 0.4 OUTLIER -156.75 67.73 4.34 Favored Pre-proline 0 C--O 1.199 -1.581 0 O-C-N 121.819 -0.55 . . . . 0.0 109.98 179.083 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.828 ' HG3' ' CA ' ' A' ' 39' ' ' LYS . 80.0 Cg_endo -119.61 -174.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 122.382 2.054 . . . . 0.0 111.075 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.639 ' HB3' ' O ' ' A' ' 14' ' ' ASN . 3.2 t70 -165.11 -168.71 1.47 Allowed 'General case' 0 N--CA 1.51 2.565 0 O-C-N 120.357 -1.464 . . . . 0.0 111.963 176.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.03 HD13 ' HG2' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -129.93 120.76 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.715 -0.616 . . . . 0.0 109.778 -179.043 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.715 ' N ' HD12 ' A' ' 44' ' ' ILE . 1.3 pp -157.98 -177.96 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-O 121.829 0.823 . . . . 0.0 109.876 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.608 ' NH1' HG21 ' A' ' 57' ' ' VAL . 0.5 OUTLIER -91.19 100.26 13.12 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.102 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.805 ' HG ' HD22 ' A' ' 8' ' ' LEU . 9.4 mp -69.71 93.32 0.72 Allowed 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.917 ' O ' HG22 ' A' ' 7' ' ' VAL . 8.2 ptp85 -113.12 -165.41 0.99 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.722 -0.791 . . . . 0.0 113.059 -175.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -147.36 164.55 32.94 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -111.68 172.63 6.78 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 117.894 -1.522 . . . . 0.0 110.9 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.98 -43.31 2.96 Favored Glycine 0 N--CA 1.498 2.825 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.0 p -126.8 178.84 5.69 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.254 -1.145 . . . . 0.0 109.337 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.596 ' O ' ' N ' ' A' ' 92' ' ' LEU . 2.1 mttm -92.91 105.69 17.77 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 122.684 1.23 . . . . 0.0 108.866 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.625 ' HE3' HD23 ' A' ' 92' ' ' LEU . 0.8 OUTLIER -149.53 99.7 2.92 Favored 'General case' 0 C--N 1.279 -2.479 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.814 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.839 HG13 ' HB3' ' A' ' 48' ' ' ARG . 3.9 t -138.78 107.58 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 CA-C-O 121.245 0.545 . . . . 0.0 110.547 -178.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.819 ' CE1' ' HB2' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -101.04 127.4 47.58 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 178.54 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.861 HG22 ' CB ' ' A' ' 87' ' ' GLU . 2.2 p -117.6 123.84 72.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 C-N-CA 116.611 -2.036 . . . . 0.0 108.852 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.819 ' HB2' ' CE1' ' A' ' 56' ' ' HIS . 0.3 OUTLIER -162.75 -176.35 4.92 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 -178.681 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 1.03 ' HG2' HD13 ' A' ' 44' ' ' ILE . 38.2 mttt -133.42 124.48 27.18 Favored 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.617 ' HB1' ' CB ' ' A' ' 32' ' ' ALA . . . -110.75 109.29 19.46 Favored 'General case' 0 N--CA 1.505 2.287 0 C-N-CA 118.595 -1.242 . . . . 0.0 113.424 -176.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.845 ' HB2' ' HB2' ' A' ' 83' ' ' PHE . 11.2 m0 -132.38 -163.46 1.34 Allowed 'General case' 0 N--CA 1.515 2.822 0 O-C-N 121.86 -0.525 . . . . 0.0 110.589 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.698 ' CB ' ' HG3' ' A' ' 39' ' ' LYS . 0.5 OUTLIER -125.26 89.04 2.98 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 120.423 -1.423 . . . . 0.0 112.217 179.93 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.885 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 4.3 mt-10 -167.17 -179.44 4.57 Favored 'General case' 0 N--CA 1.514 2.752 0 CA-C-O 121.514 0.674 . . . . 0.0 111.064 177.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.597 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 2.1 mt -78.26 99.88 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.086 0 O-C-N 119.429 -2.045 . . . . 0.0 115.012 -176.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.859 HG13 ' CD1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -90.92 -168.91 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 120.586 -1.321 . . . . 0.0 110.317 177.51 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.618 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 12.1 t70 -124.72 129.86 51.3 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.822 ' HA ' ' CB ' ' A' ' 77' ' ' GLU 0.253 . . -66.18 98.6 0.16 Allowed Pre-proline 0 N--CA 1.511 2.623 0 CA-C-O 117.51 -1.233 . . . . 0.0 111.862 -177.542 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.615 ' HD3' ' O ' ' A' ' 66' ' ' ASP . 48.9 Cg_endo -92.95 85.68 0.19 Allowed 'Trans proline' 0 N--CA 1.483 0.893 0 O-C-N 123.818 1.43 . . . . 0.0 112.994 -178.266 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.5 mttm 38.99 54.03 2.07 Favored 'General case' 0 N--CA 1.511 2.597 0 CA-C-O 121.71 0.767 . . . . 0.0 111.538 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.622 ' HA ' ' HD3' ' A' ' 25' ' ' ARG . 0.9 OUTLIER -91.8 -9.7 42.56 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.289 -0.882 . . . . 0.0 112.216 -179.083 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.765 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER 62.67 35.46 0.21 Allowed Pre-proline 0 N--CA 1.508 2.432 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -179.649 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.795 ' HG2' ' HA ' ' A' ' 76' ' ' PRO . 56.8 Cg_endo -93.41 115.13 0.27 Allowed 'Trans proline' 0 C--N 1.315 -1.193 0 N-CA-C 109.822 -0.876 . . . . 0.0 109.822 178.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.0 -19.75 39.85 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.951 -1.093 . . . . 0.0 111.715 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.457 ' CD1' ' N ' ' A' ' 74' ' ' TRP . 37.8 m95 -82.28 -39.21 23.27 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.398 -0.814 . . . . 0.0 110.137 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.551 ' SD ' ' HE3' ' A' ' 81' ' ' LYS . 2.1 mtm -170.42 132.2 0.96 Allowed Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.708 -0.62 . . . . 0.0 109.556 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.795 ' HA ' ' HG2' ' A' ' 72' ' ' PRO . 46.4 Cg_endo -87.33 -178.16 2.34 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.682 1.359 . . . . 0.0 112.129 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.822 ' CB ' ' HA ' ' A' ' 67' ' ' ALA . 0.3 OUTLIER -88.94 11.39 18.27 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 118.092 -1.443 . . . . 0.0 110.321 -179.328 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.702 ' C ' HG22 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -94.18 81.6 4.08 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.229 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.702 HG22 ' C ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -177.97 164.44 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 118.145 -1.422 . . . . 0.0 112.57 -177.462 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.54 ' N ' HG13 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -73.84 104.32 4.68 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 104.556 -2.387 . . . . 0.0 104.556 175.218 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.79 ' HB3' ' HD2' ' A' ' 82' ' ' PRO 0.262 2.8 mttm -164.16 -162.41 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.682 0 C-N-CA 118.857 -1.137 . . . . 0.0 110.112 -174.267 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.79 ' HD2' ' HB3' ' A' ' 81' ' ' LYS . 43.4 Cg_endo -69.87 121.65 8.31 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 N-CA-C 107.529 -1.758 . . . . 0.0 107.529 176.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.885 ' CZ ' ' HB3' ' A' ' 63' ' ' GLU . 0.4 OUTLIER -57.37 151.51 16.12 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.878 -1.139 . . . . 0.0 109.892 -178.734 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.733 ' H ' HG11 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -148.04 88.8 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.51 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.388 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.748 ' HB2' ' CG ' ' A' ' 59' ' ' LYS . 14.6 mmtp -79.93 118.16 21.43 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.523 ' CE ' ' O ' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -72.67 156.55 38.84 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 124.256 1.979 . . . . 0.0 114.3 -175.419 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.861 ' CB ' HG22 ' A' ' 57' ' ' VAL . 0.5 OUTLIER -163.34 143.7 8.98 Favored 'General case' 0 C--N 1.271 -2.817 0 CA-C-N 111.096 -2.774 . . . . 0.0 108.828 177.865 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.4 ' O ' HG12 ' A' ' 57' ' ' VAL . 1.0 OUTLIER -55.0 117.49 3.49 Favored 'General case' 0 N--CA 1.506 2.351 0 CA-C-O 122.13 0.967 . . . . 0.0 113.38 -176.487 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.781 HG23 ' HA ' ' A' ' 56' ' ' HIS . 42.8 mt -83.12 106.08 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.34 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -84.55 122.75 29.46 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.455 -0.778 . . . . 0.0 109.132 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.505 ' HG3' HG22 ' A' ' 89' ' ' ILE . 16.7 mtmm -140.44 -179.72 6.18 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.813 -1.179 . . . . 0.0 112.063 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.625 HD23 ' HE3' ' A' ' 54' ' ' LYS . 2.7 pp -78.08 -176.62 4.65 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 115.383 -0.826 . . . . 0.0 108.848 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.532 ' N ' HD12 ' A' ' 92' ' ' LEU . 1.2 tp10 . . . . . 0 N--CA 1.494 1.774 0 CA-C-O 118.367 -0.825 . . . . 0.0 109.484 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.968 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -152.49 158.5 42.66 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.175 -0.953 . . . . 0.0 110.476 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.4 t -153.86 146.89 24.52 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.464 -0.773 . . . . 0.0 109.583 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 20' ' ' THR . 22.3 mmt180 -116.94 124.52 49.62 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.28 -0.888 . . . . 0.0 110.052 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.77 ' HA ' HG22 ' A' ' 20' ' ' THR . 6.1 t-20 -72.55 135.86 45.7 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.512 -0.742 . . . . 0.0 109.582 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.687 ' CD1' HD22 ' A' ' 47' ' ' LEU . 4.3 m-85 -142.22 166.81 23.67 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.603 -0.839 . . . . 0.0 111.355 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.504 ' O ' HD23 ' A' ' 47' ' ' LEU . 10.8 m -136.62 131.77 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.808 -0.557 . . . . 0.0 111.143 -178.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.717 HD13 ' OE1' ' A' ' 15' ' ' GLU . 0.4 OUTLIER -159.07 161.97 36.53 Favored 'General case' 0 N--CA 1.512 2.641 0 O-C-N 120.922 -1.111 . . . . 0.0 111.877 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.466 ' N ' ' O ' ' A' ' 15' ' ' GLU . 10.7 tpt180 -148.81 112.51 5.08 Favored 'General case' 0 N--CA 1.512 2.647 0 O-C-N 121.012 -1.055 . . . . 0.0 112.832 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.929 ' HB3' ' CD2' ' A' ' 16' ' ' HIS . 5.8 t0 -98.61 -144.09 0.32 Allowed 'General case' 0 N--CA 1.508 2.428 0 O-C-N 121.273 -0.892 . . . . 0.0 109.405 177.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.755 ' HA ' ' HB3' ' A' ' 41' ' ' ASN . 2.4 mt-10 72.63 57.54 0.13 Allowed 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 102.576 -3.12 . . . . 0.0 102.576 -174.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.654 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 69.8 m-20 74.14 -5.15 2.12 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 112.272 -2.24 . . . . 0.0 111.844 -177.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.07 -83.53 1.42 Allowed Glycine 0 N--CA 1.482 1.764 0 C-N-CA 118.25 -1.928 . . . . 0.0 109.729 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.731 ' HB3' ' CD1' ' A' ' 45' ' ' ILE . 0.7 OUTLIER -129.19 -74.49 0.56 Allowed 'General case' 0 N--CA 1.51 2.529 0 O-C-N 121.634 -0.921 . . . . 0.0 112.744 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.773 ' CA ' ' HB2' ' A' ' 10' ' ' ASP . 35.2 tt0 -164.89 127.89 2.3 Favored 'General case' 0 N--CA 1.522 3.136 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.929 ' CD2' ' HB3' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -99.37 124.4 44.45 Favored 'General case' 0 N--CA 1.512 2.671 0 C-N-CA 116.208 -2.197 . . . . 0.0 115.415 -176.377 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.484 ' CA ' ' CE1' ' A' ' 19' ' ' PHE . . . -178.09 134.62 2.45 Favored Glycine 0 N--CA 1.48 1.586 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.212 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.423 ' C ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -132.88 91.07 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 120.87 -1.37 . . . . 0.0 108.112 177.254 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.671 ' N ' ' CD1' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -174.81 -170.65 0.49 Allowed 'General case' 0 N--CA 1.504 2.251 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.727 -178.667 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.77 HG22 ' HA ' ' A' ' 5' ' ' ASN . 18.1 p -106.09 151.46 24.66 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.033 -1.042 . . . . 0.0 111.24 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -129.62 142.07 13.25 Favored Glycine 0 N--CA 1.504 3.195 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -71.49 -61.8 1.64 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.158 -1.201 . . . . 0.0 108.564 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.691 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -99.96 115.37 65.6 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.102 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.473 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 36.9 Cg_endo -61.65 -32.63 87.14 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.318 1.167 . . . . 0.0 111.1 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.499 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 43.1 mtt180 -83.25 -64.7 1.12 Allowed 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.384 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.639 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -57.43 -39.49 76.35 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.967 -1.083 . . . . 0.0 111.528 -179.661 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' A' ' 23' ' ' GLN . . . -74.57 -16.38 60.81 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 120.396 -1.44 . . . . 0.0 109.669 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 25' ' ' ARG . . . -57.21 -60.05 4.19 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.442 -0.786 . . . . 0.0 110.301 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.712 HD22 ' HG2' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -62.04 -46.08 90.75 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 118.512 -1.275 . . . . 0.0 108.145 179.199 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.626 ' N ' ' HG ' ' A' ' 29' ' ' LEU . 2.8 mmpt? -49.51 -48.07 48.34 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.224 -0.922 . . . . 0.0 110.741 179.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.522 ' C ' ' HB2' ' A' ' 36' ' ' SER . . . -62.13 -49.58 75.31 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.308 -0.87 . . . . 0.0 110.856 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.982 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -59.17 -35.32 73.34 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.306 -0.871 . . . . 0.0 109.807 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.433 ' CA ' ' HG3' ' A' ' 82' ' ' PRO . 0.1 OUTLIER -38.89 -48.43 1.56 Allowed 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.6 mmt180 -92.47 -75.16 0.49 Allowed 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 118.593 -1.243 . . . . 0.0 112.235 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.582 ' O ' ' CG ' ' A' ' 16' ' ' HIS . . . -117.11 -3.03 18.01 Favored Glycine 0 N--CA 1.5 2.946 0 CA-C-O 118.078 -1.401 . . . . 0.0 116.527 -176.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.661 ' HB2' ' CA ' ' A' ' 32' ' ' ALA . 0.4 OUTLIER -82.32 -4.14 56.67 Favored 'General case' 0 N--CA 1.508 2.428 0 CA-C-N 122.358 3.079 . . . . 0.0 111.154 -176.684 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 60' ' ' ALA . . . -145.99 109.53 0.5 Allowed Glycine 0 C--N 1.287 -2.145 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.42 ' O ' ' N ' ' A' ' 40' ' ' ALA . 0.3 OUTLIER -76.56 -23.17 53.55 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 117.965 -1.494 . . . . 0.0 109.828 -179.745 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.692 ' HG3' ' HB2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER 67.67 -55.87 0.47 Allowed 'General case' 0 N--CA 1.51 2.564 0 CA-C-O 121.53 0.681 . . . . 0.0 109.188 -179.566 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 38' ' ' THR . . . -65.65 -29.09 69.61 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 104.49 -2.411 . . . . 0.0 104.49 174.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.755 ' HB3' ' HA ' ' A' ' 11' ' ' GLU 0.282 0.4 OUTLIER -140.59 71.94 30.75 Favored Pre-proline 0 N--CA 1.485 1.288 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 176.986 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.995 ' HB2' ' CD1' ' A' ' 61' ' ' TRP . 93.8 Cg_endo -110.71 167.5 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 121.166 1.244 . . . . 0.0 111.779 -177.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -164.96 -170.63 2.0 Favored 'General case' 0 N--CA 1.511 2.59 0 C-N-CA 118.021 -1.472 . . . . 0.0 112.707 177.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.731 HG22 ' HD3' ' A' ' 59' ' ' LYS . 0.2 OUTLIER -93.99 134.42 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.731 ' CD1' ' HB3' ' A' ' 14' ' ' ASN . 2.2 tp -120.06 129.96 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.673 -1.267 . . . . 0.0 113.749 -177.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.1 mtm180 -92.3 84.27 5.16 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 104.023 -2.584 . . . . 0.0 104.023 173.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.687 HD22 ' CD1' ' A' ' 6' ' ' PHE . 0.1 OUTLIER -76.03 94.38 3.42 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -177.871 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -139.81 177.0 8.27 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.178 -1.009 . . . . 0.0 111.929 -178.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.443 ' HB2' ' HB3' ' A' ' 54' ' ' LYS . 0.3 OUTLIER -147.82 -176.14 5.15 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 177.914 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.22 179.57 4.65 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 117.92 -1.512 . . . . 0.0 110.584 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.01 -71.93 0.72 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.562 ' HB ' HD22 ' A' ' 92' ' ' LEU . 35.3 p -82.21 169.44 16.58 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.728 -0.866 . . . . 0.0 109.569 178.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.581 ' O ' ' N ' ' A' ' 92' ' ' LEU . 11.6 mttt -83.15 89.6 6.97 Favored 'General case' 0 C--O 1.204 -1.34 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.443 ' HB3' ' HB2' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -127.89 100.72 6.03 Favored 'General case' 0 C--N 1.282 -2.334 0 O-C-N 120.85 -1.156 . . . . 0.0 109.702 -178.74 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 52.8 t -151.07 129.04 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-O 121.832 0.825 . . . . 0.0 110.797 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.779 ' CE1' ' HB2' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -146.24 110.64 5.09 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 179.334 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.661 ' CG1' ' HB3' ' A' ' 87' ' ' GLU . 21.9 t -105.82 99.95 9.59 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.305 0 C-N-CA 117.497 -1.681 . . . . 0.0 107.735 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 1.016 ' CD1' HG22 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -135.03 179.54 6.26 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 179.563 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.809 ' HB3' ' CZ2' ' A' ' 61' ' ' TRP . 39.7 mttt -133.06 135.07 45.13 Favored 'General case' 0 C--N 1.275 -2.658 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 177.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.982 ' HB1' ' HB2' ' A' ' 32' ' ' ALA . . . -122.85 111.29 16.48 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-N 120.8 1.636 . . . . 0.0 112.911 -175.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.995 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 2.7 m0 -128.11 -165.07 1.44 Allowed 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.739 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 7.3 mmtp -122.25 92.2 3.67 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 120.669 -1.27 . . . . 0.0 111.083 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.952 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 4.5 tp10 -173.51 169.74 4.28 Favored 'General case' 0 N--CA 1.502 2.175 0 CA-C-O 121.469 0.652 . . . . 0.0 110.955 178.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.687 ' CG1' ' HA ' ' A' ' 80' ' ' SER . 2.1 mt -71.71 102.14 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.533 3.679 0 O-C-N 119.421 -2.049 . . . . 0.0 116.305 -175.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 1.061 HG13 ' CD1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -102.0 -167.94 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 120.449 -1.407 . . . . 0.0 110.858 177.09 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.705 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 11.6 t70 -116.1 134.58 54.79 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.509 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.819 ' HA ' ' HB2' ' A' ' 77' ' ' GLU 0.28 . . -72.46 97.57 0.15 Allowed Pre-proline 0 N--CA 1.511 2.595 0 CA-C-O 117.466 -1.254 . . . . 0.0 112.761 -178.242 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.705 ' HD3' ' O ' ' A' ' 66' ' ' ASP . 53.6 Cg_endo -73.35 123.81 8.98 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 O-C-N 123.273 1.144 . . . . 0.0 111.315 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER 53.25 37.9 26.34 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.313 -0.867 . . . . 0.0 109.044 -179.307 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.606 ' HB3' ' HD3' ' A' ' 72' ' ' PRO . 6.6 m-80 2.07 -75.57 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.75 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 11.8 ptm180 34.63 44.22 0.29 Allowed Pre-proline 0 N--CA 1.513 2.707 0 CA-C-N 118.121 0.419 . . . . 0.0 110.355 -177.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.75 ' HD3' ' N ' ' A' ' 71' ' ' ARG . 54.5 Cg_endo -105.85 114.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.324 -0.737 0 C-N-CA 121.922 1.748 . . . . 0.0 112.85 -176.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.85 -39.46 15.82 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.196 -1.002 . . . . 0.0 108.956 177.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.509 ' CD1' ' N ' ' A' ' 74' ' ' TRP . 6.4 m95 -89.7 -38.19 14.04 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.331 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.444 ' HB2' ' O ' ' A' ' 74' ' ' TRP . 7.1 ttm -179.58 146.02 0.44 Allowed Pre-proline 0 N--CA 1.51 2.549 0 O-C-N 121.746 -0.596 . . . . 0.0 111.485 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.598 ' HB3' ' HG3' ' A' ' 72' ' ' PRO . 48.3 Cg_endo -94.54 174.7 1.29 Allowed 'Trans proline' 0 N--CA 1.486 1.087 0 C-N-CA 122.113 1.875 . . . . 0.0 111.041 178.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.819 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 3.8 mt-10 -95.26 16.02 17.75 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 117.892 -1.523 . . . . 0.0 110.812 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.697 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 0.3 OUTLIER -98.28 80.83 2.69 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.22 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.647 ' CG1' ' HD2' ' A' ' 81' ' ' LYS . 0.6 OUTLIER 178.59 170.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 C-N-CA 118.128 -1.429 . . . . 0.0 112.122 -177.706 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.687 ' HA ' ' CG1' ' A' ' 64' ' ' ILE . 1.4 m -70.77 109.77 5.16 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 175.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.83 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -169.09 -156.88 0.0 OUTLIER Pre-proline 0 C--O 1.192 -1.973 0 C-N-CA 118.882 -1.127 . . . . 0.0 108.651 -174.916 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.83 ' HD2' ' HB3' ' A' ' 81' ' ' LYS . 43.7 Cg_endo -74.7 127.22 10.72 Favored 'Trans proline' 0 C--N 1.299 -2.052 0 N-CA-C 108.905 -1.229 . . . . 0.0 108.905 178.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 1.061 ' CD1' HG13 ' A' ' 65' ' ' VAL . 0.8 OUTLIER -58.9 151.64 21.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.506 -1.371 . . . . 0.0 108.087 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 1.016 HG22 ' CD1' ' A' ' 58' ' ' PHE . 9.8 p -149.64 95.49 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.508 0 CA-C-O 122.015 0.912 . . . . 0.0 109.764 -178.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.748 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -78.53 119.0 21.19 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 179.611 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.638 ' HB3' ' CZ ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -85.71 94.37 9.08 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 122.716 1.246 . . . . 0.0 113.845 -176.157 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.661 ' HB3' ' CG1' ' A' ' 57' ' ' VAL . 0.0 OUTLIER -99.47 176.96 5.32 Favored 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 114.584 -1.189 . . . . 0.0 108.733 175.985 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.508 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -44.04 133.39 5.13 Favored 'General case' 0 N--CA 1.514 2.769 0 O-C-N 120.613 -1.304 . . . . 0.0 113.627 -175.81 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.81 HD11 ' CD2' ' A' ' 58' ' ' PHE . 40.8 mt -139.22 119.03 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.995 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -135.71 108.74 7.66 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.605 -0.684 . . . . 0.0 109.442 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -114.44 150.44 34.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.179 -0.951 . . . . 0.0 110.355 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.581 ' N ' ' O ' ' A' ' 53' ' ' LYS . 1.2 pp -65.46 178.51 0.94 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.117 0.96 . . . . 0.0 111.405 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.481 ' HA ' ' NH1' ' A' ' 4' ' ' ARG . 3.5 tp10 . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.844 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 41.0 t . . . . . 0 N--CA 1.494 1.763 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -145.95 106.36 4.06 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.537 -0.727 . . . . 0.0 110.096 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.47 ' HB ' ' CB ' ' A' ' 20' ' ' THR . 0.8 OUTLIER -86.3 110.71 19.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.34 -0.85 . . . . 0.0 109.569 179.729 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.526 ' O ' ' HA ' ' A' ' 20' ' ' THR . 0.1 OUTLIER -78.43 122.01 25.27 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.367 -0.833 . . . . 0.0 109.578 -179.789 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.778 ' CA ' HG22 ' A' ' 20' ' ' THR . 51.0 t30 -77.17 143.19 39.25 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.606 -0.684 . . . . 0.0 110.581 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.402 ' HE2' ' HB2' ' A' ' 4' ' ' ARG . 45.9 m-85 -138.98 148.72 43.84 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.119 0.485 . . . . 0.0 109.737 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.868 HG22 ' O ' ' A' ' 48' ' ' ARG . 29.9 m -125.97 140.04 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 O-C-N 121.331 -0.855 . . . . 0.0 112.504 -177.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.829 HD22 ' HG ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -161.91 167.36 24.77 Favored 'General case' 0 N--CA 1.511 2.621 0 O-C-N 121.408 -0.807 . . . . 0.0 111.836 179.485 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.549 ' O ' ' N ' ' A' ' 14' ' ' ASN . 3.4 ttm-85 -134.82 107.95 7.68 Favored 'General case' 0 N--CA 1.526 3.328 0 O-C-N 121.15 -0.969 . . . . 0.0 112.856 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.858 ' HB2' ' CB ' ' A' ' 16' ' ' HIS . 0.7 OUTLIER -74.55 -158.18 0.07 Allowed 'General case' 0 N--CA 1.513 2.688 0 O-C-N 120.998 -1.064 . . . . 0.0 111.878 -179.611 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.593 ' HA ' ' HB3' ' A' ' 41' ' ' ASN . 0.2 OUTLIER 70.9 48.94 0.38 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 -177.366 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.623 ' HA ' ' O ' ' A' ' 42' ' ' PRO . 97.8 m-20 58.63 8.37 0.89 Allowed 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 112.498 -2.137 . . . . 0.0 113.216 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.16 -75.89 1.27 Allowed Glycine 0 N--CA 1.49 2.299 0 C-N-CA 117.88 -2.105 . . . . 0.0 108.368 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.949 ' HB3' HD13 ' A' ' 45' ' ' ILE . 0.8 OUTLIER -119.25 -78.72 0.59 Allowed 'General case' 0 C--N 1.293 -1.862 0 CA-C-O 122.261 1.029 . . . . 0.0 108.316 177.388 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.7 ' CB ' HG21 ' A' ' 45' ' ' ILE . 1.7 tp10 -177.01 140.55 0.31 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 178.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.858 ' CB ' ' HB2' ' A' ' 10' ' ' ASP . 0.1 OUTLIER -87.29 122.67 31.37 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 116.286 -2.166 . . . . 0.0 112.324 -179.608 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.557 ' HA2' ' CZ ' ' A' ' 19' ' ' PHE . . . -177.25 120.13 0.72 Allowed Glycine 0 C--N 1.28 -2.542 0 CA-C-N 113.496 -1.684 . . . . 0.0 110.019 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.9 82.69 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.61 ' N ' ' CD1' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -174.23 -173.43 0.79 Allowed 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.226 -179.165 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.778 HG22 ' CA ' ' A' ' 5' ' ' ASN . 39.0 p -102.12 150.62 23.08 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.421 -0.8 . . . . 0.0 112.441 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -130.25 121.29 3.3 Favored Glycine 0 N--CA 1.499 2.846 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 178.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.67 -45.01 70.13 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.49 -1.006 . . . . 0.0 109.823 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.689 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -118.02 135.4 23.42 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.034 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -69.29 -45.23 1.93 Allowed 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.384 1.202 . . . . 0.0 110.74 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.576 ' O ' HD22 ' A' ' 29' ' ' LEU . 40.3 mtt180 -82.3 -64.93 1.08 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.652 -0.655 . . . . 0.0 111.208 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.625 ' HG3' ' HA ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -47.0 -45.09 20.82 Favored 'General case' 0 N--CA 1.51 2.569 0 O-C-N 121.187 -0.946 . . . . 0.0 111.861 -179.374 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.689 ' HB3' ' O ' ' A' ' 23' ' ' GLN . . . -73.41 -17.79 61.22 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.181 -1.007 . . . . 0.0 110.642 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.93 -52.51 16.86 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.847 -1.158 . . . . 0.0 111.759 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.995 HD12 HG21 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -52.64 -57.24 10.67 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.849 0.833 . . . . 0.0 109.66 -179.073 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.409 ' NZ ' ' OE1' ' A' ' 26' ' ' GLN . 30.7 mtmt -69.68 -34.4 73.91 Favored 'General case' 0 N--CA 1.511 2.592 0 O-C-N 121.284 -0.885 . . . . 0.0 113.151 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.675 ' C ' ' HB2' ' A' ' 36' ' ' SER . . . -59.29 -43.58 92.58 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.757 -1.214 . . . . 0.0 112.129 -178.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.891 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -65.49 -32.75 74.53 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 118.621 -1.232 . . . . 0.0 110.062 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.497 ' HB2' ' HG3' ' A' ' 82' ' ' PRO . 46.8 t30 -40.04 -50.01 2.56 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.0 mtm105 -94.65 -74.76 0.53 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.196 -1.002 . . . . 0.0 113.097 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.425 ' O ' ' CE1' ' A' ' 16' ' ' HIS . . . -113.53 -0.06 24.8 Favored Glycine 0 N--CA 1.504 3.2 0 N-CA-C 116.758 1.463 . . . . 0.0 116.758 -175.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.675 ' HB2' ' C ' ' A' ' 31' ' ' ALA . 0.3 OUTLIER -87.64 4.05 45.39 Favored 'General case' 0 N--CA 1.506 2.34 0 CA-C-N 122.248 3.024 . . . . 0.0 110.843 -177.272 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.468 ' C ' ' HE1' ' A' ' 16' ' ' HIS . . . -166.58 117.68 0.75 Allowed Glycine 0 N--CA 1.482 1.739 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.506 ' O ' ' HB3' ' A' ' 39' ' ' LYS . 28.2 m -78.29 -17.28 56.82 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 120.525 2.163 . . . . 0.0 109.691 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.829 ' CA ' ' HG3' ' A' ' 42' ' ' PRO . 4.6 tttm 73.27 -56.8 0.65 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -178.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.9 -19.36 65.71 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 175.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.593 ' HB3' ' HA ' ' A' ' 11' ' ' GLU 0.278 0.2 OUTLIER -160.23 68.08 2.78 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.845 -0.535 . . . . 0.0 111.332 179.108 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.829 ' HG3' ' CA ' ' A' ' 39' ' ' LYS . 76.8 Cg_endo -116.95 -175.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.411 2.074 . . . . 0.0 109.369 178.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.452 ' HB3' ' O ' ' A' ' 14' ' ' ASN . 1.7 t70 -168.54 -173.98 2.07 Favored 'General case' 0 N--CA 1.514 2.775 0 C-N-CA 116.988 -1.885 . . . . 0.0 113.431 176.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.873 HG22 ' HD3' ' A' ' 59' ' ' LYS . 1.6 pp -81.52 136.28 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.949 HD13 ' HB3' ' A' ' 14' ' ' ASN . 3.1 tp -147.94 139.53 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 117.634 -1.626 . . . . 0.0 114.184 -177.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.505 ' H ' HD12 ' A' ' 45' ' ' ILE . 49.4 mtt-85 -88.75 95.28 10.21 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 173.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.829 ' HG ' HD22 ' A' ' 8' ' ' LEU . 0.3 OUTLIER -66.52 93.16 0.23 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -178.357 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.868 ' O ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -117.29 -169.01 1.58 Allowed 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.214 -176.954 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -160.23 118.92 2.68 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -73.37 152.3 40.9 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 118.437 -1.305 . . . . 0.0 111.244 -177.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.4 -43.24 1.72 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 107.521 -2.231 . . . . 0.0 107.521 -178.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 68.2 p -125.52 140.5 52.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.836 -0.802 . . . . 0.0 109.033 178.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.62 ' HA ' ' CA ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -64.58 90.92 0.08 Allowed 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 122.484 1.135 . . . . 0.0 110.207 -179.29 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 48' ' ' ARG . 9.2 mttp -136.98 123.87 21.36 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.675 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.466 HG21 ' CD1' ' A' ' 92' ' ' LEU . 71.7 t -153.82 96.35 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.613 -0.679 . . . . 0.0 111.028 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.796 ' CE1' ' HB2' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -88.44 137.15 32.58 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 177.237 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.529 ' HB ' ' CB ' ' A' ' 87' ' ' GLU . 2.2 t -116.79 116.12 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 O-C-N 119.755 -1.841 . . . . 0.0 110.381 -178.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.796 ' HB2' ' CE1' ' A' ' 56' ' ' HIS . 0.5 OUTLIER -157.51 174.95 14.6 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.289 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.873 ' HD3' HG22 ' A' ' 44' ' ' ILE . 16.8 mttm -132.04 127.33 35.93 Favored 'General case' 0 N--CA 1.505 2.296 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 177.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.891 ' HB1' ' HB2' ' A' ' 32' ' ' ALA . . . -115.67 110.29 18.94 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 120.747 -1.221 . . . . 0.0 113.198 -175.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.762 ' O ' ' HA ' ' A' ' 82' ' ' PRO . 14.1 m0 -126.49 -167.21 1.69 Allowed 'General case' 0 N--CA 1.512 2.675 0 O-C-N 121.943 -0.473 . . . . 0.0 110.307 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.718 ' HB2' ' HB2' ' A' ' 39' ' ' LYS . 0.7 OUTLIER -123.45 88.13 2.86 Favored 'General case' 0 N--CA 1.507 2.382 0 CA-C-N 120.158 1.345 . . . . 0.0 112.569 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.879 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 3.6 mt-10 -165.97 172.34 11.6 Favored 'General case' 0 N--CA 1.51 2.573 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.283 176.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.668 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 9.2 tt -73.61 101.42 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.523 3.186 0 N-CA-C 116.824 2.157 . . . . 0.0 116.824 -174.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.902 HG13 ' CD1' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -88.29 -166.57 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.406 -1.434 . . . . 0.0 109.883 176.63 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.643 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 9.2 t0 -124.43 129.08 50.01 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.843 ' HA ' ' CB ' ' A' ' 77' ' ' GLU . . . -64.3 99.3 0.18 Allowed Pre-proline 0 N--CA 1.507 2.396 0 CA-C-O 117.79 -1.1 . . . . 0.0 111.784 -178.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.694 ' HD3' ' HB3' ' A' ' 77' ' ' GLU . 52.1 Cg_endo -88.9 -160.33 0.1 OUTLIER 'Trans proline' 0 C--N 1.316 -1.141 0 O-C-N 124.105 1.581 . . . . 0.0 110.528 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.3 mttt -70.11 64.57 0.24 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.292 -0.88 . . . . 0.0 109.092 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.762 ' ND2' HD11 ' A' ' 29' ' ' LEU . 5.4 m-20 -102.37 -12.4 17.93 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.473 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.743 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER 59.8 44.69 0.98 Allowed Pre-proline 0 N--CA 1.506 2.358 0 C-N-CA 122.796 0.439 . . . . 0.0 111.209 -177.528 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.743 ' HD3' ' N ' ' A' ' 71' ' ' ARG . 48.9 Cg_endo -92.89 99.89 0.16 Allowed 'Trans proline' 0 C--N 1.323 -0.797 0 C-N-CA 121.152 1.234 . . . . 0.0 110.495 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.19 -34.07 24.05 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.365 -0.834 . . . . 0.0 112.065 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.465 ' CD1' ' N ' ' A' ' 74' ' ' TRP . 32.2 m95 -81.55 -31.46 32.68 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.444 -0.785 . . . . 0.0 110.514 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.456 ' O ' ' HB2' ' A' ' 72' ' ' PRO . 12.5 tpt -164.75 110.38 0.85 Allowed Pre-proline 0 N--CA 1.496 1.861 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.703 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 48.2 Cg_endo -79.28 -178.91 4.96 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.898 1.473 . . . . 0.0 112.693 -178.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.843 ' CB ' ' HA ' ' A' ' 67' ' ' ALA . 3.1 tt0 -90.21 6.61 42.03 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 118.429 -1.308 . . . . 0.0 110.09 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.736 ' O ' HG22 ' A' ' 79' ' ' ILE . 1.5 tppm? -92.28 77.05 5.22 Favored 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.778 HD11 ' CB ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -168.08 158.63 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 C-N-CA 118.272 -1.371 . . . . 0.0 112.146 -177.711 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.578 ' HA ' ' HB ' ' A' ' 64' ' ' ILE . 1.7 m -77.09 103.35 6.97 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 175.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.875 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -173.17 -152.18 0.0 OUTLIER Pre-proline 0 C--O 1.196 -1.711 0 O-C-N 121.302 -0.874 . . . . 0.0 108.759 -175.757 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.875 ' HD2' ' HB3' ' A' ' 81' ' ' LYS . 43.4 Cg_endo -68.34 123.7 10.84 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 117.808 -0.995 . . . . 0.0 111.639 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.902 ' CD1' HG13 ' A' ' 65' ' ' VAL . 0.7 OUTLIER -63.43 159.4 18.44 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.184 -0.947 . . . . 0.0 109.382 178.83 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.995 HG21 HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -153.16 93.94 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 C-N-CA 120.034 -0.666 . . . . 0.0 109.62 178.376 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.734 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 3.1 tptt -73.5 125.59 28.29 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 177.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.586 ' HB3' ' CZ ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -94.05 90.64 6.5 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 122.337 1.065 . . . . 0.0 113.783 -175.257 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.529 ' CB ' ' HB ' ' A' ' 57' ' ' VAL . 4.2 mt-10 -86.35 150.63 24.2 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 115.293 -0.867 . . . . 0.0 108.755 176.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -56.89 122.14 11.54 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.363 -0.836 . . . . 0.0 111.911 -177.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.664 HG23 ' HA ' ' A' ' 56' ' ' HIS . 88.1 mt -73.79 125.13 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -106.06 -179.52 3.96 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.47 0.652 . . . . 0.0 109.637 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.613 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -133.86 95.99 3.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.894 -1.129 . . . . 0.0 109.889 179.723 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.741 HD12 ' HB2' ' A' ' 93' ' ' GLU . 2.7 pp -177.31 -175.78 0.58 Allowed 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.633 -0.667 . . . . 0.0 111.181 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.741 ' HB2' HD12 ' A' ' 92' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.497 1.883 0 CA-C-O 118.584 -0.722 . . . . 0.0 111.733 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.497 1.889 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -160.17 137.01 9.14 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.417 -0.802 . . . . 0.0 110.779 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.0 p -79.22 151.97 30.9 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.529 -0.732 . . . . 0.0 109.919 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.543 ' HB3' ' HD2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -84.44 127.17 33.86 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.126 -0.984 . . . . 0.0 110.104 179.705 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.831 ' CA ' HG22 ' A' ' 20' ' ' THR . 43.9 t30 -74.35 137.49 42.83 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.496 -0.752 . . . . 0.0 110.58 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.437 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 25.7 m-85 -145.01 151.1 38.04 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.347 0.594 . . . . 0.0 111.057 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.708 HG22 ' O ' ' A' ' 48' ' ' ARG . 11.7 m -111.21 146.55 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.665 -0.647 . . . . 0.0 111.173 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.1 HD21 HD21 ' A' ' 47' ' ' LEU . 4.6 mp -152.33 145.08 24.3 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.422 -0.799 . . . . 0.0 111.862 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -134.11 91.56 2.83 Favored 'General case' 0 N--CA 1.514 2.756 0 O-C-N 121.073 -1.017 . . . . 0.0 111.243 176.647 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.762 ' HB2' ' N ' ' A' ' 16' ' ' HIS . 1.7 t70 -69.63 -159.4 0.03 OUTLIER 'General case' 0 N--CA 1.51 2.565 0 C-N-CA 123.932 0.893 . . . . 0.0 112.007 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.578 ' HA ' ' HB3' ' A' ' 41' ' ' ASN . 0.1 OUTLIER 72.23 52.56 0.19 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 -176.957 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.599 ' HA ' ' O ' ' A' ' 42' ' ' PRO . 92.4 m-20 61.28 6.91 1.49 Allowed 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 112.539 -2.118 . . . . 0.0 112.783 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.421 ' O ' ' HB3' ' A' ' 43' ' ' ASP . . . -90.17 -75.43 1.3 Allowed Glycine 0 N--CA 1.485 1.95 0 C-N-CA 117.98 -2.057 . . . . 0.0 108.82 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.872 ' CG ' HD13 ' A' ' 45' ' ' ILE . 8.2 m120 -125.22 -76.77 0.59 Allowed 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.596 0.713 . . . . 0.0 111.337 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.733 ' HB2' HG21 ' A' ' 45' ' ' ILE . 8.1 mt-10 -169.31 151.42 4.57 Favored 'General case' 0 N--CA 1.511 2.582 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.762 ' N ' ' HB2' ' A' ' 10' ' ' ASP . 2.6 p-80 -99.1 118.68 36.39 Favored 'General case' 0 N--CA 1.507 2.388 0 C-N-CA 115.021 -2.672 . . . . 0.0 113.125 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.57 ' HA2' ' CZ ' ' A' ' 19' ' ' PHE . . . 175.21 132.07 1.53 Allowed Glycine 0 C--N 1.285 -2.292 0 C-N-CA 119.493 -1.336 . . . . 0.0 112.251 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.6 86.78 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 175.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.623 ' N ' ' CD1' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -172.54 -172.26 0.89 Allowed 'General case' 0 N--CA 1.5 2.073 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.733 -178.132 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.831 HG22 ' CA ' ' A' ' 5' ' ' ASN . 57.2 p -107.62 158.46 17.23 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.493 -0.755 . . . . 0.0 111.703 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -130.69 130.97 6.31 Favored Glycine 0 N--CA 1.501 3.02 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.4 ttpt -60.84 -47.82 84.64 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.309 -1.113 . . . . 0.0 108.765 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.665 ' HB3' ' HB3' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -115.7 114.13 42.22 Favored Pre-proline 0 N--CA 1.486 1.362 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.403 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.94 -35.86 41.66 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.65 1.342 . . . . 0.0 110.823 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.593 ' HB3' ' HA ' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -83.08 -62.92 1.47 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.209 -0.932 . . . . 0.0 109.862 179.419 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.665 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 1.0 OUTLIER -53.44 -41.97 66.65 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.129 -0.982 . . . . 0.0 111.886 -179.683 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' A' ' 23' ' ' GLN . . . -74.57 -15.69 60.84 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 120.593 -1.317 . . . . 0.0 110.42 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.61 -51.89 63.29 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.79 -1.194 . . . . 0.0 110.642 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.064 HD12 HG21 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -61.9 -50.46 72.1 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 121.558 0.694 . . . . 0.0 109.559 -179.555 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -69.41 -37.87 77.65 Favored 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -178.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.43 ' C ' ' HB2' ' A' ' 36' ' ' SER . . . -60.5 -43.73 96.75 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 120.719 -1.238 . . . . 0.0 112.461 -177.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.724 ' CB ' ' HB1' ' A' ' 60' ' ' ALA . . . -64.51 -33.34 75.67 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 118.77 -1.172 . . . . 0.0 110.15 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.545 ' N ' ' HG3' ' A' ' 82' ' ' PRO . 0.2 OUTLIER -42.74 -46.34 5.1 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.802 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.5 mtp85 -95.51 -72.83 0.61 Allowed 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.269 -0.972 . . . . 0.0 112.254 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.443 ' O ' ' CG ' ' A' ' 16' ' ' HIS . . . -115.72 -0.72 21.47 Favored Glycine 0 N--CA 1.499 2.877 0 N-CA-C 117.48 1.752 . . . . 0.0 117.48 -175.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.693 ' CB ' ' HA ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -82.03 -2.29 51.21 Favored 'General case' 0 N--CA 1.514 2.73 0 CA-C-N 123.615 3.708 . . . . 0.0 110.94 -176.744 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.414 ' C ' ' HE1' ' A' ' 16' ' ' HIS . . . -163.49 120.84 0.97 Allowed Glycine 0 C--N 1.297 -1.637 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -178.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.532 ' O ' ' HB3' ' A' ' 39' ' ' LYS . 23.5 m -77.73 -15.61 59.01 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 119.825 1.813 . . . . 0.0 109.494 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.84 ' CA ' ' HG3' ' A' ' 42' ' ' PRO . 7.6 tttm 75.21 -56.27 0.62 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -178.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.43 -18.89 65.62 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 175.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.578 ' HB3' ' HA ' ' A' ' 11' ' ' GLU 0.27 0.4 OUTLIER -160.44 67.31 2.62 Favored Pre-proline 0 C--O 1.202 -1.446 0 O-C-N 121.661 -0.649 . . . . 0.0 111.147 179.097 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.84 ' HG3' ' CA ' ' A' ' 39' ' ' LYS . 82.9 Cg_endo -118.0 -176.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.3 -2.012 0 C-N-CA 122.019 1.813 . . . . 0.0 109.615 178.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.459 ' HB2' ' C ' ' A' ' 12' ' ' ASP . 0.7 OUTLIER -168.04 -169.49 1.14 Allowed 'General case' 0 N--CA 1.512 2.643 0 O-C-N 119.826 -1.796 . . . . 0.0 113.902 177.036 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.868 HG22 ' HD3' ' A' ' 59' ' ' LYS . 1.6 pp -91.5 142.6 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.872 HD13 ' CG ' ' A' ' 14' ' ' ASN . 1.1 tp -161.59 142.67 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 117.958 -1.497 . . . . 0.0 113.422 -178.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.508 ' HG3' HG13 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -87.03 96.23 10.21 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 174.184 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 1.1 HD21 HD21 ' A' ' 8' ' ' LEU . 9.0 mp -63.21 95.77 0.09 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 -178.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.708 ' O ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -103.2 -172.88 2.19 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.704 -177.603 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -159.45 142.98 14.6 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -97.56 139.63 33.18 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.701 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.71 -56.43 0.53 Allowed Glycine 0 N--CA 1.494 2.563 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.409 ' HB ' HD22 ' A' ' 92' ' ' LEU . 7.1 p -115.27 -175.6 2.73 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.424 -1.045 . . . . 0.0 109.007 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.639 ' O ' ' N ' ' A' ' 92' ' ' LEU . 3.0 mmtt -97.45 99.07 10.49 Favored 'General case' 0 C--O 1.203 -1.365 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.781 ' HG3' HD23 ' A' ' 92' ' ' LEU . 5.3 mtmm -146.4 98.8 3.13 Favored 'General case' 0 C--N 1.281 -2.395 0 O-C-N 120.495 -1.378 . . . . 0.0 109.816 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 6.7 t -137.03 100.2 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 CA-C-O 121.399 0.618 . . . . 0.0 110.338 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.932 ' CE1' ' HB2' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -91.61 138.09 31.85 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.926 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.52 ' HB ' ' CB ' ' A' ' 87' ' ' GLU . 2.5 t -114.59 104.09 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 O-C-N 119.91 -1.744 . . . . 0.0 109.258 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.932 ' HB2' ' CE1' ' A' ' 56' ' ' HIS . 0.6 OUTLIER -146.62 175.58 10.49 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.376 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.868 ' HD3' HG22 ' A' ' 44' ' ' ILE . 24.5 mttm -130.04 128.12 41.3 Favored 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 177.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.724 ' HB1' ' CB ' ' A' ' 32' ' ' ALA . . . -114.18 113.26 24.43 Favored 'General case' 0 N--CA 1.505 2.312 0 C-N-CA 118.199 -1.4 . . . . 0.0 113.605 -176.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.814 ' HB2' ' HB2' ' A' ' 83' ' ' PHE . 13.6 m0 -130.26 -168.42 1.97 Allowed 'General case' 0 N--CA 1.516 2.841 0 O-C-N 121.713 -0.617 . . . . 0.0 110.802 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.668 ' HB2' ' HB2' ' A' ' 39' ' ' LYS . 1.3 tmtm? -120.68 89.02 3.05 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.696 -1.253 . . . . 0.0 111.283 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.84 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 2.1 mt-10 -165.79 168.67 15.81 Favored 'General case' 0 N--CA 1.508 2.456 0 CA-C-O 121.354 0.597 . . . . 0.0 109.994 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.676 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 4.7 tt -72.56 101.15 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.522 3.138 0 O-C-N 119.612 -1.93 . . . . 0.0 115.68 -176.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.985 HG13 ' CD1' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -91.86 -166.58 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.501 -1.375 . . . . 0.0 110.838 177.948 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.681 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 7.5 t70 -120.39 130.19 54.26 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.862 ' HA ' ' CB ' ' A' ' 77' ' ' GLU . . . -65.64 100.47 0.23 Allowed Pre-proline 0 N--CA 1.509 2.505 0 CA-C-O 118.061 -0.971 . . . . 0.0 113.308 -177.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.681 ' HD3' ' O ' ' A' ' 66' ' ' ASP . 55.8 Cg_endo -84.01 -163.48 0.2 Allowed 'Trans proline' 0 N--CA 1.485 1.019 0 O-C-N 123.625 1.329 . . . . 0.0 110.502 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.2 mmpp? -69.83 64.87 0.22 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.158 -0.964 . . . . 0.0 109.841 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.808 ' ND2' HD11 ' A' ' 29' ' ' LEU . 3.8 m-20 -97.94 -12.6 21.84 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.986 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.704 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER 44.87 51.08 8.21 Favored Pre-proline 0 N--CA 1.504 2.271 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.374 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.798 ' HG2' ' HA ' ' A' ' 76' ' ' PRO . 55.1 Cg_endo -99.97 112.0 0.07 OUTLIER 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 121.861 1.707 . . . . 0.0 109.518 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.78 -19.98 47.32 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.766 -1.209 . . . . 0.0 112.106 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.435 ' CD1' ' N ' ' A' ' 74' ' ' TRP . 44.5 m95 -81.96 -37.75 26.22 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.308 -0.87 . . . . 0.0 110.46 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.461 ' O ' ' HB2' ' A' ' 72' ' ' PRO . 20.9 ttm -168.89 130.75 1.12 Allowed Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.673 -0.642 . . . . 0.0 109.665 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.798 ' HA ' ' HG2' ' A' ' 72' ' ' PRO . 47.5 Cg_endo -88.59 179.82 2.47 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.662 1.349 . . . . 0.0 111.803 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.862 ' CB ' ' HA ' ' A' ' 67' ' ' ALA . 3.7 tt0 -88.71 9.23 25.09 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 118.005 -1.478 . . . . 0.0 110.1 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.707 ' H ' ' HB2' ' A' ' 67' ' ' ALA . 40.6 tptt -93.74 82.49 4.32 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.678 HG22 ' C ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -179.82 163.21 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 C-N-CA 118.006 -1.478 . . . . 0.0 112.501 -178.51 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.591 ' HA ' ' HB ' ' A' ' 64' ' ' ILE . 1.1 m -72.01 105.35 3.86 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 175.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.711 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 11.2 pttp -167.81 -154.92 0.0 OUTLIER Pre-proline 0 C--O 1.196 -1.729 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -175.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.743 ' HA ' ' O ' ' A' ' 61' ' ' TRP . 49.7 Cg_endo -75.59 128.99 11.44 Favored 'Trans proline' 0 C--N 1.299 -2.066 0 N-CA-C 109.761 -0.899 . . . . 0.0 109.761 178.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.985 ' CD1' HG13 ' A' ' 65' ' ' VAL . 1.1 m-30 -64.73 157.15 28.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.217 -0.927 . . . . 0.0 109.423 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 1.064 HG21 HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -152.15 95.66 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.153 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.748 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -74.01 130.15 39.28 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 105.917 -1.882 . . . . 0.0 105.917 178.16 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.632 ' HB3' ' CZ ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -99.36 92.24 5.32 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 122.615 1.197 . . . . 0.0 113.908 -175.338 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.52 ' CB ' ' HB ' ' A' ' 57' ' ' VAL . 24.0 mt-10 -88.75 151.94 22.1 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 175.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -55.4 116.69 2.99 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-O 122.316 1.055 . . . . 0.0 112.77 -176.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.846 HG23 ' HA ' ' A' ' 56' ' ' HIS . 23.7 mt -83.84 140.54 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.428 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.24 144.14 48.77 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 177.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.537 ' HG2' ' O ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -159.96 175.57 12.87 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.571 -1.331 . . . . 0.0 112.607 -178.732 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.781 HD23 ' HG3' ' A' ' 54' ' ' LYS . 1.9 pp -74.26 -178.59 3.49 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.529 0.681 . . . . 0.0 110.369 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 . . . . . 0 N--CA 1.493 1.721 0 O-C-N 121.339 -0.851 . . . . 0.0 109.896 179.334 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 120.774 0.321 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -126.37 114.68 18.54 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.296 -0.877 . . . . 0.0 109.947 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.406 ' OG1' ' HB ' ' A' ' 20' ' ' THR . 5.2 t -162.84 173.34 13.86 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.444 -0.785 . . . . 0.0 110.342 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.55 ' O ' ' HA ' ' A' ' 20' ' ' THR . 5.1 mmp_? -121.93 119.58 31.96 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.423 -0.798 . . . . 0.0 110.213 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.698 ' CA ' HG22 ' A' ' 20' ' ' THR . 19.5 t-20 -74.54 140.88 44.78 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.557 -0.714 . . . . 0.0 110.228 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.557 ' HD1' HD22 ' A' ' 47' ' ' LEU . 8.5 m-85 -152.57 168.29 26.07 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.476 -0.765 . . . . 0.0 110.421 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.573 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -150.24 141.52 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 O-C-N 121.444 -0.785 . . . . 0.0 111.591 -178.007 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.967 HD21 ' HG ' ' A' ' 47' ' ' LEU . 1.5 mp -148.12 167.68 24.39 Favored 'General case' 0 N--CA 1.52 3.052 0 O-C-N 121.287 -0.883 . . . . 0.0 112.942 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.539 ' N ' ' O ' ' A' ' 15' ' ' GLU . 9.3 ptt-85 -136.3 95.37 3.17 Favored 'General case' 0 N--CA 1.517 2.908 0 O-C-N 121.488 -0.757 . . . . 0.0 111.28 176.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.82 ' HB2' ' N ' ' A' ' 16' ' ' HIS . 5.1 t0 -82.46 -150.93 0.09 Allowed 'General case' 0 N--CA 1.509 2.508 0 C-N-CA 124.136 0.974 . . . . 0.0 113.081 -178.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.55 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 0.8 OUTLIER 73.56 53.63 0.11 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 104.048 -2.575 . . . . 0.0 104.048 -175.936 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.55 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 1.9 m-20 63.98 3.96 1.85 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 112.683 -2.053 . . . . 0.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -89.52 -76.54 1.31 Allowed Glycine 0 N--CA 1.479 1.55 0 C-N-CA 117.795 -2.145 . . . . 0.0 107.795 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.886 ' CG ' HD13 ' A' ' 45' ' ' ILE . 3.5 m120 -126.74 -77.03 0.58 Allowed 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.452 0.644 . . . . 0.0 111.576 178.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 1.109 ' HB2' HG21 ' A' ' 45' ' ' ILE . 4.6 mt-10 -171.28 154.84 4.08 Favored 'General case' 0 N--CA 1.512 2.626 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.82 ' N ' ' HB2' ' A' ' 10' ' ' ASP . 0.2 OUTLIER -119.62 120.29 36.23 Favored 'General case' 0 N--CA 1.511 2.615 0 C-N-CA 114.848 -2.741 . . . . 0.0 115.047 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.42 ' HA2' ' CZ ' ' A' ' 19' ' ' PHE . . . -176.45 128.35 1.34 Allowed Glycine 0 C--N 1.29 -1.999 0 CA-C-N 113.561 -1.654 . . . . 0.0 110.113 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.418 ' C ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -134.78 92.05 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 177.449 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.671 ' N ' ' CD1' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -175.25 -173.3 0.65 Allowed 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 121.283 0.563 . . . . 0.0 110.281 -178.743 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.698 HG22 ' CA ' ' A' ' 5' ' ' ASN . 22.2 p -106.1 126.56 52.36 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.289 -0.882 . . . . 0.0 110.953 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -97.68 131.15 10.49 Favored Glycine 0 N--CA 1.501 3.001 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.1 mtmp? -59.54 -39.2 83.17 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.55 -0.971 . . . . 0.0 109.57 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.813 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -127.42 125.35 23.89 Favored Pre-proline 0 N--CA 1.489 1.493 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.112 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.856 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 37.0 Cg_endo -63.06 -40.82 31.65 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 O-C-N 123.493 1.26 . . . . 0.0 110.924 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.411 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 2.8 ttt180 -87.47 -61.19 1.78 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.499 -0.751 . . . . 0.0 111.46 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.471 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 14.5 tt0 -55.76 -40.94 73.28 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 120.938 -1.101 . . . . 0.0 111.71 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.813 ' HB3' ' O ' ' A' ' 23' ' ' GLN . . . -79.8 -18.92 49.75 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.828 -1.149 . . . . 0.0 109.446 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.856 ' HB2' ' O ' ' A' ' 24' ' ' PRO . . . -62.74 -57.7 10.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.358 -0.839 . . . . 0.0 110.808 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.492 ' O ' ' HG2' ' A' ' 82' ' ' PRO . 2.4 pp -58.38 -44.37 88.87 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.354 -178.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.476 ' HB2' ' HE3' ' A' ' 30' ' ' LYS . 1.0 OUTLIER -70.46 -35.47 73.35 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 120.793 -1.192 . . . . 0.0 111.689 179.249 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 27' ' ' ALA . . . -56.59 -42.01 77.97 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.187 -0.946 . . . . 0.0 113.079 -177.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.843 ' CB ' ' HB1' ' A' ' 60' ' ' ALA . . . -73.03 -29.92 63.36 Favored 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 118.865 -1.134 . . . . 0.0 110.096 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.577 ' CB ' ' HG3' ' A' ' 82' ' ' PRO . 6.3 t-20 -41.37 -46.89 3.45 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.371 0.605 . . . . 0.0 109.369 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.8 mmm-85 -92.97 -74.57 0.52 Allowed 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 118.884 -1.126 . . . . 0.0 112.938 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.474 ' O ' ' CD2' ' A' ' 16' ' ' HIS . . . -115.93 -3.96 19.34 Favored Glycine 0 N--CA 1.499 2.855 0 N-CA-C 117.065 1.586 . . . . 0.0 117.065 -175.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.757 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 0.6 OUTLIER -79.02 -4.27 49.26 Favored 'General case' 0 N--CA 1.51 2.558 0 CA-C-N 122.633 3.216 . . . . 0.0 110.573 -176.948 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.54 ' O ' ' HG3' ' A' ' 39' ' ' LYS . . . -154.31 117.72 0.81 Allowed Glycine 0 C--N 1.292 -1.873 0 N-CA-C 108.579 -1.809 . . . . 0.0 108.579 -178.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.459 ' HB ' ' C ' ' A' ' 41' ' ' ASN . 90.2 m -68.9 -17.12 63.92 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 119.348 1.574 . . . . 0.0 108.107 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.8 ' CA ' ' HG3' ' A' ' 42' ' ' PRO . 10.0 mtmt 71.36 -59.64 0.54 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.72 -20.02 61.97 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 175.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.505 ' HB3' ' HA ' ' A' ' 11' ' ' GLU 0.279 0.6 OUTLIER -149.66 65.25 7.59 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.722 -0.612 . . . . 0.0 110.638 178.628 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.8 ' HG3' ' CA ' ' A' ' 39' ' ' LYS . 75.1 Cg_endo -117.03 -174.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 121.167 1.245 . . . . 0.0 111.322 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.406 ' N ' ' HE1' ' A' ' 61' ' ' TRP . 1.3 t70 -167.13 -168.23 1.05 Allowed 'General case' 0 N--CA 1.512 2.672 0 C-N-CA 118.07 -1.452 . . . . 0.0 112.887 177.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.876 HG22 ' HD3' ' A' ' 59' ' ' LYS . 1.2 pp -95.85 149.62 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 1.109 HG21 ' HB2' ' A' ' 15' ' ' GLU . 1.8 tp -163.09 144.05 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 C-N-CA 117.773 -1.571 . . . . 0.0 113.883 -178.105 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.565 ' H ' HD12 ' A' ' 45' ' ' ILE . 32.8 mtt180 -85.35 95.63 9.29 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 174.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.967 ' HG ' HD21 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -70.15 94.88 0.93 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.448 -0.782 . . . . 0.0 109.361 -178.063 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -129.18 -177.32 4.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.563 -0.711 . . . . 0.0 110.078 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -150.13 117.72 6.15 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.98 152.28 38.76 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 118.597 -1.241 . . . . 0.0 110.358 -177.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.86 -32.33 7.36 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.5 p -146.4 176.78 9.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.401 -1.058 . . . . 0.0 110.656 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.802 ' HA ' ' CA ' ' A' ' 92' ' ' LEU . 5.1 mttm -75.36 92.57 2.81 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.789 0.804 . . . . 0.0 110.094 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.515 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -141.93 115.21 8.87 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.364 179.482 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 54' ' ' LYS . 2.4 t -155.76 142.84 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 CA-C-O 122.002 0.906 . . . . 0.0 111.216 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.866 ' CE1' ' HB2' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -162.78 129.89 3.61 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 179.598 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.595 HG12 ' HB2' ' A' ' 87' ' ' GLU . 11.5 t -118.31 115.88 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 117.311 -1.756 . . . . 0.0 109.23 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.866 ' HB2' ' CE1' ' A' ' 56' ' ' HIS . 0.8 OUTLIER -153.76 -176.63 5.92 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 -179.817 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.876 ' HD3' HG22 ' A' ' 44' ' ' ILE . 30.2 mttt -137.39 133.97 35.4 Favored 'General case' 0 N--CA 1.51 2.566 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 177.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.843 ' HB1' ' CB ' ' A' ' 32' ' ' ALA . . . -117.04 112.69 21.28 Favored 'General case' 0 N--CA 1.51 2.557 0 CA-C-N 120.662 1.574 . . . . 0.0 113.653 -176.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.779 ' HB2' ' HB2' ' A' ' 83' ' ' PHE . 11.7 m0 -133.59 -165.51 1.64 Allowed 'General case' 0 N--CA 1.514 2.726 0 O-C-N 122.036 -0.415 . . . . 0.0 111.344 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.66 ' HB2' ' HB3' ' A' ' 39' ' ' LYS . 1.6 tptp -123.78 91.4 3.46 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.643 -1.285 . . . . 0.0 111.776 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.899 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 1.1 mt-10 -165.37 -173.0 2.65 Favored 'General case' 0 N--CA 1.51 2.573 0 CA-C-O 121.223 0.535 . . . . 0.0 110.452 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.606 ' C ' ' HE1' ' A' ' 83' ' ' PHE . 12.6 tt -94.86 98.68 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.117 0 O-C-N 118.977 -2.327 . . . . 0.0 116.081 -176.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.998 HG13 ' CD1' ' A' ' 83' ' ' PHE . 0.3 OUTLIER -103.65 -168.54 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 120.137 -1.602 . . . . 0.0 108.706 176.329 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.784 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 5.9 t0 -114.23 145.63 41.47 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.663 -0.648 . . . . 0.0 111.379 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.91 ' HA ' ' HB3' ' A' ' 77' ' ' GLU 0.25 . . -66.25 101.38 0.28 Allowed Pre-proline 0 N--CA 1.511 2.6 0 CA-C-O 118.075 -0.964 . . . . 0.0 113.167 -178.772 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.803 ' HG3' ' HG2' ' A' ' 86' ' ' LYS . 55.0 Cg_endo -70.81 64.53 2.42 Favored 'Trans proline' 0 N--CA 1.5 1.906 0 O-C-N 123.85 1.448 . . . . 0.0 110.961 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 50.2 40.94 23.23 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 120.994 -1.066 . . . . 0.0 108.69 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.694 ' HB3' ' HG3' ' A' ' 72' ' ' PRO . 6.3 m120 -55.37 -18.83 7.36 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.489 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.792 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER 49.99 43.22 1.55 Allowed Pre-proline 0 N--CA 1.495 1.809 0 CA-C-O 120.484 0.183 . . . . 0.0 110.784 -176.642 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.792 ' HD3' ' N ' ' A' ' 71' ' ' ARG . 57.8 Cg_endo -100.05 135.09 0.22 Allowed 'Trans proline' 0 C--O 1.219 -0.446 0 C-N-CA 121.481 1.454 . . . . 0.0 109.435 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.27 -28.55 25.25 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 120.892 -1.13 . . . . 0.0 111.105 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.447 ' CD1' ' N ' ' A' ' 74' ' ' TRP . 41.0 m95 -84.71 -35.94 22.17 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.542 -0.724 . . . . 0.0 111.424 -178.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.522 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 2.4 tpt -175.06 132.11 0.45 Allowed Pre-proline 0 N--CA 1.51 2.55 0 O-C-N 121.23 -0.919 . . . . 0.0 111.689 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.769 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 44.3 Cg_endo -93.55 -178.21 0.71 Allowed 'Trans proline' 0 N--CA 1.489 1.264 0 C-N-CA 122.401 2.067 . . . . 0.0 111.455 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.91 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 7.8 tt0 -86.12 9.24 17.97 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 117.729 -1.588 . . . . 0.0 110.82 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.784 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -88.05 82.2 7.25 Favored 'General case' 0 N--CA 1.507 2.406 0 C-N-CA 118.861 -1.136 . . . . 0.0 108.292 178.786 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.776 HG22 ' C ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER 179.02 165.89 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.382 0 C-N-CA 118.384 -1.326 . . . . 0.0 112.673 -178.105 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.56 ' N ' HG13 ' A' ' 79' ' ' ILE . 13.3 m -77.69 107.13 9.96 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 175.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.938 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -171.54 -152.86 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.331 0 O-C-N 121.107 -0.995 . . . . 0.0 108.644 -176.106 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.938 ' HD2' ' HB2' ' A' ' 81' ' ' LYS . 44.2 Cg_endo -71.86 123.66 9.53 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 117.316 -1.323 . . . . 0.0 110.005 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.998 ' CD1' HG13 ' A' ' 65' ' ' VAL . 0.5 OUTLIER -61.74 161.0 10.75 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.226 -0.921 . . . . 0.0 110.601 -179.665 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.787 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -155.6 95.55 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.083 178.081 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.744 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 0.9 OUTLIER -71.16 133.92 46.55 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 178.131 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.803 ' HG2' ' HG3' ' A' ' 68' ' ' PRO . 0.0 OUTLIER -101.91 92.3 4.75 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -173.795 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.595 ' HB2' HG12 ' A' ' 57' ' ' VAL . 2.6 mp0 -93.47 163.58 13.52 Favored 'General case' 0 C--N 1.28 -2.431 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 174.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.444 ' O ' HG23 ' A' ' 57' ' ' VAL . 1.4 mtt-85 -54.88 146.53 17.24 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 120.959 -1.088 . . . . 0.0 113.448 -176.169 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.658 HD11 ' CE2' ' A' ' 58' ' ' PHE . 97.8 mt -128.76 149.51 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.538 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.508 ' HB3' ' CD2' ' A' ' 92' ' ' LEU . 1.8 tm-20 -163.33 -175.12 4.09 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.402 -0.811 . . . . 0.0 110.348 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.55 ' C ' ' HB3' ' A' ' 53' ' ' LYS . 9.2 mtmm -114.39 97.18 6.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.938 -1.101 . . . . 0.0 109.743 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.802 ' CA ' ' HA ' ' A' ' 53' ' ' LYS . 0.6 OUTLIER -170.47 -176.93 2.27 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.33 -0.856 . . . . 0.0 110.937 179.167 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 . . . . . 0 N--CA 1.497 1.922 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.796 179.905 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.6 p . . . . . 0 N--CA 1.494 1.752 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -118.23 160.93 20.73 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.257 -0.902 . . . . 0.0 109.468 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.0 t -79.09 175.02 10.97 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.385 -0.822 . . . . 0.0 110.271 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 20' ' ' THR . 11.1 mmt85 -136.55 126.02 25.13 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.24 -0.912 . . . . 0.0 110.035 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.58 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 3.7 t30 -76.96 144.52 38.74 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.593 -0.692 . . . . 0.0 111.158 -179.058 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.603 ' HB3' ' CD2' ' A' ' 47' ' ' LEU . 18.2 m-85 -140.8 170.53 15.58 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.411 ' O ' HD23 ' A' ' 47' ' ' LEU . 3.5 m -138.93 130.53 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.421 0 O-C-N 121.141 -0.974 . . . . 0.0 112.177 -177.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.689 HD12 ' C ' ' A' ' 15' ' ' GLU . 0.2 OUTLIER -149.39 161.86 41.25 Favored 'General case' 0 N--CA 1.511 2.604 0 O-C-N 121.071 -1.018 . . . . 0.0 112.222 -179.884 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.511 ' O ' ' N ' ' A' ' 14' ' ' ASN . 12.6 tpt180 -142.72 99.2 3.43 Favored 'General case' 0 N--CA 1.511 2.619 0 O-C-N 121.192 -0.943 . . . . 0.0 111.554 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.823 ' HB2' ' N ' ' A' ' 16' ' ' HIS . 19.1 t70 -80.71 -146.53 0.05 Allowed 'General case' 0 N--CA 1.507 2.399 0 C-N-CA 123.662 0.785 . . . . 0.0 110.167 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.722 ' HA ' ' HB3' ' A' ' 41' ' ' ASN . 0.3 OUTLIER 71.0 55.44 0.23 Allowed 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 104.109 -2.552 . . . . 0.0 104.109 -176.057 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.568 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 0.7 OUTLIER 67.04 1.26 2.28 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-N 112.985 -1.916 . . . . 0.0 111.706 -178.848 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.474 ' O ' ' HB3' ' A' ' 43' ' ' ASP . . . -94.98 -77.52 1.37 Allowed Glycine 0 N--CA 1.477 1.369 0 C-N-CA 118.136 -1.983 . . . . 0.0 109.086 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.83 ' HB3' HD13 ' A' ' 45' ' ' ILE . 2.4 m-80 -126.25 -80.3 0.61 Allowed 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.7 ' C ' ' HB2' ' A' ' 10' ' ' ASP . 28.3 tt0 -168.44 139.8 2.7 Favored 'General case' 0 N--CA 1.509 2.524 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 -178.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.823 ' N ' ' HB2' ' A' ' 10' ' ' ASP . 0.9 OUTLIER -109.56 120.98 44.16 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 116.065 -2.254 . . . . 0.0 115.361 -176.318 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.542 ' HA3' ' CE1' ' A' ' 19' ' ' PHE . . . -179.62 129.64 1.39 Allowed Glycine 0 C--N 1.288 -2.109 0 CA-C-N 112.96 -1.927 . . . . 0.0 109.555 178.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.82 94.37 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 177.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.624 ' N ' ' CD1' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -175.74 -169.29 0.34 Allowed 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 121.286 0.565 . . . . 0.0 110.591 -178.388 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.58 ' HA ' ' HA ' ' A' ' 5' ' ' ASN . 2.7 p -105.59 150.64 25.22 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.431 -0.793 . . . . 0.0 111.508 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -130.1 128.55 5.66 Favored Glycine 0 N--CA 1.5 2.945 0 N-CA-C 108.669 -1.773 . . . . 0.0 108.669 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -60.9 -52.82 63.41 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.41 -1.053 . . . . 0.0 108.823 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.616 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 5.0 mp0 -106.47 99.32 23.79 Favored Pre-proline 0 N--CA 1.487 1.392 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.774 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 36.8 Cg_endo -59.74 -29.18 89.06 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.508 1.267 . . . . 0.0 110.398 -179.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.61 -61.15 1.86 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.363 -0.836 . . . . 0.0 109.919 178.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.679 ' HG3' ' HA ' ' A' ' 72' ' ' PRO . 16.6 tm0? -65.84 -42.9 89.93 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 120.871 -1.143 . . . . 0.0 112.397 -179.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.616 ' HB3' ' O ' ' A' ' 23' ' ' GLN . . . -73.07 -17.36 61.42 Favored 'General case' 0 N--CA 1.482 1.138 0 O-C-N 120.69 -1.257 . . . . 0.0 109.885 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.774 ' HB2' ' O ' ' A' ' 24' ' ' PRO . . . -61.07 -53.05 61.94 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.237 -0.914 . . . . 0.0 111.592 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.905 HD13 ' N ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -63.48 -56.84 12.91 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 -179.082 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.448 ' NZ ' ' O ' ' A' ' 75' ' ' MET . 0.1 OUTLIER -48.17 -44.13 32.25 Favored 'General case' 0 N--CA 1.506 2.347 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.93 179.121 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.537 ' C ' ' HB2' ' A' ' 36' ' ' SER . . . -54.83 -43.1 72.67 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.455 -0.778 . . . . 0.0 111.965 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 1.147 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -72.86 -28.25 62.4 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.701 -1.25 . . . . 0.0 110.807 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.575 ' HB2' ' HG3' ' A' ' 82' ' ' PRO . 2.0 t30 -39.59 -46.95 1.86 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -95.11 -74.59 0.54 Allowed 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.154 -1.018 . . . . 0.0 112.91 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.47 ' O ' ' CD2' ' A' ' 16' ' ' HIS . . . -113.81 -4.96 22.59 Favored Glycine 0 N--CA 1.502 3.039 0 N-CA-C 116.798 1.479 . . . . 0.0 116.798 -175.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.701 ' CB ' ' HA ' ' A' ' 32' ' ' ALA . 0.4 OUTLIER -82.44 -7.13 59.64 Favored 'General case' 0 N--CA 1.506 2.363 0 CA-C-N 122.166 2.983 . . . . 0.0 110.157 -177.353 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.512 ' HA3' ' O ' ' A' ' 60' ' ' ALA . . . -141.44 111.74 0.72 Allowed Glycine 0 C--N 1.289 -2.028 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.509 ' O ' ' HB3' ' A' ' 39' ' ' LYS . 5.2 m -69.05 -20.94 64.12 Favored 'General case' 0 C--N 1.312 -1.054 0 O-C-N 120.672 -1.487 . . . . 0.0 109.4 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.693 ' HA ' ' HG3' ' A' ' 42' ' ' PRO . 5.6 ttpt 67.64 -52.04 0.51 Allowed 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 38' ' ' THR . . . -70.65 -27.95 64.44 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 174.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.722 ' HB3' ' HA ' ' A' ' 11' ' ' GLU 0.274 0.7 OUTLIER -142.41 71.19 21.57 Favored Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.468 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 1.013 ' HB2' ' CD1' ' A' ' 61' ' ' TRP . 72.2 Cg_endo -112.89 169.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 121.75 1.633 . . . . 0.0 112.208 -178.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.53 ' HB2' ' C ' ' A' ' 12' ' ' ASP . 0.7 OUTLIER -167.82 -167.47 0.86 Allowed 'General case' 0 N--CA 1.517 2.891 0 C-N-CA 117.692 -1.603 . . . . 0.0 113.949 177.091 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.809 HG22 ' HD3' ' A' ' 59' ' ' LYS . 0.2 OUTLIER -84.09 123.58 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -178.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.83 HD13 ' HB3' ' A' ' 14' ' ' ASN . 0.7 OUTLIER -108.1 117.52 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.846 -1.159 . . . . 0.0 113.648 -177.856 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.505 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 0.3 OUTLIER -87.73 88.14 7.57 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 103.492 -2.781 . . . . 0.0 103.492 173.249 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.603 ' CD2' ' HB3' ' A' ' 6' ' ' PHE . 0.1 OUTLIER -79.14 94.43 5.37 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -177.62 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.532 ' HB3' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -135.9 178.45 7.04 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.589 -0.694 . . . . 0.0 111.431 -178.666 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -157.22 117.56 3.51 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 178.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -75.14 172.58 12.13 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.207 -177.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.2 -56.18 3.22 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 107.883 -2.087 . . . . 0.0 107.883 -178.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.9 p -111.52 -177.12 3.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.865 -0.785 . . . . 0.0 109.17 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.617 ' O ' ' N ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -89.71 97.04 10.97 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 122.506 1.146 . . . . 0.0 108.581 179.109 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.523 ' HG2' ' CZ ' ' A' ' 6' ' ' PHE . 5.7 mtmt -146.63 109.55 4.65 Favored 'General case' 0 C--N 1.28 -2.453 0 O-C-N 120.912 -1.118 . . . . 0.0 109.604 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.532 HG22 ' HB3' ' A' ' 48' ' ' ARG . 2.8 t -154.05 149.75 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.698 0.761 . . . . 0.0 110.522 -178.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.769 ' CE1' ' HB2' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -160.81 122.67 3.07 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 179.276 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.642 HG12 ' HB2' ' A' ' 87' ' ' GLU . 12.9 t -113.32 100.55 10.92 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 C-N-CA 117.722 -1.591 . . . . 0.0 108.188 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.769 ' HB2' ' CE1' ' A' ' 56' ' ' HIS . 0.3 OUTLIER -144.72 178.79 7.74 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 179.601 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.829 ' HB3' ' CZ2' ' A' ' 61' ' ' TRP . 44.2 mttt -131.62 134.56 46.13 Favored 'General case' 0 C--N 1.274 -2.715 0 N-CA-C 104.245 -2.502 . . . . 0.0 104.245 176.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 1.147 ' HB1' ' HB2' ' A' ' 32' ' ' ALA . . . -123.54 109.72 14.15 Favored 'General case' 0 N--CA 1.495 1.825 0 C-N-CA 117.593 -1.643 . . . . 0.0 112.599 -175.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 1.013 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 5.3 m0 -124.91 -163.07 1.15 Allowed 'General case' 0 N--CA 1.508 2.442 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.426 -178.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.646 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -124.51 88.55 2.92 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.042 -1.036 . . . . 0.0 111.015 179.541 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.921 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 4.4 mt-10 -167.15 171.64 10.71 Favored 'General case' 0 N--CA 1.507 2.397 0 CA-C-O 121.745 0.783 . . . . 0.0 110.449 177.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.677 ' CG1' ' HA ' ' A' ' 80' ' ' SER . 2.3 mt -72.47 98.37 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.519 2.989 0 O-C-N 119.594 -1.942 . . . . 0.0 115.478 -176.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.863 HG13 ' CD1' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -94.27 -164.54 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.296 -1.503 . . . . 0.0 109.288 176.101 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.672 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 14.2 t70 -120.13 136.93 54.43 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 178.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.797 ' HA ' ' HB2' ' A' ' 77' ' ' GLU 0.251 . . -68.72 100.6 0.26 Allowed Pre-proline 0 N--CA 1.503 2.177 0 CA-C-O 117.799 -1.096 . . . . 0.0 111.615 -177.924 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.672 ' HD3' ' O ' ' A' ' 66' ' ' ASP . 49.3 Cg_endo -88.52 -153.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.319 -1.003 0 O-C-N 124.086 1.572 . . . . 0.0 111.241 -179.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.04 61.7 0.08 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.128 -0.983 . . . . 0.0 110.102 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.743 ' CG ' HD21 ' A' ' 29' ' ' LEU . 0.7 OUTLIER -99.63 -14.88 18.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.622 -0.673 . . . . 0.0 110.989 -179.583 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.716 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER 49.72 52.6 12.91 Favored Pre-proline 0 N--CA 1.488 1.429 0 O-C-N 121.892 -0.505 . . . . 0.0 109.992 -178.096 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.716 ' HD3' ' N ' ' A' ' 71' ' ' ARG . 53.2 Cg_endo -98.74 108.01 0.07 OUTLIER 'Trans proline' 0 C--N 1.317 -1.124 0 C-N-CA 122.05 1.834 . . . . 0.0 110.831 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.81 -31.32 23.93 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.966 -1.084 . . . . 0.0 111.447 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.453 ' CD1' ' N ' ' A' ' 74' ' ' TRP . 41.8 m95 -83.65 -32.63 25.55 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.688 -0.633 . . . . 0.0 110.907 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.448 ' O ' ' NZ ' ' A' ' 30' ' ' LYS . 2.3 mtm -167.98 106.76 0.56 Allowed Pre-proline 0 N--CA 1.499 2.003 0 O-C-N 121.467 -0.771 . . . . 0.0 111.08 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.765 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 51.0 Cg_endo -79.59 -179.93 5.78 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.696 1.366 . . . . 0.0 110.929 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 1.002 ' HG3' HG21 ' A' ' 84' ' ' VAL . 14.0 mm-40 -96.46 18.87 13.1 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 117.193 -1.803 . . . . 0.0 111.634 -178.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.667 ' C ' HG22 ' A' ' 79' ' ' ILE . 5.8 tttm -90.39 76.27 6.72 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 177.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.667 HG22 ' C ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -179.98 171.48 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 C-N-CA 118.095 -1.442 . . . . 0.0 112.326 -176.294 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.677 ' HA ' ' CG1' ' A' ' 64' ' ' ILE . 29.4 t -71.31 110.37 5.9 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 175.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.854 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . 3.5 mttm -164.83 -154.49 0.0 OUTLIER Pre-proline 0 C--O 1.191 -2.003 0 C-N-CA 119.093 -1.043 . . . . 0.0 108.761 -174.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.854 ' HD2' ' HB3' ' A' ' 81' ' ' LYS . 50.6 Cg_endo -81.94 130.66 6.68 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 N-CA-C 109.336 -1.063 . . . . 0.0 109.336 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.921 ' CZ ' ' HB3' ' A' ' 63' ' ' GLU . 1.5 m-30 -62.13 152.37 33.16 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 118.233 -1.387 . . . . 0.0 108.568 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 1.002 HG21 ' HG3' ' A' ' 77' ' ' GLU . 15.5 m -147.21 96.81 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.241 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.647 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.743 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -74.57 129.26 37.42 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 104.751 -2.314 . . . . 0.0 104.751 177.117 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.503 ' CB ' ' CZ ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -102.67 88.19 3.16 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -173.694 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.642 ' HB2' HG12 ' A' ' 57' ' ' VAL . 4.3 mp0 -91.81 161.56 14.81 Favored 'General case' 0 C--N 1.283 -2.311 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 174.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.464 ' HD2' ' HA ' ' A' ' 88' ' ' ARG . 0.9 OUTLIER -53.0 151.7 4.54 Favored 'General case' 0 N--CA 1.51 2.535 0 O-C-N 120.521 -1.362 . . . . 0.0 113.933 -175.241 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.628 HG12 ' HA ' ' A' ' 56' ' ' HIS . 74.7 mt -130.36 158.3 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.039 -178.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -145.9 148.16 32.53 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.583 -0.698 . . . . 0.0 109.964 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.422 ' HE3' ' HB3' ' A' ' 91' ' ' LYS . 0.2 OUTLIER -149.08 145.85 27.44 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.689 -1.257 . . . . 0.0 112.243 -178.866 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.617 ' N ' ' O ' ' A' ' 53' ' ' LYS . 0.3 OUTLIER -72.44 -178.08 2.44 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.673 -0.642 . . . . 0.0 109.571 179.243 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 118.325 -0.845 . . . . 0.0 109.807 179.349 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.625 ' HG3' ' O ' ' A' ' 21' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.505 2.301 0 CA-C-O 121.259 0.552 . . . . 0.0 111.379 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.737 ' HB2' HG22 ' A' ' 20' ' ' THR . 19.4 t-20 -84.99 148.03 26.4 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.593 -0.692 . . . . 0.0 110.284 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -144.03 156.25 44.31 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.734 ' C ' HD23 ' A' ' 8' ' ' LEU . 32.9 m -129.62 132.21 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 120.867 -1.146 . . . . 0.0 111.9 -178.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.85 HD13 ' CD2' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -162.7 164.91 26.22 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.602 -0.686 . . . . 0.0 110.86 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.417 ' H ' ' HB2' ' A' ' 14' ' ' ASN . 15.0 mtt85 -130.96 114.51 15.32 Favored 'General case' 0 N--CA 1.514 2.728 0 O-C-N 121.041 -1.037 . . . . 0.0 113.27 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.781 ' HB2' ' CB ' ' A' ' 16' ' ' HIS . 0.8 OUTLIER -75.07 -155.14 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 124.581 1.153 . . . . 0.0 111.216 179.471 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.613 ' HB2' ' O ' ' A' ' 10' ' ' ASP . 3.4 mp0 69.03 52.3 0.51 Allowed 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 -177.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.65 ' HA ' ' O ' ' A' ' 42' ' ' PRO . 33.5 m-20 58.07 8.8 0.82 Allowed 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 112.101 -2.318 . . . . 0.0 113.286 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.18 -75.65 1.3 Allowed Glycine 0 N--CA 1.487 2.092 0 C-N-CA 118.034 -2.032 . . . . 0.0 109.279 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.756 ' ND2' HD13 ' A' ' 45' ' ' ILE . 1.0 OUTLIER -118.4 -78.06 0.58 Allowed 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.876 1.322 . . . . 0.0 108.991 178.853 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.548 ' HA ' ' OD1' ' A' ' 10' ' ' ASP . 2.2 mt-10 -179.23 133.82 0.12 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.781 ' CB ' ' HB2' ' A' ' 10' ' ' ASP . 0.2 OUTLIER -79.72 123.58 27.8 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 115.712 -2.395 . . . . 0.0 111.376 -178.532 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.701 ' HA2' ' CZ ' ' A' ' 19' ' ' PHE . . . -168.89 109.2 0.32 Allowed Glycine 0 C--N 1.285 -2.287 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.872 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.31 81.32 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 176.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.701 ' CZ ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -176.24 -173.32 0.54 Allowed 'General case' 0 N--CA 1.507 2.396 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.032 -178.487 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.737 HG22 ' HB2' ' A' ' 5' ' ' ASN . 37.5 p -106.97 137.0 45.87 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.508 -0.745 . . . . 0.0 111.967 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.625 ' O ' ' HG3' ' A' ' 4' ' ' ARG . . . -115.58 128.3 7.98 Favored Glycine 0 N--CA 1.499 2.854 0 N-CA-C 108.172 -1.971 . . . . 0.0 108.172 178.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.7 pttp -57.29 -40.0 76.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.936 -1.332 . . . . 0.0 110.266 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.832 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 2.4 tp-100 -121.49 136.36 25.86 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 120.975 -1.078 . . . . 0.0 109.311 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.52 ' HB3' ' HD3' ' A' ' 4' ' ' ARG . 38.5 Cg_endo -67.29 -52.84 0.55 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.365 1.192 . . . . 0.0 111.422 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.662 ' HB3' ' HA ' ' A' ' 70' ' ' ASN . 26.8 mtt180 -82.28 -57.55 3.33 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.498 -0.751 . . . . 0.0 111.036 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.592 ' HB3' ' HG2' ' A' ' 23' ' ' GLN . 9.0 tt0 -52.87 -43.21 65.95 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.209 -0.932 . . . . 0.0 111.393 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.832 ' HB3' ' O ' ' A' ' 23' ' ' GLN . . . -77.74 -13.59 59.85 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 120.908 -1.12 . . . . 0.0 109.719 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 25' ' ' ARG . . . -62.1 -51.51 67.63 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.189 -0.944 . . . . 0.0 109.866 178.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.745 ' HB2' ' HG2' ' A' ' 77' ' ' GLU . 3.0 pp -69.2 -42.9 75.16 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.317 -0.953 . . . . 0.0 109.657 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.738 ' HE2' HD11 ' A' ' 29' ' ' LEU . 11.4 mmtt -61.78 -42.97 99.68 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.43 -0.794 . . . . 0.0 111.305 178.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.44 ' C ' ' HB2' ' A' ' 36' ' ' SER . . . -59.81 -48.43 81.73 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -177.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.623 ' HA ' ' CB ' ' A' ' 36' ' ' SER . . . -62.5 -33.24 74.49 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 118.707 -1.197 . . . . 0.0 109.958 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -44.96 -45.3 10.43 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.7 -70.84 0.72 Allowed 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.346 -0.942 . . . . 0.0 112.441 178.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.546 ' O ' ' CD2' ' A' ' 16' ' ' HIS . . . -114.67 2.07 23.25 Favored Glycine 0 N--CA 1.502 3.079 0 N-CA-C 117.529 1.771 . . . . 0.0 117.529 -175.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.623 ' CB ' ' HA ' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -88.3 -2.51 58.64 Favored 'General case' 0 N--CA 1.511 2.62 0 CA-C-N 123.401 3.6 . . . . 0.0 111.081 -177.238 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 60' ' ' ALA . . . -164.34 117.11 0.74 Allowed Glycine 0 N--CA 1.482 1.759 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -178.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.536 ' O ' ' HB3' ' A' ' 39' ' ' LYS . 50.9 m -76.74 -20.22 56.77 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 119.898 1.849 . . . . 0.0 110.234 -178.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.834 ' CA ' ' HG3' ' A' ' 42' ' ' PRO . 0.3 OUTLIER 76.59 -56.6 0.56 Allowed 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -178.514 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.89 -19.36 65.01 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 175.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.605 ' HB3' ' HA ' ' A' ' 11' ' ' GLU 0.282 0.3 OUTLIER -158.43 68.49 3.61 Favored Pre-proline 0 C--O 1.202 -1.412 0 O-C-N 121.738 -0.602 . . . . 0.0 110.408 179.144 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.834 ' HG3' ' CA ' ' A' ' 39' ' ' LYS 0.251 81.6 Cg_endo -119.1 -173.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.301 -1.955 0 C-N-CA 122.084 1.856 . . . . 0.0 110.442 178.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.61 ' HB3' ' O ' ' A' ' 14' ' ' ASN . 4.6 t70 -162.51 -173.44 3.56 Favored 'General case' 0 N--CA 1.507 2.388 0 O-C-N 120.367 -1.458 . . . . 0.0 111.817 176.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.017 HD13 ' HG2' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -127.65 123.8 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.782 ' N ' HD12 ' A' ' 44' ' ' ILE . 7.7 tt -166.23 170.68 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 119.267 -0.973 . . . . 0.0 110.221 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.498 ' HG3' HG13 ' A' ' 57' ' ' VAL . 2.3 mtp180 -78.21 98.7 5.95 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.85 ' CD2' HD13 ' A' ' 8' ' ' LEU . 10.8 mp -70.14 97.04 1.14 Allowed 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 . . . . . 0 N--CA 1.489 1.525 0 O-C-N 121.125 -0.984 . . . . 0.0 111.87 -178.048 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.415 ' C ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 120.995 0.426 . . . . 0.0 110.048 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.421 ' O ' HG23 ' A' ' 89' ' ' ILE . 42.8 t -150.59 118.73 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.7 -0.625 . . . . 0.0 110.078 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.667 ' NE2' ' HB2' ' A' ' 58' ' ' PHE . 0.3 OUTLIER -131.04 117.58 19.35 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 178.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.697 ' CG1' ' HB3' ' A' ' 87' ' ' GLU . 7.9 t -105.99 115.86 48.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 C-N-CA 117.571 -1.652 . . . . 0.0 108.377 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.97 ' CD1' HG12 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -162.22 -177.19 5.56 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 -178.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 1.017 ' HG2' HD13 ' A' ' 44' ' ' ILE . 30.0 mttt -129.98 132.75 46.4 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 177.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.497 ' O ' ' CD1' ' A' ' 61' ' ' TRP . . . -121.62 109.55 14.9 Favored 'General case' 0 N--CA 1.504 2.242 0 CA-C-N 120.429 1.468 . . . . 0.0 112.575 -177.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.803 ' HB2' ' HB2' ' A' ' 83' ' ' PHE . 10.6 m0 -131.24 -173.85 3.22 Favored 'General case' 0 N--CA 1.512 2.638 0 O-C-N 121.673 -0.642 . . . . 0.0 111.1 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.676 ' HB3' ' HG3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -114.52 91.85 3.76 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.157 -0.964 . . . . 0.0 109.876 178.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.916 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 3.4 tp10 -171.04 163.91 7.42 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.561 0.696 . . . . 0.0 110.373 178.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.713 ' HB ' ' HA ' ' A' ' 80' ' ' SER . 6.0 tt -70.2 93.94 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.52 3.038 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 -175.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.709 HG22 ' H ' ' A' ' 66' ' ' ASP . 1.4 p -97.86 -161.08 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 O-C-N 120.096 -1.627 . . . . 0.0 109.067 176.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.709 ' H ' HG22 ' A' ' 65' ' ' VAL . 1.0 OUTLIER -115.95 140.4 49.28 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.296 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.838 ' HB2' ' HB2' ' A' ' 76' ' ' PRO 0.254 . . -58.39 100.41 0.22 Allowed Pre-proline 0 N--CA 1.502 2.171 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.297 -178.111 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.653 ' HD2' ' HB2' ' A' ' 77' ' ' GLU . 54.5 Cg_endo -76.38 83.82 1.96 Allowed 'Trans proline' 0 N--CA 1.492 1.391 0 O-C-N 124.166 1.614 . . . . 0.0 112.366 -177.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.6 mttt 41.3 38.94 0.87 Allowed 'General case' 0 N--CA 1.507 2.413 0 CA-C-O 121.3 0.571 . . . . 0.0 111.476 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.662 ' HA ' ' HB3' ' A' ' 25' ' ' ARG . 20.0 m-20 -77.81 -19.18 55.42 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.476 -0.765 . . . . 0.0 111.406 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.699 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER 41.77 50.77 5.05 Favored Pre-proline 0 N--CA 1.507 2.412 0 CA-C-O 121.028 0.442 . . . . 0.0 112.02 -178.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.74 ' HG2' ' HA ' ' A' ' 76' ' ' PRO . 55.5 Cg_endo -99.22 99.68 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.591 1.528 . . . . 0.0 108.76 179.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.89 -19.17 16.21 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.191 -0.943 . . . . 0.0 111.829 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.446 ' CD1' ' N ' ' A' ' 74' ' ' TRP . 41.0 m95 -79.41 -42.59 25.15 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 121.443 -0.786 . . . . 0.0 109.808 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.404 ' O ' ' HG2' ' A' ' 72' ' ' PRO . 6.6 ttm -176.21 123.55 0.31 Allowed Pre-proline 0 N--CA 1.503 2.177 0 O-C-N 121.581 -0.699 . . . . 0.0 110.487 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.838 ' HB2' ' HB2' ' A' ' 67' ' ' ALA . 51.8 Cg_endo -83.18 176.84 7.06 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 O-C-N 124.091 1.574 . . . . 0.0 111.101 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.817 ' CB ' ' HA ' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -87.87 12.67 12.5 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 117.697 -1.601 . . . . 0.0 110.726 -179.645 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.694 ' C ' HG22 ' A' ' 79' ' ' ILE . 4.6 tttm -82.63 79.88 8.91 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.694 HG22 ' C ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER 177.87 170.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 C-N-CA 118.388 -1.325 . . . . 0.0 111.903 -177.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.713 ' HA ' ' HB ' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -69.08 106.29 2.74 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 104.207 -2.516 . . . . 0.0 104.207 175.243 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.846 ' HB3' ' HD2' ' A' ' 82' ' ' PRO 0.26 0.7 OUTLIER -165.02 -155.54 0.01 OUTLIER Pre-proline 0 C--O 1.194 -1.867 0 C-N-CA 119.143 -1.023 . . . . 0.0 108.847 -173.402 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.846 ' HD2' ' HB3' ' A' ' 81' ' ' LYS . 51.2 Cg_endo -78.15 125.01 6.9 Favored 'Trans proline' 0 C--N 1.302 -1.876 0 N-CA-C 108.792 -1.272 . . . . 0.0 108.792 178.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.916 ' CZ ' ' HB3' ' A' ' 63' ' ' GLU . 2.0 m-30 -61.38 145.81 50.35 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.288 -1.508 . . . . 0.0 108.158 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.97 HG12 ' CD1' ' A' ' 58' ' ' PHE . 2.1 t -143.21 94.84 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.466 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.673 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 2.7 mmtm -88.18 117.08 26.83 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.638 ' HB3' ' CZ ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -72.97 162.36 29.58 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 124.344 2.021 . . . . 0.0 114.091 -175.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.697 ' HB3' ' CG1' ' A' ' 57' ' ' VAL . 5.0 mt-10 -165.53 155.66 13.05 Favored 'General case' 0 C--N 1.271 -2.846 0 CA-C-N 110.544 -3.025 . . . . 0.0 107.857 177.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.462 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -47.01 132.45 11.88 Favored 'General case' 0 N--CA 1.507 2.423 0 CA-C-O 122.194 0.997 . . . . 0.0 113.031 -175.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.515 HG23 ' HA ' ' A' ' 56' ' ' HIS . 5.2 mt . . . . . 0 N--CA 1.492 1.665 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.335 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.485 ' O ' ' HA ' ' A' ' 20' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.893 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.804 ' HA ' HG22 ' A' ' 20' ' ' THR . 0.1 OUTLIER -78.17 121.53 24.46 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.695 -0.628 . . . . 0.0 110.849 -179.3 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.607 ' HB3' HD21 ' A' ' 47' ' ' LEU . 39.5 m-85 -109.6 167.45 10.13 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.426 -0.796 . . . . 0.0 110.549 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.695 ' C ' HD23 ' A' ' 8' ' ' LEU . 29.8 m -139.72 129.83 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 O-C-N 121.527 -0.733 . . . . 0.0 111.695 -178.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.845 HD13 HD11 ' A' ' 47' ' ' LEU . 0.3 OUTLIER -164.98 159.49 18.08 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.118 -0.989 . . . . 0.0 111.746 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.512 ' O ' ' N ' ' A' ' 14' ' ' ASN . 2.5 ttm-85 -140.12 114.91 9.52 Favored 'General case' 0 N--CA 1.511 2.577 0 O-C-N 121.083 -1.011 . . . . 0.0 112.755 178.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.81 ' HB2' ' CB ' ' A' ' 16' ' ' HIS . 0.7 OUTLIER -73.49 -153.19 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 125.154 1.381 . . . . 0.0 111.444 179.647 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.566 ' HB2' ' O ' ' A' ' 10' ' ' ASP . 0.6 OUTLIER 71.9 50.95 0.23 Allowed 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 -177.594 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.624 ' HA ' ' O ' ' A' ' 42' ' ' PRO . 86.5 m-20 59.14 6.6 0.72 Allowed 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 112.539 -2.118 . . . . 0.0 112.591 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.04 -77.33 1.34 Allowed Glycine 0 N--CA 1.485 1.903 0 C-N-CA 117.937 -2.078 . . . . 0.0 109.77 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.707 ' CA ' HG12 ' A' ' 45' ' ' ILE . 6.1 m-20 -117.49 -81.67 0.62 Allowed 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 122.183 0.992 . . . . 0.0 111.566 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.588 ' HB3' HD12 ' A' ' 8' ' ' LEU . 7.8 mt-10 -170.12 129.84 0.93 Allowed 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.81 ' CB ' ' HB2' ' A' ' 10' ' ' ASP . 0.2 OUTLIER -81.25 121.51 26.25 Favored 'General case' 0 N--CA 1.505 2.281 0 C-N-CA 115.273 -2.571 . . . . 0.0 112.17 -178.086 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.695 ' HA2' ' CZ ' ' A' ' 19' ' ' PHE . . . -176.89 122.84 0.86 Allowed Glycine 0 C--N 1.284 -2.322 0 CA-C-N 114.149 -1.387 . . . . 0.0 111.977 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.27 86.46 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 176.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.695 ' CZ ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -175.42 -172.11 0.54 Allowed 'General case' 0 N--CA 1.504 2.228 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.022 -178.08 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.804 HG22 ' HA ' ' A' ' 5' ' ' ASN . 42.8 p -108.56 153.74 22.94 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.121 -0.987 . . . . 0.0 111.885 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -135.89 131.55 5.78 Favored Glycine 0 N--CA 1.507 3.367 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.14 -50.88 69.89 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.149 -1.206 . . . . 0.0 109.225 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.513 ' HB2' ' HG2' ' A' ' 26' ' ' GLN . 37.2 mm-40 -126.71 124.71 24.22 Favored Pre-proline 0 N--CA 1.492 1.641 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.9 -19.67 46.11 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 123.614 1.323 . . . . 0.0 112.085 -178.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.55 ' HD2' ' HA ' ' A' ' 70' ' ' ASN . 8.5 mtt180 -82.84 -68.03 0.74 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.298 -0.877 . . . . 0.0 110.739 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.607 ' HB2' ' HA ' ' A' ' 72' ' ' PRO . 13.6 pt20 -58.93 -37.57 77.01 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.982 -1.073 . . . . 0.0 112.148 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.0 -22.85 63.09 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 120.765 -1.21 . . . . 0.0 109.661 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.77 -58.17 9.8 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.112 -0.992 . . . . 0.0 111.688 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.569 HD21 ' HB3' ' A' ' 72' ' ' PRO . 2.6 pp -56.26 -50.27 71.81 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 119.041 -1.064 . . . . 0.0 110.709 -178.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.532 ' N ' HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -69.79 -37.68 76.42 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 120.582 -1.324 . . . . 0.0 112.892 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.413 ' C ' ' HB2' ' A' ' 36' ' ' SER . . . -62.01 -45.09 95.12 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.723 -1.235 . . . . 0.0 112.306 -177.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.781 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -62.42 -34.52 76.93 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 118.694 -1.202 . . . . 0.0 109.535 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.606 ' CA ' ' HG3' ' A' ' 82' ' ' PRO . 0.2 OUTLIER -40.88 -48.1 3.06 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.185 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 -97.04 -72.31 0.65 Allowed 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.212 -0.995 . . . . 0.0 112.086 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.532 ' O ' ' CD2' ' A' ' 16' ' ' HIS . . . -114.52 -1.23 23.22 Favored Glycine 0 N--CA 1.501 2.991 0 N-CA-C 117.401 1.72 . . . . 0.0 117.401 -175.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.604 ' CB ' ' HA ' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -86.04 -1.71 57.62 Favored 'General case' 0 N--CA 1.514 2.75 0 CA-C-N 123.255 3.527 . . . . 0.0 110.941 -177.017 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -162.4 119.56 0.89 Allowed Glycine 0 C--N 1.299 -1.521 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.496 ' O ' ' HB3' ' A' ' 39' ' ' LYS . 12.9 m -81.08 -15.2 56.67 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 120.417 -1.637 . . . . 0.0 109.665 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.834 ' CA ' ' HG3' ' A' ' 42' ' ' PRO . 7.6 tttp 72.84 -59.16 0.58 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.45 -18.02 65.12 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.121 -1.436 . . . . 0.0 107.121 175.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.549 ' HB3' ' HA ' ' A' ' 11' ' ' GLU 0.285 0.3 OUTLIER -159.05 67.77 3.2 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.678 -0.639 . . . . 0.0 110.87 179.233 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.834 ' HG3' ' CA ' ' A' ' 39' ' ' LYS . 78.2 Cg_endo -119.13 -174.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.472 2.115 . . . . 0.0 110.927 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -166.47 -172.83 2.3 Favored 'General case' 0 N--CA 1.513 2.716 0 O-C-N 120.156 -1.59 . . . . 0.0 113.029 176.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.866 HD13 ' HG2' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -126.02 124.34 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.713 ' N ' HD12 ' A' ' 44' ' ' ILE . 1.6 pp -157.32 -176.43 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.435 -0.791 . . . . 0.0 110.336 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.887 ' HB3' HG13 ' A' ' 55' ' ' VAL . 16.7 mtt85 -85.56 94.56 9.07 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.845 HD11 HD13 ' A' ' 8' ' ' LEU . 5.3 tt -73.55 94.41 2.14 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.497 ' HG2' HG23 ' A' ' 7' ' ' VAL . 4.2 ptp180 . . . . . 0 N--CA 1.496 1.839 0 C-N-CA 119.478 -0.889 . . . . 0.0 112.282 -177.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 48' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 121.647 0.737 . . . . 0.0 110.382 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.887 HG13 ' HB3' ' A' ' 46' ' ' ARG . 35.2 t -149.26 94.25 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.899 ' HA ' HG23 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -79.92 124.92 29.11 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 179.189 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.661 HG12 ' HB2' ' A' ' 87' ' ' GLU . 2.9 t -109.37 106.46 20.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 C-N-CA 117.362 -1.735 . . . . 0.0 107.152 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.783 ' HA ' ' O ' ' A' ' 85' ' ' LYS . 0.3 OUTLIER -150.03 167.74 25.87 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.866 ' HG2' HD13 ' A' ' 44' ' ' ILE . 8.3 mttm -121.17 118.96 31.0 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.781 ' HB1' ' HB2' ' A' ' 32' ' ' ALA . . . -106.69 107.33 18.29 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 118.609 -1.236 . . . . 0.0 112.484 -176.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.794 ' HB2' ' HB2' ' A' ' 83' ' ' PHE . 18.5 m0 -128.49 -166.13 1.59 Allowed 'General case' 0 N--CA 1.512 2.635 0 O-C-N 121.842 -0.536 . . . . 0.0 111.021 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.748 ' HB2' ' HB2' ' A' ' 39' ' ' LYS . 0.3 OUTLIER -123.2 86.53 2.59 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 120.967 -1.083 . . . . 0.0 110.966 179.747 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.757 ' CB ' ' CZ ' ' A' ' 83' ' ' PHE . 19.7 mp0 -161.19 171.14 18.98 Favored 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.646 ' HB ' ' HA ' ' A' ' 80' ' ' SER . 2.8 tt -78.48 98.04 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.136 0 O-C-N 119.301 -2.124 . . . . 0.0 115.49 -177.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 1.122 HG13 ' CD1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -89.85 -168.41 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.309 -1.495 . . . . 0.0 110.342 177.739 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.62 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 10.9 t70 -119.66 133.85 55.47 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.806 ' HA ' ' CB ' ' A' ' 77' ' ' GLU . . . -66.01 101.33 0.27 Allowed Pre-proline 0 N--CA 1.504 2.273 0 CA-C-O 117.93 -1.033 . . . . 0.0 111.902 -178.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.681 ' CB ' ' HD2' ' A' ' 86' ' ' LYS . 52.5 Cg_endo -86.93 -166.66 0.31 Allowed 'Trans proline' 0 C--N 1.315 -1.221 0 O-C-N 123.875 1.461 . . . . 0.0 111.467 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.0 mmmt -69.44 62.02 0.15 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.447 -0.783 . . . . 0.0 110.295 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.55 ' HA ' ' HD2' ' A' ' 25' ' ' ARG . 1.0 OUTLIER -101.65 -9.35 20.99 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.653 -0.654 . . . . 0.0 111.213 -179.842 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.755 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER 56.52 44.06 1.33 Allowed Pre-proline 0 N--CA 1.508 2.441 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -179.244 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.755 ' HD3' ' N ' ' A' ' 71' ' ' ARG . 49.0 Cg_endo -94.06 98.99 0.13 Allowed 'Trans proline' 0 C--N 1.316 -1.183 0 C-N-CA 120.84 1.026 . . . . 0.0 110.015 178.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.9 -18.33 50.86 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.15 -0.968 . . . . 0.0 111.444 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.519 ' CD1' ' N ' ' A' ' 74' ' ' TRP . 6.9 m0 -80.29 -37.82 32.01 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.154 -0.966 . . . . 0.0 109.579 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.457 ' O ' ' HB2' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -167.64 122.57 0.82 Allowed Pre-proline 0 N--CA 1.496 1.83 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.612 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.766 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 49.5 Cg_endo -81.92 -179.8 5.06 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.589 1.31 . . . . 0.0 112.62 -178.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.806 ' CB ' ' HA ' ' A' ' 67' ' ' ALA . 1.3 mt-10 -92.2 11.0 27.12 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 118.315 -1.354 . . . . 0.0 110.684 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.691 ' C ' HG22 ' A' ' 79' ' ' ILE . 0.6 OUTLIER -92.46 82.83 4.89 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.94 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.691 HG22 ' C ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -176.87 161.55 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 C-N-CA 118.146 -1.422 . . . . 0.0 112.392 -177.837 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.646 ' HA ' ' HB ' ' A' ' 64' ' ' ILE . 0.3 OUTLIER -75.07 104.94 5.85 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 175.501 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.768 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 11.5 pttp -169.81 -152.58 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.784 0 C-N-CA 118.843 -1.143 . . . . 0.0 108.393 -174.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.768 ' HD2' ' HB2' ' A' ' 81' ' ' LYS . 51.0 Cg_endo -74.83 127.33 10.72 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 N-CA-C 109.547 -0.982 . . . . 0.0 109.547 178.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 1.122 ' CD1' HG13 ' A' ' 65' ' ' VAL . 0.8 OUTLIER -65.16 160.19 21.84 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.987 -1.071 . . . . 0.0 109.737 179.502 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.704 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -154.64 92.7 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 177.25 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.783 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -77.51 122.35 25.11 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 178.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.681 ' HD2' ' CB ' ' A' ' 68' ' ' PRO . 0.0 OUTLIER -85.24 92.2 8.36 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 122.864 1.316 . . . . 0.0 113.29 -175.783 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.661 ' HB2' HG12 ' A' ' 57' ' ' VAL . 3.2 mm-40 -88.5 153.94 20.75 Favored 'General case' 0 C--N 1.28 -2.448 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.459 176.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -53.38 111.11 0.64 Allowed 'General case' 0 N--CA 1.51 2.557 0 CA-C-O 122.092 0.949 . . . . 0.0 113.087 -176.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.899 HG23 ' HA ' ' A' ' 56' ' ' HIS . 10.4 mt . . . . . 0 N--CA 1.5 2.029 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.085 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.495 ' O ' ' HA ' ' A' ' 20' ' ' THR . 3.0 mpt_? . . . . . 0 N--CA 1.5 2.057 0 CA-C-O 120.834 0.349 . . . . 0.0 110.068 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.49 ' CA ' HG22 ' A' ' 20' ' ' THR . 6.7 t-20 -77.43 143.55 38.5 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.65 -0.657 . . . . 0.0 110.417 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -142.65 137.56 30.05 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.576 -0.702 . . . . 0.0 110.264 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.917 HG22 ' O ' ' A' ' 48' ' ' ARG . 17.0 m -119.39 132.78 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.516 -0.74 . . . . 0.0 111.599 -178.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.805 HD22 ' HG ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -163.39 161.45 24.42 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.107 -0.995 . . . . 0.0 111.291 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.433 ' H ' ' HB2' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -131.99 110.58 10.85 Favored 'General case' 0 N--CA 1.513 2.718 0 O-C-N 121.13 -0.981 . . . . 0.0 113.154 -179.375 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.83 ' HB2' ' CB ' ' A' ' 16' ' ' HIS . 0.9 OUTLIER -73.48 -156.16 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 C-N-CA 124.274 1.03 . . . . 0.0 111.101 179.337 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.665 ' HA ' ' HB3' ' A' ' 41' ' ' ASN . 3.0 mp0 70.92 51.66 0.3 Allowed 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 -177.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.615 ' HA ' ' O ' ' A' ' 42' ' ' PRO . 86.4 m-20 59.45 7.95 1.09 Allowed 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 112.306 -2.224 . . . . 0.0 113.027 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.28 -77.69 1.33 Allowed Glycine 0 N--CA 1.486 1.992 0 C-N-CA 117.954 -2.07 . . . . 0.0 109.061 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.639 ' O ' ' HB3' ' A' ' 43' ' ' ASP . 8.0 m-20 -117.11 -77.24 0.57 Allowed 'General case' 0 C--N 1.296 -1.753 0 CA-C-O 122.606 1.193 . . . . 0.0 109.909 178.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.569 ' HA ' ' OD1' ' A' ' 10' ' ' ASP . 1.3 mt-10 -178.05 138.08 0.19 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 178.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.83 ' CB ' ' HB2' ' A' ' 10' ' ' ASP . 0.2 OUTLIER -87.37 122.45 31.14 Favored 'General case' 0 N--CA 1.501 2.119 0 C-N-CA 115.672 -2.411 . . . . 0.0 112.22 -178.623 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.669 ' HA2' ' CE1' ' A' ' 19' ' ' PHE . . . -174.43 110.16 0.32 Allowed Glycine 0 C--N 1.283 -2.375 0 CA-C-N 113.804 -1.543 . . . . 0.0 110.834 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.449 ' C ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -130.96 81.87 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.2 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.669 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -175.17 -173.49 0.67 Allowed 'General case' 0 N--CA 1.502 2.161 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.077 -179.682 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 4' ' ' ARG . 57.3 p -103.23 144.8 30.86 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.418 -0.801 . . . . 0.0 111.809 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -124.29 133.58 8.76 Favored Glycine 0 N--CA 1.503 3.111 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.4 mttt -66.46 -58.64 4.83 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.241 -1.153 . . . . 0.0 108.752 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.545 ' HB3' ' HB3' ' A' ' 26' ' ' GLN . 0.9 OUTLIER -109.45 106.05 58.02 Favored Pre-proline 0 C--N 1.303 -1.424 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 177.9 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.608 ' HB2' HD13 ' A' ' 89' ' ' ILE . 36.9 Cg_endo -60.04 -26.46 82.49 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.945 1.498 . . . . 0.0 111.309 -178.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.622 ' HD3' ' HA ' ' A' ' 70' ' ' ASN . 3.6 mtt-85 -85.23 -58.39 2.7 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.268 -0.895 . . . . 0.0 109.239 178.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.758 ' HG3' ' HA ' ' A' ' 72' ' ' PRO . 1.0 OUTLIER -59.01 -43.53 91.54 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.921 -1.112 . . . . 0.0 110.807 179.552 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.41 -18.15 63.73 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 118.993 -1.083 . . . . 0.0 109.78 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 25' ' ' ARG . . . -59.76 -60.11 4.36 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.436 -0.79 . . . . 0.0 111.703 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.567 ' HB3' ' HG3' ' A' ' 77' ' ' GLU . 1.8 pp -63.89 -44.13 93.93 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 118.933 -1.107 . . . . 0.0 110.524 -179.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.401 ' HG3' ' CD1' ' A' ' 29' ' ' LEU . 37.6 mtmt -66.48 -43.7 84.67 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 120.781 -1.199 . . . . 0.0 112.476 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.23 -45.46 88.07 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.929 -1.107 . . . . 0.0 112.864 -177.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.646 ' HA ' ' CB ' ' A' ' 36' ' ' SER . . . -56.64 -37.52 70.87 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 118.781 -1.167 . . . . 0.0 109.493 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.494 ' CB ' ' HG3' ' A' ' 82' ' ' PRO . 4.4 t-20 -42.39 -47.05 4.87 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.98 -73.44 0.58 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 119.035 -1.066 . . . . 0.0 112.545 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.512 ' O ' ' CD2' ' A' ' 16' ' ' HIS . . . -116.76 1.63 19.92 Favored Glycine 0 N--CA 1.502 3.092 0 N-CA-C 117.213 1.645 . . . . 0.0 117.213 -175.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.646 ' CB ' ' HA ' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -85.17 -4.85 59.3 Favored 'General case' 0 N--CA 1.51 2.545 0 CA-C-N 122.929 3.364 . . . . 0.0 110.99 -176.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 60' ' ' ALA . . . -165.37 120.89 0.96 Allowed Glycine 0 N--CA 1.478 1.494 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -177.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.57 ' O ' ' HB3' ' A' ' 39' ' ' LYS . 32.4 m -77.66 -14.81 59.52 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 120.359 -1.671 . . . . 0.0 110.195 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.828 ' CA ' ' HG3' ' A' ' 42' ' ' PRO . 1.2 tmtt? 72.01 -56.57 0.64 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -178.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.97 -18.73 63.36 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 176.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.665 ' HB3' ' HA ' ' A' ' 11' ' ' GLU 0.278 0.4 OUTLIER -156.75 67.73 4.34 Favored Pre-proline 0 C--O 1.199 -1.581 0 O-C-N 121.819 -0.55 . . . . 0.0 109.98 179.083 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.828 ' HG3' ' CA ' ' A' ' 39' ' ' LYS . 80.0 Cg_endo -119.61 -174.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 122.382 2.054 . . . . 0.0 111.075 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.639 ' HB3' ' O ' ' A' ' 14' ' ' ASN . 3.2 t70 -165.11 -168.71 1.47 Allowed 'General case' 0 N--CA 1.51 2.565 0 O-C-N 120.357 -1.464 . . . . 0.0 111.963 176.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.03 HD13 ' HG2' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -129.93 120.76 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.715 -0.616 . . . . 0.0 109.778 -179.043 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.715 ' N ' HD12 ' A' ' 44' ' ' ILE . 1.3 pp -157.98 -177.96 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-O 121.829 0.823 . . . . 0.0 109.876 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.608 ' NH1' HG21 ' A' ' 57' ' ' VAL . 0.5 OUTLIER -91.19 100.26 13.12 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.102 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.805 ' HG ' HD22 ' A' ' 8' ' ' LEU . 9.4 mp -69.71 93.32 0.72 Allowed 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.917 ' O ' HG22 ' A' ' 7' ' ' VAL . 8.2 ptp85 . . . . . 0 N--CA 1.49 1.547 0 C-N-CA 119.722 -0.791 . . . . 0.0 113.059 -175.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.584 ' O ' ' HA ' ' A' ' 48' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.404 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.839 HG13 ' HB3' ' A' ' 48' ' ' ARG . 3.9 t -138.78 107.58 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 CA-C-O 121.245 0.545 . . . . 0.0 110.547 -178.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.781 ' HA ' HG23 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -101.04 127.4 47.58 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 178.54 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.861 HG22 ' CB ' ' A' ' 87' ' ' GLU . 2.2 p -117.6 123.84 72.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 C-N-CA 116.611 -2.036 . . . . 0.0 108.852 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.673 ' HA ' ' O ' ' A' ' 85' ' ' LYS . 0.3 OUTLIER -162.75 -176.35 4.92 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 -178.681 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 1.03 ' HG2' HD13 ' A' ' 44' ' ' ILE . 38.2 mttt -133.42 124.48 27.18 Favored 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.617 ' HB1' ' CB ' ' A' ' 32' ' ' ALA . . . -110.75 109.29 19.46 Favored 'General case' 0 N--CA 1.505 2.287 0 C-N-CA 118.595 -1.242 . . . . 0.0 113.424 -176.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.845 ' HB2' ' HB2' ' A' ' 83' ' ' PHE . 11.2 m0 -132.38 -163.46 1.34 Allowed 'General case' 0 N--CA 1.515 2.822 0 O-C-N 121.86 -0.525 . . . . 0.0 110.589 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.698 ' CB ' ' HG3' ' A' ' 39' ' ' LYS . 0.5 OUTLIER -125.26 89.04 2.98 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 120.423 -1.423 . . . . 0.0 112.217 179.93 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.885 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 4.3 mt-10 -167.17 -179.44 4.57 Favored 'General case' 0 N--CA 1.514 2.752 0 CA-C-O 121.514 0.674 . . . . 0.0 111.064 177.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.597 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 2.1 mt -78.26 99.88 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.086 0 O-C-N 119.429 -2.045 . . . . 0.0 115.012 -176.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.859 HG13 ' CD1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -90.92 -168.91 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 120.586 -1.321 . . . . 0.0 110.317 177.51 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.618 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 12.1 t70 -124.72 129.86 51.3 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.822 ' HA ' ' CB ' ' A' ' 77' ' ' GLU 0.253 . . -66.18 98.6 0.16 Allowed Pre-proline 0 N--CA 1.511 2.623 0 CA-C-O 117.51 -1.233 . . . . 0.0 111.862 -177.542 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.615 ' HD3' ' O ' ' A' ' 66' ' ' ASP . 48.9 Cg_endo -92.95 85.68 0.19 Allowed 'Trans proline' 0 N--CA 1.483 0.893 0 O-C-N 123.818 1.43 . . . . 0.0 112.994 -178.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.5 mttm 38.99 54.03 2.07 Favored 'General case' 0 N--CA 1.511 2.597 0 CA-C-O 121.71 0.767 . . . . 0.0 111.538 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.622 ' HA ' ' HD3' ' A' ' 25' ' ' ARG . 0.9 OUTLIER -91.8 -9.7 42.56 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.289 -0.882 . . . . 0.0 112.216 -179.083 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.765 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER 62.67 35.46 0.21 Allowed Pre-proline 0 N--CA 1.508 2.432 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -179.649 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.795 ' HG2' ' HA ' ' A' ' 76' ' ' PRO . 56.8 Cg_endo -93.41 115.13 0.27 Allowed 'Trans proline' 0 C--N 1.315 -1.193 0 N-CA-C 109.822 -0.876 . . . . 0.0 109.822 178.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.0 -19.75 39.85 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.951 -1.093 . . . . 0.0 111.715 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.457 ' CD1' ' N ' ' A' ' 74' ' ' TRP . 37.8 m95 -82.28 -39.21 23.27 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.398 -0.814 . . . . 0.0 110.137 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.551 ' SD ' ' HE3' ' A' ' 81' ' ' LYS . 2.1 mtm -170.42 132.2 0.96 Allowed Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.708 -0.62 . . . . 0.0 109.556 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.795 ' HA ' ' HG2' ' A' ' 72' ' ' PRO . 46.4 Cg_endo -87.33 -178.16 2.34 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.682 1.359 . . . . 0.0 112.129 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.822 ' CB ' ' HA ' ' A' ' 67' ' ' ALA . 0.3 OUTLIER -88.94 11.39 18.27 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 118.092 -1.443 . . . . 0.0 110.321 -179.328 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.702 ' C ' HG22 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -94.18 81.6 4.08 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.229 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.702 HG22 ' C ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -177.97 164.44 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 118.145 -1.422 . . . . 0.0 112.57 -177.462 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.54 ' N ' HG13 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -73.84 104.32 4.68 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 104.556 -2.387 . . . . 0.0 104.556 175.218 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.79 ' HB3' ' HD2' ' A' ' 82' ' ' PRO 0.262 2.8 mttm -164.16 -162.41 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.682 0 C-N-CA 118.857 -1.137 . . . . 0.0 110.112 -174.267 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.79 ' HD2' ' HB3' ' A' ' 81' ' ' LYS . 43.4 Cg_endo -69.87 121.65 8.31 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 N-CA-C 107.529 -1.758 . . . . 0.0 107.529 176.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.885 ' CZ ' ' HB3' ' A' ' 63' ' ' GLU . 0.4 OUTLIER -57.37 151.51 16.12 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.878 -1.139 . . . . 0.0 109.892 -178.734 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.733 ' H ' HG11 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -148.04 88.8 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.51 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.388 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.748 ' HB2' ' CG ' ' A' ' 59' ' ' LYS . 14.6 mmtp -79.93 118.16 21.43 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.523 ' O ' ' CE ' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -72.67 156.55 38.84 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 124.256 1.979 . . . . 0.0 114.3 -175.419 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.861 ' CB ' HG22 ' A' ' 57' ' ' VAL . 0.5 OUTLIER -163.34 143.7 8.98 Favored 'General case' 0 C--N 1.271 -2.817 0 CA-C-N 111.096 -2.774 . . . . 0.0 108.828 177.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.4 ' O ' HG12 ' A' ' 57' ' ' VAL . 1.0 OUTLIER -55.0 117.49 3.49 Favored 'General case' 0 N--CA 1.506 2.351 0 CA-C-O 122.13 0.967 . . . . 0.0 113.38 -176.487 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.781 HG23 ' HA ' ' A' ' 56' ' ' HIS . 42.8 mt . . . . . 0 N--CA 1.494 1.747 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.34 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 20' ' ' THR . 22.3 mmt180 . . . . . 0 N--CA 1.499 2.001 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.77 ' HA ' HG22 ' A' ' 20' ' ' THR . 6.1 t-20 -72.55 135.86 45.7 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.512 -0.742 . . . . 0.0 109.582 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.687 ' CD1' HD22 ' A' ' 47' ' ' LEU . 4.3 m-85 -142.22 166.81 23.67 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.603 -0.839 . . . . 0.0 111.355 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.504 ' O ' HD23 ' A' ' 47' ' ' LEU . 10.8 m -136.62 131.77 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.808 -0.557 . . . . 0.0 111.143 -178.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.717 HD13 ' OE1' ' A' ' 15' ' ' GLU . 0.4 OUTLIER -159.07 161.97 36.53 Favored 'General case' 0 N--CA 1.512 2.641 0 O-C-N 120.922 -1.111 . . . . 0.0 111.877 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.466 ' N ' ' O ' ' A' ' 15' ' ' GLU . 10.7 tpt180 -148.81 112.51 5.08 Favored 'General case' 0 N--CA 1.512 2.647 0 O-C-N 121.012 -1.055 . . . . 0.0 112.832 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.929 ' HB3' ' CD2' ' A' ' 16' ' ' HIS . 5.8 t0 -98.61 -144.09 0.32 Allowed 'General case' 0 N--CA 1.508 2.428 0 O-C-N 121.273 -0.892 . . . . 0.0 109.405 177.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.755 ' HA ' ' HB3' ' A' ' 41' ' ' ASN . 2.4 mt-10 72.63 57.54 0.13 Allowed 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 102.576 -3.12 . . . . 0.0 102.576 -174.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.654 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 69.8 m-20 74.14 -5.15 2.12 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 112.272 -2.24 . . . . 0.0 111.844 -177.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.07 -83.53 1.42 Allowed Glycine 0 N--CA 1.482 1.764 0 C-N-CA 118.25 -1.928 . . . . 0.0 109.729 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.731 ' HB3' ' CD1' ' A' ' 45' ' ' ILE . 0.7 OUTLIER -129.19 -74.49 0.56 Allowed 'General case' 0 N--CA 1.51 2.529 0 O-C-N 121.634 -0.921 . . . . 0.0 112.744 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.773 ' CA ' ' HB2' ' A' ' 10' ' ' ASP . 35.2 tt0 -164.89 127.89 2.3 Favored 'General case' 0 N--CA 1.522 3.136 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.929 ' CD2' ' HB3' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -99.37 124.4 44.45 Favored 'General case' 0 N--CA 1.512 2.671 0 C-N-CA 116.208 -2.197 . . . . 0.0 115.415 -176.377 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.484 ' CA ' ' CE1' ' A' ' 19' ' ' PHE . . . -178.09 134.62 2.45 Favored Glycine 0 N--CA 1.48 1.586 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.212 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.423 ' C ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -132.88 91.07 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 120.87 -1.37 . . . . 0.0 108.112 177.254 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.671 ' CD1' ' N ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -174.81 -170.65 0.49 Allowed 'General case' 0 N--CA 1.504 2.251 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.727 -178.667 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.77 HG22 ' HA ' ' A' ' 5' ' ' ASN . 18.1 p -106.09 151.46 24.66 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.033 -1.042 . . . . 0.0 111.24 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -129.62 142.07 13.25 Favored Glycine 0 N--CA 1.504 3.195 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -71.49 -61.8 1.64 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.158 -1.201 . . . . 0.0 108.564 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.691 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -99.96 115.37 65.6 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.102 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.473 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 36.9 Cg_endo -61.65 -32.63 87.14 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.318 1.167 . . . . 0.0 111.1 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.499 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 43.1 mtt180 -83.25 -64.7 1.12 Allowed 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.384 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.639 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -57.43 -39.49 76.35 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.967 -1.083 . . . . 0.0 111.528 -179.661 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' A' ' 23' ' ' GLN . . . -74.57 -16.38 60.81 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 120.396 -1.44 . . . . 0.0 109.669 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.577 ' HB2' ' HE1' ' A' ' 56' ' ' HIS . . . -57.21 -60.05 4.19 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.442 -0.786 . . . . 0.0 110.301 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.712 HD22 ' HG2' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -62.04 -46.08 90.75 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 118.512 -1.275 . . . . 0.0 108.145 179.199 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.626 ' N ' ' HG ' ' A' ' 29' ' ' LEU . 2.8 mmpt? -49.51 -48.07 48.34 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.224 -0.922 . . . . 0.0 110.741 179.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.522 ' C ' ' HB2' ' A' ' 36' ' ' SER . . . -62.13 -49.58 75.31 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.308 -0.87 . . . . 0.0 110.856 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.982 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -59.17 -35.32 73.34 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.306 -0.871 . . . . 0.0 109.807 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.433 ' CA ' ' HG3' ' A' ' 82' ' ' PRO . 1.1 t-20 -38.89 -48.43 1.56 Allowed 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.6 mmt180 -92.47 -75.16 0.49 Allowed 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 118.593 -1.243 . . . . 0.0 112.235 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.582 ' O ' ' CG ' ' A' ' 16' ' ' HIS . . . -117.11 -3.03 18.01 Favored Glycine 0 N--CA 1.5 2.946 0 CA-C-O 118.078 -1.401 . . . . 0.0 116.527 -176.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.661 ' HB2' ' CA ' ' A' ' 32' ' ' ALA . 0.4 OUTLIER -82.32 -4.14 56.67 Favored 'General case' 0 N--CA 1.508 2.428 0 CA-C-N 122.358 3.079 . . . . 0.0 111.154 -176.684 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 60' ' ' ALA . . . -145.99 109.53 0.5 Allowed Glycine 0 C--N 1.287 -2.145 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.42 ' O ' ' N ' ' A' ' 40' ' ' ALA . 0.3 OUTLIER -76.56 -23.17 53.55 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 117.965 -1.494 . . . . 0.0 109.828 -179.745 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.692 ' HG3' ' HB2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER 67.67 -55.87 0.47 Allowed 'General case' 0 N--CA 1.51 2.564 0 CA-C-O 121.53 0.681 . . . . 0.0 109.188 -179.566 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 38' ' ' THR . . . -65.65 -29.09 69.61 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 104.49 -2.411 . . . . 0.0 104.49 174.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.755 ' HB3' ' HA ' ' A' ' 11' ' ' GLU 0.282 0.7 OUTLIER -140.59 71.94 30.75 Favored Pre-proline 0 N--CA 1.485 1.288 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 176.986 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.995 ' HB2' ' CD1' ' A' ' 61' ' ' TRP . 93.8 Cg_endo -110.71 167.5 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 121.166 1.244 . . . . 0.0 111.779 -177.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -164.96 -170.63 2.0 Favored 'General case' 0 N--CA 1.511 2.59 0 C-N-CA 118.021 -1.472 . . . . 0.0 112.707 177.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.731 HG22 ' HD3' ' A' ' 59' ' ' LYS . 0.2 OUTLIER -93.99 134.42 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.731 ' CD1' ' HB3' ' A' ' 14' ' ' ASN . 2.2 tp -120.06 129.96 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.673 -1.267 . . . . 0.0 113.749 -177.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.1 mtm180 -92.3 84.27 5.16 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 104.023 -2.584 . . . . 0.0 104.023 173.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.687 HD22 ' CD1' ' A' ' 6' ' ' PHE . 0.1 OUTLIER -76.03 94.38 3.42 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -177.871 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 C-N-CA 119.178 -1.009 . . . . 0.0 111.929 -178.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 121.146 0.498 . . . . 0.0 109.702 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 52.8 t -151.07 129.04 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-O 121.832 0.825 . . . . 0.0 110.797 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.581 ' NE2' ' HB2' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -146.24 110.64 5.09 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 179.334 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.661 ' CG1' ' HB3' ' A' ' 87' ' ' GLU . 21.9 t -105.82 99.95 9.59 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.305 0 C-N-CA 117.497 -1.681 . . . . 0.0 107.735 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 1.016 ' CD1' HG22 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -135.03 179.54 6.26 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 179.563 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.809 ' HB3' ' CZ2' ' A' ' 61' ' ' TRP . 39.7 mttt -133.06 135.07 45.13 Favored 'General case' 0 C--N 1.275 -2.658 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 177.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.982 ' HB1' ' HB2' ' A' ' 32' ' ' ALA . . . -122.85 111.29 16.48 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-N 120.8 1.636 . . . . 0.0 112.911 -175.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.995 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 2.7 m0 -128.11 -165.07 1.44 Allowed 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.739 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 7.3 mmtp -122.25 92.2 3.67 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 120.669 -1.27 . . . . 0.0 111.083 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.952 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 4.5 tp10 -173.51 169.74 4.28 Favored 'General case' 0 N--CA 1.502 2.175 0 CA-C-O 121.469 0.652 . . . . 0.0 110.955 178.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.687 ' CG1' ' HA ' ' A' ' 80' ' ' SER . 2.1 mt -71.71 102.14 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.533 3.679 0 O-C-N 119.421 -2.049 . . . . 0.0 116.305 -175.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 1.061 HG13 ' CD1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -102.0 -167.94 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 120.449 -1.407 . . . . 0.0 110.858 177.09 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.705 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 11.6 t70 -116.1 134.58 54.79 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.509 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.819 ' HA ' ' HB2' ' A' ' 77' ' ' GLU 0.28 . . -72.46 97.57 0.15 Allowed Pre-proline 0 N--CA 1.511 2.595 0 CA-C-O 117.466 -1.254 . . . . 0.0 112.761 -178.242 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.705 ' HD3' ' O ' ' A' ' 66' ' ' ASP . 53.6 Cg_endo -73.35 123.81 8.98 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 O-C-N 123.273 1.144 . . . . 0.0 111.315 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER 53.25 37.9 26.34 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.313 -0.867 . . . . 0.0 109.044 -179.307 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.606 ' HB3' ' HD3' ' A' ' 72' ' ' PRO . 6.6 m-80 2.07 -75.57 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.75 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 11.8 ptm180 34.63 44.22 0.29 Allowed Pre-proline 0 N--CA 1.513 2.707 0 CA-C-N 118.121 0.419 . . . . 0.0 110.355 -177.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.75 ' HD3' ' N ' ' A' ' 71' ' ' ARG . 54.5 Cg_endo -105.85 114.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.324 -0.737 0 C-N-CA 121.922 1.748 . . . . 0.0 112.85 -176.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.85 -39.46 15.82 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.196 -1.002 . . . . 0.0 108.956 177.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.509 ' CD1' ' N ' ' A' ' 74' ' ' TRP . 6.4 m95 -89.7 -38.19 14.04 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.331 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.444 ' HB2' ' O ' ' A' ' 74' ' ' TRP . 7.1 ttm -179.58 146.02 0.44 Allowed Pre-proline 0 N--CA 1.51 2.549 0 O-C-N 121.746 -0.596 . . . . 0.0 111.485 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.598 ' HB3' ' HG3' ' A' ' 72' ' ' PRO . 48.3 Cg_endo -94.54 174.7 1.29 Allowed 'Trans proline' 0 N--CA 1.486 1.087 0 C-N-CA 122.113 1.875 . . . . 0.0 111.041 178.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.819 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 3.8 mt-10 -95.26 16.02 17.75 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 117.892 -1.523 . . . . 0.0 110.812 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.697 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 0.3 OUTLIER -98.28 80.83 2.69 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.22 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.647 ' CG1' ' HD2' ' A' ' 81' ' ' LYS . 0.6 OUTLIER 178.59 170.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 C-N-CA 118.128 -1.429 . . . . 0.0 112.122 -177.706 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.687 ' HA ' ' CG1' ' A' ' 64' ' ' ILE . 1.4 m -70.77 109.77 5.16 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 175.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.83 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -169.09 -156.88 0.0 OUTLIER Pre-proline 0 C--O 1.192 -1.973 0 C-N-CA 118.882 -1.127 . . . . 0.0 108.651 -174.916 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.83 ' HD2' ' HB3' ' A' ' 81' ' ' LYS . 43.7 Cg_endo -74.7 127.22 10.72 Favored 'Trans proline' 0 C--N 1.299 -2.052 0 N-CA-C 108.905 -1.229 . . . . 0.0 108.905 178.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 1.061 ' CD1' HG13 ' A' ' 65' ' ' VAL . 0.8 OUTLIER -58.9 151.64 21.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.506 -1.371 . . . . 0.0 108.087 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 1.016 HG22 ' CD1' ' A' ' 58' ' ' PHE . 9.8 p -149.64 95.49 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.508 0 CA-C-O 122.015 0.912 . . . . 0.0 109.764 -178.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.748 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -78.53 119.0 21.19 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 179.611 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.638 ' HB3' ' CZ ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -85.71 94.37 9.08 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 122.716 1.246 . . . . 0.0 113.845 -176.157 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.661 ' HB3' ' CG1' ' A' ' 57' ' ' VAL . 0.0 OUTLIER -99.47 176.96 5.32 Favored 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 114.584 -1.189 . . . . 0.0 108.733 175.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.508 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -44.04 133.39 5.13 Favored 'General case' 0 N--CA 1.514 2.769 0 O-C-N 120.613 -1.304 . . . . 0.0 113.627 -175.81 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.81 HD11 ' CD2' ' A' ' 58' ' ' PHE . 40.8 mt . . . . . 0 N--CA 1.499 2.01 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.995 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.526 ' O ' ' HA ' ' A' ' 20' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.882 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.778 ' CA ' HG22 ' A' ' 20' ' ' THR . 51.0 t30 -77.17 143.19 39.25 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.606 -0.684 . . . . 0.0 110.581 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.402 ' HE2' ' HB2' ' A' ' 4' ' ' ARG . 45.9 m-85 -138.98 148.72 43.84 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.119 0.485 . . . . 0.0 109.737 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.868 HG22 ' O ' ' A' ' 48' ' ' ARG . 29.9 m -125.97 140.04 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 O-C-N 121.331 -0.855 . . . . 0.0 112.504 -177.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.829 HD22 ' HG ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -161.91 167.36 24.77 Favored 'General case' 0 N--CA 1.511 2.621 0 O-C-N 121.408 -0.807 . . . . 0.0 111.836 179.485 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.549 ' O ' ' N ' ' A' ' 14' ' ' ASN . 3.4 ttm-85 -134.82 107.95 7.68 Favored 'General case' 0 N--CA 1.526 3.328 0 O-C-N 121.15 -0.969 . . . . 0.0 112.856 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.858 ' HB2' ' CB ' ' A' ' 16' ' ' HIS . 0.7 OUTLIER -74.55 -158.18 0.07 Allowed 'General case' 0 N--CA 1.513 2.688 0 O-C-N 120.998 -1.064 . . . . 0.0 111.878 -179.611 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.593 ' HA ' ' HB3' ' A' ' 41' ' ' ASN . 0.2 OUTLIER 70.9 48.94 0.38 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 -177.366 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.623 ' HA ' ' O ' ' A' ' 42' ' ' PRO . 97.8 m-20 58.63 8.37 0.89 Allowed 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 112.498 -2.137 . . . . 0.0 113.216 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.16 -75.89 1.27 Allowed Glycine 0 N--CA 1.49 2.299 0 C-N-CA 117.88 -2.105 . . . . 0.0 108.368 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.949 ' HB3' HD13 ' A' ' 45' ' ' ILE . 0.8 OUTLIER -119.25 -78.72 0.59 Allowed 'General case' 0 C--N 1.293 -1.862 0 CA-C-O 122.261 1.029 . . . . 0.0 108.316 177.388 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.7 ' CB ' HG21 ' A' ' 45' ' ' ILE . 1.7 tp10 -177.01 140.55 0.31 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 178.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.858 ' CB ' ' HB2' ' A' ' 10' ' ' ASP . 0.3 OUTLIER -87.29 122.67 31.37 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 116.286 -2.166 . . . . 0.0 112.324 -179.608 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.557 ' HA2' ' CZ ' ' A' ' 19' ' ' PHE . . . -177.25 120.13 0.72 Allowed Glycine 0 C--N 1.28 -2.542 0 CA-C-N 113.496 -1.684 . . . . 0.0 110.019 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.9 82.69 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.61 ' CD1' ' N ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -174.23 -173.43 0.79 Allowed 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.226 -179.165 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.778 HG22 ' CA ' ' A' ' 5' ' ' ASN . 39.0 p -102.12 150.62 23.08 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.421 -0.8 . . . . 0.0 112.441 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -130.25 121.29 3.3 Favored Glycine 0 N--CA 1.499 2.846 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 178.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.67 -45.01 70.13 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.49 -1.006 . . . . 0.0 109.823 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.689 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -118.02 135.4 23.42 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.034 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -69.29 -45.23 1.93 Allowed 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.384 1.202 . . . . 0.0 110.74 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.576 ' O ' HD22 ' A' ' 29' ' ' LEU . 40.3 mtt180 -82.3 -64.93 1.08 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.652 -0.655 . . . . 0.0 111.208 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.625 ' HG3' ' HA ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -47.0 -45.09 20.82 Favored 'General case' 0 N--CA 1.51 2.569 0 O-C-N 121.187 -0.946 . . . . 0.0 111.861 -179.374 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.689 ' HB3' ' O ' ' A' ' 23' ' ' GLN . . . -73.41 -17.79 61.22 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.181 -1.007 . . . . 0.0 110.642 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.555 ' HB2' ' HE1' ' A' ' 56' ' ' HIS . . . -71.93 -52.51 16.86 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.847 -1.158 . . . . 0.0 111.759 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.995 HD12 HG21 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -52.64 -57.24 10.67 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.849 0.833 . . . . 0.0 109.66 -179.073 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.409 ' NZ ' ' OE1' ' A' ' 26' ' ' GLN . 30.7 mtmt -69.68 -34.4 73.91 Favored 'General case' 0 N--CA 1.511 2.592 0 O-C-N 121.284 -0.885 . . . . 0.0 113.151 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.675 ' C ' ' HB2' ' A' ' 36' ' ' SER . . . -59.29 -43.58 92.58 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.757 -1.214 . . . . 0.0 112.129 -178.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.891 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -65.49 -32.75 74.53 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 118.621 -1.232 . . . . 0.0 110.062 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.497 ' HB2' ' HG3' ' A' ' 82' ' ' PRO . 46.8 t30 -40.04 -50.01 2.56 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.0 mtm105 -94.65 -74.76 0.53 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.196 -1.002 . . . . 0.0 113.097 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.498 ' O ' ' CD2' ' A' ' 16' ' ' HIS . . . -113.53 -0.06 24.8 Favored Glycine 0 N--CA 1.504 3.2 0 N-CA-C 116.758 1.463 . . . . 0.0 116.758 -175.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.675 ' HB2' ' C ' ' A' ' 31' ' ' ALA . 0.3 OUTLIER -87.64 4.05 45.39 Favored 'General case' 0 N--CA 1.506 2.34 0 CA-C-N 122.248 3.024 . . . . 0.0 110.843 -177.272 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -166.58 117.68 0.75 Allowed Glycine 0 N--CA 1.482 1.739 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.506 ' O ' ' HB3' ' A' ' 39' ' ' LYS . 28.2 m -78.29 -17.28 56.82 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 120.525 2.163 . . . . 0.0 109.691 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.829 ' CA ' ' HG3' ' A' ' 42' ' ' PRO . 4.6 tttm 73.27 -56.8 0.65 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -178.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.9 -19.36 65.71 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 175.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.593 ' HB3' ' HA ' ' A' ' 11' ' ' GLU 0.278 0.2 OUTLIER -160.23 68.08 2.78 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.845 -0.535 . . . . 0.0 111.332 179.108 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.829 ' HG3' ' CA ' ' A' ' 39' ' ' LYS . 76.8 Cg_endo -116.95 -175.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.411 2.074 . . . . 0.0 109.369 178.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.452 ' HB3' ' O ' ' A' ' 14' ' ' ASN . 1.7 t70 -168.54 -173.98 2.07 Favored 'General case' 0 N--CA 1.514 2.775 0 C-N-CA 116.988 -1.885 . . . . 0.0 113.431 176.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.873 HG22 ' HD3' ' A' ' 59' ' ' LYS . 1.6 pp -81.52 136.28 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.949 HD13 ' HB3' ' A' ' 14' ' ' ASN . 3.1 tp -147.94 139.53 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 117.634 -1.626 . . . . 0.0 114.184 -177.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.505 ' H ' HD12 ' A' ' 45' ' ' ILE . 49.4 mtt-85 -88.75 95.28 10.21 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 173.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.829 ' HG ' HD22 ' A' ' 8' ' ' LEU . 0.3 OUTLIER -66.52 93.16 0.23 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -178.357 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.868 ' O ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.296 -1.754 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.214 -176.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 48' ' ' ARG . 9.2 mttp . . . . . 0 N--CA 1.495 1.806 0 CA-C-O 120.695 0.284 . . . . 0.0 110.675 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.426 HG23 ' C ' ' A' ' 54' ' ' LYS . 71.7 t -153.82 96.35 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.613 -0.679 . . . . 0.0 111.028 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.76 ' CD2' ' HB2' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -88.44 137.15 32.58 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 177.237 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.529 ' HB ' ' CB ' ' A' ' 87' ' ' GLU . 2.2 t -116.79 116.12 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 O-C-N 119.755 -1.841 . . . . 0.0 110.381 -178.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.734 ' HA ' ' O ' ' A' ' 85' ' ' LYS . 0.5 OUTLIER -157.51 174.95 14.6 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.289 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.873 ' HD3' HG22 ' A' ' 44' ' ' ILE . 16.8 mttm -132.04 127.33 35.93 Favored 'General case' 0 N--CA 1.505 2.296 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 177.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.891 ' HB1' ' HB2' ' A' ' 32' ' ' ALA . . . -115.67 110.29 18.94 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 120.747 -1.221 . . . . 0.0 113.198 -175.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.762 ' O ' ' HA ' ' A' ' 82' ' ' PRO . 14.1 m0 -126.49 -167.21 1.69 Allowed 'General case' 0 N--CA 1.512 2.675 0 O-C-N 121.943 -0.473 . . . . 0.0 110.307 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.718 ' HB2' ' HB2' ' A' ' 39' ' ' LYS . 0.7 OUTLIER -123.45 88.13 2.86 Favored 'General case' 0 N--CA 1.507 2.382 0 CA-C-N 120.158 1.345 . . . . 0.0 112.569 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.879 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 3.6 mt-10 -165.97 172.34 11.6 Favored 'General case' 0 N--CA 1.51 2.573 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.283 176.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.668 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 9.2 tt -73.61 101.42 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.523 3.186 0 N-CA-C 116.824 2.157 . . . . 0.0 116.824 -174.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.902 HG13 ' CD1' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -88.29 -166.57 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.406 -1.434 . . . . 0.0 109.883 176.63 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.643 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 9.2 t0 -124.43 129.08 50.01 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.843 ' HA ' ' CB ' ' A' ' 77' ' ' GLU . . . -64.3 99.3 0.18 Allowed Pre-proline 0 N--CA 1.507 2.396 0 CA-C-O 117.79 -1.1 . . . . 0.0 111.784 -178.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.694 ' HD3' ' HB3' ' A' ' 77' ' ' GLU . 52.1 Cg_endo -88.9 -160.33 0.1 OUTLIER 'Trans proline' 0 C--N 1.316 -1.141 0 O-C-N 124.105 1.581 . . . . 0.0 110.528 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.3 mttt -70.11 64.57 0.24 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.292 -0.88 . . . . 0.0 109.092 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.762 ' ND2' HD11 ' A' ' 29' ' ' LEU . 5.4 m-20 -102.37 -12.4 17.93 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.473 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.743 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER 59.8 44.69 0.98 Allowed Pre-proline 0 N--CA 1.506 2.358 0 C-N-CA 122.796 0.439 . . . . 0.0 111.209 -177.528 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.743 ' HD3' ' N ' ' A' ' 71' ' ' ARG . 48.9 Cg_endo -92.89 99.89 0.16 Allowed 'Trans proline' 0 C--N 1.323 -0.797 0 C-N-CA 121.152 1.234 . . . . 0.0 110.495 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.19 -34.07 24.05 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.365 -0.834 . . . . 0.0 112.065 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.465 ' CD1' ' N ' ' A' ' 74' ' ' TRP . 32.2 m95 -81.55 -31.46 32.68 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.444 -0.785 . . . . 0.0 110.514 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.456 ' O ' ' HB2' ' A' ' 72' ' ' PRO . 12.5 tpt -164.75 110.38 0.85 Allowed Pre-proline 0 N--CA 1.496 1.861 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.703 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 48.2 Cg_endo -79.28 -178.91 4.96 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.898 1.473 . . . . 0.0 112.693 -178.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.843 ' CB ' ' HA ' ' A' ' 67' ' ' ALA . 3.1 tt0 -90.21 6.61 42.03 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 118.429 -1.308 . . . . 0.0 110.09 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.736 ' O ' HG22 ' A' ' 79' ' ' ILE . 1.5 tppm? -92.28 77.05 5.22 Favored 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.778 HD11 ' CB ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -168.08 158.63 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 C-N-CA 118.272 -1.371 . . . . 0.0 112.146 -177.711 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.578 ' HA ' ' HB ' ' A' ' 64' ' ' ILE . 1.7 m -77.09 103.35 6.97 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 175.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.875 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -173.17 -152.18 0.0 OUTLIER Pre-proline 0 C--O 1.196 -1.711 0 O-C-N 121.302 -0.874 . . . . 0.0 108.759 -175.757 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.875 ' HD2' ' HB3' ' A' ' 81' ' ' LYS . 43.4 Cg_endo -68.34 123.7 10.84 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 117.808 -0.995 . . . . 0.0 111.639 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.902 ' CD1' HG13 ' A' ' 65' ' ' VAL . 0.7 OUTLIER -63.43 159.4 18.44 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.184 -0.947 . . . . 0.0 109.382 178.83 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.995 HG21 HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -153.16 93.94 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 C-N-CA 120.034 -0.666 . . . . 0.0 109.62 178.376 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.734 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 3.1 tptt -73.5 125.59 28.29 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 177.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.586 ' HB3' ' CZ ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -94.05 90.64 6.5 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 122.337 1.065 . . . . 0.0 113.783 -175.257 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.529 ' CB ' ' HB ' ' A' ' 57' ' ' VAL . 4.2 mt-10 -86.35 150.63 24.2 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 115.293 -0.867 . . . . 0.0 108.755 176.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -56.89 122.14 11.54 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.363 -0.836 . . . . 0.0 111.911 -177.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.664 HG23 ' HA ' ' A' ' 56' ' ' HIS . 88.1 mt . . . . . 0 N--CA 1.492 1.673 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.543 ' HB3' ' HD2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 120.853 0.359 . . . . 0.0 110.104 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.831 ' CA ' HG22 ' A' ' 20' ' ' THR . 43.9 t30 -74.35 137.49 42.83 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.496 -0.752 . . . . 0.0 110.58 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.437 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 25.7 m-85 -145.01 151.1 38.04 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.347 0.594 . . . . 0.0 111.057 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.708 HG22 ' O ' ' A' ' 48' ' ' ARG . 11.7 m -111.21 146.55 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.665 -0.647 . . . . 0.0 111.173 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.1 HD21 HD21 ' A' ' 47' ' ' LEU . 4.6 mp -152.33 145.08 24.3 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.422 -0.799 . . . . 0.0 111.862 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -134.11 91.56 2.83 Favored 'General case' 0 N--CA 1.514 2.756 0 O-C-N 121.073 -1.017 . . . . 0.0 111.243 176.647 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.762 ' HB2' ' N ' ' A' ' 16' ' ' HIS . 1.7 t70 -69.63 -159.4 0.03 OUTLIER 'General case' 0 N--CA 1.51 2.565 0 C-N-CA 123.932 0.893 . . . . 0.0 112.007 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.578 ' HA ' ' HB3' ' A' ' 41' ' ' ASN . 0.1 OUTLIER 72.23 52.56 0.19 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 -176.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.599 ' HA ' ' O ' ' A' ' 42' ' ' PRO . 92.4 m-20 61.28 6.91 1.49 Allowed 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 112.539 -2.118 . . . . 0.0 112.783 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.421 ' O ' ' HB3' ' A' ' 43' ' ' ASP . . . -90.17 -75.43 1.3 Allowed Glycine 0 N--CA 1.485 1.95 0 C-N-CA 117.98 -2.057 . . . . 0.0 108.82 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.872 ' CG ' HD13 ' A' ' 45' ' ' ILE . 8.2 m120 -125.22 -76.77 0.59 Allowed 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.596 0.713 . . . . 0.0 111.337 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.733 ' HB2' HG21 ' A' ' 45' ' ' ILE . 8.1 mt-10 -169.31 151.42 4.57 Favored 'General case' 0 N--CA 1.511 2.582 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.762 ' N ' ' HB2' ' A' ' 10' ' ' ASP . 0.4 OUTLIER -99.1 118.68 36.39 Favored 'General case' 0 N--CA 1.507 2.388 0 C-N-CA 115.021 -2.672 . . . . 0.0 113.125 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.57 ' HA2' ' CZ ' ' A' ' 19' ' ' PHE . . . 175.21 132.07 1.53 Allowed Glycine 0 C--N 1.285 -2.292 0 C-N-CA 119.493 -1.336 . . . . 0.0 112.251 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.6 86.78 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 175.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.623 ' CD1' ' N ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -172.54 -172.26 0.89 Allowed 'General case' 0 N--CA 1.5 2.073 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.733 -178.132 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.831 HG22 ' CA ' ' A' ' 5' ' ' ASN . 57.2 p -107.62 158.46 17.23 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.493 -0.755 . . . . 0.0 111.703 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -130.69 130.97 6.31 Favored Glycine 0 N--CA 1.501 3.02 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.4 ttpt -60.84 -47.82 84.64 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.309 -1.113 . . . . 0.0 108.765 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.665 ' HB3' ' HB3' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -115.7 114.13 42.22 Favored Pre-proline 0 N--CA 1.486 1.362 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.403 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.94 -35.86 41.66 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.65 1.342 . . . . 0.0 110.823 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.593 ' HB3' ' HA ' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -83.08 -62.92 1.47 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.209 -0.932 . . . . 0.0 109.862 179.419 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.665 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 1.0 OUTLIER -53.44 -41.97 66.65 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.129 -0.982 . . . . 0.0 111.886 -179.683 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' A' ' 23' ' ' GLN . . . -74.57 -15.69 60.84 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 120.593 -1.317 . . . . 0.0 110.42 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.61 -51.89 63.29 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.79 -1.194 . . . . 0.0 110.642 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.064 HD12 HG21 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -61.9 -50.46 72.1 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 121.558 0.694 . . . . 0.0 109.559 -179.555 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -69.41 -37.87 77.65 Favored 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -178.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.43 ' C ' ' HB2' ' A' ' 36' ' ' SER . . . -60.5 -43.73 96.75 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 120.719 -1.238 . . . . 0.0 112.461 -177.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.724 ' CB ' ' HB1' ' A' ' 60' ' ' ALA . . . -64.51 -33.34 75.67 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 118.77 -1.172 . . . . 0.0 110.15 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.545 ' N ' ' HG3' ' A' ' 82' ' ' PRO . 0.2 OUTLIER -42.74 -46.34 5.1 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.802 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.5 mtp85 -95.51 -72.83 0.61 Allowed 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.269 -0.972 . . . . 0.0 112.254 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.548 ' O ' ' CD2' ' A' ' 16' ' ' HIS . . . -115.72 -0.72 21.47 Favored Glycine 0 N--CA 1.499 2.877 0 N-CA-C 117.48 1.752 . . . . 0.0 117.48 -175.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.693 ' CB ' ' HA ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -82.03 -2.29 51.21 Favored 'General case' 0 N--CA 1.514 2.73 0 CA-C-N 123.615 3.708 . . . . 0.0 110.94 -176.744 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -163.49 120.84 0.97 Allowed Glycine 0 C--N 1.297 -1.637 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -178.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.532 ' O ' ' HB3' ' A' ' 39' ' ' LYS . 23.5 m -77.73 -15.61 59.01 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 119.825 1.813 . . . . 0.0 109.494 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.84 ' CA ' ' HG3' ' A' ' 42' ' ' PRO . 7.6 tttm 75.21 -56.27 0.62 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -178.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.43 -18.89 65.62 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 175.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.578 ' HB3' ' HA ' ' A' ' 11' ' ' GLU 0.27 0.4 OUTLIER -160.44 67.31 2.62 Favored Pre-proline 0 C--O 1.202 -1.446 0 O-C-N 121.661 -0.649 . . . . 0.0 111.147 179.097 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.84 ' HG3' ' CA ' ' A' ' 39' ' ' LYS . 82.9 Cg_endo -118.0 -176.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.3 -2.012 0 C-N-CA 122.019 1.813 . . . . 0.0 109.615 178.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.459 ' HB2' ' C ' ' A' ' 12' ' ' ASP . 0.7 OUTLIER -168.04 -169.49 1.14 Allowed 'General case' 0 N--CA 1.512 2.643 0 O-C-N 119.826 -1.796 . . . . 0.0 113.902 177.036 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.868 HG22 ' HD3' ' A' ' 59' ' ' LYS . 1.6 pp -91.5 142.6 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.872 HD13 ' CG ' ' A' ' 14' ' ' ASN . 1.1 tp -161.59 142.67 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 117.958 -1.497 . . . . 0.0 113.422 -178.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.508 ' HG3' HG13 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -87.03 96.23 10.21 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 174.184 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 1.1 HD21 HD21 ' A' ' 8' ' ' LEU . 9.0 mp -63.21 95.77 0.09 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 -178.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.708 ' O ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.296 -1.747 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.704 -177.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.626 ' O ' ' HA ' ' A' ' 48' ' ' ARG . 5.3 mtmm . . . . . 0 N--CA 1.487 1.382 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 6.7 t -137.03 100.2 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 CA-C-O 121.399 0.618 . . . . 0.0 110.338 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.846 ' HA ' HG23 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -91.61 138.09 31.85 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.52 ' HB ' ' CB ' ' A' ' 87' ' ' GLU . 2.5 t -114.59 104.09 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 O-C-N 119.91 -1.744 . . . . 0.0 109.258 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.748 ' HA ' ' O ' ' A' ' 85' ' ' LYS . 0.6 OUTLIER -146.62 175.58 10.49 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.376 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.868 ' HD3' HG22 ' A' ' 44' ' ' ILE . 24.5 mttm -130.04 128.12 41.3 Favored 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 177.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.724 ' HB1' ' CB ' ' A' ' 32' ' ' ALA . . . -114.18 113.26 24.43 Favored 'General case' 0 N--CA 1.505 2.312 0 C-N-CA 118.199 -1.4 . . . . 0.0 113.605 -176.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.814 ' HB2' ' HB2' ' A' ' 83' ' ' PHE . 13.6 m0 -130.26 -168.42 1.97 Allowed 'General case' 0 N--CA 1.516 2.841 0 O-C-N 121.713 -0.617 . . . . 0.0 110.802 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.668 ' HB2' ' HB2' ' A' ' 39' ' ' LYS . 1.3 tmtm? -120.68 89.02 3.05 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.696 -1.253 . . . . 0.0 111.283 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.84 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 2.1 mt-10 -165.79 168.67 15.81 Favored 'General case' 0 N--CA 1.508 2.456 0 CA-C-O 121.354 0.597 . . . . 0.0 109.994 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.676 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 4.7 tt -72.56 101.15 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.522 3.138 0 O-C-N 119.612 -1.93 . . . . 0.0 115.68 -176.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.985 HG13 ' CD1' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -91.86 -166.58 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.501 -1.375 . . . . 0.0 110.838 177.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.681 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 7.5 t70 -120.39 130.19 54.26 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.862 ' HA ' ' CB ' ' A' ' 77' ' ' GLU . . . -65.64 100.47 0.23 Allowed Pre-proline 0 N--CA 1.509 2.505 0 CA-C-O 118.061 -0.971 . . . . 0.0 113.308 -177.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.681 ' HD3' ' O ' ' A' ' 66' ' ' ASP . 55.8 Cg_endo -84.01 -163.48 0.2 Allowed 'Trans proline' 0 N--CA 1.485 1.019 0 O-C-N 123.625 1.329 . . . . 0.0 110.502 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.2 mmpp? -69.83 64.87 0.22 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.158 -0.964 . . . . 0.0 109.841 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.808 ' ND2' HD11 ' A' ' 29' ' ' LEU . 3.8 m-20 -97.94 -12.6 21.84 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.986 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.704 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER 44.87 51.08 8.21 Favored Pre-proline 0 N--CA 1.504 2.271 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.374 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.798 ' HG2' ' HA ' ' A' ' 76' ' ' PRO . 55.1 Cg_endo -99.97 112.0 0.07 OUTLIER 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 121.861 1.707 . . . . 0.0 109.518 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.78 -19.98 47.32 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.766 -1.209 . . . . 0.0 112.106 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.435 ' CD1' ' N ' ' A' ' 74' ' ' TRP . 44.5 m95 -81.96 -37.75 26.22 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.308 -0.87 . . . . 0.0 110.46 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.461 ' O ' ' HB2' ' A' ' 72' ' ' PRO . 20.9 ttm -168.89 130.75 1.12 Allowed Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.673 -0.642 . . . . 0.0 109.665 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.798 ' HA ' ' HG2' ' A' ' 72' ' ' PRO . 47.5 Cg_endo -88.59 179.82 2.47 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.662 1.349 . . . . 0.0 111.803 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.862 ' CB ' ' HA ' ' A' ' 67' ' ' ALA . 3.7 tt0 -88.71 9.23 25.09 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 118.005 -1.478 . . . . 0.0 110.1 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.707 ' H ' ' HB2' ' A' ' 67' ' ' ALA . 40.6 tptt -93.74 82.49 4.32 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.678 HG22 ' C ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -179.82 163.21 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 C-N-CA 118.006 -1.478 . . . . 0.0 112.501 -178.51 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.591 ' HA ' ' HB ' ' A' ' 64' ' ' ILE . 1.1 m -72.01 105.35 3.86 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 175.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.711 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 11.2 pttp -167.81 -154.92 0.0 OUTLIER Pre-proline 0 C--O 1.196 -1.729 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -175.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.743 ' HA ' ' O ' ' A' ' 61' ' ' TRP . 49.7 Cg_endo -75.59 128.99 11.44 Favored 'Trans proline' 0 C--N 1.299 -2.066 0 N-CA-C 109.761 -0.899 . . . . 0.0 109.761 178.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.985 ' CD1' HG13 ' A' ' 65' ' ' VAL . 1.1 m-30 -64.73 157.15 28.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.217 -0.927 . . . . 0.0 109.423 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 1.064 HG21 HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -152.15 95.66 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.153 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.748 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -74.01 130.15 39.28 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 105.917 -1.882 . . . . 0.0 105.917 178.16 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.632 ' HB3' ' CZ ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -99.36 92.24 5.32 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 122.615 1.197 . . . . 0.0 113.908 -175.338 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.52 ' CB ' ' HB ' ' A' ' 57' ' ' VAL . 24.0 mt-10 -88.75 151.94 22.1 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 175.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -55.4 116.69 2.99 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-O 122.316 1.055 . . . . 0.0 112.77 -176.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.846 HG23 ' HA ' ' A' ' 56' ' ' HIS . 23.7 mt . . . . . 0 N--CA 1.491 1.611 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.428 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.55 ' O ' ' HA ' ' A' ' 20' ' ' THR . 5.1 mmp_? . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 120.79 0.329 . . . . 0.0 110.213 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.698 ' CA ' HG22 ' A' ' 20' ' ' THR . 19.5 t-20 -74.54 140.88 44.78 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.557 -0.714 . . . . 0.0 110.228 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.557 ' HD1' HD22 ' A' ' 47' ' ' LEU . 8.5 m-85 -152.57 168.29 26.07 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.476 -0.765 . . . . 0.0 110.421 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.573 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -150.24 141.52 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 O-C-N 121.444 -0.785 . . . . 0.0 111.591 -178.007 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.967 HD21 ' HG ' ' A' ' 47' ' ' LEU . 1.5 mp -148.12 167.68 24.39 Favored 'General case' 0 N--CA 1.52 3.052 0 O-C-N 121.287 -0.883 . . . . 0.0 112.942 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.539 ' N ' ' O ' ' A' ' 15' ' ' GLU . 9.3 ptt-85 -136.3 95.37 3.17 Favored 'General case' 0 N--CA 1.517 2.908 0 O-C-N 121.488 -0.757 . . . . 0.0 111.28 176.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.82 ' HB2' ' N ' ' A' ' 16' ' ' HIS . 5.1 t0 -82.46 -150.93 0.09 Allowed 'General case' 0 N--CA 1.509 2.508 0 C-N-CA 124.136 0.974 . . . . 0.0 113.081 -178.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.55 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 0.8 OUTLIER 73.56 53.63 0.11 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 104.048 -2.575 . . . . 0.0 104.048 -175.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.55 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 1.9 m-20 63.98 3.96 1.85 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 112.683 -2.053 . . . . 0.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -89.52 -76.54 1.31 Allowed Glycine 0 N--CA 1.479 1.55 0 C-N-CA 117.795 -2.145 . . . . 0.0 107.795 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.886 ' CG ' HD13 ' A' ' 45' ' ' ILE . 3.5 m120 -126.74 -77.03 0.58 Allowed 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.452 0.644 . . . . 0.0 111.576 178.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 1.109 ' HB2' HG21 ' A' ' 45' ' ' ILE . 4.6 mt-10 -171.28 154.84 4.08 Favored 'General case' 0 N--CA 1.512 2.626 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.82 ' N ' ' HB2' ' A' ' 10' ' ' ASP . 0.2 OUTLIER -119.62 120.29 36.23 Favored 'General case' 0 N--CA 1.511 2.615 0 C-N-CA 114.848 -2.741 . . . . 0.0 115.047 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.42 ' HA2' ' CZ ' ' A' ' 19' ' ' PHE . . . -176.45 128.35 1.34 Allowed Glycine 0 C--N 1.29 -1.999 0 CA-C-N 113.561 -1.654 . . . . 0.0 110.113 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.418 ' C ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -134.78 92.05 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 177.449 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.671 ' CD1' ' N ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -175.25 -173.3 0.65 Allowed 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 121.283 0.563 . . . . 0.0 110.281 -178.743 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.698 HG22 ' CA ' ' A' ' 5' ' ' ASN . 22.2 p -106.1 126.56 52.36 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.289 -0.882 . . . . 0.0 110.953 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -97.68 131.15 10.49 Favored Glycine 0 N--CA 1.501 3.001 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.1 mtmp? -59.54 -39.2 83.17 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.55 -0.971 . . . . 0.0 109.57 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.813 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -127.42 125.35 23.89 Favored Pre-proline 0 N--CA 1.489 1.493 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.112 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.856 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 37.0 Cg_endo -63.06 -40.82 31.65 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 O-C-N 123.493 1.26 . . . . 0.0 110.924 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.411 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 2.8 ttt180 -87.47 -61.19 1.78 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.499 -0.751 . . . . 0.0 111.46 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.471 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 14.5 tt0 -55.76 -40.94 73.28 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 120.938 -1.101 . . . . 0.0 111.71 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.813 ' HB3' ' O ' ' A' ' 23' ' ' GLN . . . -79.8 -18.92 49.75 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.828 -1.149 . . . . 0.0 109.446 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.856 ' HB2' ' O ' ' A' ' 24' ' ' PRO . . . -62.74 -57.7 10.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.358 -0.839 . . . . 0.0 110.808 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.492 ' O ' ' HG2' ' A' ' 82' ' ' PRO . 2.4 pp -58.38 -44.37 88.87 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.354 -178.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.476 ' HB2' ' HE3' ' A' ' 30' ' ' LYS . 1.0 OUTLIER -70.46 -35.47 73.35 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 120.793 -1.192 . . . . 0.0 111.689 179.249 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 27' ' ' ALA . . . -56.59 -42.01 77.97 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.187 -0.946 . . . . 0.0 113.079 -177.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.843 ' CB ' ' HB1' ' A' ' 60' ' ' ALA . . . -73.03 -29.92 63.36 Favored 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 118.865 -1.134 . . . . 0.0 110.096 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.577 ' CB ' ' HG3' ' A' ' 82' ' ' PRO . 6.3 t-20 -41.37 -46.89 3.45 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.371 0.605 . . . . 0.0 109.369 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.8 mmm-85 -92.97 -74.57 0.52 Allowed 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 118.884 -1.126 . . . . 0.0 112.938 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.474 ' O ' ' CD2' ' A' ' 16' ' ' HIS . . . -115.93 -3.96 19.34 Favored Glycine 0 N--CA 1.499 2.855 0 N-CA-C 117.065 1.586 . . . . 0.0 117.065 -175.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.757 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 0.6 OUTLIER -79.02 -4.27 49.26 Favored 'General case' 0 N--CA 1.51 2.558 0 CA-C-N 122.633 3.216 . . . . 0.0 110.573 -176.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.54 ' O ' ' HG3' ' A' ' 39' ' ' LYS . . . -154.31 117.72 0.81 Allowed Glycine 0 C--N 1.292 -1.873 0 N-CA-C 108.579 -1.809 . . . . 0.0 108.579 -178.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.459 ' HB ' ' C ' ' A' ' 41' ' ' ASN . 90.2 m -68.9 -17.12 63.92 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 119.348 1.574 . . . . 0.0 108.107 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.8 ' CA ' ' HG3' ' A' ' 42' ' ' PRO . 10.0 mtmt 71.36 -59.64 0.54 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.72 -20.02 61.97 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 175.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.505 ' HB3' ' HA ' ' A' ' 11' ' ' GLU 0.279 0.1 OUTLIER -149.66 65.25 7.59 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.722 -0.612 . . . . 0.0 110.638 178.628 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.8 ' HG3' ' CA ' ' A' ' 39' ' ' LYS . 75.1 Cg_endo -117.03 -174.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 121.167 1.245 . . . . 0.0 111.322 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.406 ' N ' ' HE1' ' A' ' 61' ' ' TRP . 1.3 t70 -167.13 -168.23 1.05 Allowed 'General case' 0 N--CA 1.512 2.672 0 C-N-CA 118.07 -1.452 . . . . 0.0 112.887 177.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.876 HG22 ' HD3' ' A' ' 59' ' ' LYS . 1.2 pp -95.85 149.62 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 1.109 HG21 ' HB2' ' A' ' 15' ' ' GLU . 1.8 tp -163.09 144.05 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 C-N-CA 117.773 -1.571 . . . . 0.0 113.883 -178.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.565 ' H ' HD12 ' A' ' 45' ' ' ILE . 32.8 mtt180 -85.35 95.63 9.29 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 174.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.967 ' HG ' HD21 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -70.15 94.88 0.93 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.448 -0.782 . . . . 0.0 109.361 -178.063 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.563 -0.711 . . . . 0.0 110.078 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.515 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.937 0 CA-C-O 121.187 0.518 . . . . 0.0 110.364 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 54' ' ' LYS . 2.4 t -155.76 142.84 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 CA-C-O 122.002 0.906 . . . . 0.0 111.216 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.666 ' NE2' ' HB2' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -162.78 129.89 3.61 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 179.598 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.595 HG12 ' HB2' ' A' ' 87' ' ' GLU . 11.5 t -118.31 115.88 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 117.311 -1.756 . . . . 0.0 109.23 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.744 ' HA ' ' O ' ' A' ' 85' ' ' LYS . 0.8 OUTLIER -153.76 -176.63 5.92 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 -179.817 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.876 ' HD3' HG22 ' A' ' 44' ' ' ILE . 30.2 mttt -137.39 133.97 35.4 Favored 'General case' 0 N--CA 1.51 2.566 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 177.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.843 ' HB1' ' CB ' ' A' ' 32' ' ' ALA . . . -117.04 112.69 21.28 Favored 'General case' 0 N--CA 1.51 2.557 0 CA-C-N 120.662 1.574 . . . . 0.0 113.653 -176.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.779 ' HB2' ' HB2' ' A' ' 83' ' ' PHE . 11.7 m0 -133.59 -165.51 1.64 Allowed 'General case' 0 N--CA 1.514 2.726 0 O-C-N 122.036 -0.415 . . . . 0.0 111.344 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.66 ' HB2' ' HB3' ' A' ' 39' ' ' LYS . 1.6 tptp -123.78 91.4 3.46 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.643 -1.285 . . . . 0.0 111.776 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.899 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 1.1 mt-10 -165.37 -173.0 2.65 Favored 'General case' 0 N--CA 1.51 2.573 0 CA-C-O 121.223 0.535 . . . . 0.0 110.452 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.606 ' C ' ' HE1' ' A' ' 83' ' ' PHE . 12.6 tt -94.86 98.68 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.117 0 O-C-N 118.977 -2.327 . . . . 0.0 116.081 -176.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.998 HG13 ' CD1' ' A' ' 83' ' ' PHE . 0.3 OUTLIER -103.65 -168.54 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 120.137 -1.602 . . . . 0.0 108.706 176.329 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.784 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 5.9 t0 -114.23 145.63 41.47 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.663 -0.648 . . . . 0.0 111.379 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.91 ' HA ' ' HB3' ' A' ' 77' ' ' GLU 0.25 . . -66.25 101.38 0.28 Allowed Pre-proline 0 N--CA 1.511 2.6 0 CA-C-O 118.075 -0.964 . . . . 0.0 113.167 -178.772 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.803 ' HG3' ' HG2' ' A' ' 86' ' ' LYS . 55.0 Cg_endo -70.81 64.53 2.42 Favored 'Trans proline' 0 N--CA 1.5 1.906 0 O-C-N 123.85 1.448 . . . . 0.0 110.961 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 50.2 40.94 23.23 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 120.994 -1.066 . . . . 0.0 108.69 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.694 ' HB3' ' HG3' ' A' ' 72' ' ' PRO . 6.3 m120 -55.37 -18.83 7.36 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.489 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.792 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER 49.99 43.22 1.55 Allowed Pre-proline 0 N--CA 1.495 1.809 0 CA-C-O 120.484 0.183 . . . . 0.0 110.784 -176.642 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.792 ' HD3' ' N ' ' A' ' 71' ' ' ARG . 57.8 Cg_endo -100.05 135.09 0.22 Allowed 'Trans proline' 0 C--O 1.219 -0.446 0 C-N-CA 121.481 1.454 . . . . 0.0 109.435 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.27 -28.55 25.25 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 120.892 -1.13 . . . . 0.0 111.105 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.447 ' CD1' ' N ' ' A' ' 74' ' ' TRP . 41.0 m95 -84.71 -35.94 22.17 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.542 -0.724 . . . . 0.0 111.424 -178.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.522 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 2.4 tpt -175.06 132.11 0.45 Allowed Pre-proline 0 N--CA 1.51 2.55 0 O-C-N 121.23 -0.919 . . . . 0.0 111.689 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.769 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 44.3 Cg_endo -93.55 -178.21 0.71 Allowed 'Trans proline' 0 N--CA 1.489 1.264 0 C-N-CA 122.401 2.067 . . . . 0.0 111.455 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.91 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 7.8 tt0 -86.12 9.24 17.97 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 117.729 -1.588 . . . . 0.0 110.82 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.784 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -88.05 82.2 7.25 Favored 'General case' 0 N--CA 1.507 2.406 0 C-N-CA 118.861 -1.136 . . . . 0.0 108.292 178.786 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.776 HG22 ' C ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER 179.02 165.89 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.382 0 C-N-CA 118.384 -1.326 . . . . 0.0 112.673 -178.105 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.56 ' N ' HG13 ' A' ' 79' ' ' ILE . 13.3 m -77.69 107.13 9.96 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 175.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.938 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -171.54 -152.86 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.331 0 O-C-N 121.107 -0.995 . . . . 0.0 108.644 -176.106 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.938 ' HD2' ' HB2' ' A' ' 81' ' ' LYS . 44.2 Cg_endo -71.86 123.66 9.53 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 117.316 -1.323 . . . . 0.0 110.005 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.998 ' CD1' HG13 ' A' ' 65' ' ' VAL . 0.5 OUTLIER -61.74 161.0 10.75 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.226 -0.921 . . . . 0.0 110.601 -179.665 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.787 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -155.6 95.55 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.083 178.081 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.744 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 0.9 OUTLIER -71.16 133.92 46.55 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 178.131 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.803 ' HG2' ' HG3' ' A' ' 68' ' ' PRO . 0.0 OUTLIER -101.91 92.3 4.75 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -173.795 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.595 ' HB2' HG12 ' A' ' 57' ' ' VAL . 2.6 mp0 -93.47 163.58 13.52 Favored 'General case' 0 C--N 1.28 -2.431 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 174.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.444 ' O ' HG23 ' A' ' 57' ' ' VAL . 1.4 mtt-85 -54.88 146.53 17.24 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 120.959 -1.088 . . . . 0.0 113.448 -176.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.658 HD11 ' CE2' ' A' ' 58' ' ' PHE . 97.8 mt . . . . . 0 N--CA 1.496 1.854 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.538 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 20' ' ' THR . 11.1 mmt85 . . . . . 0 N--CA 1.496 1.875 0 CA-C-O 120.917 0.389 . . . . 0.0 110.035 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.58 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 3.7 t30 -76.96 144.52 38.74 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.593 -0.692 . . . . 0.0 111.158 -179.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.603 ' HB3' ' CD2' ' A' ' 47' ' ' LEU . 18.2 m-85 -140.8 170.53 15.58 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.411 ' O ' HD23 ' A' ' 47' ' ' LEU . 3.5 m -138.93 130.53 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.421 0 O-C-N 121.141 -0.974 . . . . 0.0 112.177 -177.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.689 HD12 ' C ' ' A' ' 15' ' ' GLU . 0.2 OUTLIER -149.39 161.86 41.25 Favored 'General case' 0 N--CA 1.511 2.604 0 O-C-N 121.071 -1.018 . . . . 0.0 112.222 -179.884 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.511 ' O ' ' N ' ' A' ' 14' ' ' ASN . 12.6 tpt180 -142.72 99.2 3.43 Favored 'General case' 0 N--CA 1.511 2.619 0 O-C-N 121.192 -0.943 . . . . 0.0 111.554 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.823 ' HB2' ' N ' ' A' ' 16' ' ' HIS . 19.1 t70 -80.71 -146.53 0.05 Allowed 'General case' 0 N--CA 1.507 2.399 0 C-N-CA 123.662 0.785 . . . . 0.0 110.167 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.722 ' HA ' ' HB3' ' A' ' 41' ' ' ASN . 0.3 OUTLIER 71.0 55.44 0.23 Allowed 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 104.109 -2.552 . . . . 0.0 104.109 -176.057 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.568 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 0.7 OUTLIER 67.04 1.26 2.28 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-N 112.985 -1.916 . . . . 0.0 111.706 -178.848 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.474 ' O ' ' HB3' ' A' ' 43' ' ' ASP . . . -94.98 -77.52 1.37 Allowed Glycine 0 N--CA 1.477 1.369 0 C-N-CA 118.136 -1.983 . . . . 0.0 109.086 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.83 ' HB3' HD13 ' A' ' 45' ' ' ILE . 2.4 m-80 -126.25 -80.3 0.61 Allowed 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.7 ' C ' ' HB2' ' A' ' 10' ' ' ASP . 28.3 tt0 -168.44 139.8 2.7 Favored 'General case' 0 N--CA 1.509 2.524 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 -178.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.823 ' N ' ' HB2' ' A' ' 10' ' ' ASP . 0.9 OUTLIER -109.56 120.98 44.16 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 116.065 -2.254 . . . . 0.0 115.361 -176.318 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.542 ' HA3' ' CE1' ' A' ' 19' ' ' PHE . . . -179.62 129.64 1.39 Allowed Glycine 0 C--N 1.288 -2.109 0 CA-C-N 112.96 -1.927 . . . . 0.0 109.555 178.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.82 94.37 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 177.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.624 ' CD1' ' N ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -175.74 -169.29 0.34 Allowed 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 121.286 0.565 . . . . 0.0 110.591 -178.388 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.58 ' HA ' ' HA ' ' A' ' 5' ' ' ASN . 2.7 p -105.59 150.64 25.22 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.431 -0.793 . . . . 0.0 111.508 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -130.1 128.55 5.66 Favored Glycine 0 N--CA 1.5 2.945 0 N-CA-C 108.669 -1.773 . . . . 0.0 108.669 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -60.9 -52.82 63.41 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.41 -1.053 . . . . 0.0 108.823 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.616 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 5.0 mp0 -106.47 99.32 23.79 Favored Pre-proline 0 N--CA 1.487 1.392 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.774 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 36.8 Cg_endo -59.74 -29.18 89.06 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.508 1.267 . . . . 0.0 110.398 -179.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.61 -61.15 1.86 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.363 -0.836 . . . . 0.0 109.919 178.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.679 ' HG3' ' HA ' ' A' ' 72' ' ' PRO . 16.6 tm0? -65.84 -42.9 89.93 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 120.871 -1.143 . . . . 0.0 112.397 -179.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.616 ' HB3' ' O ' ' A' ' 23' ' ' GLN . . . -73.07 -17.36 61.42 Favored 'General case' 0 N--CA 1.482 1.138 0 O-C-N 120.69 -1.257 . . . . 0.0 109.885 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.774 ' HB2' ' O ' ' A' ' 24' ' ' PRO . . . -61.07 -53.05 61.94 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.237 -0.914 . . . . 0.0 111.592 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.905 ' N ' HD13 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -63.48 -56.84 12.91 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 -179.082 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.448 ' NZ ' ' O ' ' A' ' 75' ' ' MET . 0.1 OUTLIER -48.17 -44.13 32.25 Favored 'General case' 0 N--CA 1.506 2.347 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.93 179.121 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.537 ' C ' ' HB2' ' A' ' 36' ' ' SER . . . -54.83 -43.1 72.67 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.455 -0.778 . . . . 0.0 111.965 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 1.147 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -72.86 -28.25 62.4 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.701 -1.25 . . . . 0.0 110.807 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.575 ' HB2' ' HG3' ' A' ' 82' ' ' PRO . 2.0 t30 -39.59 -46.95 1.86 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -95.11 -74.59 0.54 Allowed 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.154 -1.018 . . . . 0.0 112.91 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.47 ' O ' ' CD2' ' A' ' 16' ' ' HIS . . . -113.81 -4.96 22.59 Favored Glycine 0 N--CA 1.502 3.039 0 N-CA-C 116.798 1.479 . . . . 0.0 116.798 -175.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.701 ' CB ' ' HA ' ' A' ' 32' ' ' ALA . 0.4 OUTLIER -82.44 -7.13 59.64 Favored 'General case' 0 N--CA 1.506 2.363 0 CA-C-N 122.166 2.983 . . . . 0.0 110.157 -177.353 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.512 ' HA3' ' O ' ' A' ' 60' ' ' ALA . . . -141.44 111.74 0.72 Allowed Glycine 0 C--N 1.289 -2.028 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.509 ' O ' ' HB3' ' A' ' 39' ' ' LYS . 5.2 m -69.05 -20.94 64.12 Favored 'General case' 0 C--N 1.312 -1.054 0 O-C-N 120.672 -1.487 . . . . 0.0 109.4 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.693 ' HA ' ' HG3' ' A' ' 42' ' ' PRO . 5.6 ttpt 67.64 -52.04 0.51 Allowed 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 38' ' ' THR . . . -70.65 -27.95 64.44 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 174.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.722 ' HB3' ' HA ' ' A' ' 11' ' ' GLU 0.274 0.2 OUTLIER -142.41 71.19 21.57 Favored Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.468 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 1.013 ' HB2' ' CD1' ' A' ' 61' ' ' TRP . 72.2 Cg_endo -112.89 169.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 121.75 1.633 . . . . 0.0 112.208 -178.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.53 ' HB2' ' C ' ' A' ' 12' ' ' ASP . 0.7 OUTLIER -167.82 -167.47 0.86 Allowed 'General case' 0 N--CA 1.517 2.891 0 C-N-CA 117.692 -1.603 . . . . 0.0 113.949 177.091 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.809 HG22 ' HD3' ' A' ' 59' ' ' LYS . 0.2 OUTLIER -84.09 123.58 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -178.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.83 HD13 ' HB3' ' A' ' 14' ' ' ASN . 0.7 OUTLIER -108.1 117.52 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.846 -1.159 . . . . 0.0 113.648 -177.856 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.505 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 0.3 OUTLIER -87.73 88.14 7.57 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 103.492 -2.781 . . . . 0.0 103.492 173.249 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.661 ' HB2' ' CD2' ' A' ' 56' ' ' HIS . 0.1 OUTLIER -79.14 94.43 5.37 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -177.62 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.532 ' HB3' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.478 0 O-C-N 121.589 -0.694 . . . . 0.0 111.431 -178.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.523 ' HG2' ' CZ ' ' A' ' 6' ' ' PHE . 5.7 mtmt . . . . . 0 N--CA 1.484 1.238 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.532 HG22 ' HB3' ' A' ' 48' ' ' ARG . 2.8 t -154.05 149.75 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.698 0.761 . . . . 0.0 110.522 -178.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.661 ' CD2' ' HB2' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -160.81 122.67 3.07 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 179.276 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.642 HG12 ' HB2' ' A' ' 87' ' ' GLU . 12.9 t -113.32 100.55 10.92 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 C-N-CA 117.722 -1.591 . . . . 0.0 108.188 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.743 ' HA ' ' O ' ' A' ' 85' ' ' LYS . 0.3 OUTLIER -144.72 178.79 7.74 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 179.601 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.829 ' HB3' ' CZ2' ' A' ' 61' ' ' TRP . 44.2 mttt -131.62 134.56 46.13 Favored 'General case' 0 C--N 1.274 -2.715 0 N-CA-C 104.245 -2.502 . . . . 0.0 104.245 176.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 1.147 ' HB1' ' HB2' ' A' ' 32' ' ' ALA . . . -123.54 109.72 14.15 Favored 'General case' 0 N--CA 1.495 1.825 0 C-N-CA 117.593 -1.643 . . . . 0.0 112.599 -175.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 1.013 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 5.3 m0 -124.91 -163.07 1.15 Allowed 'General case' 0 N--CA 1.508 2.442 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.426 -178.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.646 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -124.51 88.55 2.92 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.042 -1.036 . . . . 0.0 111.015 179.541 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.921 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 4.4 mt-10 -167.15 171.64 10.71 Favored 'General case' 0 N--CA 1.507 2.397 0 CA-C-O 121.745 0.783 . . . . 0.0 110.449 177.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.677 ' CG1' ' HA ' ' A' ' 80' ' ' SER . 2.3 mt -72.47 98.37 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.519 2.989 0 O-C-N 119.594 -1.942 . . . . 0.0 115.478 -176.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.863 HG13 ' CD1' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -94.27 -164.54 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.296 -1.503 . . . . 0.0 109.288 176.101 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.672 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 14.2 t70 -120.13 136.93 54.43 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 178.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.797 ' HA ' ' HB2' ' A' ' 77' ' ' GLU 0.251 . . -68.72 100.6 0.26 Allowed Pre-proline 0 N--CA 1.503 2.177 0 CA-C-O 117.799 -1.096 . . . . 0.0 111.615 -177.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.672 ' HD3' ' O ' ' A' ' 66' ' ' ASP . 49.3 Cg_endo -88.52 -153.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.319 -1.003 0 O-C-N 124.086 1.572 . . . . 0.0 111.241 -179.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.04 61.7 0.08 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.128 -0.983 . . . . 0.0 110.102 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.743 ' CG ' HD21 ' A' ' 29' ' ' LEU . 0.7 OUTLIER -99.63 -14.88 18.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.622 -0.673 . . . . 0.0 110.989 -179.583 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.716 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER 49.72 52.6 12.91 Favored Pre-proline 0 N--CA 1.488 1.429 0 O-C-N 121.892 -0.505 . . . . 0.0 109.992 -178.096 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.716 ' HD3' ' N ' ' A' ' 71' ' ' ARG . 53.2 Cg_endo -98.74 108.01 0.07 OUTLIER 'Trans proline' 0 C--N 1.317 -1.124 0 C-N-CA 122.05 1.834 . . . . 0.0 110.831 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.81 -31.32 23.93 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.966 -1.084 . . . . 0.0 111.447 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.453 ' CD1' ' N ' ' A' ' 74' ' ' TRP . 41.8 m95 -83.65 -32.63 25.55 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.688 -0.633 . . . . 0.0 110.907 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.448 ' O ' ' NZ ' ' A' ' 30' ' ' LYS . 2.3 mtm -167.98 106.76 0.56 Allowed Pre-proline 0 N--CA 1.499 2.003 0 O-C-N 121.467 -0.771 . . . . 0.0 111.08 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.765 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 51.0 Cg_endo -79.59 -179.93 5.78 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.696 1.366 . . . . 0.0 110.929 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 1.002 ' HG3' HG21 ' A' ' 84' ' ' VAL . 14.0 mm-40 -96.46 18.87 13.1 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 117.193 -1.803 . . . . 0.0 111.634 -178.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.667 ' C ' HG22 ' A' ' 79' ' ' ILE . 5.8 tttm -90.39 76.27 6.72 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 177.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.667 HG22 ' C ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -179.98 171.48 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 C-N-CA 118.095 -1.442 . . . . 0.0 112.326 -176.294 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.677 ' HA ' ' CG1' ' A' ' 64' ' ' ILE . 29.4 t -71.31 110.37 5.9 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 175.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.854 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . 3.5 mttm -164.83 -154.49 0.0 OUTLIER Pre-proline 0 C--O 1.191 -2.003 0 C-N-CA 119.093 -1.043 . . . . 0.0 108.761 -174.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.854 ' HD2' ' HB3' ' A' ' 81' ' ' LYS . 50.6 Cg_endo -81.94 130.66 6.68 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 N-CA-C 109.336 -1.063 . . . . 0.0 109.336 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.921 ' CZ ' ' HB3' ' A' ' 63' ' ' GLU . 1.5 m-30 -62.13 152.37 33.16 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 118.233 -1.387 . . . . 0.0 108.568 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 1.002 HG21 ' HG3' ' A' ' 77' ' ' GLU . 15.5 m -147.21 96.81 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.241 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.647 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.743 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -74.57 129.26 37.42 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 104.751 -2.314 . . . . 0.0 104.751 177.117 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.503 ' CB ' ' CZ ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -102.67 88.19 3.16 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -173.694 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.642 ' HB2' HG12 ' A' ' 57' ' ' VAL . 4.3 mp0 -91.81 161.56 14.81 Favored 'General case' 0 C--N 1.283 -2.311 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 174.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.464 ' HD2' ' HA ' ' A' ' 88' ' ' ARG . 0.9 OUTLIER -53.0 151.7 4.54 Favored 'General case' 0 N--CA 1.51 2.535 0 O-C-N 120.521 -1.362 . . . . 0.0 113.933 -175.241 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.628 HG12 ' HA ' ' A' ' 56' ' ' HIS . 74.7 mt . . . . . 0 N--CA 1.494 1.739 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.039 -178.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.496 1.837 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.428 ' O ' ' HA ' ' A' ' 22' ' ' LYS . 11.3 m120 -131.34 113.99 14.45 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.523 -0.736 . . . . 0.0 109.751 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.787 HG22 ' HB ' ' A' ' 20' ' ' THR . 1.7 m -139.95 131.54 27.16 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.414 -0.804 . . . . 0.0 109.8 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.625 ' HG3' ' O ' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -120.1 121.96 39.99 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.417 -0.802 . . . . 0.0 111.379 -179.169 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.737 ' HB2' HG22 ' A' ' 20' ' ' THR . 19.4 t-20 -84.99 148.03 26.4 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.593 -0.692 . . . . 0.0 110.284 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -144.03 156.25 44.31 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.734 ' C ' HD23 ' A' ' 8' ' ' LEU . 32.9 m -129.62 132.21 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 120.867 -1.146 . . . . 0.0 111.9 -178.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.85 HD13 ' CD2' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -162.7 164.91 26.22 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.602 -0.686 . . . . 0.0 110.86 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.417 ' H ' ' HB2' ' A' ' 14' ' ' ASN . 15.0 mtt85 -130.96 114.51 15.32 Favored 'General case' 0 N--CA 1.514 2.728 0 O-C-N 121.041 -1.037 . . . . 0.0 113.27 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.781 ' HB2' ' CB ' ' A' ' 16' ' ' HIS . 0.8 OUTLIER -75.07 -155.14 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 124.581 1.153 . . . . 0.0 111.216 179.471 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.613 ' HB2' ' O ' ' A' ' 10' ' ' ASP . 3.4 mp0 69.03 52.3 0.51 Allowed 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 -177.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.65 ' HA ' ' O ' ' A' ' 42' ' ' PRO . 33.5 m-20 58.07 8.8 0.82 Allowed 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 112.101 -2.318 . . . . 0.0 113.286 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.18 -75.65 1.3 Allowed Glycine 0 N--CA 1.487 2.092 0 C-N-CA 118.034 -2.032 . . . . 0.0 109.279 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.756 ' ND2' HD13 ' A' ' 45' ' ' ILE . 1.0 OUTLIER -118.4 -78.06 0.58 Allowed 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.876 1.322 . . . . 0.0 108.991 178.853 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.548 ' HA ' ' OD1' ' A' ' 10' ' ' ASP . 2.2 mt-10 -179.23 133.82 0.12 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.781 ' CB ' ' HB2' ' A' ' 10' ' ' ASP . 0.2 OUTLIER -79.72 123.58 27.8 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 115.712 -2.395 . . . . 0.0 111.376 -178.532 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.701 ' HA2' ' CZ ' ' A' ' 19' ' ' PHE . . . -168.89 109.2 0.32 Allowed Glycine 0 C--N 1.285 -2.287 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.872 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.31 81.32 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 176.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.701 ' CZ ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -176.24 -173.32 0.54 Allowed 'General case' 0 N--CA 1.507 2.396 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.032 -178.487 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.787 ' HB ' HG22 ' A' ' 3' ' ' THR . 37.5 p -106.97 137.0 45.87 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.508 -0.745 . . . . 0.0 111.967 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.625 ' O ' ' HG3' ' A' ' 4' ' ' ARG . . . -115.58 128.3 7.98 Favored Glycine 0 N--CA 1.499 2.854 0 N-CA-C 108.172 -1.971 . . . . 0.0 108.172 178.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 10.7 pttp -57.29 -40.0 76.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.936 -1.332 . . . . 0.0 110.266 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.832 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 2.4 tp-100 -121.49 136.36 25.86 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 120.975 -1.078 . . . . 0.0 109.311 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.52 ' HB3' ' HD3' ' A' ' 4' ' ' ARG . 38.5 Cg_endo -67.29 -52.84 0.55 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.365 1.192 . . . . 0.0 111.422 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.662 ' HB3' ' HA ' ' A' ' 70' ' ' ASN . 26.8 mtt180 -82.28 -57.55 3.33 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.498 -0.751 . . . . 0.0 111.036 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.592 ' HB3' ' HG2' ' A' ' 23' ' ' GLN . 9.0 tt0 -52.87 -43.21 65.95 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.209 -0.932 . . . . 0.0 111.393 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.832 ' HB3' ' O ' ' A' ' 23' ' ' GLN . . . -77.74 -13.59 59.85 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 120.908 -1.12 . . . . 0.0 109.719 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 25' ' ' ARG . . . -62.1 -51.51 67.63 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.189 -0.944 . . . . 0.0 109.866 178.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.745 ' HB2' ' HG2' ' A' ' 77' ' ' GLU . 3.0 pp -69.2 -42.9 75.16 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.317 -0.953 . . . . 0.0 109.657 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.738 ' HE2' HD11 ' A' ' 29' ' ' LEU . 11.4 mmtt -61.78 -42.97 99.68 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.43 -0.794 . . . . 0.0 111.305 178.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.44 ' C ' ' HB2' ' A' ' 36' ' ' SER . . . -59.81 -48.43 81.73 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -177.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.623 ' HA ' ' CB ' ' A' ' 36' ' ' SER . . . -62.5 -33.24 74.49 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 118.707 -1.197 . . . . 0.0 109.958 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -44.96 -45.3 10.43 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.7 -70.84 0.72 Allowed 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.346 -0.942 . . . . 0.0 112.441 178.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.546 ' O ' ' CD2' ' A' ' 16' ' ' HIS . . . -114.67 2.07 23.25 Favored Glycine 0 N--CA 1.502 3.079 0 N-CA-C 117.529 1.771 . . . . 0.0 117.529 -175.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.623 ' CB ' ' HA ' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -88.3 -2.51 58.64 Favored 'General case' 0 N--CA 1.511 2.62 0 CA-C-N 123.401 3.6 . . . . 0.0 111.081 -177.238 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 60' ' ' ALA . . . -164.34 117.11 0.74 Allowed Glycine 0 N--CA 1.482 1.759 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -178.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.536 ' O ' ' HB3' ' A' ' 39' ' ' LYS . 50.9 m -76.74 -20.22 56.77 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 119.898 1.849 . . . . 0.0 110.234 -178.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.834 ' CA ' ' HG3' ' A' ' 42' ' ' PRO . 0.3 OUTLIER 76.59 -56.6 0.56 Allowed 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -178.514 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.89 -19.36 65.01 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 175.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.605 ' HB3' ' HA ' ' A' ' 11' ' ' GLU 0.282 0.3 OUTLIER -158.43 68.49 3.61 Favored Pre-proline 0 C--O 1.202 -1.412 0 O-C-N 121.738 -0.602 . . . . 0.0 110.408 179.144 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.834 ' HG3' ' CA ' ' A' ' 39' ' ' LYS 0.251 81.6 Cg_endo -119.1 -173.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.301 -1.955 0 C-N-CA 122.084 1.856 . . . . 0.0 110.442 178.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.61 ' HB3' ' O ' ' A' ' 14' ' ' ASN . 4.6 t70 -162.51 -173.44 3.56 Favored 'General case' 0 N--CA 1.507 2.388 0 O-C-N 120.367 -1.458 . . . . 0.0 111.817 176.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.017 HD13 ' HG2' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -127.65 123.8 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.782 ' N ' HD12 ' A' ' 44' ' ' ILE . 7.7 tt -166.23 170.68 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 119.267 -0.973 . . . . 0.0 110.221 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.498 ' HG3' HG13 ' A' ' 57' ' ' VAL . 2.3 mtp180 -78.21 98.7 5.95 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.85 ' CD2' HD13 ' A' ' 8' ' ' LEU . 10.8 mp -70.14 97.04 1.14 Allowed 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -123.61 -178.94 4.17 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.125 -0.984 . . . . 0.0 111.87 -178.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.622 ' HG2' ' CG2' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -150.1 132.5 15.61 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 178.58 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -88.54 -178.3 5.8 Favored 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 118.124 -1.43 . . . . 0.0 111.134 -177.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.93 -58.63 3.9 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 -178.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.559 ' OG1' ' NZ ' ' A' ' 54' ' ' LYS . 4.7 p -105.24 -179.24 3.89 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.543 -0.975 . . . . 0.0 109.273 178.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.61 ' O ' ' N ' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -89.64 99.14 12.2 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 120.972 -1.08 . . . . 0.0 108.211 179.277 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.569 ' HB3' ' HB2' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -144.35 106.51 4.35 Favored 'General case' 0 C--N 1.281 -2.394 0 O-C-N 120.964 -1.085 . . . . 0.0 110.048 -179.28 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.421 ' O ' HG23 ' A' ' 89' ' ' ILE . 42.8 t -150.59 118.73 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.7 -0.625 . . . . 0.0 110.078 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.667 ' NE2' ' HB2' ' A' ' 58' ' ' PHE . 0.3 OUTLIER -131.04 117.58 19.35 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 178.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.697 ' CG1' ' HB3' ' A' ' 87' ' ' GLU . 7.9 t -105.99 115.86 48.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 C-N-CA 117.571 -1.652 . . . . 0.0 108.377 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.97 ' CD1' HG12 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -162.22 -177.19 5.56 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 -178.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 1.017 ' HG2' HD13 ' A' ' 44' ' ' ILE . 30.0 mttt -129.98 132.75 46.4 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 177.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.497 ' O ' ' CD1' ' A' ' 61' ' ' TRP . . . -121.62 109.55 14.9 Favored 'General case' 0 N--CA 1.504 2.242 0 CA-C-N 120.429 1.468 . . . . 0.0 112.575 -177.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.803 ' HB2' ' HB2' ' A' ' 83' ' ' PHE . 10.6 m0 -131.24 -173.85 3.22 Favored 'General case' 0 N--CA 1.512 2.638 0 O-C-N 121.673 -0.642 . . . . 0.0 111.1 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.676 ' HB3' ' HG3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -114.52 91.85 3.76 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.157 -0.964 . . . . 0.0 109.876 178.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.916 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 3.4 tp10 -171.04 163.91 7.42 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.561 0.696 . . . . 0.0 110.373 178.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.713 ' HB ' ' HA ' ' A' ' 80' ' ' SER . 6.0 tt -70.2 93.94 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.52 3.038 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 -175.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.709 HG22 ' H ' ' A' ' 66' ' ' ASP . 1.4 p -97.86 -161.08 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 O-C-N 120.096 -1.627 . . . . 0.0 109.067 176.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.709 ' H ' HG22 ' A' ' 65' ' ' VAL . 1.0 OUTLIER -115.95 140.4 49.28 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.296 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.838 ' HB2' ' HB2' ' A' ' 76' ' ' PRO 0.254 . . -58.39 100.41 0.22 Allowed Pre-proline 0 N--CA 1.502 2.171 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.297 -178.111 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.653 ' HD2' ' HB2' ' A' ' 77' ' ' GLU . 54.5 Cg_endo -76.38 83.82 1.96 Allowed 'Trans proline' 0 N--CA 1.492 1.391 0 O-C-N 124.166 1.614 . . . . 0.0 112.366 -177.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.6 mttt 41.3 38.94 0.87 Allowed 'General case' 0 N--CA 1.507 2.413 0 CA-C-O 121.3 0.571 . . . . 0.0 111.476 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.662 ' HA ' ' HB3' ' A' ' 25' ' ' ARG . 20.0 m-20 -77.81 -19.18 55.42 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.476 -0.765 . . . . 0.0 111.406 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.699 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER 41.77 50.77 5.05 Favored Pre-proline 0 N--CA 1.507 2.412 0 CA-C-O 121.028 0.442 . . . . 0.0 112.02 -178.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.74 ' HG2' ' HA ' ' A' ' 76' ' ' PRO . 55.5 Cg_endo -99.22 99.68 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.591 1.528 . . . . 0.0 108.76 179.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.89 -19.17 16.21 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.191 -0.943 . . . . 0.0 111.829 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.446 ' CD1' ' N ' ' A' ' 74' ' ' TRP . 41.0 m95 -79.41 -42.59 25.15 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 121.443 -0.786 . . . . 0.0 109.808 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.404 ' O ' ' HG2' ' A' ' 72' ' ' PRO . 6.6 ttm -176.21 123.55 0.31 Allowed Pre-proline 0 N--CA 1.503 2.177 0 O-C-N 121.581 -0.699 . . . . 0.0 110.487 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.838 ' HB2' ' HB2' ' A' ' 67' ' ' ALA . 51.8 Cg_endo -83.18 176.84 7.06 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 O-C-N 124.091 1.574 . . . . 0.0 111.101 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.817 ' CB ' ' HA ' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -87.87 12.67 12.5 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 117.697 -1.601 . . . . 0.0 110.726 -179.645 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.694 ' C ' HG22 ' A' ' 79' ' ' ILE . 4.6 tttm -82.63 79.88 8.91 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.694 HG22 ' C ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER 177.87 170.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 C-N-CA 118.388 -1.325 . . . . 0.0 111.903 -177.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.713 ' HA ' ' HB ' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -69.08 106.29 2.74 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 104.207 -2.516 . . . . 0.0 104.207 175.243 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.846 ' HB3' ' HD2' ' A' ' 82' ' ' PRO 0.26 0.7 OUTLIER -165.02 -155.54 0.01 OUTLIER Pre-proline 0 C--O 1.194 -1.867 0 C-N-CA 119.143 -1.023 . . . . 0.0 108.847 -173.402 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.846 ' HD2' ' HB3' ' A' ' 81' ' ' LYS . 51.2 Cg_endo -78.15 125.01 6.9 Favored 'Trans proline' 0 C--N 1.302 -1.876 0 N-CA-C 108.792 -1.272 . . . . 0.0 108.792 178.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.916 ' CZ ' ' HB3' ' A' ' 63' ' ' GLU . 2.0 m-30 -61.38 145.81 50.35 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.288 -1.508 . . . . 0.0 108.158 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.97 HG12 ' CD1' ' A' ' 58' ' ' PHE . 2.1 t -143.21 94.84 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.466 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.673 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 2.7 mmtm -88.18 117.08 26.83 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.638 ' HB3' ' CZ ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -72.97 162.36 29.58 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 124.344 2.021 . . . . 0.0 114.091 -175.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.697 ' HB3' ' CG1' ' A' ' 57' ' ' VAL . 5.0 mt-10 -165.53 155.66 13.05 Favored 'General case' 0 C--N 1.271 -2.846 0 CA-C-N 110.544 -3.025 . . . . 0.0 107.857 177.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.462 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -47.01 132.45 11.88 Favored 'General case' 0 N--CA 1.507 2.423 0 CA-C-O 122.194 0.997 . . . . 0.0 113.031 -175.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.515 HG23 ' HA ' ' A' ' 56' ' ' HIS . 5.2 mt -121.68 142.36 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.335 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.408 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 44.1 mt-10 -141.71 122.99 14.81 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.411 ' NZ ' ' O ' ' A' ' 92' ' ' LEU . 0.7 OUTLIER -138.5 174.3 10.69 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.467 -1.396 . . . . 0.0 111.784 -179.458 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.61 ' N ' ' O ' ' A' ' 53' ' ' LYS . 2.1 pp -70.85 131.26 43.51 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.593 0.711 . . . . 0.0 109.737 -179.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 . . . . . 0 C--N 1.293 -1.852 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.027 -179.886 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.2 t . . . . . 0 N--CA 1.497 1.899 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 37.4 p-10 -116.44 145.71 43.07 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.421 -0.799 . . . . 0.0 110.163 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.1 m -153.94 158.89 41.36 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.97 -1.081 . . . . 0.0 109.859 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.485 ' O ' ' HA ' ' A' ' 20' ' ' THR . 0.0 OUTLIER -97.68 126.16 42.85 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.238 -0.913 . . . . 0.0 109.924 -179.724 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.804 ' HA ' HG22 ' A' ' 20' ' ' THR . 0.1 OUTLIER -78.17 121.53 24.46 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.695 -0.628 . . . . 0.0 110.849 -179.3 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.736 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 39.5 m-85 -109.6 167.45 10.13 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.426 -0.796 . . . . 0.0 110.549 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.695 ' C ' HD23 ' A' ' 8' ' ' LEU . 29.8 m -139.72 129.83 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 O-C-N 121.527 -0.733 . . . . 0.0 111.695 -178.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.845 HD13 HD11 ' A' ' 47' ' ' LEU . 0.3 OUTLIER -164.98 159.49 18.08 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.118 -0.989 . . . . 0.0 111.746 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.512 ' O ' ' N ' ' A' ' 14' ' ' ASN . 2.5 ttm-85 -140.12 114.91 9.52 Favored 'General case' 0 N--CA 1.511 2.577 0 O-C-N 121.083 -1.011 . . . . 0.0 112.755 178.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.81 ' HB2' ' CB ' ' A' ' 16' ' ' HIS . 0.7 OUTLIER -73.49 -153.19 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 125.154 1.381 . . . . 0.0 111.444 179.647 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.566 ' HB2' ' O ' ' A' ' 10' ' ' ASP . 0.6 OUTLIER 71.9 50.95 0.23 Allowed 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 -177.594 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.624 ' HA ' ' O ' ' A' ' 42' ' ' PRO . 86.5 m-20 59.14 6.6 0.72 Allowed 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 112.539 -2.118 . . . . 0.0 112.591 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.04 -77.33 1.34 Allowed Glycine 0 N--CA 1.485 1.903 0 C-N-CA 117.937 -2.078 . . . . 0.0 109.77 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.707 ' CA ' HG12 ' A' ' 45' ' ' ILE . 6.1 m-20 -117.49 -81.67 0.62 Allowed 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 122.183 0.992 . . . . 0.0 111.566 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.588 ' HB3' HD12 ' A' ' 8' ' ' LEU . 7.8 mt-10 -170.12 129.84 0.93 Allowed 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.81 ' CB ' ' HB2' ' A' ' 10' ' ' ASP . 0.2 OUTLIER -81.25 121.51 26.25 Favored 'General case' 0 N--CA 1.505 2.281 0 C-N-CA 115.273 -2.571 . . . . 0.0 112.17 -178.086 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.695 ' HA2' ' CZ ' ' A' ' 19' ' ' PHE . . . -176.89 122.84 0.86 Allowed Glycine 0 C--N 1.284 -2.322 0 CA-C-N 114.149 -1.387 . . . . 0.0 111.977 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.27 86.46 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 176.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.695 ' CZ ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -175.42 -172.11 0.54 Allowed 'General case' 0 N--CA 1.504 2.228 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.022 -178.08 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.804 HG22 ' HA ' ' A' ' 5' ' ' ASN . 42.8 p -108.56 153.74 22.94 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.121 -0.987 . . . . 0.0 111.885 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -135.89 131.55 5.78 Favored Glycine 0 N--CA 1.507 3.367 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.14 -50.88 69.89 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.149 -1.206 . . . . 0.0 109.225 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.513 ' HB2' ' HG2' ' A' ' 26' ' ' GLN . 37.2 mm-40 -126.71 124.71 24.22 Favored Pre-proline 0 N--CA 1.492 1.641 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.9 -19.67 46.11 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 123.614 1.323 . . . . 0.0 112.085 -178.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.55 ' HD2' ' HA ' ' A' ' 70' ' ' ASN . 8.5 mtt180 -82.84 -68.03 0.74 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.298 -0.877 . . . . 0.0 110.739 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.607 ' HB2' ' HA ' ' A' ' 72' ' ' PRO . 13.6 pt20 -58.93 -37.57 77.01 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.982 -1.073 . . . . 0.0 112.148 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.0 -22.85 63.09 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 120.765 -1.21 . . . . 0.0 109.661 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.77 -58.17 9.8 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.112 -0.992 . . . . 0.0 111.688 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.569 HD21 ' HB3' ' A' ' 72' ' ' PRO . 2.6 pp -56.26 -50.27 71.81 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 119.041 -1.064 . . . . 0.0 110.709 -178.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.532 ' N ' HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -69.79 -37.68 76.42 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 120.582 -1.324 . . . . 0.0 112.892 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.413 ' C ' ' HB2' ' A' ' 36' ' ' SER . . . -62.01 -45.09 95.12 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.723 -1.235 . . . . 0.0 112.306 -177.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.781 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -62.42 -34.52 76.93 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 118.694 -1.202 . . . . 0.0 109.535 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.606 ' CA ' ' HG3' ' A' ' 82' ' ' PRO . 0.2 OUTLIER -40.88 -48.1 3.06 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.185 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 -97.04 -72.31 0.65 Allowed 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.212 -0.995 . . . . 0.0 112.086 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.532 ' O ' ' CD2' ' A' ' 16' ' ' HIS . . . -114.52 -1.23 23.22 Favored Glycine 0 N--CA 1.501 2.991 0 N-CA-C 117.401 1.72 . . . . 0.0 117.401 -175.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.604 ' CB ' ' HA ' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -86.04 -1.71 57.62 Favored 'General case' 0 N--CA 1.514 2.75 0 CA-C-N 123.255 3.527 . . . . 0.0 110.941 -177.017 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -162.4 119.56 0.89 Allowed Glycine 0 C--N 1.299 -1.521 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.496 ' O ' ' HB3' ' A' ' 39' ' ' LYS . 12.9 m -81.08 -15.2 56.67 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 120.417 -1.637 . . . . 0.0 109.665 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.834 ' CA ' ' HG3' ' A' ' 42' ' ' PRO . 7.6 tttp 72.84 -59.16 0.58 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.45 -18.02 65.12 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.121 -1.436 . . . . 0.0 107.121 175.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.549 ' HB3' ' HA ' ' A' ' 11' ' ' GLU 0.285 0.3 OUTLIER -159.05 67.77 3.2 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.678 -0.639 . . . . 0.0 110.87 179.233 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.834 ' HG3' ' CA ' ' A' ' 39' ' ' LYS . 78.2 Cg_endo -119.13 -174.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.472 2.115 . . . . 0.0 110.927 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -166.47 -172.83 2.3 Favored 'General case' 0 N--CA 1.513 2.716 0 O-C-N 120.156 -1.59 . . . . 0.0 113.029 176.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.866 HD13 ' HG2' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -126.02 124.34 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.713 ' N ' HD12 ' A' ' 44' ' ' ILE . 1.6 pp -157.32 -176.43 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.435 -0.791 . . . . 0.0 110.336 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.887 ' HB3' HG13 ' A' ' 55' ' ' VAL . 16.7 mtt85 -85.56 94.56 9.07 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.845 HD11 HD13 ' A' ' 8' ' ' LEU . 5.3 tt -73.55 94.41 2.14 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.497 ' HG2' HG23 ' A' ' 7' ' ' VAL . 4.2 ptp180 -81.66 -176.76 6.23 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 119.478 -0.889 . . . . 0.0 112.282 -177.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.736 ' HA ' ' HA ' ' A' ' 6' ' ' PHE . 0.4 OUTLIER -137.94 161.54 36.39 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 -179.27 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.668 ' N ' ' HG2' ' A' ' 49' ' ' GLU . 4.5 mtt180 -102.48 154.53 19.01 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 117.512 -1.675 . . . . 0.0 110.318 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.83 -76.93 0.23 Allowed Glycine 0 N--CA 1.495 2.596 0 N-CA-C 107.569 -2.213 . . . . 0.0 107.569 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.577 ' HA ' ' HG3' ' A' ' 93' ' ' GLU . 21.7 p -98.38 -170.47 1.96 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 177.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.516 ' CB ' ' O ' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -105.71 91.14 3.63 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 120.382 -1.449 . . . . 0.0 109.346 179.712 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.683 ' HB3' ' HB3' ' A' ' 49' ' ' GLU . 0.1 OUTLIER -114.45 149.44 36.27 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.382 179.638 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.887 HG13 ' HB3' ' A' ' 46' ' ' ARG . 35.2 t -149.26 94.25 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.899 ' HA ' HG23 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -79.92 124.92 29.11 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 179.189 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.661 HG12 ' HB2' ' A' ' 87' ' ' GLU . 2.9 t -109.37 106.46 20.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 C-N-CA 117.362 -1.735 . . . . 0.0 107.152 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.783 ' HA ' ' O ' ' A' ' 85' ' ' LYS . 0.3 OUTLIER -150.03 167.74 25.87 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.866 ' HG2' HD13 ' A' ' 44' ' ' ILE . 8.3 mttm -121.17 118.96 31.0 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.781 ' HB1' ' HB2' ' A' ' 32' ' ' ALA . . . -106.69 107.33 18.29 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 118.609 -1.236 . . . . 0.0 112.484 -176.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.794 ' HB2' ' HB2' ' A' ' 83' ' ' PHE . 18.5 m0 -128.49 -166.13 1.59 Allowed 'General case' 0 N--CA 1.512 2.635 0 O-C-N 121.842 -0.536 . . . . 0.0 111.021 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.748 ' HB2' ' HB2' ' A' ' 39' ' ' LYS . 0.3 OUTLIER -123.2 86.53 2.59 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 120.967 -1.083 . . . . 0.0 110.966 179.747 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.757 ' CB ' ' CZ ' ' A' ' 83' ' ' PHE . 19.7 mp0 -161.19 171.14 18.98 Favored 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.646 ' HB ' ' HA ' ' A' ' 80' ' ' SER . 2.8 tt -78.48 98.04 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.136 0 O-C-N 119.301 -2.124 . . . . 0.0 115.49 -177.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 1.122 HG13 ' CD1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -89.85 -168.41 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.309 -1.495 . . . . 0.0 110.342 177.739 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.62 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 10.9 t70 -119.66 133.85 55.47 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.806 ' HA ' ' CB ' ' A' ' 77' ' ' GLU . . . -66.01 101.33 0.27 Allowed Pre-proline 0 N--CA 1.504 2.273 0 CA-C-O 117.93 -1.033 . . . . 0.0 111.902 -178.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.681 ' CB ' ' HD2' ' A' ' 86' ' ' LYS . 52.5 Cg_endo -86.93 -166.66 0.31 Allowed 'Trans proline' 0 C--N 1.315 -1.221 0 O-C-N 123.875 1.461 . . . . 0.0 111.467 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.0 mmmt -69.44 62.02 0.15 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.447 -0.783 . . . . 0.0 110.295 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.55 ' HA ' ' HD2' ' A' ' 25' ' ' ARG . 1.0 OUTLIER -101.65 -9.35 20.99 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.653 -0.654 . . . . 0.0 111.213 -179.842 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.755 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER 56.52 44.06 1.33 Allowed Pre-proline 0 N--CA 1.508 2.441 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -179.244 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.755 ' HD3' ' N ' ' A' ' 71' ' ' ARG . 49.0 Cg_endo -94.06 98.99 0.13 Allowed 'Trans proline' 0 C--N 1.316 -1.183 0 C-N-CA 120.84 1.026 . . . . 0.0 110.015 178.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.9 -18.33 50.86 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.15 -0.968 . . . . 0.0 111.444 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.519 ' CD1' ' N ' ' A' ' 74' ' ' TRP . 6.9 m0 -80.29 -37.82 32.01 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.154 -0.966 . . . . 0.0 109.579 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.457 ' O ' ' HB2' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -167.64 122.57 0.82 Allowed Pre-proline 0 N--CA 1.496 1.83 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.612 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.766 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 49.5 Cg_endo -81.92 -179.8 5.06 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.589 1.31 . . . . 0.0 112.62 -178.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.806 ' CB ' ' HA ' ' A' ' 67' ' ' ALA . 1.3 mt-10 -92.2 11.0 27.12 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 118.315 -1.354 . . . . 0.0 110.684 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.691 ' C ' HG22 ' A' ' 79' ' ' ILE . 0.6 OUTLIER -92.46 82.83 4.89 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.94 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.691 HG22 ' C ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -176.87 161.55 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 C-N-CA 118.146 -1.422 . . . . 0.0 112.392 -177.837 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.646 ' HA ' ' HB ' ' A' ' 64' ' ' ILE . 0.3 OUTLIER -75.07 104.94 5.85 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 175.501 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.768 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 11.5 pttp -169.81 -152.58 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.784 0 C-N-CA 118.843 -1.143 . . . . 0.0 108.393 -174.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.768 ' HD2' ' HB2' ' A' ' 81' ' ' LYS . 51.0 Cg_endo -74.83 127.33 10.72 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 N-CA-C 109.547 -0.982 . . . . 0.0 109.547 178.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 1.122 ' CD1' HG13 ' A' ' 65' ' ' VAL . 0.8 OUTLIER -65.16 160.19 21.84 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.987 -1.071 . . . . 0.0 109.737 179.502 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.704 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -154.64 92.7 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 177.25 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.783 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -77.51 122.35 25.11 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 178.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.681 ' HD2' ' CB ' ' A' ' 68' ' ' PRO . 0.0 OUTLIER -85.24 92.2 8.36 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 122.864 1.316 . . . . 0.0 113.29 -175.783 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.661 ' HB2' HG12 ' A' ' 57' ' ' VAL . 3.2 mm-40 -88.5 153.94 20.75 Favored 'General case' 0 C--N 1.28 -2.448 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.459 176.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -53.38 111.11 0.64 Allowed 'General case' 0 N--CA 1.51 2.557 0 CA-C-O 122.092 0.949 . . . . 0.0 113.087 -176.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.899 HG23 ' HA ' ' A' ' 56' ' ' HIS . 10.4 mt -84.55 131.75 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.085 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -101.82 152.3 21.06 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.577 -0.702 . . . . 0.0 109.158 178.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -163.69 95.23 0.8 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.554 -1.341 . . . . 0.0 112.702 -179.481 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.516 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 1.1 pp -170.0 124.07 0.75 Allowed 'General case' 0 N--CA 1.506 2.371 0 C-N-CA 119.563 -0.855 . . . . 0.0 112.497 177.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.577 ' HG3' ' HA ' ' A' ' 52' ' ' THR . 18.9 tt0 . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 118.184 -0.912 . . . . 0.0 109.823 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 120.809 0.338 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.26 148.1 34.05 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.205 -0.934 . . . . 0.0 110.515 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 1.5 m -78.25 151.18 33.21 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.189 0.519 . . . . 0.0 111.313 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.495 ' O ' ' HA ' ' A' ' 20' ' ' THR . 3.0 mpt_? -113.54 136.27 52.98 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.306 -0.871 . . . . 0.0 110.068 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.49 ' CA ' HG22 ' A' ' 20' ' ' THR . 6.7 t-20 -77.43 143.55 38.5 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.65 -0.657 . . . . 0.0 110.417 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -142.65 137.56 30.05 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.576 -0.702 . . . . 0.0 110.264 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.917 HG22 ' O ' ' A' ' 48' ' ' ARG . 17.0 m -119.39 132.78 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.516 -0.74 . . . . 0.0 111.599 -178.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.805 HD22 ' HG ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -163.39 161.45 24.42 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.107 -0.995 . . . . 0.0 111.291 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.433 ' H ' ' HB2' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -131.99 110.58 10.85 Favored 'General case' 0 N--CA 1.513 2.718 0 O-C-N 121.13 -0.981 . . . . 0.0 113.154 -179.375 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.83 ' HB2' ' CB ' ' A' ' 16' ' ' HIS . 0.9 OUTLIER -73.48 -156.16 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 C-N-CA 124.274 1.03 . . . . 0.0 111.101 179.337 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.665 ' HA ' ' HB3' ' A' ' 41' ' ' ASN . 3.0 mp0 70.92 51.66 0.3 Allowed 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 -177.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.615 ' HA ' ' O ' ' A' ' 42' ' ' PRO . 86.4 m-20 59.45 7.95 1.09 Allowed 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 112.306 -2.224 . . . . 0.0 113.027 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.28 -77.69 1.33 Allowed Glycine 0 N--CA 1.486 1.992 0 C-N-CA 117.954 -2.07 . . . . 0.0 109.061 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.639 ' O ' ' HB3' ' A' ' 43' ' ' ASP . 8.0 m-20 -117.11 -77.24 0.57 Allowed 'General case' 0 C--N 1.296 -1.753 0 CA-C-O 122.606 1.193 . . . . 0.0 109.909 178.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.569 ' HA ' ' OD1' ' A' ' 10' ' ' ASP . 1.3 mt-10 -178.05 138.08 0.19 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 178.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.83 ' CB ' ' HB2' ' A' ' 10' ' ' ASP . 0.2 OUTLIER -87.37 122.45 31.14 Favored 'General case' 0 N--CA 1.501 2.119 0 C-N-CA 115.672 -2.411 . . . . 0.0 112.22 -178.623 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.669 ' HA2' ' CE1' ' A' ' 19' ' ' PHE . . . -174.43 110.16 0.32 Allowed Glycine 0 C--N 1.283 -2.375 0 CA-C-N 113.804 -1.543 . . . . 0.0 110.834 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.449 ' C ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -130.96 81.87 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.2 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.669 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -175.17 -173.49 0.67 Allowed 'General case' 0 N--CA 1.502 2.161 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.077 -179.682 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 4' ' ' ARG . 57.3 p -103.23 144.8 30.86 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.418 -0.801 . . . . 0.0 111.809 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -124.29 133.58 8.76 Favored Glycine 0 N--CA 1.503 3.111 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 5.4 mttt -66.46 -58.64 4.83 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.241 -1.153 . . . . 0.0 108.752 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.545 ' HB3' ' HB3' ' A' ' 26' ' ' GLN . 0.9 OUTLIER -109.45 106.05 58.02 Favored Pre-proline 0 C--N 1.303 -1.424 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 177.9 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.608 ' HB2' HD13 ' A' ' 89' ' ' ILE . 36.9 Cg_endo -60.04 -26.46 82.49 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.945 1.498 . . . . 0.0 111.309 -178.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.622 ' HD3' ' HA ' ' A' ' 70' ' ' ASN . 3.6 mtt-85 -85.23 -58.39 2.7 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.268 -0.895 . . . . 0.0 109.239 178.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.758 ' HG3' ' HA ' ' A' ' 72' ' ' PRO . 1.0 OUTLIER -59.01 -43.53 91.54 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.921 -1.112 . . . . 0.0 110.807 179.552 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.41 -18.15 63.73 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 118.993 -1.083 . . . . 0.0 109.78 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 25' ' ' ARG . . . -59.76 -60.11 4.36 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.436 -0.79 . . . . 0.0 111.703 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.567 ' HB3' ' HG3' ' A' ' 77' ' ' GLU . 1.8 pp -63.89 -44.13 93.93 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 118.933 -1.107 . . . . 0.0 110.524 -179.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.401 ' HG3' ' CD1' ' A' ' 29' ' ' LEU . 37.6 mtmt -66.48 -43.7 84.67 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 120.781 -1.199 . . . . 0.0 112.476 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.23 -45.46 88.07 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.929 -1.107 . . . . 0.0 112.864 -177.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.646 ' HA ' ' CB ' ' A' ' 36' ' ' SER . . . -56.64 -37.52 70.87 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 118.781 -1.167 . . . . 0.0 109.493 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.494 ' CB ' ' HG3' ' A' ' 82' ' ' PRO . 4.4 t-20 -42.39 -47.05 4.87 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.98 -73.44 0.58 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 119.035 -1.066 . . . . 0.0 112.545 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.512 ' O ' ' CD2' ' A' ' 16' ' ' HIS . . . -116.76 1.63 19.92 Favored Glycine 0 N--CA 1.502 3.092 0 N-CA-C 117.213 1.645 . . . . 0.0 117.213 -175.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.646 ' CB ' ' HA ' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -85.17 -4.85 59.3 Favored 'General case' 0 N--CA 1.51 2.545 0 CA-C-N 122.929 3.364 . . . . 0.0 110.99 -176.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 60' ' ' ALA . . . -165.37 120.89 0.96 Allowed Glycine 0 N--CA 1.478 1.494 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -177.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.57 ' O ' ' HB3' ' A' ' 39' ' ' LYS . 32.4 m -77.66 -14.81 59.52 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 120.359 -1.671 . . . . 0.0 110.195 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.828 ' CA ' ' HG3' ' A' ' 42' ' ' PRO . 1.2 tmtt? 72.01 -56.57 0.64 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -178.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.97 -18.73 63.36 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 176.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.665 ' HB3' ' HA ' ' A' ' 11' ' ' GLU 0.278 0.4 OUTLIER -156.75 67.73 4.34 Favored Pre-proline 0 C--O 1.199 -1.581 0 O-C-N 121.819 -0.55 . . . . 0.0 109.98 179.083 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.828 ' HG3' ' CA ' ' A' ' 39' ' ' LYS . 80.0 Cg_endo -119.61 -174.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 122.382 2.054 . . . . 0.0 111.075 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.639 ' HB3' ' O ' ' A' ' 14' ' ' ASN . 3.2 t70 -165.11 -168.71 1.47 Allowed 'General case' 0 N--CA 1.51 2.565 0 O-C-N 120.357 -1.464 . . . . 0.0 111.963 176.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.03 HD13 ' HG2' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -129.93 120.76 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.715 -0.616 . . . . 0.0 109.778 -179.043 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.715 ' N ' HD12 ' A' ' 44' ' ' ILE . 1.3 pp -157.98 -177.96 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-O 121.829 0.823 . . . . 0.0 109.876 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.608 ' NH1' HG21 ' A' ' 57' ' ' VAL . 0.5 OUTLIER -91.19 100.26 13.12 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.102 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.805 ' HG ' HD22 ' A' ' 8' ' ' LEU . 9.4 mp -69.71 93.32 0.72 Allowed 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.917 ' O ' HG22 ' A' ' 7' ' ' VAL . 8.2 ptp85 -113.12 -165.41 0.99 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.722 -0.791 . . . . 0.0 113.059 -175.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -147.36 164.55 32.94 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -111.68 172.63 6.78 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 117.894 -1.522 . . . . 0.0 110.9 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.98 -43.31 2.96 Favored Glycine 0 N--CA 1.498 2.825 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.0 p -126.8 178.84 5.69 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.254 -1.145 . . . . 0.0 109.337 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.596 ' O ' ' N ' ' A' ' 92' ' ' LEU . 2.1 mttm -92.91 105.69 17.77 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 122.684 1.23 . . . . 0.0 108.866 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.625 ' HE3' HD23 ' A' ' 92' ' ' LEU . 0.8 OUTLIER -149.53 99.7 2.92 Favored 'General case' 0 C--N 1.279 -2.479 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.814 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.839 HG13 ' HB3' ' A' ' 48' ' ' ARG . 3.9 t -138.78 107.58 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 CA-C-O 121.245 0.545 . . . . 0.0 110.547 -178.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.781 ' HA ' HG23 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -101.04 127.4 47.58 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 178.54 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.861 HG22 ' CB ' ' A' ' 87' ' ' GLU . 2.2 p -117.6 123.84 72.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 C-N-CA 116.611 -2.036 . . . . 0.0 108.852 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.673 ' HA ' ' O ' ' A' ' 85' ' ' LYS . 0.3 OUTLIER -162.75 -176.35 4.92 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 -178.681 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 1.03 ' HG2' HD13 ' A' ' 44' ' ' ILE . 38.2 mttt -133.42 124.48 27.18 Favored 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.617 ' HB1' ' CB ' ' A' ' 32' ' ' ALA . . . -110.75 109.29 19.46 Favored 'General case' 0 N--CA 1.505 2.287 0 C-N-CA 118.595 -1.242 . . . . 0.0 113.424 -176.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.845 ' HB2' ' HB2' ' A' ' 83' ' ' PHE . 11.2 m0 -132.38 -163.46 1.34 Allowed 'General case' 0 N--CA 1.515 2.822 0 O-C-N 121.86 -0.525 . . . . 0.0 110.589 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.698 ' CB ' ' HG3' ' A' ' 39' ' ' LYS . 0.5 OUTLIER -125.26 89.04 2.98 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 120.423 -1.423 . . . . 0.0 112.217 179.93 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.885 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 4.3 mt-10 -167.17 -179.44 4.57 Favored 'General case' 0 N--CA 1.514 2.752 0 CA-C-O 121.514 0.674 . . . . 0.0 111.064 177.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.597 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 2.1 mt -78.26 99.88 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.086 0 O-C-N 119.429 -2.045 . . . . 0.0 115.012 -176.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.859 HG13 ' CD1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -90.92 -168.91 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 120.586 -1.321 . . . . 0.0 110.317 177.51 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.618 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 12.1 t70 -124.72 129.86 51.3 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.822 ' HA ' ' CB ' ' A' ' 77' ' ' GLU 0.253 . . -66.18 98.6 0.16 Allowed Pre-proline 0 N--CA 1.511 2.623 0 CA-C-O 117.51 -1.233 . . . . 0.0 111.862 -177.542 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.615 ' HD3' ' O ' ' A' ' 66' ' ' ASP . 48.9 Cg_endo -92.95 85.68 0.19 Allowed 'Trans proline' 0 N--CA 1.483 0.893 0 O-C-N 123.818 1.43 . . . . 0.0 112.994 -178.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.5 mttm 38.99 54.03 2.07 Favored 'General case' 0 N--CA 1.511 2.597 0 CA-C-O 121.71 0.767 . . . . 0.0 111.538 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.622 ' HA ' ' HD3' ' A' ' 25' ' ' ARG . 0.9 OUTLIER -91.8 -9.7 42.56 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.289 -0.882 . . . . 0.0 112.216 -179.083 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.765 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER 62.67 35.46 0.21 Allowed Pre-proline 0 N--CA 1.508 2.432 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -179.649 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.795 ' HG2' ' HA ' ' A' ' 76' ' ' PRO . 56.8 Cg_endo -93.41 115.13 0.27 Allowed 'Trans proline' 0 C--N 1.315 -1.193 0 N-CA-C 109.822 -0.876 . . . . 0.0 109.822 178.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.0 -19.75 39.85 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.951 -1.093 . . . . 0.0 111.715 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.457 ' CD1' ' N ' ' A' ' 74' ' ' TRP . 37.8 m95 -82.28 -39.21 23.27 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.398 -0.814 . . . . 0.0 110.137 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.551 ' SD ' ' HE3' ' A' ' 81' ' ' LYS . 2.1 mtm -170.42 132.2 0.96 Allowed Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.708 -0.62 . . . . 0.0 109.556 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.795 ' HA ' ' HG2' ' A' ' 72' ' ' PRO . 46.4 Cg_endo -87.33 -178.16 2.34 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.682 1.359 . . . . 0.0 112.129 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.822 ' CB ' ' HA ' ' A' ' 67' ' ' ALA . 0.3 OUTLIER -88.94 11.39 18.27 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 118.092 -1.443 . . . . 0.0 110.321 -179.328 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.702 ' C ' HG22 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -94.18 81.6 4.08 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.229 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.702 HG22 ' C ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -177.97 164.44 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 118.145 -1.422 . . . . 0.0 112.57 -177.462 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.54 ' N ' HG13 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -73.84 104.32 4.68 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 104.556 -2.387 . . . . 0.0 104.556 175.218 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.79 ' HB3' ' HD2' ' A' ' 82' ' ' PRO 0.262 2.8 mttm -164.16 -162.41 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.682 0 C-N-CA 118.857 -1.137 . . . . 0.0 110.112 -174.267 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.79 ' HD2' ' HB3' ' A' ' 81' ' ' LYS . 43.4 Cg_endo -69.87 121.65 8.31 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 N-CA-C 107.529 -1.758 . . . . 0.0 107.529 176.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.885 ' CZ ' ' HB3' ' A' ' 63' ' ' GLU . 0.4 OUTLIER -57.37 151.51 16.12 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.878 -1.139 . . . . 0.0 109.892 -178.734 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.733 ' H ' HG11 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -148.04 88.8 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.51 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.388 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.748 ' HB2' ' CG ' ' A' ' 59' ' ' LYS . 14.6 mmtp -79.93 118.16 21.43 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.523 ' O ' ' CE ' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -72.67 156.55 38.84 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 124.256 1.979 . . . . 0.0 114.3 -175.419 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.861 ' CB ' HG22 ' A' ' 57' ' ' VAL . 0.5 OUTLIER -163.34 143.7 8.98 Favored 'General case' 0 C--N 1.271 -2.817 0 CA-C-N 111.096 -2.774 . . . . 0.0 108.828 177.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.4 ' O ' HG12 ' A' ' 57' ' ' VAL . 1.0 OUTLIER -55.0 117.49 3.49 Favored 'General case' 0 N--CA 1.506 2.351 0 CA-C-O 122.13 0.967 . . . . 0.0 113.38 -176.487 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.781 HG23 ' HA ' ' A' ' 56' ' ' HIS . 42.8 mt -83.12 106.08 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.34 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -84.55 122.75 29.46 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.455 -0.778 . . . . 0.0 109.132 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.505 ' HG3' HG22 ' A' ' 89' ' ' ILE . 16.7 mtmm -140.44 -179.72 6.18 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.813 -1.179 . . . . 0.0 112.063 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.625 HD23 ' HE3' ' A' ' 54' ' ' LYS . 2.7 pp -78.08 -176.62 4.65 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 115.383 -0.826 . . . . 0.0 108.848 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.532 ' C ' HD12 ' A' ' 92' ' ' LEU . 1.2 tp10 . . . . . 0 N--CA 1.494 1.774 0 CA-C-O 118.367 -0.825 . . . . 0.0 109.484 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.968 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -152.49 158.5 42.66 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.175 -0.953 . . . . 0.0 110.476 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.4 t -153.86 146.89 24.52 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.464 -0.773 . . . . 0.0 109.583 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 20' ' ' THR . 22.3 mmt180 -116.94 124.52 49.62 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.28 -0.888 . . . . 0.0 110.052 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.77 ' HA ' HG22 ' A' ' 20' ' ' THR . 6.1 t-20 -72.55 135.86 45.7 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.512 -0.742 . . . . 0.0 109.582 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.687 ' CD1' HD22 ' A' ' 47' ' ' LEU . 4.3 m-85 -142.22 166.81 23.67 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.603 -0.839 . . . . 0.0 111.355 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.504 ' O ' HD23 ' A' ' 47' ' ' LEU . 10.8 m -136.62 131.77 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.808 -0.557 . . . . 0.0 111.143 -178.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.717 HD13 ' OE1' ' A' ' 15' ' ' GLU . 0.4 OUTLIER -159.07 161.97 36.53 Favored 'General case' 0 N--CA 1.512 2.641 0 O-C-N 120.922 -1.111 . . . . 0.0 111.877 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.466 ' N ' ' O ' ' A' ' 15' ' ' GLU . 10.7 tpt180 -148.81 112.51 5.08 Favored 'General case' 0 N--CA 1.512 2.647 0 O-C-N 121.012 -1.055 . . . . 0.0 112.832 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.929 ' HB3' ' CD2' ' A' ' 16' ' ' HIS . 5.8 t0 -98.61 -144.09 0.32 Allowed 'General case' 0 N--CA 1.508 2.428 0 O-C-N 121.273 -0.892 . . . . 0.0 109.405 177.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.755 ' HA ' ' HB3' ' A' ' 41' ' ' ASN . 2.4 mt-10 72.63 57.54 0.13 Allowed 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 102.576 -3.12 . . . . 0.0 102.576 -174.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.654 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 69.8 m-20 74.14 -5.15 2.12 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 112.272 -2.24 . . . . 0.0 111.844 -177.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.07 -83.53 1.42 Allowed Glycine 0 N--CA 1.482 1.764 0 C-N-CA 118.25 -1.928 . . . . 0.0 109.729 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.731 ' HB3' ' CD1' ' A' ' 45' ' ' ILE . 0.7 OUTLIER -129.19 -74.49 0.56 Allowed 'General case' 0 N--CA 1.51 2.529 0 O-C-N 121.634 -0.921 . . . . 0.0 112.744 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.773 ' CA ' ' HB2' ' A' ' 10' ' ' ASP . 35.2 tt0 -164.89 127.89 2.3 Favored 'General case' 0 N--CA 1.522 3.136 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.929 ' CD2' ' HB3' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -99.37 124.4 44.45 Favored 'General case' 0 N--CA 1.512 2.671 0 C-N-CA 116.208 -2.197 . . . . 0.0 115.415 -176.377 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.484 ' CA ' ' CE1' ' A' ' 19' ' ' PHE . . . -178.09 134.62 2.45 Favored Glycine 0 N--CA 1.48 1.586 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.212 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.423 ' C ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -132.88 91.07 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 120.87 -1.37 . . . . 0.0 108.112 177.254 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.671 ' CD1' ' N ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -174.81 -170.65 0.49 Allowed 'General case' 0 N--CA 1.504 2.251 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.727 -178.667 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.77 HG22 ' HA ' ' A' ' 5' ' ' ASN . 18.1 p -106.09 151.46 24.66 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.033 -1.042 . . . . 0.0 111.24 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -129.62 142.07 13.25 Favored Glycine 0 N--CA 1.504 3.195 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -71.49 -61.8 1.64 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.158 -1.201 . . . . 0.0 108.564 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.691 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -99.96 115.37 65.6 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.102 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.473 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 36.9 Cg_endo -61.65 -32.63 87.14 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.318 1.167 . . . . 0.0 111.1 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.499 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 43.1 mtt180 -83.25 -64.7 1.12 Allowed 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.384 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.639 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -57.43 -39.49 76.35 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.967 -1.083 . . . . 0.0 111.528 -179.661 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' A' ' 23' ' ' GLN . . . -74.57 -16.38 60.81 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 120.396 -1.44 . . . . 0.0 109.669 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.577 ' HB2' ' HE1' ' A' ' 56' ' ' HIS . . . -57.21 -60.05 4.19 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.442 -0.786 . . . . 0.0 110.301 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.712 HD22 ' HG2' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -62.04 -46.08 90.75 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 118.512 -1.275 . . . . 0.0 108.145 179.199 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.626 ' N ' ' HG ' ' A' ' 29' ' ' LEU . 2.8 mmpt? -49.51 -48.07 48.34 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.224 -0.922 . . . . 0.0 110.741 179.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.522 ' C ' ' HB2' ' A' ' 36' ' ' SER . . . -62.13 -49.58 75.31 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.308 -0.87 . . . . 0.0 110.856 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.982 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -59.17 -35.32 73.34 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.306 -0.871 . . . . 0.0 109.807 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.433 ' CA ' ' HG3' ' A' ' 82' ' ' PRO . 1.1 t-20 -38.89 -48.43 1.56 Allowed 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.6 mmt180 -92.47 -75.16 0.49 Allowed 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 118.593 -1.243 . . . . 0.0 112.235 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.582 ' O ' ' CG ' ' A' ' 16' ' ' HIS . . . -117.11 -3.03 18.01 Favored Glycine 0 N--CA 1.5 2.946 0 CA-C-O 118.078 -1.401 . . . . 0.0 116.527 -176.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.661 ' HB2' ' CA ' ' A' ' 32' ' ' ALA . 0.4 OUTLIER -82.32 -4.14 56.67 Favored 'General case' 0 N--CA 1.508 2.428 0 CA-C-N 122.358 3.079 . . . . 0.0 111.154 -176.684 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 60' ' ' ALA . . . -145.99 109.53 0.5 Allowed Glycine 0 C--N 1.287 -2.145 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.42 ' O ' ' N ' ' A' ' 40' ' ' ALA . 0.3 OUTLIER -76.56 -23.17 53.55 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 117.965 -1.494 . . . . 0.0 109.828 -179.745 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.692 ' HG3' ' HB2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER 67.67 -55.87 0.47 Allowed 'General case' 0 N--CA 1.51 2.564 0 CA-C-O 121.53 0.681 . . . . 0.0 109.188 -179.566 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 38' ' ' THR . . . -65.65 -29.09 69.61 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 104.49 -2.411 . . . . 0.0 104.49 174.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.755 ' HB3' ' HA ' ' A' ' 11' ' ' GLU 0.282 0.7 OUTLIER -140.59 71.94 30.75 Favored Pre-proline 0 N--CA 1.485 1.288 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 176.986 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.995 ' HB2' ' CD1' ' A' ' 61' ' ' TRP . 93.8 Cg_endo -110.71 167.5 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 121.166 1.244 . . . . 0.0 111.779 -177.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -164.96 -170.63 2.0 Favored 'General case' 0 N--CA 1.511 2.59 0 C-N-CA 118.021 -1.472 . . . . 0.0 112.707 177.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.731 HG22 ' HD3' ' A' ' 59' ' ' LYS . 0.2 OUTLIER -93.99 134.42 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.731 ' CD1' ' HB3' ' A' ' 14' ' ' ASN . 2.2 tp -120.06 129.96 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.673 -1.267 . . . . 0.0 113.749 -177.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.1 mtm180 -92.3 84.27 5.16 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 104.023 -2.584 . . . . 0.0 104.023 173.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.687 HD22 ' CD1' ' A' ' 6' ' ' PHE . 0.1 OUTLIER -76.03 94.38 3.42 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -177.871 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -139.81 177.0 8.27 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.178 -1.009 . . . . 0.0 111.929 -178.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.443 ' CB ' ' HE2' ' A' ' 54' ' ' LYS . 0.3 OUTLIER -147.82 -176.14 5.15 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 177.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.22 179.57 4.65 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 117.92 -1.512 . . . . 0.0 110.584 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.01 -71.93 0.72 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.562 ' HB ' HD22 ' A' ' 92' ' ' LEU . 35.3 p -82.21 169.44 16.58 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.728 -0.866 . . . . 0.0 109.569 178.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.581 ' O ' ' N ' ' A' ' 92' ' ' LEU . 11.6 mttt -83.15 89.6 6.97 Favored 'General case' 0 C--O 1.204 -1.34 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.443 ' HE2' ' CB ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -127.89 100.72 6.03 Favored 'General case' 0 C--N 1.282 -2.334 0 O-C-N 120.85 -1.156 . . . . 0.0 109.702 -178.74 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 52.8 t -151.07 129.04 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-O 121.832 0.825 . . . . 0.0 110.797 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.581 ' NE2' ' HB2' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -146.24 110.64 5.09 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 179.334 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.661 ' CG1' ' HB3' ' A' ' 87' ' ' GLU . 21.9 t -105.82 99.95 9.59 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.305 0 C-N-CA 117.497 -1.681 . . . . 0.0 107.735 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 1.016 ' CD1' HG22 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -135.03 179.54 6.26 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 179.563 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.809 ' HB3' ' CZ2' ' A' ' 61' ' ' TRP . 39.7 mttt -133.06 135.07 45.13 Favored 'General case' 0 C--N 1.275 -2.658 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 177.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.982 ' HB1' ' HB2' ' A' ' 32' ' ' ALA . . . -122.85 111.29 16.48 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-N 120.8 1.636 . . . . 0.0 112.911 -175.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.995 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 2.7 m0 -128.11 -165.07 1.44 Allowed 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.739 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 7.3 mmtp -122.25 92.2 3.67 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 120.669 -1.27 . . . . 0.0 111.083 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.952 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 4.5 tp10 -173.51 169.74 4.28 Favored 'General case' 0 N--CA 1.502 2.175 0 CA-C-O 121.469 0.652 . . . . 0.0 110.955 178.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.687 ' CG1' ' HA ' ' A' ' 80' ' ' SER . 2.1 mt -71.71 102.14 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.533 3.679 0 O-C-N 119.421 -2.049 . . . . 0.0 116.305 -175.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 1.061 HG13 ' CD1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -102.0 -167.94 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 120.449 -1.407 . . . . 0.0 110.858 177.09 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.705 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 11.6 t70 -116.1 134.58 54.79 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.509 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.819 ' HA ' ' HB2' ' A' ' 77' ' ' GLU 0.28 . . -72.46 97.57 0.15 Allowed Pre-proline 0 N--CA 1.511 2.595 0 CA-C-O 117.466 -1.254 . . . . 0.0 112.761 -178.242 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.705 ' HD3' ' O ' ' A' ' 66' ' ' ASP . 53.6 Cg_endo -73.35 123.81 8.98 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 O-C-N 123.273 1.144 . . . . 0.0 111.315 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER 53.25 37.9 26.34 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.313 -0.867 . . . . 0.0 109.044 -179.307 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.606 ' HB3' ' HD3' ' A' ' 72' ' ' PRO . 6.6 m-80 2.07 -75.57 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.75 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 11.8 ptm180 34.63 44.22 0.29 Allowed Pre-proline 0 N--CA 1.513 2.707 0 CA-C-N 118.121 0.419 . . . . 0.0 110.355 -177.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.75 ' HD3' ' N ' ' A' ' 71' ' ' ARG . 54.5 Cg_endo -105.85 114.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.324 -0.737 0 C-N-CA 121.922 1.748 . . . . 0.0 112.85 -176.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.85 -39.46 15.82 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.196 -1.002 . . . . 0.0 108.956 177.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.509 ' CD1' ' N ' ' A' ' 74' ' ' TRP . 6.4 m95 -89.7 -38.19 14.04 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.331 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.444 ' HB2' ' O ' ' A' ' 74' ' ' TRP . 7.1 ttm -179.58 146.02 0.44 Allowed Pre-proline 0 N--CA 1.51 2.549 0 O-C-N 121.746 -0.596 . . . . 0.0 111.485 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.598 ' HB3' ' HG3' ' A' ' 72' ' ' PRO . 48.3 Cg_endo -94.54 174.7 1.29 Allowed 'Trans proline' 0 N--CA 1.486 1.087 0 C-N-CA 122.113 1.875 . . . . 0.0 111.041 178.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.819 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 3.8 mt-10 -95.26 16.02 17.75 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 117.892 -1.523 . . . . 0.0 110.812 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.697 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 0.3 OUTLIER -98.28 80.83 2.69 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.22 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.647 ' CG1' ' HD2' ' A' ' 81' ' ' LYS . 0.6 OUTLIER 178.59 170.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 C-N-CA 118.128 -1.429 . . . . 0.0 112.122 -177.706 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.687 ' HA ' ' CG1' ' A' ' 64' ' ' ILE . 1.4 m -70.77 109.77 5.16 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 175.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.83 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -169.09 -156.88 0.0 OUTLIER Pre-proline 0 C--O 1.192 -1.973 0 C-N-CA 118.882 -1.127 . . . . 0.0 108.651 -174.916 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.83 ' HD2' ' HB3' ' A' ' 81' ' ' LYS . 43.7 Cg_endo -74.7 127.22 10.72 Favored 'Trans proline' 0 C--N 1.299 -2.052 0 N-CA-C 108.905 -1.229 . . . . 0.0 108.905 178.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 1.061 ' CD1' HG13 ' A' ' 65' ' ' VAL . 0.8 OUTLIER -58.9 151.64 21.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.506 -1.371 . . . . 0.0 108.087 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 1.016 HG22 ' CD1' ' A' ' 58' ' ' PHE . 9.8 p -149.64 95.49 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.508 0 CA-C-O 122.015 0.912 . . . . 0.0 109.764 -178.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.748 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -78.53 119.0 21.19 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 179.611 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.638 ' HB3' ' CZ ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -85.71 94.37 9.08 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 122.716 1.246 . . . . 0.0 113.845 -176.157 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.661 ' HB3' ' CG1' ' A' ' 57' ' ' VAL . 0.0 OUTLIER -99.47 176.96 5.32 Favored 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 114.584 -1.189 . . . . 0.0 108.733 175.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.508 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -44.04 133.39 5.13 Favored 'General case' 0 N--CA 1.514 2.769 0 O-C-N 120.613 -1.304 . . . . 0.0 113.627 -175.81 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.81 HD11 ' CD2' ' A' ' 58' ' ' PHE . 40.8 mt -139.22 119.03 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.995 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -135.71 108.74 7.66 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.605 -0.684 . . . . 0.0 109.442 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -114.44 150.44 34.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.179 -0.951 . . . . 0.0 110.355 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.581 ' N ' ' O ' ' A' ' 53' ' ' LYS . 1.2 pp -65.46 178.51 0.94 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.117 0.96 . . . . 0.0 111.405 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.481 ' HA ' ' NH1' ' A' ' 4' ' ' ARG . 3.5 tp10 . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.844 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 41.0 t . . . . . 0 N--CA 1.494 1.763 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -145.95 106.36 4.06 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.537 -0.727 . . . . 0.0 110.096 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.47 ' HB ' ' CB ' ' A' ' 20' ' ' THR . 0.8 OUTLIER -86.3 110.71 19.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.34 -0.85 . . . . 0.0 109.569 179.729 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.526 ' O ' ' HA ' ' A' ' 20' ' ' THR . 0.1 OUTLIER -78.43 122.01 25.27 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.367 -0.833 . . . . 0.0 109.578 -179.789 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.778 ' CA ' HG22 ' A' ' 20' ' ' THR . 51.0 t30 -77.17 143.19 39.25 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.606 -0.684 . . . . 0.0 110.581 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.402 ' HE2' ' HB2' ' A' ' 4' ' ' ARG . 45.9 m-85 -138.98 148.72 43.84 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.119 0.485 . . . . 0.0 109.737 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.868 HG22 ' O ' ' A' ' 48' ' ' ARG . 29.9 m -125.97 140.04 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 O-C-N 121.331 -0.855 . . . . 0.0 112.504 -177.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.829 HD22 ' HG ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -161.91 167.36 24.77 Favored 'General case' 0 N--CA 1.511 2.621 0 O-C-N 121.408 -0.807 . . . . 0.0 111.836 179.485 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.549 ' O ' ' N ' ' A' ' 14' ' ' ASN . 3.4 ttm-85 -134.82 107.95 7.68 Favored 'General case' 0 N--CA 1.526 3.328 0 O-C-N 121.15 -0.969 . . . . 0.0 112.856 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.858 ' HB2' ' CB ' ' A' ' 16' ' ' HIS . 0.7 OUTLIER -74.55 -158.18 0.07 Allowed 'General case' 0 N--CA 1.513 2.688 0 O-C-N 120.998 -1.064 . . . . 0.0 111.878 -179.611 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.593 ' HA ' ' HB3' ' A' ' 41' ' ' ASN . 0.2 OUTLIER 70.9 48.94 0.38 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 -177.366 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.623 ' HA ' ' O ' ' A' ' 42' ' ' PRO . 97.8 m-20 58.63 8.37 0.89 Allowed 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 112.498 -2.137 . . . . 0.0 113.216 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.16 -75.89 1.27 Allowed Glycine 0 N--CA 1.49 2.299 0 C-N-CA 117.88 -2.105 . . . . 0.0 108.368 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.949 ' HB3' HD13 ' A' ' 45' ' ' ILE . 0.8 OUTLIER -119.25 -78.72 0.59 Allowed 'General case' 0 C--N 1.293 -1.862 0 CA-C-O 122.261 1.029 . . . . 0.0 108.316 177.388 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.7 ' CB ' HG21 ' A' ' 45' ' ' ILE . 1.7 tp10 -177.01 140.55 0.31 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 178.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.858 ' CB ' ' HB2' ' A' ' 10' ' ' ASP . 0.3 OUTLIER -87.29 122.67 31.37 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 116.286 -2.166 . . . . 0.0 112.324 -179.608 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.557 ' HA2' ' CZ ' ' A' ' 19' ' ' PHE . . . -177.25 120.13 0.72 Allowed Glycine 0 C--N 1.28 -2.542 0 CA-C-N 113.496 -1.684 . . . . 0.0 110.019 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.9 82.69 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.61 ' CD1' ' N ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -174.23 -173.43 0.79 Allowed 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.226 -179.165 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.778 HG22 ' CA ' ' A' ' 5' ' ' ASN . 39.0 p -102.12 150.62 23.08 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.421 -0.8 . . . . 0.0 112.441 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -130.25 121.29 3.3 Favored Glycine 0 N--CA 1.499 2.846 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 178.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.67 -45.01 70.13 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.49 -1.006 . . . . 0.0 109.823 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.689 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -118.02 135.4 23.42 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.034 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -69.29 -45.23 1.93 Allowed 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.384 1.202 . . . . 0.0 110.74 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.576 ' O ' HD22 ' A' ' 29' ' ' LEU . 40.3 mtt180 -82.3 -64.93 1.08 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.652 -0.655 . . . . 0.0 111.208 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.625 ' HG3' ' HA ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -47.0 -45.09 20.82 Favored 'General case' 0 N--CA 1.51 2.569 0 O-C-N 121.187 -0.946 . . . . 0.0 111.861 -179.374 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.689 ' HB3' ' O ' ' A' ' 23' ' ' GLN . . . -73.41 -17.79 61.22 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.181 -1.007 . . . . 0.0 110.642 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.555 ' HB2' ' HE1' ' A' ' 56' ' ' HIS . . . -71.93 -52.51 16.86 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.847 -1.158 . . . . 0.0 111.759 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.995 HD12 HG21 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -52.64 -57.24 10.67 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.849 0.833 . . . . 0.0 109.66 -179.073 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.409 ' NZ ' ' OE1' ' A' ' 26' ' ' GLN . 30.7 mtmt -69.68 -34.4 73.91 Favored 'General case' 0 N--CA 1.511 2.592 0 O-C-N 121.284 -0.885 . . . . 0.0 113.151 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.675 ' C ' ' HB2' ' A' ' 36' ' ' SER . . . -59.29 -43.58 92.58 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.757 -1.214 . . . . 0.0 112.129 -178.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.891 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -65.49 -32.75 74.53 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 118.621 -1.232 . . . . 0.0 110.062 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.497 ' HB2' ' HG3' ' A' ' 82' ' ' PRO . 46.8 t30 -40.04 -50.01 2.56 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.0 mtm105 -94.65 -74.76 0.53 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.196 -1.002 . . . . 0.0 113.097 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.498 ' O ' ' CD2' ' A' ' 16' ' ' HIS . . . -113.53 -0.06 24.8 Favored Glycine 0 N--CA 1.504 3.2 0 N-CA-C 116.758 1.463 . . . . 0.0 116.758 -175.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.675 ' HB2' ' C ' ' A' ' 31' ' ' ALA . 0.3 OUTLIER -87.64 4.05 45.39 Favored 'General case' 0 N--CA 1.506 2.34 0 CA-C-N 122.248 3.024 . . . . 0.0 110.843 -177.272 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -166.58 117.68 0.75 Allowed Glycine 0 N--CA 1.482 1.739 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.506 ' O ' ' HB3' ' A' ' 39' ' ' LYS . 28.2 m -78.29 -17.28 56.82 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 120.525 2.163 . . . . 0.0 109.691 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.829 ' CA ' ' HG3' ' A' ' 42' ' ' PRO . 4.6 tttm 73.27 -56.8 0.65 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -178.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.9 -19.36 65.71 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 175.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.593 ' HB3' ' HA ' ' A' ' 11' ' ' GLU 0.278 0.2 OUTLIER -160.23 68.08 2.78 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.845 -0.535 . . . . 0.0 111.332 179.108 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.829 ' HG3' ' CA ' ' A' ' 39' ' ' LYS . 76.8 Cg_endo -116.95 -175.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.411 2.074 . . . . 0.0 109.369 178.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.452 ' HB3' ' O ' ' A' ' 14' ' ' ASN . 1.7 t70 -168.54 -173.98 2.07 Favored 'General case' 0 N--CA 1.514 2.775 0 C-N-CA 116.988 -1.885 . . . . 0.0 113.431 176.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.873 HG22 ' HD3' ' A' ' 59' ' ' LYS . 1.6 pp -81.52 136.28 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.949 HD13 ' HB3' ' A' ' 14' ' ' ASN . 3.1 tp -147.94 139.53 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 117.634 -1.626 . . . . 0.0 114.184 -177.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.505 ' H ' HD12 ' A' ' 45' ' ' ILE . 49.4 mtt-85 -88.75 95.28 10.21 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 173.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.829 ' HG ' HD22 ' A' ' 8' ' ' LEU . 0.3 OUTLIER -66.52 93.16 0.23 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -178.357 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.868 ' O ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -117.29 -169.01 1.58 Allowed 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.214 -176.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -160.23 118.92 2.68 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -73.37 152.3 40.9 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 118.437 -1.305 . . . . 0.0 111.244 -177.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.4 -43.24 1.72 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 107.521 -2.231 . . . . 0.0 107.521 -178.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 68.2 p -125.52 140.5 52.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.836 -0.802 . . . . 0.0 109.033 178.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.62 ' HA ' ' CA ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -64.58 90.92 0.08 Allowed 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 122.484 1.135 . . . . 0.0 110.207 -179.29 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 48' ' ' ARG . 9.2 mttp -136.98 123.87 21.36 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.675 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.466 HG21 ' CD1' ' A' ' 92' ' ' LEU . 71.7 t -153.82 96.35 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.613 -0.679 . . . . 0.0 111.028 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.76 ' CD2' ' HB2' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -88.44 137.15 32.58 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 177.237 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.529 ' HB ' ' CB ' ' A' ' 87' ' ' GLU . 2.2 t -116.79 116.12 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 O-C-N 119.755 -1.841 . . . . 0.0 110.381 -178.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.734 ' HA ' ' O ' ' A' ' 85' ' ' LYS . 0.5 OUTLIER -157.51 174.95 14.6 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.289 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.873 ' HD3' HG22 ' A' ' 44' ' ' ILE . 16.8 mttm -132.04 127.33 35.93 Favored 'General case' 0 N--CA 1.505 2.296 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 177.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.891 ' HB1' ' HB2' ' A' ' 32' ' ' ALA . . . -115.67 110.29 18.94 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 120.747 -1.221 . . . . 0.0 113.198 -175.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.762 ' O ' ' HA ' ' A' ' 82' ' ' PRO . 14.1 m0 -126.49 -167.21 1.69 Allowed 'General case' 0 N--CA 1.512 2.675 0 O-C-N 121.943 -0.473 . . . . 0.0 110.307 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.718 ' HB2' ' HB2' ' A' ' 39' ' ' LYS . 0.7 OUTLIER -123.45 88.13 2.86 Favored 'General case' 0 N--CA 1.507 2.382 0 CA-C-N 120.158 1.345 . . . . 0.0 112.569 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.879 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 3.6 mt-10 -165.97 172.34 11.6 Favored 'General case' 0 N--CA 1.51 2.573 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.283 176.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.668 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 9.2 tt -73.61 101.42 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.523 3.186 0 N-CA-C 116.824 2.157 . . . . 0.0 116.824 -174.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.902 HG13 ' CD1' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -88.29 -166.57 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.406 -1.434 . . . . 0.0 109.883 176.63 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.643 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 9.2 t0 -124.43 129.08 50.01 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.843 ' HA ' ' CB ' ' A' ' 77' ' ' GLU . . . -64.3 99.3 0.18 Allowed Pre-proline 0 N--CA 1.507 2.396 0 CA-C-O 117.79 -1.1 . . . . 0.0 111.784 -178.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.694 ' HD3' ' HB3' ' A' ' 77' ' ' GLU . 52.1 Cg_endo -88.9 -160.33 0.1 OUTLIER 'Trans proline' 0 C--N 1.316 -1.141 0 O-C-N 124.105 1.581 . . . . 0.0 110.528 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.3 mttt -70.11 64.57 0.24 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.292 -0.88 . . . . 0.0 109.092 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.762 ' ND2' HD11 ' A' ' 29' ' ' LEU . 5.4 m-20 -102.37 -12.4 17.93 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.473 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.743 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER 59.8 44.69 0.98 Allowed Pre-proline 0 N--CA 1.506 2.358 0 C-N-CA 122.796 0.439 . . . . 0.0 111.209 -177.528 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.743 ' HD3' ' N ' ' A' ' 71' ' ' ARG . 48.9 Cg_endo -92.89 99.89 0.16 Allowed 'Trans proline' 0 C--N 1.323 -0.797 0 C-N-CA 121.152 1.234 . . . . 0.0 110.495 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.19 -34.07 24.05 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.365 -0.834 . . . . 0.0 112.065 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.465 ' CD1' ' N ' ' A' ' 74' ' ' TRP . 32.2 m95 -81.55 -31.46 32.68 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.444 -0.785 . . . . 0.0 110.514 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.456 ' O ' ' HB2' ' A' ' 72' ' ' PRO . 12.5 tpt -164.75 110.38 0.85 Allowed Pre-proline 0 N--CA 1.496 1.861 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.703 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 48.2 Cg_endo -79.28 -178.91 4.96 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.898 1.473 . . . . 0.0 112.693 -178.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.843 ' CB ' ' HA ' ' A' ' 67' ' ' ALA . 3.1 tt0 -90.21 6.61 42.03 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 118.429 -1.308 . . . . 0.0 110.09 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.736 ' O ' HG22 ' A' ' 79' ' ' ILE . 1.5 tppm? -92.28 77.05 5.22 Favored 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.778 HD11 ' CB ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -168.08 158.63 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 C-N-CA 118.272 -1.371 . . . . 0.0 112.146 -177.711 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.578 ' HA ' ' HB ' ' A' ' 64' ' ' ILE . 1.7 m -77.09 103.35 6.97 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 175.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.875 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -173.17 -152.18 0.0 OUTLIER Pre-proline 0 C--O 1.196 -1.711 0 O-C-N 121.302 -0.874 . . . . 0.0 108.759 -175.757 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.875 ' HD2' ' HB3' ' A' ' 81' ' ' LYS . 43.4 Cg_endo -68.34 123.7 10.84 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 117.808 -0.995 . . . . 0.0 111.639 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.902 ' CD1' HG13 ' A' ' 65' ' ' VAL . 0.7 OUTLIER -63.43 159.4 18.44 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.184 -0.947 . . . . 0.0 109.382 178.83 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.995 HG21 HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -153.16 93.94 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 C-N-CA 120.034 -0.666 . . . . 0.0 109.62 178.376 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.734 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 3.1 tptt -73.5 125.59 28.29 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 177.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.586 ' HB3' ' CZ ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -94.05 90.64 6.5 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 122.337 1.065 . . . . 0.0 113.783 -175.257 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.529 ' CB ' ' HB ' ' A' ' 57' ' ' VAL . 4.2 mt-10 -86.35 150.63 24.2 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 115.293 -0.867 . . . . 0.0 108.755 176.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -56.89 122.14 11.54 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.363 -0.836 . . . . 0.0 111.911 -177.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.664 HG23 ' HA ' ' A' ' 56' ' ' HIS . 88.1 mt -73.79 125.13 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -106.06 -179.52 3.96 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.47 0.652 . . . . 0.0 109.637 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.613 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -133.86 95.99 3.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.894 -1.129 . . . . 0.0 109.889 179.723 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.741 HD12 ' HB2' ' A' ' 93' ' ' GLU . 2.7 pp -177.31 -175.78 0.58 Allowed 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.633 -0.667 . . . . 0.0 111.181 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.741 ' HB2' HD12 ' A' ' 92' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.497 1.883 0 CA-C-O 118.584 -0.722 . . . . 0.0 111.733 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.497 1.889 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -160.17 137.01 9.14 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.417 -0.802 . . . . 0.0 110.779 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.0 p -79.22 151.97 30.9 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.529 -0.732 . . . . 0.0 109.919 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.543 ' HB3' ' HD2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -84.44 127.17 33.86 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.126 -0.984 . . . . 0.0 110.104 179.705 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.831 ' CA ' HG22 ' A' ' 20' ' ' THR . 43.9 t30 -74.35 137.49 42.83 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.496 -0.752 . . . . 0.0 110.58 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.437 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 25.7 m-85 -145.01 151.1 38.04 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.347 0.594 . . . . 0.0 111.057 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.708 HG22 ' O ' ' A' ' 48' ' ' ARG . 11.7 m -111.21 146.55 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.665 -0.647 . . . . 0.0 111.173 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.1 HD21 HD21 ' A' ' 47' ' ' LEU . 4.6 mp -152.33 145.08 24.3 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.422 -0.799 . . . . 0.0 111.862 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -134.11 91.56 2.83 Favored 'General case' 0 N--CA 1.514 2.756 0 O-C-N 121.073 -1.017 . . . . 0.0 111.243 176.647 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.762 ' HB2' ' N ' ' A' ' 16' ' ' HIS . 1.7 t70 -69.63 -159.4 0.03 OUTLIER 'General case' 0 N--CA 1.51 2.565 0 C-N-CA 123.932 0.893 . . . . 0.0 112.007 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.578 ' HA ' ' HB3' ' A' ' 41' ' ' ASN . 0.1 OUTLIER 72.23 52.56 0.19 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 -176.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.599 ' HA ' ' O ' ' A' ' 42' ' ' PRO . 92.4 m-20 61.28 6.91 1.49 Allowed 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 112.539 -2.118 . . . . 0.0 112.783 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.421 ' O ' ' HB3' ' A' ' 43' ' ' ASP . . . -90.17 -75.43 1.3 Allowed Glycine 0 N--CA 1.485 1.95 0 C-N-CA 117.98 -2.057 . . . . 0.0 108.82 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.872 ' CG ' HD13 ' A' ' 45' ' ' ILE . 8.2 m120 -125.22 -76.77 0.59 Allowed 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.596 0.713 . . . . 0.0 111.337 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.733 ' HB2' HG21 ' A' ' 45' ' ' ILE . 8.1 mt-10 -169.31 151.42 4.57 Favored 'General case' 0 N--CA 1.511 2.582 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.762 ' N ' ' HB2' ' A' ' 10' ' ' ASP . 0.4 OUTLIER -99.1 118.68 36.39 Favored 'General case' 0 N--CA 1.507 2.388 0 C-N-CA 115.021 -2.672 . . . . 0.0 113.125 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.57 ' HA2' ' CZ ' ' A' ' 19' ' ' PHE . . . 175.21 132.07 1.53 Allowed Glycine 0 C--N 1.285 -2.292 0 C-N-CA 119.493 -1.336 . . . . 0.0 112.251 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.6 86.78 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 175.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.623 ' CD1' ' N ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -172.54 -172.26 0.89 Allowed 'General case' 0 N--CA 1.5 2.073 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.733 -178.132 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.831 HG22 ' CA ' ' A' ' 5' ' ' ASN . 57.2 p -107.62 158.46 17.23 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.493 -0.755 . . . . 0.0 111.703 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -130.69 130.97 6.31 Favored Glycine 0 N--CA 1.501 3.02 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.4 ttpt -60.84 -47.82 84.64 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.309 -1.113 . . . . 0.0 108.765 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.665 ' HB3' ' HB3' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -115.7 114.13 42.22 Favored Pre-proline 0 N--CA 1.486 1.362 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.403 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.94 -35.86 41.66 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.65 1.342 . . . . 0.0 110.823 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.593 ' HB3' ' HA ' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -83.08 -62.92 1.47 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.209 -0.932 . . . . 0.0 109.862 179.419 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.665 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 1.0 OUTLIER -53.44 -41.97 66.65 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.129 -0.982 . . . . 0.0 111.886 -179.683 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' A' ' 23' ' ' GLN . . . -74.57 -15.69 60.84 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 120.593 -1.317 . . . . 0.0 110.42 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.61 -51.89 63.29 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.79 -1.194 . . . . 0.0 110.642 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.064 HD12 HG21 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -61.9 -50.46 72.1 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 121.558 0.694 . . . . 0.0 109.559 -179.555 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -69.41 -37.87 77.65 Favored 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -178.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.43 ' C ' ' HB2' ' A' ' 36' ' ' SER . . . -60.5 -43.73 96.75 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 120.719 -1.238 . . . . 0.0 112.461 -177.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.724 ' CB ' ' HB1' ' A' ' 60' ' ' ALA . . . -64.51 -33.34 75.67 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 118.77 -1.172 . . . . 0.0 110.15 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.545 ' N ' ' HG3' ' A' ' 82' ' ' PRO . 0.2 OUTLIER -42.74 -46.34 5.1 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.802 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.5 mtp85 -95.51 -72.83 0.61 Allowed 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.269 -0.972 . . . . 0.0 112.254 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.548 ' O ' ' CD2' ' A' ' 16' ' ' HIS . . . -115.72 -0.72 21.47 Favored Glycine 0 N--CA 1.499 2.877 0 N-CA-C 117.48 1.752 . . . . 0.0 117.48 -175.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.693 ' CB ' ' HA ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -82.03 -2.29 51.21 Favored 'General case' 0 N--CA 1.514 2.73 0 CA-C-N 123.615 3.708 . . . . 0.0 110.94 -176.744 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -163.49 120.84 0.97 Allowed Glycine 0 C--N 1.297 -1.637 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -178.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.532 ' O ' ' HB3' ' A' ' 39' ' ' LYS . 23.5 m -77.73 -15.61 59.01 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 119.825 1.813 . . . . 0.0 109.494 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.84 ' CA ' ' HG3' ' A' ' 42' ' ' PRO . 7.6 tttm 75.21 -56.27 0.62 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -178.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.43 -18.89 65.62 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 175.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.578 ' HB3' ' HA ' ' A' ' 11' ' ' GLU 0.27 0.4 OUTLIER -160.44 67.31 2.62 Favored Pre-proline 0 C--O 1.202 -1.446 0 O-C-N 121.661 -0.649 . . . . 0.0 111.147 179.097 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.84 ' HG3' ' CA ' ' A' ' 39' ' ' LYS . 82.9 Cg_endo -118.0 -176.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.3 -2.012 0 C-N-CA 122.019 1.813 . . . . 0.0 109.615 178.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.459 ' HB2' ' C ' ' A' ' 12' ' ' ASP . 0.7 OUTLIER -168.04 -169.49 1.14 Allowed 'General case' 0 N--CA 1.512 2.643 0 O-C-N 119.826 -1.796 . . . . 0.0 113.902 177.036 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.868 HG22 ' HD3' ' A' ' 59' ' ' LYS . 1.6 pp -91.5 142.6 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.872 HD13 ' CG ' ' A' ' 14' ' ' ASN . 1.1 tp -161.59 142.67 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 117.958 -1.497 . . . . 0.0 113.422 -178.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.508 ' HG3' HG13 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -87.03 96.23 10.21 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 174.184 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 1.1 HD21 HD21 ' A' ' 8' ' ' LEU . 9.0 mp -63.21 95.77 0.09 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 -178.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.708 ' O ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -103.2 -172.88 2.19 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.704 -177.603 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -159.45 142.98 14.6 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -97.56 139.63 33.18 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.701 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.71 -56.43 0.53 Allowed Glycine 0 N--CA 1.494 2.563 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.409 ' HB ' HD22 ' A' ' 92' ' ' LEU . 7.1 p -115.27 -175.6 2.73 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.424 -1.045 . . . . 0.0 109.007 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.639 ' O ' ' N ' ' A' ' 92' ' ' LEU . 3.0 mmtt -97.45 99.07 10.49 Favored 'General case' 0 C--O 1.203 -1.365 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.781 ' HG3' HD23 ' A' ' 92' ' ' LEU . 5.3 mtmm -146.4 98.8 3.13 Favored 'General case' 0 C--N 1.281 -2.395 0 O-C-N 120.495 -1.378 . . . . 0.0 109.816 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 6.7 t -137.03 100.2 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 CA-C-O 121.399 0.618 . . . . 0.0 110.338 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.846 ' HA ' HG23 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -91.61 138.09 31.85 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.52 ' HB ' ' CB ' ' A' ' 87' ' ' GLU . 2.5 t -114.59 104.09 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 O-C-N 119.91 -1.744 . . . . 0.0 109.258 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.748 ' HA ' ' O ' ' A' ' 85' ' ' LYS . 0.6 OUTLIER -146.62 175.58 10.49 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.376 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.868 ' HD3' HG22 ' A' ' 44' ' ' ILE . 24.5 mttm -130.04 128.12 41.3 Favored 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 177.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.724 ' HB1' ' CB ' ' A' ' 32' ' ' ALA . . . -114.18 113.26 24.43 Favored 'General case' 0 N--CA 1.505 2.312 0 C-N-CA 118.199 -1.4 . . . . 0.0 113.605 -176.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.814 ' HB2' ' HB2' ' A' ' 83' ' ' PHE . 13.6 m0 -130.26 -168.42 1.97 Allowed 'General case' 0 N--CA 1.516 2.841 0 O-C-N 121.713 -0.617 . . . . 0.0 110.802 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.668 ' HB2' ' HB2' ' A' ' 39' ' ' LYS . 1.3 tmtm? -120.68 89.02 3.05 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.696 -1.253 . . . . 0.0 111.283 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.84 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 2.1 mt-10 -165.79 168.67 15.81 Favored 'General case' 0 N--CA 1.508 2.456 0 CA-C-O 121.354 0.597 . . . . 0.0 109.994 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.676 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 4.7 tt -72.56 101.15 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.522 3.138 0 O-C-N 119.612 -1.93 . . . . 0.0 115.68 -176.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.985 HG13 ' CD1' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -91.86 -166.58 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.501 -1.375 . . . . 0.0 110.838 177.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.681 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 7.5 t70 -120.39 130.19 54.26 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.862 ' HA ' ' CB ' ' A' ' 77' ' ' GLU . . . -65.64 100.47 0.23 Allowed Pre-proline 0 N--CA 1.509 2.505 0 CA-C-O 118.061 -0.971 . . . . 0.0 113.308 -177.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.681 ' HD3' ' O ' ' A' ' 66' ' ' ASP . 55.8 Cg_endo -84.01 -163.48 0.2 Allowed 'Trans proline' 0 N--CA 1.485 1.019 0 O-C-N 123.625 1.329 . . . . 0.0 110.502 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.2 mmpp? -69.83 64.87 0.22 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.158 -0.964 . . . . 0.0 109.841 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.808 ' ND2' HD11 ' A' ' 29' ' ' LEU . 3.8 m-20 -97.94 -12.6 21.84 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.986 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.704 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER 44.87 51.08 8.21 Favored Pre-proline 0 N--CA 1.504 2.271 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.374 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.798 ' HG2' ' HA ' ' A' ' 76' ' ' PRO . 55.1 Cg_endo -99.97 112.0 0.07 OUTLIER 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 121.861 1.707 . . . . 0.0 109.518 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.78 -19.98 47.32 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.766 -1.209 . . . . 0.0 112.106 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.435 ' CD1' ' N ' ' A' ' 74' ' ' TRP . 44.5 m95 -81.96 -37.75 26.22 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.308 -0.87 . . . . 0.0 110.46 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.461 ' O ' ' HB2' ' A' ' 72' ' ' PRO . 20.9 ttm -168.89 130.75 1.12 Allowed Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.673 -0.642 . . . . 0.0 109.665 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.798 ' HA ' ' HG2' ' A' ' 72' ' ' PRO . 47.5 Cg_endo -88.59 179.82 2.47 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.662 1.349 . . . . 0.0 111.803 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.862 ' CB ' ' HA ' ' A' ' 67' ' ' ALA . 3.7 tt0 -88.71 9.23 25.09 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 118.005 -1.478 . . . . 0.0 110.1 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.707 ' H ' ' HB2' ' A' ' 67' ' ' ALA . 40.6 tptt -93.74 82.49 4.32 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.678 HG22 ' C ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -179.82 163.21 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 C-N-CA 118.006 -1.478 . . . . 0.0 112.501 -178.51 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.591 ' HA ' ' HB ' ' A' ' 64' ' ' ILE . 1.1 m -72.01 105.35 3.86 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 175.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.711 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 11.2 pttp -167.81 -154.92 0.0 OUTLIER Pre-proline 0 C--O 1.196 -1.729 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -175.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.743 ' HA ' ' O ' ' A' ' 61' ' ' TRP . 49.7 Cg_endo -75.59 128.99 11.44 Favored 'Trans proline' 0 C--N 1.299 -2.066 0 N-CA-C 109.761 -0.899 . . . . 0.0 109.761 178.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.985 ' CD1' HG13 ' A' ' 65' ' ' VAL . 1.1 m-30 -64.73 157.15 28.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.217 -0.927 . . . . 0.0 109.423 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 1.064 HG21 HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -152.15 95.66 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.153 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.748 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -74.01 130.15 39.28 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 105.917 -1.882 . . . . 0.0 105.917 178.16 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.632 ' HB3' ' CZ ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -99.36 92.24 5.32 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 122.615 1.197 . . . . 0.0 113.908 -175.338 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.52 ' CB ' ' HB ' ' A' ' 57' ' ' VAL . 24.0 mt-10 -88.75 151.94 22.1 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 175.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -55.4 116.69 2.99 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-O 122.316 1.055 . . . . 0.0 112.77 -176.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.846 HG23 ' HA ' ' A' ' 56' ' ' HIS . 23.7 mt -83.84 140.54 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.428 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.24 144.14 48.77 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 177.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.537 ' HG2' ' O ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -159.96 175.57 12.87 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.571 -1.331 . . . . 0.0 112.607 -178.732 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.781 HD23 ' HG3' ' A' ' 54' ' ' LYS . 1.9 pp -74.26 -178.59 3.49 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.529 0.681 . . . . 0.0 110.369 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 . . . . . 0 N--CA 1.493 1.721 0 O-C-N 121.339 -0.851 . . . . 0.0 109.896 179.334 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 120.774 0.321 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -126.37 114.68 18.54 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.296 -0.877 . . . . 0.0 109.947 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.406 ' OG1' ' HB ' ' A' ' 20' ' ' THR . 5.2 t -162.84 173.34 13.86 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.444 -0.785 . . . . 0.0 110.342 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.55 ' O ' ' HA ' ' A' ' 20' ' ' THR . 5.1 mmp_? -121.93 119.58 31.96 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.423 -0.798 . . . . 0.0 110.213 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.698 ' CA ' HG22 ' A' ' 20' ' ' THR . 19.5 t-20 -74.54 140.88 44.78 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.557 -0.714 . . . . 0.0 110.228 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.557 ' HD1' HD22 ' A' ' 47' ' ' LEU . 8.5 m-85 -152.57 168.29 26.07 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.476 -0.765 . . . . 0.0 110.421 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.573 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -150.24 141.52 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 O-C-N 121.444 -0.785 . . . . 0.0 111.591 -178.007 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.967 HD21 ' HG ' ' A' ' 47' ' ' LEU . 1.5 mp -148.12 167.68 24.39 Favored 'General case' 0 N--CA 1.52 3.052 0 O-C-N 121.287 -0.883 . . . . 0.0 112.942 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.539 ' N ' ' O ' ' A' ' 15' ' ' GLU . 9.3 ptt-85 -136.3 95.37 3.17 Favored 'General case' 0 N--CA 1.517 2.908 0 O-C-N 121.488 -0.757 . . . . 0.0 111.28 176.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.82 ' HB2' ' N ' ' A' ' 16' ' ' HIS . 5.1 t0 -82.46 -150.93 0.09 Allowed 'General case' 0 N--CA 1.509 2.508 0 C-N-CA 124.136 0.974 . . . . 0.0 113.081 -178.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.55 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 0.8 OUTLIER 73.56 53.63 0.11 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 104.048 -2.575 . . . . 0.0 104.048 -175.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.55 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 1.9 m-20 63.98 3.96 1.85 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 112.683 -2.053 . . . . 0.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -89.52 -76.54 1.31 Allowed Glycine 0 N--CA 1.479 1.55 0 C-N-CA 117.795 -2.145 . . . . 0.0 107.795 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.886 ' CG ' HD13 ' A' ' 45' ' ' ILE . 3.5 m120 -126.74 -77.03 0.58 Allowed 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.452 0.644 . . . . 0.0 111.576 178.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 1.109 ' HB2' HG21 ' A' ' 45' ' ' ILE . 4.6 mt-10 -171.28 154.84 4.08 Favored 'General case' 0 N--CA 1.512 2.626 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.82 ' N ' ' HB2' ' A' ' 10' ' ' ASP . 0.2 OUTLIER -119.62 120.29 36.23 Favored 'General case' 0 N--CA 1.511 2.615 0 C-N-CA 114.848 -2.741 . . . . 0.0 115.047 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.42 ' HA2' ' CZ ' ' A' ' 19' ' ' PHE . . . -176.45 128.35 1.34 Allowed Glycine 0 C--N 1.29 -1.999 0 CA-C-N 113.561 -1.654 . . . . 0.0 110.113 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.418 ' C ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -134.78 92.05 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 177.449 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.671 ' CD1' ' N ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -175.25 -173.3 0.65 Allowed 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 121.283 0.563 . . . . 0.0 110.281 -178.743 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.698 HG22 ' CA ' ' A' ' 5' ' ' ASN . 22.2 p -106.1 126.56 52.36 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.289 -0.882 . . . . 0.0 110.953 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -97.68 131.15 10.49 Favored Glycine 0 N--CA 1.501 3.001 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.1 mtmp? -59.54 -39.2 83.17 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.55 -0.971 . . . . 0.0 109.57 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.813 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -127.42 125.35 23.89 Favored Pre-proline 0 N--CA 1.489 1.493 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.112 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.856 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 37.0 Cg_endo -63.06 -40.82 31.65 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 O-C-N 123.493 1.26 . . . . 0.0 110.924 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.411 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 2.8 ttt180 -87.47 -61.19 1.78 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.499 -0.751 . . . . 0.0 111.46 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.471 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 14.5 tt0 -55.76 -40.94 73.28 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 120.938 -1.101 . . . . 0.0 111.71 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.813 ' HB3' ' O ' ' A' ' 23' ' ' GLN . . . -79.8 -18.92 49.75 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.828 -1.149 . . . . 0.0 109.446 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.856 ' HB2' ' O ' ' A' ' 24' ' ' PRO . . . -62.74 -57.7 10.02 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.358 -0.839 . . . . 0.0 110.808 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.492 ' O ' ' HG2' ' A' ' 82' ' ' PRO . 2.4 pp -58.38 -44.37 88.87 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.354 -178.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.476 ' HB2' ' HE3' ' A' ' 30' ' ' LYS . 1.0 OUTLIER -70.46 -35.47 73.35 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 120.793 -1.192 . . . . 0.0 111.689 179.249 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 27' ' ' ALA . . . -56.59 -42.01 77.97 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.187 -0.946 . . . . 0.0 113.079 -177.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.843 ' CB ' ' HB1' ' A' ' 60' ' ' ALA . . . -73.03 -29.92 63.36 Favored 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 118.865 -1.134 . . . . 0.0 110.096 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.577 ' CB ' ' HG3' ' A' ' 82' ' ' PRO . 6.3 t-20 -41.37 -46.89 3.45 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.371 0.605 . . . . 0.0 109.369 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.8 mmm-85 -92.97 -74.57 0.52 Allowed 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 118.884 -1.126 . . . . 0.0 112.938 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.474 ' O ' ' CD2' ' A' ' 16' ' ' HIS . . . -115.93 -3.96 19.34 Favored Glycine 0 N--CA 1.499 2.855 0 N-CA-C 117.065 1.586 . . . . 0.0 117.065 -175.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.757 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 0.6 OUTLIER -79.02 -4.27 49.26 Favored 'General case' 0 N--CA 1.51 2.558 0 CA-C-N 122.633 3.216 . . . . 0.0 110.573 -176.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.54 ' O ' ' HG3' ' A' ' 39' ' ' LYS . . . -154.31 117.72 0.81 Allowed Glycine 0 C--N 1.292 -1.873 0 N-CA-C 108.579 -1.809 . . . . 0.0 108.579 -178.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.459 ' HB ' ' C ' ' A' ' 41' ' ' ASN . 90.2 m -68.9 -17.12 63.92 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 119.348 1.574 . . . . 0.0 108.107 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.8 ' CA ' ' HG3' ' A' ' 42' ' ' PRO . 10.0 mtmt 71.36 -59.64 0.54 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.72 -20.02 61.97 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 175.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.505 ' HB3' ' HA ' ' A' ' 11' ' ' GLU 0.279 0.1 OUTLIER -149.66 65.25 7.59 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.722 -0.612 . . . . 0.0 110.638 178.628 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.8 ' HG3' ' CA ' ' A' ' 39' ' ' LYS . 75.1 Cg_endo -117.03 -174.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 121.167 1.245 . . . . 0.0 111.322 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.406 ' N ' ' HE1' ' A' ' 61' ' ' TRP . 1.3 t70 -167.13 -168.23 1.05 Allowed 'General case' 0 N--CA 1.512 2.672 0 C-N-CA 118.07 -1.452 . . . . 0.0 112.887 177.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.876 HG22 ' HD3' ' A' ' 59' ' ' LYS . 1.2 pp -95.85 149.62 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 1.109 HG21 ' HB2' ' A' ' 15' ' ' GLU . 1.8 tp -163.09 144.05 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 C-N-CA 117.773 -1.571 . . . . 0.0 113.883 -178.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.565 ' H ' HD12 ' A' ' 45' ' ' ILE . 32.8 mtt180 -85.35 95.63 9.29 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 174.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.967 ' HG ' HD21 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -70.15 94.88 0.93 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.448 -0.782 . . . . 0.0 109.361 -178.063 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -129.18 -177.32 4.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.563 -0.711 . . . . 0.0 110.078 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -150.13 117.72 6.15 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.98 152.28 38.76 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 118.597 -1.241 . . . . 0.0 110.358 -177.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.86 -32.33 7.36 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.5 p -146.4 176.78 9.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.401 -1.058 . . . . 0.0 110.656 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.802 ' HA ' ' CA ' ' A' ' 92' ' ' LEU . 5.1 mttm -75.36 92.57 2.81 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.789 0.804 . . . . 0.0 110.094 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.515 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -141.93 115.21 8.87 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.364 179.482 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 54' ' ' LYS . 2.4 t -155.76 142.84 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 CA-C-O 122.002 0.906 . . . . 0.0 111.216 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.666 ' NE2' ' HB2' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -162.78 129.89 3.61 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 179.598 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.595 HG12 ' HB2' ' A' ' 87' ' ' GLU . 11.5 t -118.31 115.88 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 117.311 -1.756 . . . . 0.0 109.23 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.744 ' HA ' ' O ' ' A' ' 85' ' ' LYS . 0.8 OUTLIER -153.76 -176.63 5.92 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 -179.817 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.876 ' HD3' HG22 ' A' ' 44' ' ' ILE . 30.2 mttt -137.39 133.97 35.4 Favored 'General case' 0 N--CA 1.51 2.566 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 177.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.843 ' HB1' ' CB ' ' A' ' 32' ' ' ALA . . . -117.04 112.69 21.28 Favored 'General case' 0 N--CA 1.51 2.557 0 CA-C-N 120.662 1.574 . . . . 0.0 113.653 -176.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.779 ' HB2' ' HB2' ' A' ' 83' ' ' PHE . 11.7 m0 -133.59 -165.51 1.64 Allowed 'General case' 0 N--CA 1.514 2.726 0 O-C-N 122.036 -0.415 . . . . 0.0 111.344 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.66 ' HB2' ' HB3' ' A' ' 39' ' ' LYS . 1.6 tptp -123.78 91.4 3.46 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.643 -1.285 . . . . 0.0 111.776 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.899 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 1.1 mt-10 -165.37 -173.0 2.65 Favored 'General case' 0 N--CA 1.51 2.573 0 CA-C-O 121.223 0.535 . . . . 0.0 110.452 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.606 ' C ' ' HE1' ' A' ' 83' ' ' PHE . 12.6 tt -94.86 98.68 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.117 0 O-C-N 118.977 -2.327 . . . . 0.0 116.081 -176.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.998 HG13 ' CD1' ' A' ' 83' ' ' PHE . 0.3 OUTLIER -103.65 -168.54 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 120.137 -1.602 . . . . 0.0 108.706 176.329 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.784 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 5.9 t0 -114.23 145.63 41.47 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.663 -0.648 . . . . 0.0 111.379 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.91 ' HA ' ' HB3' ' A' ' 77' ' ' GLU 0.25 . . -66.25 101.38 0.28 Allowed Pre-proline 0 N--CA 1.511 2.6 0 CA-C-O 118.075 -0.964 . . . . 0.0 113.167 -178.772 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.803 ' HG3' ' HG2' ' A' ' 86' ' ' LYS . 55.0 Cg_endo -70.81 64.53 2.42 Favored 'Trans proline' 0 N--CA 1.5 1.906 0 O-C-N 123.85 1.448 . . . . 0.0 110.961 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 50.2 40.94 23.23 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 120.994 -1.066 . . . . 0.0 108.69 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.694 ' HB3' ' HG3' ' A' ' 72' ' ' PRO . 6.3 m120 -55.37 -18.83 7.36 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.489 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.792 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER 49.99 43.22 1.55 Allowed Pre-proline 0 N--CA 1.495 1.809 0 CA-C-O 120.484 0.183 . . . . 0.0 110.784 -176.642 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.792 ' HD3' ' N ' ' A' ' 71' ' ' ARG . 57.8 Cg_endo -100.05 135.09 0.22 Allowed 'Trans proline' 0 C--O 1.219 -0.446 0 C-N-CA 121.481 1.454 . . . . 0.0 109.435 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.27 -28.55 25.25 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 120.892 -1.13 . . . . 0.0 111.105 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.447 ' CD1' ' N ' ' A' ' 74' ' ' TRP . 41.0 m95 -84.71 -35.94 22.17 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.542 -0.724 . . . . 0.0 111.424 -178.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.522 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 2.4 tpt -175.06 132.11 0.45 Allowed Pre-proline 0 N--CA 1.51 2.55 0 O-C-N 121.23 -0.919 . . . . 0.0 111.689 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.769 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 44.3 Cg_endo -93.55 -178.21 0.71 Allowed 'Trans proline' 0 N--CA 1.489 1.264 0 C-N-CA 122.401 2.067 . . . . 0.0 111.455 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.91 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 7.8 tt0 -86.12 9.24 17.97 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 117.729 -1.588 . . . . 0.0 110.82 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.784 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -88.05 82.2 7.25 Favored 'General case' 0 N--CA 1.507 2.406 0 C-N-CA 118.861 -1.136 . . . . 0.0 108.292 178.786 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.776 HG22 ' C ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER 179.02 165.89 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.382 0 C-N-CA 118.384 -1.326 . . . . 0.0 112.673 -178.105 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.56 ' N ' HG13 ' A' ' 79' ' ' ILE . 13.3 m -77.69 107.13 9.96 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 175.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.938 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -171.54 -152.86 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.331 0 O-C-N 121.107 -0.995 . . . . 0.0 108.644 -176.106 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.938 ' HD2' ' HB2' ' A' ' 81' ' ' LYS . 44.2 Cg_endo -71.86 123.66 9.53 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 117.316 -1.323 . . . . 0.0 110.005 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.998 ' CD1' HG13 ' A' ' 65' ' ' VAL . 0.5 OUTLIER -61.74 161.0 10.75 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.226 -0.921 . . . . 0.0 110.601 -179.665 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.787 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -155.6 95.55 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.083 178.081 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.744 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 0.9 OUTLIER -71.16 133.92 46.55 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 178.131 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.803 ' HG2' ' HG3' ' A' ' 68' ' ' PRO . 0.0 OUTLIER -101.91 92.3 4.75 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -173.795 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.595 ' HB2' HG12 ' A' ' 57' ' ' VAL . 2.6 mp0 -93.47 163.58 13.52 Favored 'General case' 0 C--N 1.28 -2.431 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 174.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.444 ' O ' HG23 ' A' ' 57' ' ' VAL . 1.4 mtt-85 -54.88 146.53 17.24 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 120.959 -1.088 . . . . 0.0 113.448 -176.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.658 HD11 ' CE2' ' A' ' 58' ' ' PHE . 97.8 mt -128.76 149.51 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.538 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.508 ' HB3' ' CD2' ' A' ' 92' ' ' LEU . 1.8 tm-20 -163.33 -175.12 4.09 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.402 -0.811 . . . . 0.0 110.348 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.55 ' C ' ' HB3' ' A' ' 53' ' ' LYS . 9.2 mtmm -114.39 97.18 6.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.938 -1.101 . . . . 0.0 109.743 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.802 ' CA ' ' HA ' ' A' ' 53' ' ' LYS . 0.6 OUTLIER -170.47 -176.93 2.27 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.33 -0.856 . . . . 0.0 110.937 179.167 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 . . . . . 0 N--CA 1.497 1.922 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.796 179.905 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.6 p . . . . . 0 N--CA 1.494 1.752 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -118.23 160.93 20.73 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.257 -0.902 . . . . 0.0 109.468 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.0 t -79.09 175.02 10.97 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.385 -0.822 . . . . 0.0 110.271 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 20' ' ' THR . 11.1 mmt85 -136.55 126.02 25.13 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.24 -0.912 . . . . 0.0 110.035 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.58 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 3.7 t30 -76.96 144.52 38.74 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.593 -0.692 . . . . 0.0 111.158 -179.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.603 ' HB3' ' CD2' ' A' ' 47' ' ' LEU . 18.2 m-85 -140.8 170.53 15.58 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.411 ' O ' HD23 ' A' ' 47' ' ' LEU . 3.5 m -138.93 130.53 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.421 0 O-C-N 121.141 -0.974 . . . . 0.0 112.177 -177.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.689 HD12 ' C ' ' A' ' 15' ' ' GLU . 0.2 OUTLIER -149.39 161.86 41.25 Favored 'General case' 0 N--CA 1.511 2.604 0 O-C-N 121.071 -1.018 . . . . 0.0 112.222 -179.884 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.511 ' O ' ' N ' ' A' ' 14' ' ' ASN . 12.6 tpt180 -142.72 99.2 3.43 Favored 'General case' 0 N--CA 1.511 2.619 0 O-C-N 121.192 -0.943 . . . . 0.0 111.554 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.823 ' HB2' ' N ' ' A' ' 16' ' ' HIS . 19.1 t70 -80.71 -146.53 0.05 Allowed 'General case' 0 N--CA 1.507 2.399 0 C-N-CA 123.662 0.785 . . . . 0.0 110.167 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.722 ' HA ' ' HB3' ' A' ' 41' ' ' ASN . 0.3 OUTLIER 71.0 55.44 0.23 Allowed 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 104.109 -2.552 . . . . 0.0 104.109 -176.057 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.568 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 0.7 OUTLIER 67.04 1.26 2.28 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-N 112.985 -1.916 . . . . 0.0 111.706 -178.848 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.474 ' O ' ' HB3' ' A' ' 43' ' ' ASP . . . -94.98 -77.52 1.37 Allowed Glycine 0 N--CA 1.477 1.369 0 C-N-CA 118.136 -1.983 . . . . 0.0 109.086 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.83 ' HB3' HD13 ' A' ' 45' ' ' ILE . 2.4 m-80 -126.25 -80.3 0.61 Allowed 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.7 ' C ' ' HB2' ' A' ' 10' ' ' ASP . 28.3 tt0 -168.44 139.8 2.7 Favored 'General case' 0 N--CA 1.509 2.524 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 -178.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.823 ' N ' ' HB2' ' A' ' 10' ' ' ASP . 0.9 OUTLIER -109.56 120.98 44.16 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 116.065 -2.254 . . . . 0.0 115.361 -176.318 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.542 ' HA3' ' CE1' ' A' ' 19' ' ' PHE . . . -179.62 129.64 1.39 Allowed Glycine 0 C--N 1.288 -2.109 0 CA-C-N 112.96 -1.927 . . . . 0.0 109.555 178.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.82 94.37 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 177.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.624 ' CD1' ' N ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -175.74 -169.29 0.34 Allowed 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 121.286 0.565 . . . . 0.0 110.591 -178.388 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.58 ' HA ' ' HA ' ' A' ' 5' ' ' ASN . 2.7 p -105.59 150.64 25.22 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.431 -0.793 . . . . 0.0 111.508 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -130.1 128.55 5.66 Favored Glycine 0 N--CA 1.5 2.945 0 N-CA-C 108.669 -1.773 . . . . 0.0 108.669 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -60.9 -52.82 63.41 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.41 -1.053 . . . . 0.0 108.823 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.616 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 5.0 mp0 -106.47 99.32 23.79 Favored Pre-proline 0 N--CA 1.487 1.392 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.774 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 36.8 Cg_endo -59.74 -29.18 89.06 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.508 1.267 . . . . 0.0 110.398 -179.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.61 -61.15 1.86 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.363 -0.836 . . . . 0.0 109.919 178.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.679 ' HG3' ' HA ' ' A' ' 72' ' ' PRO . 16.6 tm0? -65.84 -42.9 89.93 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 120.871 -1.143 . . . . 0.0 112.397 -179.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.616 ' HB3' ' O ' ' A' ' 23' ' ' GLN . . . -73.07 -17.36 61.42 Favored 'General case' 0 N--CA 1.482 1.138 0 O-C-N 120.69 -1.257 . . . . 0.0 109.885 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.774 ' HB2' ' O ' ' A' ' 24' ' ' PRO . . . -61.07 -53.05 61.94 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.237 -0.914 . . . . 0.0 111.592 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.905 ' N ' HD13 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -63.48 -56.84 12.91 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 -179.082 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.448 ' NZ ' ' O ' ' A' ' 75' ' ' MET . 0.1 OUTLIER -48.17 -44.13 32.25 Favored 'General case' 0 N--CA 1.506 2.347 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.93 179.121 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.537 ' C ' ' HB2' ' A' ' 36' ' ' SER . . . -54.83 -43.1 72.67 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.455 -0.778 . . . . 0.0 111.965 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 1.147 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -72.86 -28.25 62.4 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.701 -1.25 . . . . 0.0 110.807 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.575 ' HB2' ' HG3' ' A' ' 82' ' ' PRO . 2.0 t30 -39.59 -46.95 1.86 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -95.11 -74.59 0.54 Allowed 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.154 -1.018 . . . . 0.0 112.91 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.47 ' O ' ' CD2' ' A' ' 16' ' ' HIS . . . -113.81 -4.96 22.59 Favored Glycine 0 N--CA 1.502 3.039 0 N-CA-C 116.798 1.479 . . . . 0.0 116.798 -175.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.701 ' CB ' ' HA ' ' A' ' 32' ' ' ALA . 0.4 OUTLIER -82.44 -7.13 59.64 Favored 'General case' 0 N--CA 1.506 2.363 0 CA-C-N 122.166 2.983 . . . . 0.0 110.157 -177.353 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.512 ' HA3' ' O ' ' A' ' 60' ' ' ALA . . . -141.44 111.74 0.72 Allowed Glycine 0 C--N 1.289 -2.028 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.509 ' O ' ' HB3' ' A' ' 39' ' ' LYS . 5.2 m -69.05 -20.94 64.12 Favored 'General case' 0 C--N 1.312 -1.054 0 O-C-N 120.672 -1.487 . . . . 0.0 109.4 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.693 ' HA ' ' HG3' ' A' ' 42' ' ' PRO . 5.6 ttpt 67.64 -52.04 0.51 Allowed 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 38' ' ' THR . . . -70.65 -27.95 64.44 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 174.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.722 ' HB3' ' HA ' ' A' ' 11' ' ' GLU 0.274 0.2 OUTLIER -142.41 71.19 21.57 Favored Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.468 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 1.013 ' HB2' ' CD1' ' A' ' 61' ' ' TRP . 72.2 Cg_endo -112.89 169.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 121.75 1.633 . . . . 0.0 112.208 -178.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.53 ' HB2' ' C ' ' A' ' 12' ' ' ASP . 0.7 OUTLIER -167.82 -167.47 0.86 Allowed 'General case' 0 N--CA 1.517 2.891 0 C-N-CA 117.692 -1.603 . . . . 0.0 113.949 177.091 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.809 HG22 ' HD3' ' A' ' 59' ' ' LYS . 0.2 OUTLIER -84.09 123.58 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -178.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.83 HD13 ' HB3' ' A' ' 14' ' ' ASN . 0.7 OUTLIER -108.1 117.52 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.846 -1.159 . . . . 0.0 113.648 -177.856 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.505 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 0.3 OUTLIER -87.73 88.14 7.57 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 103.492 -2.781 . . . . 0.0 103.492 173.249 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.661 ' HB2' ' CD2' ' A' ' 56' ' ' HIS . 0.1 OUTLIER -79.14 94.43 5.37 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -177.62 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.532 ' HB3' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -135.9 178.45 7.04 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.589 -0.694 . . . . 0.0 111.431 -178.666 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -157.22 117.56 3.51 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 178.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -75.14 172.58 12.13 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.207 -177.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.2 -56.18 3.22 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 107.883 -2.087 . . . . 0.0 107.883 -178.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.9 p -111.52 -177.12 3.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.865 -0.785 . . . . 0.0 109.17 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.617 ' O ' ' N ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -89.71 97.04 10.97 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 122.506 1.146 . . . . 0.0 108.581 179.109 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.523 ' HG2' ' CZ ' ' A' ' 6' ' ' PHE . 5.7 mtmt -146.63 109.55 4.65 Favored 'General case' 0 C--N 1.28 -2.453 0 O-C-N 120.912 -1.118 . . . . 0.0 109.604 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.532 HG22 ' HB3' ' A' ' 48' ' ' ARG . 2.8 t -154.05 149.75 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.698 0.761 . . . . 0.0 110.522 -178.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.661 ' CD2' ' HB2' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -160.81 122.67 3.07 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 179.276 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.642 HG12 ' HB2' ' A' ' 87' ' ' GLU . 12.9 t -113.32 100.55 10.92 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 C-N-CA 117.722 -1.591 . . . . 0.0 108.188 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.743 ' HA ' ' O ' ' A' ' 85' ' ' LYS . 0.3 OUTLIER -144.72 178.79 7.74 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 179.601 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.829 ' HB3' ' CZ2' ' A' ' 61' ' ' TRP . 44.2 mttt -131.62 134.56 46.13 Favored 'General case' 0 C--N 1.274 -2.715 0 N-CA-C 104.245 -2.502 . . . . 0.0 104.245 176.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 1.147 ' HB1' ' HB2' ' A' ' 32' ' ' ALA . . . -123.54 109.72 14.15 Favored 'General case' 0 N--CA 1.495 1.825 0 C-N-CA 117.593 -1.643 . . . . 0.0 112.599 -175.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 1.013 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 5.3 m0 -124.91 -163.07 1.15 Allowed 'General case' 0 N--CA 1.508 2.442 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.426 -178.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.646 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -124.51 88.55 2.92 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.042 -1.036 . . . . 0.0 111.015 179.541 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.921 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 4.4 mt-10 -167.15 171.64 10.71 Favored 'General case' 0 N--CA 1.507 2.397 0 CA-C-O 121.745 0.783 . . . . 0.0 110.449 177.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.677 ' CG1' ' HA ' ' A' ' 80' ' ' SER . 2.3 mt -72.47 98.37 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.519 2.989 0 O-C-N 119.594 -1.942 . . . . 0.0 115.478 -176.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.863 HG13 ' CD1' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -94.27 -164.54 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.296 -1.503 . . . . 0.0 109.288 176.101 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.672 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 14.2 t70 -120.13 136.93 54.43 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 178.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.797 ' HA ' ' HB2' ' A' ' 77' ' ' GLU 0.251 . . -68.72 100.6 0.26 Allowed Pre-proline 0 N--CA 1.503 2.177 0 CA-C-O 117.799 -1.096 . . . . 0.0 111.615 -177.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.672 ' HD3' ' O ' ' A' ' 66' ' ' ASP . 49.3 Cg_endo -88.52 -153.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.319 -1.003 0 O-C-N 124.086 1.572 . . . . 0.0 111.241 -179.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.04 61.7 0.08 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.128 -0.983 . . . . 0.0 110.102 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.743 ' CG ' HD21 ' A' ' 29' ' ' LEU . 0.7 OUTLIER -99.63 -14.88 18.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.622 -0.673 . . . . 0.0 110.989 -179.583 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.716 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER 49.72 52.6 12.91 Favored Pre-proline 0 N--CA 1.488 1.429 0 O-C-N 121.892 -0.505 . . . . 0.0 109.992 -178.096 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.716 ' HD3' ' N ' ' A' ' 71' ' ' ARG . 53.2 Cg_endo -98.74 108.01 0.07 OUTLIER 'Trans proline' 0 C--N 1.317 -1.124 0 C-N-CA 122.05 1.834 . . . . 0.0 110.831 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.81 -31.32 23.93 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.966 -1.084 . . . . 0.0 111.447 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.453 ' CD1' ' N ' ' A' ' 74' ' ' TRP . 41.8 m95 -83.65 -32.63 25.55 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.688 -0.633 . . . . 0.0 110.907 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.448 ' O ' ' NZ ' ' A' ' 30' ' ' LYS . 2.3 mtm -167.98 106.76 0.56 Allowed Pre-proline 0 N--CA 1.499 2.003 0 O-C-N 121.467 -0.771 . . . . 0.0 111.08 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.765 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 51.0 Cg_endo -79.59 -179.93 5.78 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.696 1.366 . . . . 0.0 110.929 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 1.002 ' HG3' HG21 ' A' ' 84' ' ' VAL . 14.0 mm-40 -96.46 18.87 13.1 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 117.193 -1.803 . . . . 0.0 111.634 -178.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.667 ' C ' HG22 ' A' ' 79' ' ' ILE . 5.8 tttm -90.39 76.27 6.72 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 177.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.667 HG22 ' C ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -179.98 171.48 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 C-N-CA 118.095 -1.442 . . . . 0.0 112.326 -176.294 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.677 ' HA ' ' CG1' ' A' ' 64' ' ' ILE . 29.4 t -71.31 110.37 5.9 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 175.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.854 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . 3.5 mttm -164.83 -154.49 0.0 OUTLIER Pre-proline 0 C--O 1.191 -2.003 0 C-N-CA 119.093 -1.043 . . . . 0.0 108.761 -174.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.854 ' HD2' ' HB3' ' A' ' 81' ' ' LYS . 50.6 Cg_endo -81.94 130.66 6.68 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 N-CA-C 109.336 -1.063 . . . . 0.0 109.336 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.921 ' CZ ' ' HB3' ' A' ' 63' ' ' GLU . 1.5 m-30 -62.13 152.37 33.16 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 118.233 -1.387 . . . . 0.0 108.568 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 1.002 HG21 ' HG3' ' A' ' 77' ' ' GLU . 15.5 m -147.21 96.81 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.241 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.647 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.743 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -74.57 129.26 37.42 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 104.751 -2.314 . . . . 0.0 104.751 177.117 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.503 ' CB ' ' CZ ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -102.67 88.19 3.16 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -173.694 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.642 ' HB2' HG12 ' A' ' 57' ' ' VAL . 4.3 mp0 -91.81 161.56 14.81 Favored 'General case' 0 C--N 1.283 -2.311 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 174.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.464 ' HD2' ' HA ' ' A' ' 88' ' ' ARG . 0.9 OUTLIER -53.0 151.7 4.54 Favored 'General case' 0 N--CA 1.51 2.535 0 O-C-N 120.521 -1.362 . . . . 0.0 113.933 -175.241 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.628 HG12 ' HA ' ' A' ' 56' ' ' HIS . 74.7 mt -130.36 158.3 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.039 -178.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -145.9 148.16 32.53 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.583 -0.698 . . . . 0.0 109.964 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.422 ' HE3' ' HB3' ' A' ' 91' ' ' LYS . 0.2 OUTLIER -149.08 145.85 27.44 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.689 -1.257 . . . . 0.0 112.243 -178.866 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.617 ' N ' ' O ' ' A' ' 53' ' ' LYS . 0.3 OUTLIER -72.44 -178.08 2.44 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.673 -0.642 . . . . 0.0 109.571 179.243 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 118.325 -0.845 . . . . 0.0 109.807 179.349 . . . . . . . . 0 0 . 1 stop_ save_